Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,regulation of cell cycle process (GO:0010564),0.8304110258453362,3.1467642101370616,0.0,0.0,0.0,25/64,5.47%,KIF11;AURKB;MKI67;PRC1;FBXO5;PLK1;RACGAP1;CALM2;KIF20B;BUB1;PLK4;AURKA;ECT2;KIF20A;SPAG5;DBF4;NEK2;CDC25C;BORA;MAD1L1;NUMA1;PKMYT1;KNSTRN;BIRC6;RCC1
gsea,mitotic cell cycle phase transition (GO:0044772),0.7474884199419166,3.1293807038080117,0.0,0.0,0.0,62/139,11.01%,CCNA2;CDK1;TUBB4B;UBE2C;PLK1;TACC3;CCNB1;CDC25B;CCNF;UBE2S;MASTL;PLK4;AURKA;MELK;CKAP5;FOXM1;CDKN2D;CDKN2C;DBF4;NEK2;CDC25C;TUBG1;BORA;ODF2;CCNG2;NDE1;TUBA1A;PKMYT1;HAUS5;PCNT;CNTRL;CDK5RAP2;HAUS3;CEP57;PIM2;HAUS4;POLE;CEP72;RCC1;CEP192;TUBA4A;CCNE1;NEDD1;CEP70;CDC23;HAUS6;CDC27;WEE1;CCP110;CENPJ;CDC25A;CHEK2;CEP152;CLASP2;SKP2;CEP135;CDC7;HAUS8;CCNE2;HAUS1;CLASP1;CDKN3
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.7840417048556338,3.105411300321097,0.0,0.0,0.0,44/88,11.00%,CCNA2;CDK1;TUBB4B;PLK1;CCNB1;CDC25B;MASTL;PLK4;AURKA;MELK;CKAP5;FOXM1;NEK2;CDC25C;TUBG1;BORA;ODF2;NDE1;TUBA1A;PKMYT1;HAUS5;PCNT;CNTRL;CDK5RAP2;HAUS3;CEP57;HAUS4;CEP72;CEP192;TUBA4A;NEDD1;CEP70;HAUS6;WEE1;CCP110;CENPJ;CDC25A;CHEK2;CEP152;SKP2;CEP135;HAUS8;HAUS1;CLASP1
gsea,cell cycle G2/M phase transition (GO:0044839),0.7829924939703882,3.0865537919817108,0.0,0.0,0.0,44/88,11.00%,CCNA2;CDK1;TUBB4B;PLK1;CCNB1;CDC25B;MASTL;PLK4;AURKA;MELK;CKAP5;FOXM1;NEK2;CDC25C;TUBG1;BORA;ODF2;NDE1;TUBA1A;PKMYT1;HAUS5;PCNT;CNTRL;CDK5RAP2;HAUS3;CEP57;HAUS4;CEP72;CEP192;TUBA4A;NEDD1;CEP70;HAUS6;WEE1;CCP110;CENPJ;CDC25A;CHEK2;CEP152;SKP2;CEP135;HAUS8;HAUS1;CLASP1
gsea,mitotic spindle organization (GO:0007052),0.8558407163251034,3.069064605617092,0.0,0.0,0.0,78/118,9.16%,KIF11;AURKB;PRC1;CENPF;INCENP;KNL1;CENPE;PLK1;CDCA8;TPX2;BIRC5;SPC25;NDC80;KIF23;KIFC1;NUF2;SKA1;CCNB1;SPC24;BUB1;BUB3;KIF2C;DLGAP5;BUB1B;AURKA;CKAP5;MAD2L1;TTK;SGO1;CENPL;CDC20;STIL;SPDL1;SKA2;KIF18A;CENPP;KNTC1;ZWILCH;TUBG1;CENPI;CENPN;SMC1A;CENPM;GPSM2;RANGAP1;DSN1;STMN1;MIS12;CENPH;ERCC6L;MAD1L1;NDE1;NUP133;PMF1;PCNT;STAG2;NSL1;NUP107;CENPU;NUP37;CENPT;NUP160;RCC1;CEP192;WDR62;CENPK;CCDC61;AAAS;ZW10;STAG1;SUN2;NUP85;CENPO;CENPA;SMC3;XPO1;CHEK2;ZWINT
gsea,ciliary basal body-plasma membrane docking (GO:0097711),0.7713130657884255,3.050646192444022,0.0,0.0,0.0,34/67,11.00%,CDK1;TUBB4B;PLK1;PLK4;CKAP5;NEK2;TUBG1;ODF2;NDE1;TUBA1A;HAUS5;PCNT;CNTRL;CDK5RAP2;HAUS3;CEP57;HAUS4;CEP72;SCLT1;KIF24;CEP192;TUBA4A;NEDD1;CEP70;HAUS6;CEP83;CCP110;CENPJ;CEP89;CEP152;CEP135;HAUS8;HAUS1;CLASP1
gsea,positive regulation of cell cycle process (GO:0090068),0.8286873257165381,3.016563980251668,0.0,0.0,0.0,28/62,5.93%,NUSAP1;AURKB;NDC80;RACGAP1;KIF23;CCNB1;CDC25B;KIF20B;PLK4;AURKA;CIT;ECT2;KIF14;E2F8;RAD21;SPAG5;MAD2L1;GEN1;DBF4;E2F7;RHNO1;GPSM2;NUMA1;CEP295;FEN1;ATRX;RGCC;PHIP
gsea,regulation of cytokinesis (GO:0032465),0.8378983000767876,3.01471761871797,0.0,0.0,0.0,16/45,2.09%,AURKB;PRC1;PLK1;RACGAP1;KIF23;CALM2;CDC25B;KIF20B;PLK4;AURKA;CIT;ECT2;KIF14;E2F8;KIF20A;E2F7
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.8703450349091937,3.0060901244009375,0.0,0.0,0.0,62/100,5.76%,NUSAP1;KIF11;AURKB;CENPF;INCENP;KNL1;CENPE;PLK1;CDCA8;BIRC5;SPC25;NDC80;TACC3;NUF2;SKA1;CCNB1;SPC24;BUB1;BUB3;KIF2C;DLGAP5;BUB1B;AURKA;CKAP5;ESPL1;MAD2L1;TTK;SGO1;CENPL;CDC20;STIL;SPDL1;SKA2;KIF18A;CENPP;KNTC1;ZWILCH;TUBG1;CENPI;CENPN;CENPM;GPSM2;RANGAP1;DSN1;STMN1;MIS12;CENPH;ERCC6L;MAD1L1;NDE1;NUP133;PMF1;PCNT;NSL1;NUP107;CENPU;NUP37;CENPT;NUP160;RCC1;WDR62;CENPK
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.8121552063351022,2.999618012404145,0.0,0.0,0.0,37/63,11.00%,CDK1;CENPF;TUBB4B;PLK1;TPX2;HMMR;PLK4;AURKA;CKAP5;KIF14;GTSE1;NEK2;TUBG1;ODF2;NDE1;TUBA1A;HAUS5;PCNT;CNTRL;ATAD5;CDK5RAP2;HAUS3;CEP57;HAUS4;CEP72;CEP192;TUBA4A;NEDD1;CEP70;HAUS6;CCP110;CENPJ;CEP152;CEP135;HAUS8;HAUS1;CLASP1
gsea,cilium assembly (GO:0060271),0.6363264121151937,2.937260211049639,0.0,0.0,0.0,64/145,20.02%,CDK1;TUBB4B;PLK1;PLK4;CKAP5;NEK2;TUBG1;ODF2;NDE1;TUBA1A;HAUS5;PCNT;ASAP1;CNTRL;CDK5RAP2;HYLS1;HAUS3;CEP57;HAUS4;CEP72;SCLT1;KIF24;CEP192;TUBA4A;EHD3;NEDD1;CEP70;IFT80;EXOC4;HAUS6;CEP83;CCP110;CENPJ;WDR90;CEP89;CEP152;CEP135;POC1B;HAUS8;HAUS1;CLASP1;SSX2IP;CCDC28B;ARL13B;NOTCH1;HAUS7;C2CD3;PDE6D;HDAC6;DCTN1;AHI1;EXOC2;CEP76;IFT74;PCM1;KIFAP3;ALMS1;KIF3B;SPATA6;GBF1;IFT81;SFI1;NEK1;IFT140
gsea,mitotic nuclear division (GO:0140014),0.8382938026447746,2.887266048338447,0.0,0.0,0.0,35/54,9.99%,NUSAP1;KIF11;SMC4;UBE2C;PLK1;CDCA8;TPX2;NDC80;KIFC1;UBE2S;KIF18B;ESPL1;SPAG5;NCAPG2;SGO1;KIF18A;TUBG1;SMC1A;DSN1;MIS12;NDE1;STAG2;NSL1;KNSTRN;CEP192;CENPK;CCDC61;AAAS;ZW10;STAG1;SMC3;CHEK2;ZWINT;NUP62;CLASP2
gsea,mitotic sister chromatid segregation (GO:0000070),0.850829131719434,2.8767439795037326,0.0,0.0,0.0,41/70,7.01%,NUSAP1;PRC1;CDK1;SMC4;SMC2;CENPE;PLK1;CDCA8;CDCA5;KIF22;NDC80;NCAPG;KIF23;KIFC1;NCAPH;CCNB1;KIF2C;DLGAP5;CEP55;KIF18B;KIF14;NCAPD2;RAD21;ESPL1;SPAG5;NCAPG2;SGO1;NCAPD3;SPDL1;KIF18A;TUBG1;HASPIN;SMC1A;DSN1;MIS12;NSL1;NCAPH2;KNSTRN;CENPK;ZW10;CDC23
gsea,protein phosphorylation (GO:0006468),0.588065682610203,2.8729166399493637,0.0,0.0,0.0,79/229,20.29%,AURKB;CCNA2;CDK1;INCENP;PLK1;BIRC5;CDC25B;MASTL;PLK4;AURKA;MELK;CIT;TTK;CLSPN;NEK2;HASPIN;PIM1;MAP4K4;TAF1;PIM2;PRKCA;CDK19;BIRC6;BRD2;CAMK2D;CCNE1;JAK2;ROCK1;WNK1;STK10;PASK;PDPK1;MAST2;BAZ1B;NEK7;ILF3;PPP3CB;CHEK2;CREB1;BCKDK;DYRK1A;ROCK2;PIK3CD;ATR;CDC7;TBCK;RPS6KA5;VRK1;GSK3B;MAP3K3;MAP3K5;HIPK1;DCLK1;MAP3K1;GRK2;SIK2;PRKD2;PRDX4;VRK3;AAK1;OXSR1;TNIK;TAOK2;PINK1;TGFBR3;SLK;PDK2;PRKCB;TAOK1;ERG;SNRK;TRIB2;FLT1;MATK;ABL1;NEK1;DYRK2;ACVRL1;USP15
gsea,DNA repair (GO:0006281),0.6372781283288891,2.856680675619302,0.0,0.0,0.0,99/218,17.62%,CDK1;UBB;KPNA2;CDCA5;NEIL3;RAD21;CDKN2D;RAD51AP1;RAD51;TRIP13;TICRR;BRCA1;TRAIP;EME1;BRIP1;FANCD2;SMC1A;RHNO1;POLQ;BLM;UBE2T;RAD18;NSD2;BARD1;RAD54L;BTG2;RFWD3;NUCKS1;POLA1;USP1;RFC4;FEN1;RBBP8;EXO1;RFC5;POLE;POLH;NSMCE4A;BRCA2;TDP2;ZRANB3;NSMCE1;XRCC1;FANCI;FAM111A;TDP1;FANCB;PARP2;DOT1L;FAAP24;BAZ1B;PIAS4;FANCM;FANCG;CHEK2;APLF;RMI2;RAD50;RECQL4;ATR;WDR48;FANCA;ASF1A;PMS1;TOPBP1;FANCF;KMT5C;XRCC2;HUWE1;TDG;HERC2;PDS5B;MBD4;MDC1;TRIM28;PDS5A;WRN;MMS19;RNF168;SETX;PWWP3A;RPA3;SETD2;RAD9A;TRRAP;MGME1;TENT4A;MGMT;PARP3;USP47;WDHD1;RNASEH2A;RPA2;FANCC;POLD3;FTO;USP45;HINFP;MTA1
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.883739327616463,2.8249143965968964,0.0,0.0,0.0,14/31,3.13%,NUSAP1;AURKB;INCENP;PLK1;RACGAP1;KIF23;CEP55;CIT;ECT2;ANLN;KIF20A;ESPL1;CKAP2;STMN1
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.6984998780207066,2.814451673944893,0.0,0.0,0.0,55/129,11.00%,CDK1;CENPF;UBB;TUBB4B;UBE2C;FBXO5;CENPE;PLK1;TPX2;CCNB1;UBE2S;HMMR;BUB3;PLK4;BUB1B;AURKA;CKAP5;ANLN;KIF14;FZR1;MAD2L1;CDC20;NEK2;KNTC1;TUBG1;ZFP36L1;ODF2;NDE1;TUBA1A;HAUS5;PCNT;CNTRL;ZFP36L2;CDK5RAP2;HAUS3;CEP57;HAUS4;RGCC;CEP72;CEP192;TUBA4A;ZW10;NEDD1;CEP70;CDC23;HAUS6;CDC27;CCP110;CENPJ;CDC6;CEP152;CEP135;HAUS8;HAUS1;CLASP1
gsea,spindle assembly (GO:0051225),0.7540075488207546,2.8115246835868293,0.0,0.0,0.0,23/46,11.00%,KIF11;TPX2;KIFC1;NEK2;SMC1A;NUMA1;HAUS5;STAG2;HAUS3;HAUS4;RCC1;CEP192;CCDC61;AAAS;STAG1;HAUS6;SMC3;NEK7;CHEK2;CLASP2;HAUS8;HAUS1;CLASP1
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.7753579855216024,2.7998938656504935,0.0,0.0,0.0,8/41,2.13%,KIF11;CENPE;KIF22;KIF15;RACGAP1;KIF23;KIF2C;KIF18A
gsea,regulation of mitotic nuclear division (GO:0007088),0.8576533084524662,2.7713627701648726,0.0,0.0,0.0,15/31,5.93%,NUSAP1;MKI67;FBXO5;CCNB1;KIF20B;AURKA;NEK2;CDC25C;BORA;PKMYT1;CDK5RAP2;DUSP1;RGCC;RCC1;PHIP
gsea,double-strand break repair (GO:0006302),0.6618252989862404,2.7634150267110305,0.0,0.0,0.0,50/116,14.80%,KPNA2;CDCA5;RAD21;AUNIP;RAD51AP1;RAD51;GEN1;TRIP13;BRCA1;EME1;BRIP1;POLQ;BLM;HMGB2;NSD2;BARD1;RAD54B;RFWD3;NUCKS1;POLA1;FEN1;MCM8;HMGB1;RBBP8;SMC6;BRCA2;TDP2;NSMCE1;XRCC1;TDP1;PARP2;PALB2;SPIDR;BAZ1B;SAMHD1;PIAS4;CHEK2;APLF;RAD50;RECQL4;XRCC2;PAXIP1;HERC2;MDC1;REV3L;WRN;SMC5;RNF168;SETX;RPA3
gsea,mitotic spindle assembly (GO:0090307),0.8209401815738554,2.7305829541291113,0.0,0.0,0.0,17/31,11.00%,KIF11;AURKB;PRC1;TPX2;RACGAP1;KIF23;KIFC1;SMC1A;STAG2;CEP192;CCDC61;AAAS;STAG1;SMC3;CHEK2;CLASP2;CLASP1
gsea,mitotic cytokinesis (GO:0000281),0.8682914198141187,2.729173045772634,0.0,0.0,0.0,13/29,3.13%,NUSAP1;INCENP;PLK1;RACGAP1;KIF23;CEP55;CIT;ECT2;ANLN;KIF20A;ESPL1;CKAP2;STMN1
gsea,regulation of cell division (GO:0051302),0.7409184785213015,2.714733407313924,0.0,0.0,0.0,15/38,11.55%,AURKB;PRC1;PLK1;CALM2;PLK4;AURKA;KIF18B;KIF20A;BLM;BIRC6;MLLT3;CCP110;TXNIP;CSPP1;ORC6
gsea,negative regulation of cell cycle process (GO:0010948),0.7964463322788657,2.7022236898623775,0.0,0.0,0.0,14/41,4.96%,AURKB;FBXO5;RRM2;E2F8;ESPL1;EZH2;RAD51;E2F7;NEK2;BRCA1;SUZ12;CBX5;RBBP4;RBBP8
gsea,regulation of cell cycle (GO:0051726),0.5834319845582264,2.6897976720592465,0.0,0.0,0.0,67/159,21.52%,CENPF;FBXO5;PLK1;BIRC5;PCLAF;CKS2;CCNB1;KIF20B;MASTL;DLGAP5;FOXM1;CDKN2D;CDKN2C;PRR11;BRCA1;DDIAS;NR4A1;GMNN;MYBL2;BARD1;JUNB;CKS1B;FIGNL1;LIN9;LIN54;BIRC3;GADD45B;RBBP4;PIM2;DUSP1;IRF1;RGCC;PDCD4;PPP1R15A;JUN;CDC25A;NEK7;SKP2;CDKN3;MADD;HCFC1;RNF40;MLF1;HTRA2;EIF4G2;NOTCH1;TAF6;GATA3;DTL;EP300;FBXL8;JUND;KAT2B;PLAGL1;ARNTL;GBF1;ABL1;PTPRK;STAT3;TSC1;PML;E4F1;RB1;BAP1;RPRD1B;SIRT1;CCPG1
gsea,cellular response to DNA damage stimulus (GO:0006974),0.5743726117530276,2.677857000306129,0.0,0.0,0.0,111/245,20.40%,TOP2A;CDK1;PCLAF;MASTL;RAD51AP1;RAD51;TICRR;BRCA1;TRAIP;SMC1A;POLQ;BLM;UBE2T;RAD18;SUV39H1;BARD1;RAD54L;BTG2;MCM10;RFWD3;CBX5;POLA1;RFC4;FEN1;MCM8;TAF1;RBBP8;EXO1;BCL6;RFC5;SMC6;POLH;FOXP1;NSMCE4A;ZRANB3;FAM111A;BCL2;TDP1;PPP1R15A;PARP2;RTEL1;SPIDR;UBR5;DOT1L;BAZ1B;SAMHD1;FANCG;CHEK2;APLF;RMI2;RAD50;RECQL4;MRNIP;ATR;WDR48;FMR1;FANCA;ASF1A;ETAA1;TAF9;TOPBP1;FANCF;KMT5C;XRCC2;ZC3H12A;HTRA2;BCL3;HERC2;ATF2;PDS5B;MBD4;TRIM28;PDS5A;WRN;SMC5;RBBP6;MMS19;RNF168;SETX;PWWP3A;DTL;MACROD1;RAD9A;IRF7;TRRAP;DDIT3;PIDD1;TAOK2;MTREX;MGMT;PARP3;BCL2L11;NFATC2;DDX11;USP47;WDHD1;FANCC;FBXO45;USP45;HINFP;CBX1;WDR76;TAOK1;FOXO1;HELB;BCL2L1;ABL1;RAD51C;DYRK2;MUTYH;MUS81
gsea,phosphorylation (GO:0016310),0.5476992727283025,2.6768409391210897,0.0,0.0,0.0,68/196,20.42%,AURKB;CDK1;PLK1;BIRC5;CDC25B;PLK4;AURKA;MELK;NEK2;HASPIN;PIM1;MAP4K4;TAF1;PIM2;PRKCA;CDK19;BIRC6;BRD2;CAMK2D;CCNE1;JAK2;ROCK1;WNK1;STK10;PASK;PDPK1;MAST2;NEK7;ILF3;PPP3CB;CHEK2;CREB1;BCKDK;DYRK1A;ROCK2;PIK3CD;TBCK;RPS6KA5;VRK1;DGKA;GSK3B;MAP3K5;HIPK1;DCLK1;MAP3K1;GRK2;SIK2;PRKD2;AAK1;OXSR1;TNIK;TAOK2;PINK1;CERK;PIK3CA;PDK2;PRKCB;TAOK1;ERG;SNRK;TRIB2;MATK;ABL1;STAT3;NEK1;DYRK2;ACVRL1;PI4KA
gsea,modification-dependent protein catabolic process (GO:0019941),0.6177184363242284,2.676470865866121,0.0,0.0,0.0,30/99,17.72%,AURKB;UBB;UBE2C;PLK1;UBE2S;BUB3;BUB1B;AURKA;FZR1;MAD2L1;CDC20;TAF1;BIRC6;RNF19A;UHRF1;STUB1;CDC23;CDC27;RNF5;UBR4;RNF40;ANAPC1;RBBP6;RNF168;ANAPC7;DTL;BTRC;PINK1;FBXO45;FBXO11
gsea,recombinational repair (GO:0000725),0.6981330503004927,2.667934750514068,0.0,0.0,0.0,28/56,14.80%,AUNIP;RAD51AP1;RAD51;GEN1;BRCA1;RHNO1;POLQ;BLM;RAD54B;RFWD3;NUCKS1;FEN1;MCM8;RBBP8;SMC6;BRCA2;NSMCE1;XRCC1;PALB2;SPIDR;SAMHD1;RAD50;RECQL4;XRCC2;REV3L;WRN;SMC5;RPA3
gsea,sister chromatid segregation (GO:0000819),0.8905477840615899,2.6517234376481595,0.0,0.0,0.0,21/29,6.61%,TOP2A;NUSAP1;SMC4;PLK1;CDCA8;NDC80;KIFC1;KIF18B;ESPL1;SPAG5;NCAPG2;SGO1;KIF18A;TUBG1;SMC1A;DSN1;MIS12;NSL1;KNSTRN;CENPK;ZW10
gsea,positive regulation of protein kinase activity (GO:0045860),0.6272551081437868,2.629111192594477,0.0,0.0,0.0,23/74,18.38%,INCENP;CENPE;TPX2;CALM2;ECT2;KIF14;CLSPN;EZH2;CCR7;BORA;MAP4K4;CCN1;MRNIP;MMD;NAB2;ETAA1;LCP2;DDX3X;TNIK;TAOK2;PRNP;TAOK1;PIH1D1
gsea,peptidyl-serine modification (GO:0018209),0.5994875008944925,2.628604363743908,0.0,0.0,0.0,25/89,15.35%,CDK1;PLK1;MASTL;AURKA;TTK;CLSPN;TAF1;PRKCA;CAMK2D;ROCK1;WNK1;PARP2;PDPK1;MAST2;DYRK1A;ROCK2;ATR;CDC7;RPS6KA5;VRK1;GSK3B;HIPK1;GRK2;PRKD2;VRK3
gsea,peptidyl-serine phosphorylation (GO:0018105),0.6150658674553805,2.6260183635237047,0.0,0.0,0.0,24/81,15.35%,CDK1;PLK1;MASTL;AURKA;TTK;CLSPN;TAF1;PRKCA;CAMK2D;ROCK1;WNK1;PDPK1;MAST2;DYRK1A;ROCK2;ATR;CDC7;RPS6KA5;VRK1;GSK3B;HIPK1;GRK2;PRKD2;VRK3
gsea,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7508149769217296,2.6242125886071372,0.0,0.0,0.0,13/40,7.90%,CDK1;UBE2C;FBXO5;CDCA5;CCNB1;CDC25B;DLGAP5;ESPL1;CDC25C;RGCC;CDC23;CDC27;CDC25A
gsea,negative regulation of mitotic cell cycle (GO:0045930),0.8078561015612798,2.6139833053080603,0.0,0.0,0.0,12/24,9.16%,BUB1;BUB1B;MAD2L1;ZWILCH;ZFP36L1;BTG2;ZFP36L2;BCL6;RGCC;ZW10;WEE1;ZWINT
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.805674331966351,-2.6055005680612,0.0,0.0,0.0,21/38,8.99%,PDIA3;PSME2;CALR;PSMA4;PSMA3;FCER1G;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;VAMP8;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;TAP2
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.7237075271813281,2.5965165842483713,0.0,0.0,0.0,8/41,2.13%,KIF11;CENPE;KIF22;KIF15;RACGAP1;KIF23;KIF2C;KIF18A
gsea,regulation of exit from mitosis (GO:0007096),0.8477309982477305,2.589734185976204,0.0,0.0,0.0,15/25,7.48%,UBB;UBE2C;CDCA5;UBE2S;BUB3;BUB1B;ANLN;MAD2L1;CDC20;NEK2;KNTC1;RGCC;ZW10;CDC23;CDC27
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.7245818367731606,2.5846643437944046,0.0,0.0,0.0,8/40,2.13%,KIF11;CENPE;KIF22;KIF15;RACGAP1;KIF23;KIF2C;KIF18A
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.7245818367731606,2.5846643437944046,0.0,0.0,0.0,8/40,2.13%,KIF11;CENPE;KIF22;KIF15;RACGAP1;KIF23;KIF2C;KIF18A
gsea,ribosome biogenesis (GO:0042254),-0.7088882033561277,-2.577943384492854,0.0,0.0,0.0,86/134,17.93%,RPS17;RPS2;RPS6;EBNA1BP2;RPL31;RAN;RPL15;RPL7A;RPL10;RPL5;NOP16;RRS1;NOP58;NOB1;RPS25;DKC1;WDR75;RPL10A;NOC2L;ABCE1;RPL14;RPL23A;NIP7;RRP7A;FCF1;WDR43;DDX10;LTV1;WDR3;NOLC1;RPS15;RRP9;MPHOSPH10;RCL1;RPL4;RPF2;EIF6;PES1;RPL3;MRTO4;NOP56;IMP4;NPM1;EIF2A;SDAD1;FBL;DDX54;RPL41;NOL8;RRP1B;RPLP0;EXOSC1;WDR55;DCAF13;BYSL;RIOK2;HEATR3;NOM1;RPL8;KRR1;NOP14;RPL7;UTP11;WDR74;MPHOSPH6;BOP1;RPF1;NOL9;WDR12;WDR36;LSG1;NOL6;SNU13;HEATR1;ESF1;SURF6;UTP18;UTP4;NAF1;POP5;EMG1;DHX29;GTF3A;UTP6;RRP1;PWP2
gsea,ribosomal large subunit biogenesis (GO:0042273),-0.8390665564410494,-2.5743530541696953,0.0,0.0,0.0,37/43,14.24%,EBNA1BP2;RSL1D1;RPL7A;RRP15;PPAN;RPL10;NHP2;RPL5;NOP16;RRS1;RSL24D1;MAK16;RPL10A;NOC2L;RPL14;RPL23A;NIP7;MRPL20;NOP2;RPF2;EIF6;PES1;BRIX1;RPL3;MRTO4;NPM1;SDAD1;RPLP0;HEATR3;RPL7;NLE1;WDR74;BOP1;RPF1;WDR12;SNU13;SURF6
gsea,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8434337335209575,2.569157740296832,0.0,0.0,0.0,12/22,9.37%,UBE2C;FBXO5;CENPE;PLK1;CCNB1;DLGAP5;ESPL1;CDK5RAP2;DUSP1;CDC23;CDC27;CDC6
gsea,mitotic metaphase plate congression (GO:0007080),0.8477482884906395,2.567913188805175,0.0,0.0,0.0,15/30,3.35%,CENPE;CDCA8;CDCA5;KIF22;NDC80;KIFC1;NUF2;CCNB1;KIF2C;CEP55;KIF14;SPDL1;KIF18A;MIS12;MAD1L1
gsea,regulation of mitotic cell cycle (GO:0007346),0.6470826516511116,2.567705663899156,0.0,0.0,0.0,27/100,7.48%,MKI67;CDK1;UBE2C;FBXO5;PLK1;CKS2;CCNB1;CDC25B;KIF20B;UBE2S;BUB3;DLGAP5;BUB1B;FZR1;MAD2L1;CDC20;NEK2;CDC25C;BORA;CKS1B;BTG2;PKMYT1;PIM2;PRKCA;RCC1;CDC23;CDC27
gsea,establishment of mitotic spindle localization (GO:0040001),0.8581094663620019,2.566333180219233,0.0,0.0,0.0,16/22,11.00%,NUSAP1;PLK1;NDC80;ESPL1;SAPCD2;MAD2L1;SPDL1;ITGB1;GPSM2;NDE1;NUMA1;CDK5RAP2;ZW10;CENPA;CLASP2;CLASP1
gsea,chromosome condensation (GO:0030261),0.9070638959311373,2.5640140337375796,0.0,0.0,0.0,14/26,1.99%,TOP2A;NUSAP1;CDK1;INCENP;SMC4;SMC2;PLK1;CDCA5;NCAPG;NCAPH;CCNB1;NCAPD2;NCAPG2;NCAPD3
gsea,histone exchange (GO:0043486),0.8085975308556322,2.5529031534085798,0.0,0.0,0.0,19/32,9.74%,KNL1;MIS18BP1;HJURP;MIS18A;CENPL;CENPP;OIP5;CENPI;CENPN;CENPM;ANP32E;CENPH;RBBP4;CENPU;CENPT;CENPK;CENPO;CENPA;CENPQ
gsea,centromere complex assembly (GO:0034508),0.8304976343783653,2.5514619634031495,0.0,0.0,0.0,21/32,8.27%,CENPF;KNL1;CENPE;MIS18BP1;HJURP;DLGAP5;MIS18A;CENPL;CENPP;OIP5;CENPI;CENPN;CENPM;MIS12;CENPH;RBBP4;CENPU;CENPT;CENPK;CENPO;CENPA
gsea,positive regulation of cytokinesis (GO:0032467),0.8699472500923623,2.5481824088680223,0.0,0.0,0.0,8/19,1.42%,AURKB;RACGAP1;KIF23;CDC25B;KIF20B;CIT;ECT2;KIF14
gsea,positive regulation of cell division (GO:0051781),0.8699472500923623,2.5481824088680223,0.0,0.0,0.0,8/19,1.42%,AURKB;RACGAP1;KIF23;CDC25B;KIF20B;CIT;ECT2;KIF14
gsea,establishment of spindle orientation (GO:0051294),0.8509209260561951,2.547431147729522,0.0,0.0,0.0,12/20,8.27%,PLK1;NDC80;SAPCD2;MAD2L1;SPDL1;ITGB1;GPSM2;NDE1;NUMA1;CDK5RAP2;ZW10;CENPA
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.8066211600454996,-2.547306504098158,0.0,0.0,0.0,20/35,8.99%,PDIA3;PSME2;CALR;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;VAMP8;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;TAP2
gsea,chromosome organization (GO:0051276),0.6445334391207826,2.5370256800865225,0.0,0.0,0.0,18/70,8.77%,TOP2A;UBB;CDCA8;NDC80;NUF2;EZH2;HMGB2;SUV39H1;HMGN1;CENPH;NUP133;RFWD3;NUCKS1;CENPT;SATB1;NUP155;DOT1L;SAFB
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.7286008432460336,-2.535756552089996,0.0,0.0,0.0,17/42,8.60%,PFN1;PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5
gsea,protein modification by small protein conjugation (GO:0032446),0.5384799344740347,2.5289051048177633,0.0,0.0,0.0,57/180,17.72%,UBB;UBE2C;PLK1;CCNF;UBE2S;BRCA1;TRAIP;NDC1;UBE2T;RAD18;RANGAP1;BARD1;NUP133;RFWD3;NUP107;NUP37;HIF1A;NUP160;DCAF15;BIRC6;NUP35;AAAS;UHRF1;STUB1;NUP205;CDC23;RNF157;NUP85;CDC27;NUP155;KLHL24;PIAS4;NUP62;TRIM24;POM121;RNF40;NUP153;HUWE1;RNF38;HERC2;TRIM28;SUMO2;NUP93;USP9X;NUP88;RNF168;ANAPC7;NUP214;NUP98;NUP43;BTRC;SAE1;SEH1L;PINK1;NFE2L2;FBXO45;FBXO11
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.6544309064007297,2.5287609354016594,0.0,0.0,0.0,41/98,11.00%,CDK1;CENPF;TUBB4B;FBXO5;PLK1;TPX2;CCNB1;CDC25B;HMMR;PLK4;AURKA;CKAP5;KIF14;NEK2;CDC25C;TUBG1;ODF2;NDE1;TUBA1A;HAUS5;PCNT;CNTRL;CDK5RAP2;HAUS3;CEP57;HAUS4;CEP72;CEP192;TUBA4A;NEDD1;CEP70;HAUS6;CCP110;CENPJ;CDC25A;CEP152;CEP135;CDC7;HAUS8;HAUS1;CLASP1
gsea,rRNA processing (GO:0006364),-0.7041126158033838,-2.518565644855833,0.0,0.0,0.0,75/121,17.93%,RPS17;RPS2;RPS6;EBNA1BP2;RPL31;RSL1D1;RPL15;RPL7A;RRP15;RPL10;NHP2;RPL5;NOP58;NOB1;RPS25;DKC1;MAK16;WDR75;RPL10A;RPL14;RPL23A;NOP2;RRP7A;FCF1;WDR43;DDX10;WDR3;NOLC1;RPS15;RRP9;MPHOSPH10;RCL1;RPL4;EIF6;PES1;RPL3;MRTO4;NOP56;IMP4;FBL;DDX54;RPL41;NOL8;RRP1B;RPLP0;EXOSC1;THUMPD1;WDR55;DCAF13;BYSL;RIOK2;RPL8;KRR1;NOP14;RPL7;UTP11;WDR74;MPHOSPH6;BOP1;RPF1;NOL9;WDR12;WDR36;NOL6;SNU13;HEATR1;ESF1;SRFBP1;UTP18;UTP4;POP5;EMG1;UTP6;RRP1;PWP2
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.7246081683998203,2.5166245641496197,0.0,0.0,0.0,14/30,15.66%,CDK1;CIT;TAF1;PRKCA;CAMK2D;ROCK1;WNK1;PDPK1;DYRK1A;ROCK2;GSK3B;HIPK1;PRKD2;OXSR1
gsea,mitotic chromosome condensation (GO:0007076),0.8991088123315597,2.51009102624757,0.0,0.0,0.0,12/22,1.99%,NUSAP1;CDK1;SMC4;SMC2;PLK1;CDCA5;NCAPG;NCAPH;CCNB1;NCAPD2;NCAPG2;NCAPD3
gsea,DNA replication-independent nucleosome assembly (GO:0006336),0.8025506246995701,2.5098848271065424,0.0,0.0,0.0,21/32,11.12%,KNL1;MIS18BP1;ASF1B;HJURP;MIS18A;CENPL;CENPP;OIP5;CENPI;CENPN;CENPM;CENPH;RBBP4;CENPU;ATRX;CENPT;CENPK;CENPO;CENPA;CENPQ;ASF1A
gsea,mitotic G2/M transition checkpoint (GO:0044818),0.7677280696349109,2.507339199027236,0.0,0.0,0.0,8/29,4.90%,CDK1;PLK1;FZR1;CLSPN;TICRR;BRCA1;BLM;FOXN3
gsea,establishment of mitotic spindle orientation (GO:0000132),0.8793242303953516,2.5044225466300905,0.0,0.0,0.0,12/17,8.27%,PLK1;NDC80;SAPCD2;MAD2L1;SPDL1;ITGB1;GPSM2;NDE1;NUMA1;CDK5RAP2;ZW10;CENPA
gsea,regulation of intracellular signal transduction (GO:1902531),0.5096910755776513,2.5018210107743557,0.0,0.0,0.0,95/234,24.55%,AURKB;CDK1;TPX2;RACGAP1;AURKA;ECT2;DEPDC1B;FAM83D;ARHGAP11A;ARHGAP19;BRCA1;BRIP1;RHNO1;BLM;BARD1;NFKBIA;ARAP2;TNFSF11;BIRC3;MAP4K4;RBBP4;RFC4;TAF1;NTRK3;RBBP8;EXO1;RFC5;TAF5;TAGAP;ARHGEF3;MDM4;ARHGAP26;SRGAP2;PDPK1;CHEK2;RMI2;TIAM1;RAD50;ARHGAP31;ATR;MYO9B;TBCK;TAF9;TOP3A;TOPBP1;SSRP1;HIPK1;BCL3;USP2;CPNE1;NET1;TAF6;WRN;CHD3;MYO9A;PLEKHG2;PRKD2;ARHGAP10;INPP5B;RPA3;CASTOR1;SGMS1;RAD9A;EP300;IL1B;PIDD1;TNIK;TAOK2;RPA2;KAT6A;ING5;TAOK1;ARHGAP24;PTPN13;TRAF2;RBBP7;TNF;TBP;DYRK2;BRPF1;PML;SRGAP3;TTI1;PIK3R2;TRAF1;PIN1;KMT5A;JMY;RICTOR;EHMT2;ARHGEF11;RPA1;CDK2;ARHGEF2;SYDE2
gsea,protein polymerization (GO:0051258),0.7986383224726692,2.501597822917128,0.0,0.0,0.0,7/24,7.76%,UBE2C;UBE2S;DIAPH3;CKAP5;JAK2;FGF13;CENPJ
gsea,interstrand cross-link repair (GO:0036297),0.7091846265431728,2.4972685607922265,0.0,0.0,0.0,20/41,11.78%,UBB;NEIL3;RAD51AP1;RAD51;EME1;FANCD2;UBE2T;RFWD3;NUCKS1;USP1;MCM8;FANCI;FANCB;FAAP24;FANCM;FANCG;ATR;WDR48;FANCA;FANCF
gsea,replication fork processing (GO:0031297),0.7934986387931814,2.4921987797942324,0.0,0.0,0.0,18/29,11.30%,RAD51;GEN1;TRAIP;EME1;BLM;RFWD3;NUCKS1;ATRX;ALYREF;BRCA2;ZRANB3;FAM111A;RTEL1;SAMHD1;FANCM;ATR;ETAA1;ZGRF1
gsea,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.924409038387147,2.4911935318621574,0.0,0.0,0.0,12/17,3.35%,CENPF;FBXO5;PLK1;BUB1;BUB3;BUB1B;MAD2L1;TTK;CDC20;TRIP13;KNTC1;MAD1L1
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),0.615329454481202,2.485889259374162,0.0,0.0,0.0,20/68,14.75%,RACGAP1;ECT2;FOXM1;DEPDC1B;ARHGAP11A;ARHGAP19;ARAP2;TAGAP;ARHGEF3;ARHGAP26;SRGAP2;TIAM1;NUP62;ARHGAP31;MYO9B;NET1;MYO9A;PLEKHG2;ARHGAP10;INPP5B
gsea,peptidyl-threonine modification (GO:0018210),0.7020462387592817,2.481478801026901,0.0,0.0,0.0,14/32,15.66%,CDK1;CIT;TAF1;PRKCA;CAMK2D;ROCK1;WNK1;PDPK1;DYRK1A;ROCK2;GSK3B;HIPK1;PRKD2;OXSR1
gsea,rRNA metabolic process (GO:0016072),-0.7028889057771928,-2.478362668785488,0.0,0.0,0.0,67/108,17.93%,RPS17;RPS2;RPS6;EBNA1BP2;RPL31;RPL15;RPL7A;RPL10;RPL5;NOP58;NIFK;NOB1;RPS25;DKC1;WDR75;RPL10A;RPL14;RPL23A;RRP7A;FCF1;WDR43;DDX10;WDR3;NOLC1;RPS15;RRP9;MPHOSPH10;RCL1;RPL4;PES1;RPL3;MRTO4;NOP56;IMP4;FBL;DDX54;RPL41;NOL8;RRP1B;RPLP0;EXOSC1;WDR55;DCAF13;BYSL;RPL8;KRR1;NOP14;RPL7;UTP11;WDR74;MPHOSPH6;BOP1;RPF1;NOL9;WDR12;WDR36;NOL6;SNU13;HEATR1;ESF1;UTP18;UTP4;POP5;EMG1;UTP6;RRP1;PWP2
gsea,protein sumoylation (GO:0016925),0.7363335899406435,2.475219219480217,0.0,0.0,0.0,24/36,16.25%,NDC1;RANGAP1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;PIAS4;NUP62;POM121;NUP153;TRIM28;SUMO2;NUP93;NUP88;NUP214;NUP98;NUP43;SAE1;SEH1L
gsea,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.8161620993789687,2.4720910754972487,0.0,0.0,0.0,8/22,4.90%,CDK1;PLK1;FZR1;CLSPN;TICRR;BRCA1;BLM;FOXN3
gsea,CENP-A containing nucleosome assembly (GO:0034080),0.8292477057607194,2.4697260005278494,0.0,0.0,0.0,18/26,9.74%,KNL1;MIS18BP1;HJURP;MIS18A;CENPL;CENPP;OIP5;CENPI;CENPN;CENPM;CENPH;RBBP4;CENPU;CENPT;CENPK;CENPO;CENPA;CENPQ
gsea,CENP-A containing chromatin organization (GO:0061641),0.8292477057607194,2.4697260005278494,0.0,0.0,0.0,18/26,9.74%,KNL1;MIS18BP1;HJURP;MIS18A;CENPL;CENPP;OIP5;CENPI;CENPN;CENPM;CENPH;RBBP4;CENPU;CENPT;CENPK;CENPO;CENPA;CENPQ
gsea,ribonucleoprotein complex biogenesis (GO:0022613),-0.7649045164491047,-2.4683062268623175,0.0,0.0,0.0,31/40,17.27%,RPS17;RPS6;EBNA1BP2;RPL5;NOP16;RRS1;RPS25;NOC2L;RPL14;NIP7;LTV1;RPS15;RPF2;PES1;MRTO4;NPM1;SDAD1;BYSL;RIOK2;HEATR3;NOM1;NOP14;RPL7;WDR74;BOP1;WDR12;SHQ1;SURF6;NAF1;EMG1;GTF3A
gsea,mitotic spindle checkpoint signaling (GO:0071174),0.918028563690274,2.4656104213614105,0.0,0.0,0.0,11/16,3.35%,CENPF;PLK1;BUB1;BUB3;BUB1B;MAD2L1;TTK;CDC20;TRIP13;KNTC1;MAD1L1
gsea,mitotic spindle assembly checkpoint signaling (GO:0007094),0.918028563690274,2.4656104213614105,0.0,0.0,0.0,11/16,3.35%,CENPF;PLK1;BUB1;BUB3;BUB1B;MAD2L1;TTK;CDC20;TRIP13;KNTC1;MAD1L1
gsea,spindle assembly checkpoint signaling (GO:0071173),0.918028563690274,2.4656104213614105,0.0,0.0,0.0,11/16,3.35%,CENPF;PLK1;BUB1;BUB3;BUB1B;MAD2L1;TTK;CDC20;TRIP13;KNTC1;MAD1L1
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.6276364361978939,2.46122435050443,0.0,0.0,0.0,18/59,11.18%,CCNA2;INCENP;CALM2;CCNB1;CCNF;EZH2;CDKN2D;CDKN2C;CDC25C;BLM;CCNG2;PKMYT1;CCNE1;CDC25A;CDC6;CCNE2;CDKN3;ETAA1
gsea,microtubule polymerization or depolymerization (GO:0031109),0.8453979472083023,2.45490215909575,0.0,0.0,0.0,9/16,7.76%,KIF2C;KIF18B;CKAP5;KIF14;KIF18A;STMN1;KIF24;FGF13;CENPJ
gsea,DNA recombination (GO:0006310),0.7316740290166316,2.4251931143320946,0.0,0.0,0.0,15/32,13.70%,RAD21;RAD51;GEN1;RHNO1;BLM;RAD54B;RAD54L;HMGB1;EXO1;RTEL1;RAD50;RECQL4;HMGB3;XRCC2;WRN
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),0.6991359129524496,2.42443359561103,0.0,0.0,0.0,21/39,18.21%,CDK1;PLK1;FZR1;CLSPN;TICRR;BRCA1;EME1;FANCD2;BLM;RFWD3;FOXN3;CHEK2;MRNIP;TOPBP1;ATF2;MDC1;DTL;RAD9A;TAOK2;RPA2;TAOK1
gsea,regulation of cellular ketone metabolic process (GO:0010565),-0.7757845151710427,-2.424330149902965,0.0,0.0,0.0,17/32,8.60%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;ODC1;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5
gsea,translation (GO:0006412),-0.6712405656064494,-2.4236713199184203,0.0,0.0,0.0,51/102,14.03%,RPS26;RPS17;RPL22L1;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;RPL5;RPS8;RSL24D1;EEF1E1;RPS25;NOA1;RPL10A;ABCE1;RPL14;RPL23A;RRBP1;PPA1;EEF1G;RPS15;RPL4;MRPL42;RPL3;MRPS18B;ETF1;RPS27A;MRPS28;RPL41;MRPL3;RPLP0;AIMP2;GSPT2;MRPL11;MRPS7;RPL8;FARSA;YARS2;RPL7;EEF1A1;N6AMT1;MRRF;PABPC4;EEF1B2;MRPL16;MRPL13;COPS5;EIF4G1
gsea,cellular protein metabolic process (GO:0044267),-0.5549523357405983,-2.422677079576375,0.0,0.0,0.0,74/171,20.75%,LGALS1;HSP90B1;RPS26;RPS17;PDIA6;SPP1;RPS2;RPS6;RPL31;RCN1;RPL15;RPS18;RPL7A;FDX2;RPL10;RPL5;RPS8;RSL24D1;RPS25;RPN1;RPL10A;RPL14;RPL23A;RRBP1;FDX1;RPN2;NAPSA;SPCS3;RPS15;SERP1;RPL4;ATP23;MRPL42;RPL3;MRPS18B;AFG3L2;NAGPA;RPS27A;RPL41;MRPL3;CDKL3;RPLP0;P4HB;GSPT2;LAMC1;CST3;MRPL11;MRPS7;RPL8;YARS2;RABGGTB;RPL7;EEF1A1;MRRF;PABPC4;RIPK3;ADORA2B;ZDHHC2;PRKCSH;MRPL13;COPS5;EIF4G1;PSEN2;CLN5;MSRB2;UBE2M;AFP;ST3GAL6;MRPL35;MRPS18A;FARSB;DENND3;DAB2IP;ABCF1
gsea,non-canonical Wnt signaling pathway (GO:0035567),-0.6225138165091477,-2.419946845358658,0.0,0.0,0.0,22/59,14.46%,PFN1;PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;RYK;FRZB;CTNNB1;PSMD2;WNT11
gsea,DNA metabolic process (GO:0006259),0.5974741820827254,2.4188959892527144,0.0,0.0,0.0,91/204,17.44%,TOP2A;CDK1;UBB;KPNA2;NEIL3;RAD21;TYMS;RAD51AP1;RAD51;GEN1;DBF4;TICRR;BRCA1;CDC45;SMC1A;POLQ;BLM;UBE2T;TINF2;RAD18;GMNN;HMGB2;BARD1;RAD54L;BTG2;MCM10;POLA1;RFC4;FEN1;MCM8;HMGB1;RBBP8;EXO1;RFC5;CTC1;POLE;POLH;PRIM2;NSMCE4A;ZRANB3;XRCC1;UHRF1;TDP1;PARP2;RTEL1;NT5E;DOT1L;DNMT1;PRIM1;SAMHD1;FANCG;CDC6;RMI2;RAD50;RECQL4;HMGB3;ATR;CDC7;DCTPP1;FANCA;ASF1A;TERF2;TOP3A;ORC6;TOPBP1;KMT5C;XRCC2;TDG;CDT1;PDS5B;MBD4;TRIM28;PDS5A;WRN;MMS19;RFC1;PWWP3A;RPA3;RAD9A;AXIN2;TRRAP;MGMT;PARP3;POLA2;WDHD1;RNASEH2A;RPA2;FANCC;POLD3;USP45;HINFP
gsea,regulation of double-strand break repair via homologous recombination (GO:0010569),0.7040217625540804,2.411398493264604,0.0,0.0,0.0,19/33,18.67%,PARPBP;RAD51AP1;RAD51;SMCHD1;POLQ;FIGNL1;FANCB;RTEL1;SPIDR;RMI2;MRNIP;WDR48;FUS;MMS19;SIRT6;SETD2;ARID2;RPA2;HELB
gsea,organelle assembly (GO:0070925),0.5126620064889058,2.4082398900246056,0.0,0.0,0.0,65/166,23.92%,CENPF;CENPE;DLGAP5;PLK4;ANLN;NEK2;MIS12;LSM3;HAUS5;PCNT;ASAP1;HYLS1;HAUS3;CENPT;HAUS4;RCC1;SCLT1;KIF24;CCDC61;SYNPO;EHD3;IFT80;EXOC4;HAUS6;CEP83;CENPJ;CENPA;WDR90;ATXN2L;NEK7;CEP89;NUP62;POC1B;HAUS8;HAUS1;SSX2IP;CCDC28B;ARL13B;NOTCH1;HAUS7;EIF4ENIF1;ATXN2;PDE6D;HDAC6;DDX3X;AHI1;EXOC2;HGS;IFT74;TUBGCP6;PCM1;CENPW;KIF3B;GBF1;IFT81;PATL1;NEK1;IFT140;TUBGCP4;DYNC2H1;CEP164;TUBGCP3;TMEM107;DYNC1H1;IFT46
gsea,chromatin remodeling at centromere (GO:0031055),0.7958804308367341,2.403715781228734,0.0,0.0,0.0,18/28,9.74%,KNL1;MIS18BP1;HJURP;MIS18A;CENPL;CENPP;OIP5;CENPI;CENPN;CENPM;CENPH;RBBP4;CENPU;CENPT;CENPK;CENPO;CENPA;CENPQ
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5184562940772531,2.4003971335321603,0.0,0.0,0.0,45/168,21.45%,AURKB;CDK1;UBB;UBE2C;FBXO5;PLK1;CCNB1;CCNF;UBE2S;BUB3;BUB1B;AURKA;KIF14;FZR1;MAD2L1;CDC20;TAF1;FAF1;STUB1;CDC23;CDC27;RNF5;FBXO48;SKP2;ZNRF1;HUWE1;ANAPC1;TBL1X;ANAPC7;TMUB1;FBXL8;DDIT3;BTRC;MAN1B1;NFE2L2;FBXO45;MTA1;USP19;DERL2;ARNTL;UBR3;FBXW7;PML;RB1;SIRT1
gsea,maturation of LSU-rRNA (GO:0000470),-0.8184787958994039,-2.3964398770442727,0.0,0.0,0.0,20/24,14.14%,RSL1D1;RPL7A;RRP15;NHP2;NIFK;DDX18;MAK16;RPL10A;NOP2;RPL7L1;RPF2;EIF6;PES1;FTSJ3;RPL7;BOP1;RPF1;ZNHIT6;WDR12;SNU13
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.7606905113168602,2.384158660356478,0.0,0.0,0.0,22/30,16.25%,CDK1;CCNB1;REEP4;NDC1;RANGAP1;NUP133;NUP107;NUP37;NUP160;RCC1;NUP35;LBR;NUP205;NUP85;NUP155;POM121;VRK1;LMNA;NUP93;NUP98;NUP43;SEH1L
gsea,mitotic nuclear membrane organization (GO:0101024),0.7606905113168602,2.384158660356478,0.0,0.0,0.0,22/30,16.25%,CDK1;CCNB1;REEP4;NDC1;RANGAP1;NUP133;NUP107;NUP37;NUP160;RCC1;NUP35;LBR;NUP205;NUP85;NUP155;POM121;VRK1;LMNA;NUP93;NUP98;NUP43;SEH1L
gsea,ncRNA processing (GO:0034470),-0.6220620629237983,-2.383227878775478,0.0,5.8593526136665004e-05,0.001,71/138,17.93%,RPS17;RPS2;RPS6;EBNA1BP2;RPL31;RPL15;HNRNPA2B1;RPL7A;RPL10;RPL5;NOP58;NOB1;RPS25;DKC1;WDR75;RPL10A;RPL14;RPL23A;RRP7A;FCF1;WDR43;DDX10;WDR3;NOLC1;RPS15;SSB;RRP9;MPHOSPH10;RCL1;POP1;RPL4;PES1;RPL3;MRTO4;NOP56;IMP4;FBL;DDX54;RPL41;NOL8;RRP1B;RPLP0;EXOSC1;WDR55;DCAF13;BYSL;RPL8;KRR1;NOP14;RPL7;UTP11;WDR74;MPHOSPH6;BOP1;RPF1;NOL9;WDR12;WDR36;NOL6;SNU13;HEATR1;ESF1;MRPL44;UTP18;UTP4;TUT1;POP5;EMG1;UTP6;RRP1;PWP2
gsea,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.7596684124873825,2.382508633928522,0.0,0.0,0.0,16/32,11.18%,RAD51;GEN1;TRAIP;EME1;BLM;RFWD3;NUCKS1;ATRX;POLE;ALYREF;ZRANB3;FAM111A;RTEL1;FANCM;ATR;ETAA1
gsea,"protein localization to chromosome, centromeric region (GO:0071459)",0.9067888798048857,2.382104834755599,0.0,0.0,0.0,13/15,8.27%,AURKB;CDK1;KNL1;BUB3;TTK;SPDL1;ZWILCH;HASPIN;CTCF;MIS12;ZW10;MTBP;CENPA
gsea,nuclear membrane reassembly (GO:0031468),0.7479190468498448,2.3798642075381986,0.0,0.0,0.0,22/32,16.25%,CDK1;CCNB1;REEP4;NDC1;RANGAP1;NUP133;NUP107;NUP37;NUP160;RCC1;NUP35;LBR;NUP205;NUP85;NUP155;POM121;VRK1;LMNA;NUP93;NUP98;NUP43;SEH1L
gsea,ribosome assembly (GO:0042255),-0.7831269378840027,-2.3798488439045733,0.0,5.468729106088733e-05,0.001,26/32,17.93%,RPS27L;C1QBP;PPAN;RPL10;RPL5;RRS1;RSL24D1;RPL23A;MRPL20;NOP2;RRP7A;RPS15;RPF2;EIF6;BRIX1;RPL3;NPM1;EIF2A;RPLP0;MRPS7;NLE1;BOP1;EFL1;DHX29;MRPS2;PWP2
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.6742485831706371,2.3795729357355406,0.0,0.0,0.0,17/39,18.01%,CDK1;CCNB1;AURKA;E2F8;GTSE1;E2F7;CDC25C;BTG2;RGCC;MDM4;CHEK2;CNOT1;CNOT10;EP300;PIDD1;TFDP2;PLAGL1
gsea,cellular response to radiation (GO:0071478),0.7093496940696349,2.3766008329661337,0.0,0.0,0.0,7/24,8.03%,ECT2;RAD51AP1;RAD51;RHNO1;BLM;FIGNL1;SPIDR
gsea,protein K48-linked ubiquitination (GO:0070936),0.7294801867872701,2.375521624157506,0.0,0.0,0.0,7/21,11.46%,UBE2C;TNFAIP3;UBE2T;RNF5;UBR5;SKP2;ZNRF1
gsea,cilium organization (GO:0044782),0.5398251988285294,2.3752734847431634,0.0,0.0,0.0,40/92,25.77%,PLK4;ODF2;MNS1;PCNT;ASAP1;HYLS1;SCLT1;KIF24;EHD3;IFT80;EXOC4;CEP83;CCP110;CENPJ;RTTN;WDR90;CEP89;POC1B;SSX2IP;CCDC28B;ARL13B;NOTCH1;PDE6D;HDAC6;AHI1;EXOC2;IFT74;PCM1;KIFAP3;KIF3B;GBF1;IFT81;NEK1;IFT140;DYNC2H1;CEP164;TMEM107;IFT46;OFD1;CEP162
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.6127203507658152,2.3750180531648377,0.0,0.0,0.0,21/54,18.01%,CDK1;CCNB1;AURKA;E2F8;FOXM1;GTSE1;E2F7;CDC25C;BTG2;ATRX;RGCC;MDM4;CHEK2;CNOT1;PAXIP1;BCL3;CNOT10;EP300;PIDD1;TFDP2;PLAGL1
gsea,regulation of cellular amine metabolic process (GO:0033238),-0.8134606300701761,-2.370776910354824,0.0,5.126933536958188e-05,0.001,17/27,8.60%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;ODC1;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5
gsea,regulation of G0 to G1 transition (GO:0070316),0.7301027823484909,2.3672156919239895,0.0,0.0,0.0,9/32,4.96%,RRM2;EZH2;RAD51;BRCA1;RHNO1;SUZ12;CBX5;RBBP4;RBBP8
gsea,positive regulation of mitotic nuclear division (GO:0045840),0.7945486457956723,2.3634601481591853,0.0,0.0,0.0,9/21,9.51%,NUSAP1;DLGAP5;AURKA;ESPL1;RGCC;PHIP;CDC23;CDC27;NUP62
gsea,cellular response to ionizing radiation (GO:0071479),0.6464866654330979,2.355330744201861,0.0,0.0,0.0,12/37,15.11%,ECT2;RAD51AP1;RAD51;RHNO1;BLM;FIGNL1;NUCKS1;SPIDR;ATR;NET1;WRN;RAD9A
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.6893276495748686,2.350595228261279,0.0,0.0,0.0,14/54,1.90%,AURKB;CDK1;UBB;UBE2C;FBXO5;PLK1;CCNB1;UBE2S;BUB3;BUB1B;AURKA;FZR1;MAD2L1;CDC20
gsea,regulation of DNA recombination (GO:0000018),0.7555137315462175,2.348068052151087,0.0,0.0,0.0,15/24,17.10%,KPNA2;RAD51AP1;RAD51;BLM;FIGNL1;ALYREF;ZRANB3;IL7R;RTEL1;SPIDR;RAD50;ZCWPW1;SIRT6;SETD2;RPA2
gsea,regulation of cellular amino acid metabolic process (GO:0006521),-0.7829312293323958,-2.347883593528443,0.0,4.8253492112547646e-05,0.001,17/29,8.60%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;ODC1;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5
gsea,ribosomal large subunit assembly (GO:0000027),-0.85969567988836,-2.343356935978607,0.0,4.5572742550739447e-05,0.001,14/17,11.84%,PPAN;RPL10;RPL5;RRS1;RSL24D1;RPL23A;MRPL20;NOP2;RPF2;BRIX1;RPL3;RPLP0;NLE1;BOP1
gsea,protein autophosphorylation (GO:0046777),0.5550918222320012,2.330773054232794,0.0,0.0,0.0,29/76,19.58%,AURKB;AURKA;MELK;NEK2;PIM1;TAF1;PIM2;CAMK2D;JAK2;STK10;PASK;PDPK1;CHEK2;DYRK1A;ATR;VRK1;GSK3B;MAP3K3;SIK2;PRKD2;AAK1;OXSR1;TNIK;TAOK2;PINK1;SLK;TAOK1;FLT1;ABL1
gsea,negative regulation of double-strand break repair (GO:2000780),0.737613670021679,2.3299984712986865,0.0,0.0,0.0,7/20,9.44%,PARPBP;AUNIP;SMCHD1;POLQ;FANCB;UBR5;RMI2
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.6372624992053806,2.3250505859636905,0.0,0.0,0.0,20/60,12.46%,FBXO5;RRM2;TYMS;CDKN2D;CDKN2C;DBF4;CDC45;POLA1;PIM2;POLE;RCC1;CCNE1;CDC25A;CDC6;DHFR;CDC7;CCNE2;CDKN3;CDT1;E2F3
gsea,nucleus organization (GO:0006997),0.7515085285805922,2.322604960681874,0.0,1.165243187270863e-05,0.001,13/21,17.66%,CEP55;REEP4;NDC1;NUP133;NUMA1;NUP35;NUP205;SUN2;NUP155;NUP93;NUP98;SEH1L;PRM2
gsea,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.7670699685459341,2.318054964173587,0.0,2.307412252021511e-05,0.002,5/20,1.90%,UBE2C;PLK1;UBE2S;FZR1;CDC20
gsea,regulation of double-strand break repair (GO:2000779),0.6960795871180677,2.307895367397073,0.0,2.284790563276202e-05,0.002,15/28,17.10%,FOXM1;RAD51AP1;RAD51;FIGNL1;DEK;RTEL1;SPIDR;UBR5;MRNIP;ZCWPW1;SIRT6;SETD2;MGMT;DDX11;RPA2
gsea,peptide biosynthetic process (GO:0043043),-0.7024366607230654,-2.3038667698529656,0.0,0.00012952253145999632,0.003,38/65,14.03%,RPS26;RPS17;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;RPL5;RPS8;RSL24D1;RPS25;RPL10A;RPL14;RPL23A;RRBP1;RPS15;RPL4;MRPL42;RPL3;MRPS18B;RPS27A;RPL41;MRPL3;RPLP0;GSPT2;MRPL11;MRPS7;RPL8;YARS2;RPL7;EEF1A1;MRRF;PABPC4;MRPL13;COPS5;EIF4G1
gsea,carbohydrate catabolic process (GO:0016052),-0.8564119929966374,-2.2923715220908703,0.0,0.00012304640488699652,0.003,9/20,1.49%,LDHA;GAPDH;ENO1;ALDOA;PGK1;PKM;TPI1;ENO3;PGAM1
gsea,protein localization to chromosome (GO:0034502),0.7408180679257981,2.291691264926128,0.0,2.262608130623035e-05,0.002,11/22,11.34%,PLK1;RAD21;HASPIN;CTCF;TINF2;ATRX;MCM8;CENPA;MRNIP;ATR;TERF2
gsea,negative regulation of G0 to G1 transition (GO:0070317),0.7237185658010618,2.2907345107124324,0.0,2.2408522832131982e-05,0.002,8/29,4.96%,RRM2;EZH2;RAD51;BRCA1;SUZ12;CBX5;RBBP4;RBBP8
gsea,regulation of mitotic spindle organization (GO:0060236),0.7599160978859882,2.289173948641675,0.0,2.219510832896882e-05,0.002,7/21,5.08%,PLK1;TPX2;TACC3;BORA;GPSM2;NUMA1;CCSAP
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4678678861874356,2.2884038443135277,0.0,2.1985720514544584e-05,0.002,80/208,21.56%,CCNA2;ESCO2;FBXO5;TCF7;EZH2;GMNN;MYBL2;NSD2;LIN54;NUCKS1;NUP107;ATRX;SP1;FOXN3;HIF1A;POLR2A;BRCA2;NFYB;NUP35;TAF5;SAP30;SRRT;MYBL1;IRF2;CCAR1;ATXN1;CREBBP;ATF4;BHLHE40;SMC3;CHEK2;MTF2;CRABP2;FUS;NAB2;RPS6KA5;HCFC1;NFYA;MLF1;SSBP2;RORA;NOTCH1;ATF2;NFKB2;MYB;CHD3;RBBP6;JMJD1C;ENG;ATXN2;NCOA2;TCF3;HMG20A;KMT2D;EP300;TRRAP;DDIT3;NFATC2;PHF19;HINFP;GZF1;KAT6B;ARNTL;TCOF1;AJUBA;ABL1;STAT3;NONO;SPI1;ACVRL1;SMARCA2;TSC1;GON4L;CCDC88A;PML;ASCC1;AIRE;DVL1;RB1;KAT7
gsea,mitochondrial transport (GO:0006839),-0.6932866874749639,-2.288048114714747,0.0,0.00015624940303110666,0.004,14/29,16.32%,TOMM5;SLC25A5;TOMM20;TIMM23;TIMM8B;BAK1;TIMM17A;TIMM13;TIMM9;TIMM10;SLC25A24;COX18;ABCB10;MGARP
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),0.6098211739326741,2.285249577600667,0.0,2.178024649104417e-05,0.002,22/50,25.03%,UBB;XCL1;ITGB1;ZFP36L1;ZFP36L2;FOS;JUN;BAMBI;USP9X;ENG;LPXN;LRRC32;TGFBR3;PTPRK;ACVRL1;USP15;SMAD7;SIRT1;SKI;MAP3K7;CBL;ARHGEF18
gsea,regulation of glycolytic process (GO:0006110),0.6352790012669184,2.28127729518328,0.0,3.236786631307953e-05,0.003,23/44,16.25%,NDC1;NUP133;NUP107;NUP37;HIF1A;ZBTB20;NUP160;NUP35;AAAS;NUP205;NUP85;SLC2A6;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;EP300;SEH1L
gsea,regulation of phosphorylation (GO:0042325),0.5583688541666803,2.2778590916367727,0.0,3.2070913411124673e-05,0.003,40/74,21.45%,CDKN2D;CDKN2C;NDC1;BARD1;NUP133;SOCS1;NUP107;NUP37;HIF1A;NUP160;NUP35;PHIP;AAAS;NRP1;ROCK1;NUP205;NUP85;SLC2A6;NUP155;CORO1C;ITGA6;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;KCTD20;NUP98;STAT2;NUP43;EP300;AR;SEH1L;FNIP1;PRKRIP1;RANBP2;CCDC88A;PML;SIRT1
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.6181465974734461,2.2744812310236755,0.0,4.237247953712229e-05,0.004,16/45,11.01%,CCNA2;PLK1;CCNB1;CCNF;CDKN2D;CDKN2C;CDC25C;BLM;CCNG2;PKMYT1;RGCC;CCNE1;CDC25A;CDC6;CCNE2;CDKN3
gsea,regulation of cation channel activity (GO:2001257),0.6986095946855354,2.2737511598395197,0.0,4.19907454872383e-05,0.004,5/29,7.00%,CALM2;ITGB1;CNIH2;CAMK2D;FGF13
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.7056190015045257,2.2735861684150382,0.0,4.161582811681654e-05,0.004,9/22,18.21%,UBB;KIF20B;MAP4K4;SRGAP2;PACSIN1;DCLK1;TNIK;TAOK2;TAOK1
gsea,regulation of establishment of planar polarity (GO:0090175),-0.6616073894252835,-2.273128285331464,0.0,0.00026100752551787136,0.006,17/42,8.60%,PFN1;PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4328648125036742,2.2677460848456694,0.0,4.124754645206595e-05,0.004,187/442,25.93%,UBB;DLGAP5;E2F8;FOXM1;E2F7;BRCA1;BRD8;CKAP2;NR4A1;ATAD2;HMGB2;MYBL2;JUNB;NFKBIA;TNFSF11;NFATC2IP;KLF6;REL;ASXL1;CSRNP1;RBL1;ATRX;FOS;HMGB1;NFKB1;E2F2;NR4A3;SP1;HIF1A;IRF1;RGCC;MED4;KLF4;NFYB;PHIP;TCF12;THRAP3;UHRF1;IER5;IRF4;POU2F1;KLF2;CREBRF;MYBL1;IRF2;NRIP1;ATF3;JUN;CREBBP;STAT1;CD81;ZFPM1;ATF4;BPTF;SIN3A;PER1;DOT1L;CCN1;AKIRIN2;CXCL10;CALCOCO1;SERPINE1;NFATC1;PPP3CB;KMT2A;CREB1;ITGA6;GABPB2;KDM6B;MEPCE;KMT2C;NFAT5;ELK4;ETS1;TNIP3;MTF2;MED14;POU2F2;RPS6KA5;HCFC1;MAML2;RUNX1;RBMX;TAF9;ZC3H12A;HIVEP1;NCOA7;E2F3;SSBP2;PAXIP1;RORA;NOTCH1;PBX2;ATF2;E2F5;ELK3;TBL1X;NFKB2;MYB;TAF6;GABPB1;NCOA1;PCGF5;LIF;GATA3;PRKD2;ENG;SETX;NCOA2;TCF3;STAT5B;KMT2D;DDX3X;MED30;EP300;AR;STAT6;IRF7;NCOA3;DDIT3;JUND;ATF1;TET3;KAT2B;AHI1;PLSCR1;TFDP2;NFE2L2;MED13;KAT6A;HINFP;PLAGL1;MRTFB;POU2AF1;TET2;ERG;RXRA;FOXO1;KAT6B;ARNTL;MED12;LEF1;PRDM10;DCAF6;TNF;ABL1;EGR2;TNIP1;STAT3;SPI1;TFE3;SSBP3;ACVRL1;SMARCA2;FOXJ2;HELZ2;AGO2;E4F1;HDAC5;AIRE;DVL1;SMAD7;RPRD1B;SIRT1;KAT7;NPAT;ATF6;SKI;PIK3R2;BCLAF3;EGR1;CX3CL1;DAB2;ARNT;SMARCA4;PIN1;FOSL2;SENP1;CD40;ARHGEF2;CCNK;PIK3R1;TAF6L;BCLAF1;RFX5;MCRS1;SOX8
gsea,canonical glycolysis (GO:0061621),-0.9021676928554732,-2.2619413183567323,0.0,0.0002734364553044367,0.007,8/16,1.49%,GAPDH;ENO1;ALDOA;PGK1;PKM;TPI1;ENO3;PGAM1
gsea,glucose catabolic process to pyruvate (GO:0061718),-0.9021676928554732,-2.2619413183567323,0.0,0.0002734364553044367,0.007,8/16,1.49%,GAPDH;ENO1;ALDOA;PGK1;PKM;TPI1;ENO3;PGAM1
gsea,positive regulation of double-strand break repair (GO:2000781),0.6503992976081098,2.261924035639186,0.0,5.1107157336441365e-05,0.005,15/32,16.62%,FOXM1;RAD51AP1;SMCHD1;FANCB;SPIDR;MRNIP;WDR48;FUS;KMT5C;ZCWPW1;MMS19;ARID2;MGMT;PARP3;DDX11
gsea,establishment of protein localization to mitochondrion (GO:0072655),-0.7399976402043592,-2.260008887461128,0.0,0.0002624989970922592,0.007,11/25,6.92%,TOMM5;TOMM20;TIMM23;TIMM8B;HSPD1;AKT1;TIMM17A;TIMM13;TIMM9;TIMM10;CHCHD4
gsea,regulation of cell cycle phase transition (GO:1901987),0.6301737790412053,2.2593384856150487,0.0,5.0662747272646225e-05,0.005,16/59,7.48%,CDK1;UBE2C;FBXO5;PLK1;CCNB1;UBE2S;BUB3;BUB1B;FZR1;MAD2L1;GTSE1;CDC20;DBF4;TAF1;CDC23;CDC27
gsea,regulation of carbohydrate catabolic process (GO:0043470),0.6907674763572715,2.2579526287631597,0.0,5.022599945133031e-05,0.005,22/30,16.25%,NDC1;NUP133;NUP107;NUP37;HIF1A;NUP160;NUP35;AAAS;NUP205;NUP85;SLC2A6;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;EP300;SEH1L
gsea,glycolytic process (GO:0006096),-0.8904695286093001,-2.256135136122457,0.0,0.00025240288181948,0.007,9/17,1.49%,LDHA;GAPDH;ENO1;ALDOA;PGK1;PKM;TPI1;ENO3;PGAM1
gsea,regulation of purine nucleotide metabolic process (GO:1900542),0.6800792872828927,2.253229280317518,0.0,4.979671740473774e-05,0.005,22/31,16.25%,NDC1;NUP133;NUP107;NUP37;HIF1A;NUP160;NUP35;AAAS;NUP205;NUP85;SLC2A6;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;EP300;SEH1L
gsea,glycolytic process through glucose-6-phosphate (GO:0061620),-0.8885945346042083,-2.2529099932302525,0.0,0.0002734364553044367,0.008,8/17,1.49%,GAPDH;ENO1;ALDOA;PGK1;PKM;TPI1;ENO3;PGAM1
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.6215973904783942,2.2527789901826223,0.0,4.937471132503657e-05,0.005,19/46,18.01%,CDK1;CCNB1;AURKA;E2F8;GTSE1;E2F7;CDC25C;BTG2;RFWD3;RGCC;MDM4;CHEK2;CNOT1;CNOT10;EP300;PIDD1;TFDP2;RPA2;PLAGL1
gsea,positive regulation of intracellular transport (GO:0032388),0.7412002609151607,2.2489452208922533,0.0,6.854371689828607e-05,0.007,4/18,3.89%,KIF20B;SPAG5;NUMA1;PCNT
gsea,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8332524077365688,2.2479300527741835,0.0,6.797251925746701e-05,0.007,8/15,10.36%,CDK1;FBXO5;CCNB1;CDC25B;CDC25C;ATAD5;CDC25A;CDC7
gsea,pyruvate metabolic process (GO:0006090),-0.7461038081082724,-2.2464977155656696,0.0,0.000292967630683325,0.009,14/30,10.83%,LDHA;GAPDH;ENO1;ALDOA;PGK1;PKM;TPI1;ENO3;PGAM1;BSG;ALDOC;VDAC1;PFKL;DLAT
gsea,microtubule polymerization (GO:0046785),0.7446801245018184,2.24517399451701,0.0,7.704087188567689e-05,0.008,8/18,11.00%,TPX2;CKAP5;TUBG1;NDE1;FGF13;CENPJ;CLASP2;CLASP1
gsea,DNA synthesis involved in DNA repair (GO:0000731),0.6606469049139615,2.2418099247793513,0.0,7.640938932923692e-05,0.008,14/35,17.21%,UBB;PCLAF;CDKN2D;POLA1;RFC4;RFC5;POLE;POLH;WRN;RFC1;DTL;RPA3;RPA2;POLD3
gsea,response to ionizing radiation (GO:0010212),0.587033726353273,2.2372949132407434,0.0,8.526169662957535e-05,0.008,24/51,22.53%,ECT2;RAD51AP1;RAD51;TICRR;BRCA1;FANCD2;RHNO1;BLM;FIGNL1;RFWD3;SPIDR;MRNIP;TOPBP1;PAXIP1;NET1;RNF168;RAD9A;MTA1;SIRT1;CLK2;ABRAXAS1;TNKS1BP1;EYA3;INTS3
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.5486664135385578,2.232290592240112,0.0,8.457410230191749e-05,0.008,50/99,23.99%,AURKB;CDK1;TPX2;AURKA;BRCA1;BRIP1;RHNO1;BLM;BARD1;RBBP4;RFC4;TAF1;RBBP8;EXO1;RFC5;TAF5;MDM4;PDPK1;CHEK2;RMI2;RAD50;ATR;TAF9;TOP3A;TOPBP1;SSRP1;HIPK1;USP2;TAF6;WRN;CHD3;RPA3;RAD9A;EP300;RPA2;KAT6A;ING5;HEXIM1;RBBP7;TBP;DYRK2;BRPF1;PML;PIN1;KMT5A;JMY;RICTOR;EHMT2;RPA1;CDK2
gsea,regulation of gene silencing by miRNA (GO:0060964),0.6348678767035502,2.2287848135792028,0.0,9.321945498166904e-05,0.009,27/43,20.89%,NDC1;NUP133;NUP107;NUP37;POLR2A;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;NUP62;FMR1;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;SEH1L;PUM2;AJUBA;STAT3;POLR2B;RANBP2;AGO2
gsea,cellular response to interleukin-12 (GO:0071349),-0.7030646146411819,-2.2283045358591544,0.0,0.00039601141802711513,0.012,16/28,9.83%,ANXA2;CFL1;PPIA;MIF;PSME2;HNRNPA2B1;LCP1;TCP1;MTAP;GSTO1;SNRPA1;HSPA9;HNRNPF;RPLP0;P4HB;IL12RB1
gsea,regulation of ATP metabolic process (GO:1903578),0.6262913231829031,2.2250848967731502,0.0,9.24796180373701e-05,0.009,23/38,16.58%,NDC1;NUP133;NUP107;NUP37;HIF1A;NUP160;NUP35;AAAS;NUP205;NUP85;SLC2A6;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;EP300;SEH1L;PINK1
gsea,cytoskeleton-dependent intracellular transport (GO:0030705),0.7549360867994142,2.224578142761137,0.0,0.00010092657527542909,0.01,3/17,3.56%,TUBA1C;TUBA1B;TUBA1A
gsea,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7762692246811813,-2.224063205401256,0.0,0.000410154682956655,0.013,8/16,10.85%,PDIA3;CALR;FCER1G;CANX;ERAP1;ABCB9;TAP2;SEC24D
gsea,regulation of microtubule cytoskeleton organization (GO:0070507),0.7434628098316722,2.2219015131778668,0.0,0.0001001380864060898,0.01,8/18,11.41%,SKA1;SKA2;SKA3;STMN1;ROCK1;CLASP2;CLASP1;GSK3B
gsea,protein targeting to mitochondrion (GO:0006626),-0.7156834250308042,-2.2213754554511476,0.0,0.0003969238867322468,0.013,16/29,16.39%,TOMM5;TOMM20;TIMM23;TIMM8B;HSPD1;TIMM17A;TIMM13;TIMM9;TIMM10;HSPA4;CHCHD4;SAMM50;GRPEL1;TIMM29;MGARP;DNAJC15
gsea,interleukin-12-mediated signaling pathway (GO:0035722),-0.7091451135427914,-2.216306934089629,0.0,0.0003845200152718641,0.013,16/27,9.83%,ANXA2;CFL1;PPIA;MIF;PSME2;HNRNPA2B1;LCP1;TCP1;MTAP;GSTO1;SNRPA1;HSPA9;HNRNPF;RPLP0;P4HB;IL12RB1
gsea,protein targeting to ER (GO:0045047),-0.8251367819877028,-2.215969176747376,0.0,0.0003728678935969591,0.013,26/34,12.30%,RPS26;RPS17;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;RPL5;RPS8;RPS25;RPL10A;RPL14;RPL23A;SPCS3;RPS15;RPL4;RPL3;RPS27A;RPL41;RPLP0;RPL8;SRP72;RPL7;EDEM1
gsea,regulation of primary metabolic process (GO:0080090),-0.5885331316801701,-2.21316025954693,0.0,0.00038602793690038117,0.013,30/71,10.66%,FDPS;PSME2;PSMA4;PSMA3;ID2;PSMB2;IDI1;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;ODC1;DHCR7;PMVK;PSMD6;PSMD1;FASN;PSMD14;SC5D;PSMD12;SQLE;MVD;HMGCR;PSMD7;LACTB;PSMC1;PSMC5;HMGCS1;LSS
gsea,ribosomal small subunit biogenesis (GO:0042274),-0.7637824226082636,-2.212368846086643,0.0,0.00039843597772932203,0.014,20/25,17.93%,RPS17;RPS27L;RPS6;NOB1;RPS25;RRP7A;LTV1;WDR3;RPS15;NPM1;MRPS7;RIOK2;NOM1;NOP14;SNU13;SURF6;SRFBP1;UTP4;EMG1;PWP2
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7058703097126958,-2.2115505081857982,0.0,0.0003873683116812853,0.014,28/49,11.35%,RPS26;RPS17;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;RPL5;RPS8;RPS25;NCBP2;RPL10A;RPL14;RPL23A;UPF1;RPS15;RPL4;RPL3;ETF1;RPS27A;RPL41;RPLP0;GSPT2;MAGOHB;RPL8;RPL7
gsea,regulation of cellular component organization (GO:0051128),0.5257563999054001,2.2056545259517857,0.0,0.00011742760801954435,0.012,31/75,25.86%,MKI67;HJURP;AURKA;KIF14;CAMK2D;MLLT3;ROCK1;PACSIN1;ROCK2;CISH;HCFC1;SSRP1;PTPN11;NET1;TAOK2;PINK1;HIP1;TRAF2;TNF;ABL1;RAPGEF1;TMC8;BAP1;METTL4;HIP1R;ARHGEF11;KLK8;CAMSAP2;STON1;RAB5B;SGK1
gsea,double-strand break repair via homologous recombination (GO:0000724),0.599911944739405,2.2053704253176014,0.0,0.0001165243187270863,0.012,34/70,14.80%,RAD21;AUNIP;RAD51AP1;RAD51;GEN1;BRCA1;CDC45;POLQ;BLM;RAD54B;RAD54L;RFWD3;NUCKS1;FEN1;MCM8;RBBP8;SMC6;BRCA2;NSMCE1;XRCC1;FANCB;PALB2;SPIDR;SAMHD1;FANCM;RAD50;RECQL4;CDC7;XRCC2;REV3L;WRN;SMC5;GINS4;RPA3
gsea,cellular transition metal ion homeostasis (GO:0046916),-0.609312242328151,-2.202998242963383,0.0,0.00039906942125512377,0.015,20/36,23.64%,MT3;TMEM199;SLC39A6;GLRX3;TMPRSS6;MYC;SLC31A1;SLC39A7;ATP6V0A2;SLC11A1;TFRC;CCDC115;FRRS1;SLC39A14;CUL1;HMOX1;COX19;SLC39A10;ACO1;SLC39A4
gsea,ribonucleoprotein complex assembly (GO:0022618),-0.6162349854021307,-2.2004914372769395,0.0,0.000410154682956655,0.016,43/87,17.93%,RPS27L;HSP90AB1;PPAN;RPL10;SNRPF;RPL5;EIF3A;RRS1;RSL24D1;SNRPD3;EIF2S2;SRSF6;LUC7L3;RPL23A;STRAP;MRPL20;NOP2;RRP7A;PRPF19;RPS15;WDR77;RPF2;EIF6;PRMT5;BRIX1;RPL3;TXNL4A;SMN1;RPLP0;CLNS1A;MRPS7;SNRPD1;NLE1;BOP1;DENR;LUC7L;SNRPB;GEMIN5;SHQ1;PRMT7;NAF1;DHX29;PWP2
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.5403853922059072,-2.1966090781396956,0.0,0.0003996378962141767,0.016,28/72,20.67%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;TLE5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;HDAC1;DKKL1;PSMD7;PSMC1;PSMC5;FRZB;LRP6;PSMD2;WNT11;TMEM64;PSMD11;PSMB7;PSME3;DAB2IP
gsea,telomere maintenance (GO:0000723),0.6255098980893788,2.1885665150873397,0.0,0.00016010975092271403,0.017,17/40,18.99%,RAD51;BLM;TINF2;CTC1;SMC6;RTEL1;RAD50;RECQL4;ATR;TERF2;WRN;SMC5;RPA3;PARP3;RPA2;POLD3;DCLRE1B
gsea,inner mitochondrial membrane organization (GO:0007007),-0.7325146454031989,-2.188298932637092,0.0,0.00047167788540015336,0.02,7/19,7.73%,TIMM8B;TIMM13;TIMM9;TIMM10;HSPA9;AFG3L2;SAMM50
gsea,regulation of posttranscriptional gene silencing (GO:0060147),0.6392754158104044,2.185223798816154,0.0,0.00015770208549530478,0.017,25/38,20.89%,NDC1;NUP133;NUP107;NUP37;POLR2A;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;NUP62;FMR1;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;SEH1L;PUM2;POLR2B;RANBP2;AGO2
gsea,regulation of gene silencing by RNA (GO:0060966),0.6392754158104044,2.185223798816154,0.0,0.00015770208549530478,0.017,25/38,20.89%,NDC1;NUP133;NUP107;NUP37;POLR2A;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;NUP62;FMR1;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;SEH1L;PUM2;POLR2B;RANBP2;AGO2
gsea,microtubule bundle formation (GO:0001578),0.7219457071506703,2.182876912637512,0.0,0.0001565252042602652,0.017,6/19,11.00%,PLK1;KIF20A;NUMA1;CDK5RAP2;AAAS;CLASP1
gsea,protein depolymerization (GO:0051261),0.726807276653923,2.175424677009422,0.0,0.00017262862033642416,0.019,7/18,5.71%,KIF2C;KIF18B;CKAP5;KIF14;KIF18A;STMN1;KIF24
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4303546869062595,2.175186310847749,0.0,0.00017135929224571515,0.019,116/295,26.09%,AURKB;UBB;PLK1;E2F8;FOXM1;EZH2;E2F7;CTCF;SUV39H1;CBX5;TGIF1;FOSB;ATRX;ID3;HMGB1;NFKB1;TAF1;NR4A3;BCL6;IRF2BP2;FOXP1;KLF4;SAP30;KDM2B;UHRF1;SATB1;MDM4;SKIL;KLF2;SP2;ARID5B;IRF2;SUV39H2;NRIP1;ATF3;ATXN1;JUN;CREBBP;STAT1;MXD4;DDX20;ZFPM1;ATF4;BPTF;DNAJB1;SIN3A;PER1;GATAD2B;BHLHE40;FOXP4;SAP130;ARID5A;MCPH1;ELK4;MTF2;HCFC1;CNOT1;RUNX1;HIVEP1;USP2;NOTCH1;ETV6;TBL1X;MYB;CUX1;USP9X;JAZF1;CHD3;CBX7;GATA3;TCF3;CBX4;SIRT6;CXXC5;EP300;AR;IRF7;DDIT3;MXD1;FNIP1;PHF21A;MTA1;ERF;IRF2BP1;GZF1;ZEB1;HEXIM1;RXRA;CC2D1A;ZMYM5;ZHX2;TNF;STAT3;SPI1;SMARCA2;E4F1;HDAC5;RB1;SMAD7;SIRT1;HDAC9;SKI;DAB2;SMARCA4;KMT5A;EHMT2;FHL2;PTCH1;ZBTB21;TRIM33;MIER3;BATF3;SOX8;KANK2;EED;TRIB3
gsea,protein targeting (GO:0006605),-0.5628208679541853,-2.1693698737255533,0.0,0.000600226365302422,0.027,16/47,17.18%,TOMM5;TOMM20;TIMM23;TIMM8B;TIMM17A;TIMM13;TIMM9;SPCS3;TIMM10;ZDHHC24;EDEM1;ZDHHC2;PIKFYVE;MYO1C;MGARP;SEC61A1
gsea,negative regulation of DNA recombination (GO:0045910),0.6403547345206847,2.168830015045919,0.0,0.00017010849449209682,0.019,12/31,11.34%,PARPBP;SMCHD1;POLQ;BLM;TINF2;ATRX;POLR2A;ZRANB3;FANCB;RTEL1;RMI2;TERF2
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",0.4120556127286302,2.168687961195311,0.0,0.00016887582424215407,0.019,162/427,26.11%,AURKB;CENPF;UBB;PLK1;BIRC5;E2F8;FOXM1;EZH2;E2F7;BRCA1;XCL1;CTCF;GMNN;HMGB2;SUV39H1;CBX5;TGIF1;FOSB;ID3;HMGB1;NFKB1;TAF1;NR4A3;FOXN3;BCL6;IRF1;IRF2BP2;FOXP1;KLF4;ATF7IP;PDCD4;SAP30;KDM2B;UHRF1;SATB1;MDM4;SKIL;POU2F1;KLF2;SP2;ARID5B;IRF2;SUV39H2;NRIP1;ATF3;ATXN1;JUN;CREBBP;STAT1;MXD4;DDX20;SMARCC2;ZFPM1;ATF4;BPTF;DNAJB1;SIN3A;PER1;GATAD2B;BHLHE40;FOXP4;RBM15;CIC;PIAS4;ILF3;SAP130;CREB1;ARID5A;MCPH1;JARID2;ELK4;MTF2;NAB2;RPS6KA5;HCFC1;CNOT1;RUNX1;CSF2;HIVEP1;BCL3;USP2;NOTCH1;ETV6;TRIM28;ELK3;TBL1X;MYB;CUX1;USP9X;JAZF1;CHD3;CBX7;GATA3;TCF3;CBX4;SIRT6;CXXC5;SHC1;HDAC6;EP300;AR;IRF7;DDIT3;BTRC;SETDB2;MXD1;USP47;FNIP1;TFDP2;PHF21A;KAT6A;HINFP;MTA1;ERF;IRF2BP1;GZF1;ZEB1;HEXIM1;RXRA;FOXO1;KAT6B;MDFIC;ARNTL;LEF1;ZMYM5;ZHX2;TNF;PTPRK;STAT3;NONO;SPI1;SMARCA2;PML;E4F1;HDAC5;RB1;SMAD7;BAP1;SIRT1;KAT7;IKZF1;HDAC9;SKI;DAB2;SMARCA4;KMT5A;NACC1;EHMT2;FHL2;CBX3;PTCH1;ZBTB21;L3MBTL2;TRIM33;BCLAF1;MIER3;BATF3;SOX8;KANK2;EED;TRIB3;DAXX
gsea,protein autoubiquitination (GO:0051865),0.6790368603210123,2.167619050443354,0.0,0.00016766089025480047,0.019,7/22,8.06%,BRCA1;UBE2T;RAD18;UHRF1;STUB1;RNF157;KLHL24
gsea,cytoplasmic translation (GO:0002181),-0.838017575187079,-2.1613367172769746,0.0,0.0006640599628822033,0.031,28/35,11.35%,RPS26;RPS17;RPL22L1;EIF4A1;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;RPL5;RPS8;RPS25;RPL10A;RPL14;RPL23A;RPS15;EIF2B3;RPL4;RPL3;ETF1;RPS27A;RPL41;RPLP0;GSPT2;RPL8;RPL7
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.6318057598259885,2.1556268447391416,0.0,0.0001997559749607194,0.023,14/31,11.01%,CCNA2;CCNB1;CCNF;CDKN2D;CDKN2C;CDC25C;BLM;CCNG2;PKMYT1;CCNE1;CDC25A;CDC6;CCNE2;CDKN3
gsea,peptidyl-lysine modification (GO:0018205),0.5423412639381261,2.1555824143880615,0.0,0.0001983392659184448,0.023,34/65,22.36%,NDC1;RANGAP1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;PIAS4;NUP62;POM121;NUP153;TRIM28;SUMO2;NUP93;NUP88;SENP7;NUP214;NUP98;HDAC6;NUP43;EP300;SAE1;KAT2B;SEH1L;EGR2;ATPSCKMT;RANBP2;SIRT1;HDAC9;CTH
gsea,regulation of microtubule polymerization or depolymerization (GO:0031110),0.7373802103500922,2.1551411441192383,0.0,0.00019694251052465293,0.023,6/16,11.00%,SKA1;SKA2;SKA3;STMN1;CLASP2;CLASP1
gsea,cell junction organization (GO:0034330),-0.6396223239777774,-2.1412065730434557,0.0,0.0008966172139052458,0.043,6/24,11.46%,ACTB;ACTG1;SH3BP1;FLNA;MARVELD2;RAB39B
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.6259316512907448,-2.1398082899946558,0.0,0.0008948829446327018,0.044,23/42,19.19%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PUS7;PSMD12;PSMD7;PSMC1;PSMC5;PSMD2;OSM;EIF2AK2;PSMD11;PSMB7;PSME3
gsea,regulation of DNA replication (GO:0006275),0.6430505688227357,2.1342411749039716,0.0,0.0003096450427712783,0.033,15/35,13.84%,CCNA2;ESCO2;FBXO5;BLM;GMNN;NUCKS1;ATAD5;CTC1;FAF1;SMC3;CDC6;ATR;CDT1;PDS5A;RBBP6
gsea,regulation of protein localization to nucleus (GO:1900180),0.6340474755669421,2.1341184548343226,0.0,0.00030749472997425553,0.033,6/27,13.79%,CDK1;PLK1;GTSE1;SIN3A;GSK3B;LIF
gsea,positive regulation of DNA metabolic process (GO:0051054),0.586735128504995,2.1337863638131886,0.0,0.00030537407666408824,0.033,23/39,22.15%,RAD51;BRCA1;SMCHD1;ATRX;HMGB1;RGCC;TOX;RTEL1;APLF;PPP1R10;RAD50;TRIM28;USP9X;ZCWPW1;WRN;PRKD2;RNF168;SIRT6;PARP3;PML;SIRT1;ABRAXAS1;EYA3
gsea,response to light stimulus (GO:0009416),0.6074238219566692,2.133663364318993,0.0,0.00030328247339926574,0.033,4/32,5.75%,PCLAF;CDKN2D;USP1;ZRANB3
gsea,neutrophil mediated immunity (GO:0002446),-0.44633689110356894,-2.1326092295819694,0.0,0.0009479130450553804,0.048,104/220,29.08%,S100A11;PGLYRP1;CTSD;ANXA2;PPIA;PLAC8;ALDOA;MIF;HSP90AB1;PKM;NME2;ADAM8;APRT;FCER1G;PGAM1;PSMA5;GLIPR1;CCT2;CCT8;DDOST;GUSB;PSMD3;VCP;SLC2A3;TXNDC5;CD55;IMPDH1;PSMD6;PSMD1;ARSB;FABP5;VAMP8;PSMD14;FGL2;PSMD12;ALAD;ACTR2;KCNAB2;AGPAT2;MVP;TMBIM1;PSMD7;PPIE;PA2G4;PLEKHO2;ALDOC;BST2;NRAS;CST3;LGALS3;PDAP1;PFKL;VAT1;MAGT1;EEF1A1;SYNGR1;SLC11A1;OSTF1;CD14;PSMD2;PADI2;CYFIP1;NEU1;PGM1;VAMP7;SLC15A4;ITGAM;GAA;ADGRG3;ENPP4;IDH1;CEACAM1;ATP8B4;GNS;CD93;PYGB;PSMD11;LPCAT1;PSMB7;PDXK;HVCN1;JUP;PYGL;SVIP;MOSPD2;ACLY;COMMD9;PSMC2;CPPED1;RAB3D;PGRMC1;LTF;DSP;RAB27A;CKAP4;IMPDH2;HPSE;CAND1;TICAM2;HK3;PRCP;ANXA3;PLAU;ALOX5
gsea,chromatin organization (GO:0006325),0.5119780191484795,2.130763809082588,0.0,0.0003329266249345323,0.036,38/90,21.45%,EZH2;HMGB2;SUV39H1;HMGN1;PBRM1;NUCKS1;HIRIP3;RBBP4;ATRX;ARID1A;SATB1;SUV39H2;SMARCC2;BPTF;BAZ1B;SAFB;SMARCC1;KDM6B;JARID2;MTF2;HCFC1;MYB;PWWP3A;HMG20A;SETD2;SETDB2;KAT2B;DDX11;PHF19;PIH1D1;CDAN1;SPI1;SMARCA2;CHD1;HDAC5;RB1;CHD1L;SIRT1
gsea,neuron projection development (GO:0031175),0.5047838851656948,2.130511421209769,0.0,0.00033067712071200173,0.036,23/75,24.37%,UBB;KIF20B;STMN1;BTG2;MAP4K4;HMGB1;GPM6B;ROCK1;SRGAP2;PACSIN1;ARC;GSK3B;DCLK1;GPRIN3;HDGFL3;TNIK;TAOK2;TAOK1;TMEM108;RB1;UNC5A;KLK8;CAMSAP2
gsea,neutrophil degranulation (GO:0043312),-0.4466080467452443,-2.1274834115736936,0.0,0.0009808046766354793,0.05,104/219,29.08%,S100A11;PGLYRP1;CTSD;ANXA2;PPIA;PLAC8;ALDOA;MIF;HSP90AB1;PKM;NME2;ADAM8;APRT;FCER1G;PGAM1;PSMA5;GLIPR1;CCT2;CCT8;DDOST;GUSB;PSMD3;VCP;SLC2A3;TXNDC5;CD55;IMPDH1;PSMD6;PSMD1;ARSB;FABP5;VAMP8;PSMD14;FGL2;PSMD12;ALAD;ACTR2;KCNAB2;AGPAT2;MVP;TMBIM1;PSMD7;PPIE;PA2G4;PLEKHO2;ALDOC;BST2;NRAS;CST3;LGALS3;PDAP1;PFKL;VAT1;MAGT1;EEF1A1;SYNGR1;SLC11A1;OSTF1;CD14;PSMD2;PADI2;CYFIP1;NEU1;PGM1;VAMP7;SLC15A4;ITGAM;GAA;ADGRG3;ENPP4;IDH1;CEACAM1;ATP8B4;GNS;CD93;PYGB;PSMD11;LPCAT1;PSMB7;PDXK;HVCN1;JUP;PYGL;SVIP;MOSPD2;ACLY;COMMD9;PSMC2;CPPED1;RAB3D;PGRMC1;LTF;DSP;RAB27A;CKAP4;IMPDH2;HPSE;CAND1;TICAM2;HK3;PRCP;ANXA3;PLAU;ALOX5
gsea,regulation of generation of precursor metabolites and energy (GO:0043467),0.6242031164057021,2.1273789367926064,0.0,0.0003362782352526652,0.036,22/35,16.25%,NDC1;NUP133;NUP107;NUP37;HIF1A;NUP160;NUP35;AAAS;NUP205;NUP85;SLC2A6;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;EP300;SEH1L
gsea,translational termination (GO:0006415),-0.6217262823972517,-2.1261666017895906,0.0,0.0009599364920262138,0.05,35/55,23.27%,ABCE1;MRPL19;MRPL20;MRPL12;MRPL50;MRPL42;MRPS18B;ETF1;CHCHD1;MRPS28;MRPS30;MRPL3;MRPL15;GSPT2;MRPL11;MRPS7;MRPS10;MRPL38;MRPS22;N6AMT1;MRPL17;MRRF;MRPL16;MRPL13;MRPL44;GADD45GIP1;MRPS2;MRPS25;MRPL40;MRPL35;MRPS18A;MRPL53;MRPS35;MRPS5;MRPL22
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.5825564463346453,2.1230154990659034,0.0,0.0003651095320115371,0.039,17/37,26.28%,CDK1;CCNB1;NFKB1;MED4;JUN;MED14;TRIM28;SETX;MED30;MED13;MED12;LEF1;CDKN1A;MED8;BCLAF1;CSF1R;TNRC6A
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.6093750126501793,-2.1209252061875232,0.0,0.0009912071504785832,0.051,23/43,19.19%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PUS7;PSMD12;PSMD7;PSMC1;PSMC5;PSMD2;OSM;EIF2AK2;PSMD11;PSMB7;PSME3
gsea,neutrophil activation involved in immune response (GO:0002283),-0.4437278386793452,-2.116160924596673,0.0,0.00105468347045997,0.055,104/221,29.08%,S100A11;PGLYRP1;CTSD;ANXA2;PPIA;PLAC8;ALDOA;MIF;HSP90AB1;PKM;NME2;ADAM8;APRT;FCER1G;PGAM1;PSMA5;GLIPR1;CCT2;CCT8;DDOST;GUSB;PSMD3;VCP;SLC2A3;TXNDC5;CD55;IMPDH1;PSMD6;PSMD1;ARSB;FABP5;VAMP8;PSMD14;FGL2;PSMD12;ALAD;ACTR2;KCNAB2;AGPAT2;MVP;TMBIM1;PSMD7;PPIE;PA2G4;PLEKHO2;ALDOC;BST2;NRAS;CST3;LGALS3;PDAP1;PFKL;VAT1;MAGT1;EEF1A1;SYNGR1;SLC11A1;OSTF1;CD14;PSMD2;PADI2;CYFIP1;NEU1;PGM1;VAMP7;SLC15A4;ITGAM;GAA;ADGRG3;ENPP4;IDH1;CEACAM1;ATP8B4;GNS;CD93;PYGB;PSMD11;LPCAT1;PSMB7;PDXK;HVCN1;JUP;PYGL;SVIP;MOSPD2;ACLY;COMMD9;PSMC2;CPPED1;RAB3D;PGRMC1;LTF;DSP;RAB27A;CKAP4;IMPDH2;HPSE;CAND1;TICAM2;HK3;PRCP;ANXA3;PLAU;ALOX5
gsea,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.7071267548996961,2.11612712783688,0.0,0.00041670948418958016,0.043,9/17,18.21%,TPX2;STMN1;FGF13;DYRK1A;CLASP2;CLASP1;HDGFL3;KATNB1;TAOK1
gsea,proteolysis (GO:0006508),-0.47491143819975734,-2.1129326658744954,0.0,0.0010992145503238354,0.058,26/104,17.35%,GZMB;CTSD;PSMB5;PSMA6;NAPSA;TMPRSS6;SPCS3;PSMD6;DPP3;METAP2;RNPEP;ERAP1;LAP3;CAPN2;ST14;CASP3;AFG3L2;LACTB;PCSK4;NLN;CASP1;ERMP1;CASP7;VASH1;PSEN2;ZMPSTE24
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5829262373549463,2.1127410866833136,0.0,0.0004369661952265737,0.046,19/39,25.03%,UBB;ITGB1;FOS;JUN;BAMBI;USP9X;ENG;LPXN;LRRC32;TGFBR3;PTPRK;ACVRL1;USP15;SMAD7;SIRT1;SKI;MAP3K7;CBL;ARHGEF18
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),-0.6084970332723978,-2.1127108731004083,0.0,0.0010776613238468974,0.058,20/34,21.76%,COX17;NDUFAF4;NDUFA12;SCO2;NDUFAF1;CHCHD4;NDUFAB1;SAMM50;SLC25A33;ECSIT;COX18;NDUFA5;NDUFAF5;COX19;SDHAF3;NDUFAF6;FOXRED1;UQCC1;NDUFS1;TMEM126B
gsea,plasma membrane bounded cell projection assembly (GO:0120031),0.4617761028483207,2.1121291008774232,0.0,0.00043411020702247845,0.046,46/119,26.10%,PLK4;ITGB1;PCNT;MAP4K4;ASAP1;HYLS1;SCLT1;KIF24;NRP1;EHD3;IFT80;EXOC4;SRGAP2;CEP83;CENPJ;WDR90;CEP89;POC1B;SSX2IP;CCDC28B;S1PR1;ARL13B;NOTCH1;PDE6D;HDAC6;TNIK;AHI1;EXOC2;IFT74;PCM1;KIF3B;ANO6;GBF1;IFT81;NEK1;IFT140;VCL;CCDC88A;DYNC2H1;CEP164;TMEM107;IFT46;OFD1;CD2AP;CEP162;KIT
gsea,actomyosin structure organization (GO:0031032),0.6245224321563534,2.1118468873118315,0.0,0.00043129130957428053,0.046,8/27,13.19%,CIT;ITGB1;CSRP1;ROCK1;PDLIM1;ROCK2;EPB41L2;EPB41
gsea,cellular component disassembly (GO:0022411),-0.6459223123613896,-2.1110729061364615,0.0,0.00107271224773279,0.059,8/23,9.67%,CAPG;ADAM8;LCP1;TMPRSS6;BSG;CAPN2;FLOT1;LAMC1
gsea,negative regulation of Wnt signaling pathway (GO:0030178),-0.4911277764867953,-2.1091807436645396,0.0,0.0010679499292078941,0.06,30/89,21.43%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;TLE5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;HDAC1;DKKL1;RACK1;PSMD7;PSMC1;PSMC5;FRZB;LRP6;PSMD2;WNT11;TMEM64;PSMD11;PSMB7;PSME3;DAB2IP;NXN
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5526826504384944,2.1080938840366374,0.0,0.00044354418096116726,0.047,22/50,25.03%,UBB;ITGB1;FOS;PDCD4;STUB1;JUN;BAMBI;HIVEP1;USP9X;ENG;LPXN;LRRC32;TGFBR3;PTPRK;ACVRL1;USP15;SMAD7;SIRT1;SKI;MAP3K7;CBL;ARHGEF18
gsea,regulation of nucleic acid-templated transcription (GO:1903506),0.4346110148224304,2.102291589807879,0.0,0.00047804848708548226,0.051,70/177,21.56%,TCF7;EZH2;MYBL2;NSD2;LIN54;ACTN4;NUP107;ATRX;SP1;FOXN3;HIF1A;POLR2A;BRCA2;NFYB;NUP35;TAF5;SAP30;SRRT;MYBL1;IRF2;CCAR1;ATXN1;CREBBP;ATF4;BHLHE40;CHEK2;MTF2;CRABP2;FUS;NAB2;RPS6KA5;HCFC1;NFYA;MLF1;SSBP2;RORA;NOTCH1;ATF2;NFKB2;MYB;CHD3;JMJD1C;ENG;NCOA2;TCF3;HMG20A;KMT2D;EP300;TRRAP;DDIT3;NFATC2;PHF19;HINFP;GZF1;KAT6B;ARNTL;AJUBA;ABL1;STAT3;NONO;SPI1;ACVRL1;SMARCA2;GON4L;PML;ASCC1;AIRE;DVL1;RB1;KAT7
gsea,positive regulation of cellular protein localization (GO:1903829),0.5699381944512715,2.1018921079103245,0.0,0.00048242552339239554,0.052,10/39,13.79%,CDK1;PLK1;NDC80;GTSE1;NUMA1;NUP62;CENPQ;GSK3B;CDT1;LIF
gsea,positive regulation of fibroblast proliferation (GO:0048146),-0.6944844586143764,-2.1001639386373308,0.0,0.001154509477952066,0.066,7/18,17.82%,MIF;S100A6;CDK6;MYC;E2F1;PDGFB;PDGFA
gsea,activation of GTPase activity (GO:0090630),0.5534898752558455,2.0967859856294684,0.0,0.0005309968954652034,0.057,23/50,25.56%,ECT2;CCR7;RANGAP1;ADPRH;TBC1D4;NTRK3;CORO1C;TIAM1;TBC1D10B;TBCK;SCRIB;ARHGAP24;TBC1D5;RASGRP1;TSC1;RABGAP1;SIPA1L1;RALGAPA2;TAX1BP3;GRTP1;SYDE2;RALGAPB;TBC1D1
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8361655499452654,-2.096337417461356,0.0,0.001223006690998026,0.071,24/30,11.35%,RPS26;RPS17;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;RPL5;RPS8;RPS25;RPL10A;RPL14;RPL23A;RPS15;RPL4;RPL3;RPS27A;RPL41;RPLP0;RPL8;SRP72;RPL7
gsea,negative regulation of response to DNA damage stimulus (GO:2001021),0.6822752301362649,2.0942375347530815,0.0,0.0005276572923490701,0.057,7/17,9.71%,FBXO5;CDKN2D;DDIAS;TPT1;CD44;RTEL1;DYRK1A
gsea,cellular response to lectin (GO:1990858),-0.555793495597589,-2.0935057851483623,0.0,0.0011880342540813455,0.073,26/56,19.19%,PSME2;PSMA4;PSMA3;FCER1G;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;HRAS;PSMD7;PSMC1;PSMC5;NRAS;LYN;PSMD2;PLCG2;CUL1;PSMD11;PSMB7;PSME3
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.555793495597589,-2.0935057851483623,0.0,0.0011880342540813455,0.073,26/56,19.19%,PSME2;PSMA4;PSMA3;FCER1G;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;HRAS;PSMD7;PSMC1;PSMC5;NRAS;LYN;PSMD2;PLCG2;CUL1;PSMD11;PSMB7;PSME3
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.555793495597589,-2.0935057851483623,0.0,0.0011880342540813455,0.073,26/56,19.19%,PSME2;PSMA4;PSMA3;FCER1G;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;HRAS;PSMD7;PSMC1;PSMC5;NRAS;LYN;PSMD2;PLCG2;CUL1;PSMD11;PSMB7;PSME3
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4199221016158261,2.0895644190729,0.0,0.0005753388237149887,0.06,105/258,23.75%,FOXM1;BRCA1;CTCF;BLM;ATAD2;HMGB2;KLF6;FOS;CDK5RAP2;NFKB1;PIM2;SP1;HIF1A;IRF1;MED4;KLF4;BRCA2;ATF7IP;PHIP;ARID1A;MLLT3;THRAP3;IRF4;KLF2;ING1;MYBL1;NUP85;JUN;CREBBP;STAT1;SMARCC2;ATF4;CALCOCO1;NFATC1;ILF3;PPP3CB;KMT2A;CHEK2;CREB1;SMARCC1;NUP62;DYRK1A;BAMBI;KDM3A;ETS1;MED14;HCFC1;NFYA;RUNX1;HIVEP3;MAP3K5;BCL3;RORA;NOTCH1;ILF2;ARID1B;TRIM28;TBL1X;MYB;NCOA1;BICRA;GATA3;MMS19;TCF3;SHC1;MED30;EP300;AR;IRF7;DDIT3;IL1B;BTRC;NAA16;NFATC2;MED13;KAT6A;HINFP;KMT2B;ING5;RXRA;PSRC1;FOXO1;QRICH1;KAT6B;MDFIC;ARNTL;MED12;LEF1;TNF;EGR2;PHF8;STAT3;TFE3;ACVRL1;BRPF1;SMARCA2;PML;AIRE;CD86;NPAT;EGR1;AXIN1;SMARCA4;ZBTB48;ARHGEF11
gsea,mitochondrial translation (GO:0032543),-0.5821640675135888,-2.084091392396384,0.0,0.001334740663180979,0.082,37/63,23.27%,NOA1;MRPL19;MRPL20;MRPL12;MRPL50;MRPL42;MRPS18B;CHCHD1;MRPS28;MRPS30;MRPL3;MRPL15;MRPL11;MRPS7;MRPS10;MRPL38;MRPS22;MRPL17;MRRF;MRPL16;MRPL13;MRPL44;GADD45GIP1;TUFM;RARS2;MRPS2;EARS2;MRPS25;MRPL40;MRPL35;FASTKD2;MRPS18A;MRPL53;GFM1;MRPS35;MRPS5;MRPL22
gsea,cell cycle G1/S phase transition (GO:0044843),0.579704969316885,2.0837905860933144,0.0,0.0006079529672717547,0.064,21/44,23.99%,CCNA2;CDKN2D;CDKN2C;DBF4;PIM2;POLE;RCC1;CCNE1;CDC25A;CDC7;CCNE2;CDKN3;E2F3;NASP;HINFP;PHF8;RB1;PLK2;CDKN1A;CUL3;CDK2
gsea,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.6744119966300564,2.081215427692961,0.0,0.0006257787487195377,0.067,2/19,0.77%,PLK1;CALM2
gsea,extracellular matrix disassembly (GO:0022617),-0.6495636012738436,-2.0790114528854473,0.0,0.0014492132131135144,0.089,8/22,9.67%,CAPG;ADAM8;LCP1;TMPRSS6;BSG;CAPN2;FLOT1;LAMC1
gsea,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.8185053123447046,-2.077353624380396,0.0,0.001465798703025423,0.092,12/17,10.04%,CCT5;CCT7;NHP2;CCT2;CCT6A;CCT8;DKC1;TCP1;CCT4;CCT3;NOP10;RUVBL1
gsea,postreplication repair (GO:0006301),0.6165694083694757,2.075592713546516,0.0041753653444676405,0.000679129464973816,0.071,13/35,17.21%,UBB;PCLAF;BRCA1;RAD18;RFC4;RFC5;POLH;NSMCE1;RFC1;DTL;RPA3;RPA2;POLD3
gsea,sterol biosynthetic process (GO:0016126),-0.6981901015302472,-2.0694438382734277,0.0,0.0017200035091730695,0.109,13/24,11.05%,FDPS;IDI1;DHCR24;DHCR7;PMVK;MSMO1;SC5D;SQLE;MVD;HMGCR;HMGCS1;LSS;HSD17B7
gsea,positive regulation of translation (GO:0045727),-0.5608721221173836,-2.0654701139365472,0.0,0.0017968681348577268,0.113,16/52,12.13%,EIF5A;RPS27L;PKM;VIM;C1QBP;RPL5;YBX3;CNBP;EIF3D;EIF6;NPM1;CCL5;TRMT10C;EIF2B5;PIWIL2;EIF3C
gsea,homotypic cell-cell adhesion (GO:0034109),-0.6685004644936512,-2.065457414204199,0.0,0.0017687920702505748,0.113,6/20,11.00%,ACTB;PPIA;ACTG1;FLNA;PLEK;ITGB3
gsea,regulation of endopeptidase activity (GO:0052548),-0.6247548754094334,-2.0624071021414823,0.0,0.001855161181373178,0.12,7/25,6.91%,GAPDH;PSME2;PRELID1;PSMA3;SERPINE2;AKT1;HDAC1
gsea,regulation of centriole replication (GO:0046599),0.7030023016965674,2.060827038221092,0.0,0.000774460411051976,0.082,11/17,18.63%,PLK4;STIL;BRCA1;CEP295;CDK5RAP2;MDM1;CENPJ;NUP62;KAT2B;CEP76;ALMS1
gsea,telomere organization (GO:0032200),0.6076613626533917,2.0587191576015456,0.0,0.0007768287915139086,0.082,15/35,18.99%,BLM;TINF2;CTC1;RTEL1;DOT1L;RAD50;RECQL4;ATR;TERF2;WRN;RPA3;PARP3;RPA2;POLD3;DCLRE1B
gsea,actin filament bundle assembly (GO:0051017),-0.6607839105685399,-2.058593024823738,0.0,0.0019016262573444914,0.122,5/20,10.52%,HSP90B1;LCP1;NEDD9;EZR;PDXP
gsea,signal transduction in response to DNA damage (GO:0042770),0.5802669940711851,2.0572099388903,0.0,0.0007861881745441968,0.084,14/36,19.58%,CLSPN;E2F7;BRIP1;RHNO1;ATRX;MDM4;DOT1L;CHEK2;ATR;PAXIP1;BCL3;RAD9A;HINFP;ABL1
gsea,glucose metabolic process (GO:0006006),-0.6200245103046975,-2.057003251880138,0.0,0.0018977306226352693,0.122,20/32,22.98%,GAPDH;ENO1;ALDOA;PGK1;TPI1;ENO3;PGAM1;MDH2;ALDOC;GOT2;GOT1;SLC39A14;PGM1;GAA;CRY1;G6PC3;ADPGK;SLC37A4;DCXR;SORD
gsea,protein acetylation (GO:0006473),0.673132878648478,2.0561826515885335,0.0,0.0008024129732703548,0.086,12/20,23.32%,ESCO2;CREBBP;NAA40;HAT1;EP300;KAT2B;NAA16;KAT6A;ING5;FOXO1;SIRT1;NAA10
gsea,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7009943933396183,2.055605003425927,0.0,0.0008045726769251197,0.086,10/25,12.37%,FBXO5;RRM2;TYMS;E2F7;CDC45;POLA1;CCNE1;CDC6;DHFR;CDT1
gsea,mitochondrion organization (GO:0007005),-0.49160441113748576,-2.0534286733343112,0.0,0.001942203057530043,0.127,53/102,25.09%,TOMM5;TOMM20;TIMM23;PHB;TIMM8B;HSPD1;CHCHD10;HIGD1A;PHB2;CYCS;TIMM17A;TIMM13;PARK7;TIMM9;BID;TIMM10;ATP23;PTCD2;CHCHD4;BAX;AFG3L2;SAMM50;MSTO1;RAB32;SLC25A33;PPRC1;AIFM2;HSD17B10;PARP1;PRDX3;ESRRA;ATAD3A;PNPT1;MIGA1;DNM3;MGARP;COX7A1;PISD;CAV2;BNIP3;HAX1;TMEM70;NDUFS1;STOML2;DNAJA3;MTX1;WDR81;NIPSNAP2;CLUH;ALAS1;TOMM40;IFIT2;OPA1
gsea,organelle transport along microtubule (GO:0072384),0.6909600539104831,2.048570950085571,0.0,0.0009652902143072237,0.105,2/16,3.37%,UBB;NDE1
gsea,platelet aggregation (GO:0070527),-0.6911662031089626,-2.0485642196497253,0.0,0.00198538643634091,0.132,6/17,11.00%,ACTB;PPIA;ACTG1;FLNA;PLEK;ITGB3
gsea,cellular iron ion homeostasis (GO:0006879),-0.6227499335245366,-2.0437666930641876,0.0,0.0021210856461472733,0.143,12/24,17.96%,TMEM199;GLRX3;TMPRSS6;MYC;ATP6V0A2;SLC11A1;TFRC;CCDC115;FRRS1;SLC39A14;CUL1;HMOX1
gsea,positive regulation of kinase activity (GO:0033674),0.5474734350370857,2.0404000084669733,0.0,0.0011104082137522342,0.118,17/41,29.03%,CENPE;CCR7;NTRK3;CCN1;RAD50;MRNIP;MMD;LCP2;FLT1;TNF;CDKN1A;CSF1R;KIT;DAXX;VAC14;GAS6;CD74
gsea,cholesterol metabolic process (GO:0008203),-0.5978355397278483,-2.0398756107864395,0.0,0.002218301383878247,0.148,14/35,11.05%,FDPS;MT3;IDI1;FDX1;DHCR24;DHCR7;PMVK;MSMO1;SQLE;MVD;HMGCR;HMGCS1;LSS;HSD17B7
gsea,translational elongation (GO:0006414),-0.5773337173286047,-2.0386877050215824,0.0,0.002244457570623918,0.152,36/62,23.27%,EEF1G;MRPL19;MRPL20;MRPL12;MRPL50;MRPL42;MRPS18B;CHCHD1;RACK1;MRPS28;MRPS30;MRPL3;MRPL15;MRPL11;MRPS7;MRPS10;MRPL38;MRPS22;EEF1A1;MRPL17;EEF1B2;MRPL16;MRPL13;MRPL44;GADD45GIP1;TUFM;MRPS2;MRPS25;MRPL40;MRPL35;MRPS18A;MRPL53;GFM1;MRPS35;MRPS5;MRPL22
gsea,regulation of stem cell differentiation (GO:2000736),-0.5897973229384277,-2.0373903621788956,0.0,0.0022361858057088862,0.152,26/48,19.19%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;NSUN2;PSMA6;PSMD3;PSMB6;HNRNPU;PSMD6;PSMD1;PSMD14;PUS7;PSMD12;PSMD7;PSMC1;PSMC5;SMYD5;PSMD2;OSM;EIF2AK2;PSMD11;PSMB7;PSME3
gsea,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.838662576962162,-2.036014925266009,0.0,0.0022724786488138994,0.156,12/15,10.04%,CCT5;CCT7;NHP2;CCT2;CCT6A;CCT8;DKC1;TCP1;CCT4;CCT3;NOP10;RUVBL1
gsea,cell junction assembly (GO:0034329),-0.604845550381275,-2.0356296785572674,0.0022271714922048997,0.0022421789334963805,0.156,9/26,16.10%,ACTB;ACTG1;PLXND1;SH3BP1;PKP3;FLNA;RYK;DSCAM;DNM3
gsea,hexose biosynthetic process (GO:0019319),-0.6787884946091352,-2.028738557366479,0.0,0.0024717216420282635,0.169,15/24,17.51%,GAPDH;ENO1;ALDOA;PGK1;TPI1;ENO3;PGAM1;MDH2;ALDOC;GOT2;GOT1;SLC39A14;PGM1;CRY1;G6PC3
gsea,mitochondrial translational termination (GO:0070126),-0.6019405748443506,-2.0280015206459407,0.002044989775051125,0.002471581466128415,0.169,31/50,23.27%,MRPL19;MRPL20;MRPL12;MRPL50;MRPL42;MRPS18B;CHCHD1;MRPS28;MRPS30;MRPL3;MRPL15;MRPL11;MRPS7;MRPS10;MRPL38;MRPS22;MRPL17;MRRF;MRPL16;MRPL13;MRPL44;GADD45GIP1;MRPS2;MRPS25;MRPL40;MRPL35;MRPS18A;MRPL53;MRPS35;MRPS5;MRPL22
gsea,positive regulation of mitotic cell cycle (GO:0045931),0.6582671378709722,2.0278580456978377,0.0,0.001308343227812899,0.133,5/18,12.54%,CCNB1;CDC25B;PRKCA;PPP1R10;USP2
gsea,negative regulation of cell cycle (GO:0045786),0.5545357080860048,2.0269187111588174,0.0018552875695732839,0.0013007365811395681,0.133,15/39,21.25%,PLK1;MAD2L1;NR4A1;GMNN;BTG2;DUSP1;PDCD4;HTRA2;TAF6;GATA3;SCRIB;IPO5;HEXIM1;PTPRK;RB1
gsea,translesion synthesis (GO:0019985),0.5932849661024023,2.0257699091900068,0.004073319755600814,0.0013066888920840892,0.134,11/33,17.21%,UBB;PCLAF;RFC4;RFC5;POLH;REV3L;RFC1;DTL;RPA3;RPA2;POLD3
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.543864512167585,2.023931690358494,0.0,0.0013326631854419643,0.137,19/38,23.77%,UBB;BRCA1;BIRC3;STUB1;FANCI;PIAS4;WDR48;HUWE1;ZC3H12A;PAXIP1;SAE1;PINK1;MALT1;TNIP1;FBXW7;SMAD7;AXIN1;CENPS;CUL3
gsea,regulation of cellular response to heat (GO:1900034),0.5443306691795385,2.0202139371620826,0.0,0.0013783162272289638,0.142,32/62,21.45%,NDC1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;CAMK2D;IER5;NUP205;NUP85;NUP155;CREBBP;DNAJB1;NUP62;ATR;POM121;GSK3B;NUP153;BAG4;NUP93;NUP88;NUP214;RPA3;NUP98;NUP43;EP300;SEH1L;RPA2;HSPA1B;RANBP2;SIRT1
gsea,positive regulation of protein ubiquitination (GO:0031398),0.5454827202110517,2.0184510360364976,0.0,0.0014366918843055528,0.149,18/37,23.77%,UBB;PLK1;BRCA1;BIRC3;STUB1;FANCI;FANCM;HUWE1;PAXIP1;PINK1;MALT1;MTA1;FBXW7;SMAD7;AXIN1;CENPS;PIN1;CUL3
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.4308326661974948,2.0154981414665727,0.0,0.00150757451912445,0.156,59/168,28.18%,AURKB;UBE2C;PLK1;UBE2S;BUB3;BUB1B;AURKA;KIF14;FZR1;MAD2L1;CDC20;TNFAIP3;TAF1;FAF1;BIRC6;RNF19A;UHRF1;STUB1;CDC23;CDC27;RNF5;UBR4;SKP2;RNF40;ZNRF1;HUWE1;ANAPC1;TBL1X;USP9X;RBBP6;RNF168;ANAPC7;DTL;DDIT3;BTRC;PINK1;NFE2L2;FBXO45;MTA1;FBXO11;ARNTL;UBR3;FBXW7;PML;SIRT1;UBE4A;RNF213;USP33;CUL3;CBL;RNF215;ZSWIM8;FBXL14;TBX21;AREL1;HACE1;RNF8;MDM2;OTUD7B
gsea,regulation of response to DNA damage stimulus (GO:2001020),0.6279974530830242,2.0153211526274815,0.0,0.001499104999354088,0.156,12/24,19.58%,FBXO5;ANKLE1;RFWD3;USP1;POLH;NSMCE4A;NSMCE1;FMR1;ETAA1;RPA2;WDR76;ABL1
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6603561439257808,-2.013529612415982,0.0,0.00302883458183376,0.196,23/31,19.19%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PINX1;PSMD12;PSMD7;PSMC1;PSMC5;PSMD2;CUL1;AVEN;PSMD11;PSMB7;PSME3
gsea,axon development (GO:0061564),-0.5990487323307743,-2.013047187725842,0.0,0.0030112622293020246,0.197,8/24,18.06%,ACTB;S100A6;AFG3L2;RYK;ZPR1;NEFH;BAIAP2;APBB1
gsea,gluconeogenesis (GO:0006094),-0.6933288678856654,-2.0122134508172302,0.0,0.0029838753185096652,0.198,15/22,17.51%,GAPDH;ENO1;ALDOA;PGK1;TPI1;ENO3;PGAM1;MDH2;ALDOC;GOT2;GOT1;SLC39A14;PGM1;CRY1;G6PC3
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.6594428062200943,2.0111884615511055,0.0,0.0015753567112823956,0.165,10/18,21.45%,TNFAIP3;TRIM59;STAT1;PER1;TNIP3;ZC3H12A;RORA;NLRC3;TNIP1;SIRT1
gsea,cholesterol biosynthetic process (GO:0006695),-0.7034015312814524,-2.010896818175835,0.0,0.0029672919038592578,0.2,13/22,11.05%,FDPS;IDI1;DHCR24;DHCR7;PMVK;MSMO1;SC5D;SQLE;MVD;HMGCR;HMGCS1;LSS;HSD17B7
gsea,mitochondrial translational elongation (GO:0070125),-0.5954669081969358,-2.0034142264772283,0.0,0.0031611921905927557,0.21,32/52,23.27%,MRPL19;MRPL20;MRPL12;MRPL50;MRPL42;MRPS18B;CHCHD1;MRPS28;MRPS30;MRPL3;MRPL15;MRPL11;MRPS7;MRPS10;MRPL38;MRPS22;MRPL17;MRPL16;MRPL13;MRPL44;GADD45GIP1;TUFM;MRPS2;MRPS25;MRPL40;MRPL35;MRPS18A;MRPL53;GFM1;MRPS35;MRPS5;MRPL22
gsea,regulation of DNA metabolic process (GO:0051052),0.5938657009036076,2.0033760216909586,0.0,0.0017413912076436788,0.177,12/28,14.76%,KPNA2;TICRR;NUCKS1;PIF1;USP1;ALYREF;POLH;IL7R;SMG6;TERF2;CDT1;YLPM1
gsea,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.6564620501612516,-2.00336822380325,0.0,0.003142872028438947,0.21,7/19,8.50%,GZMB;BAK1;CHCHD10;YWHAE;BID;BAX;E2F1
gsea,maturation of 5.8S rRNA (GO:0000460),-0.7147752465079155,-2.0022377526723405,0.0,0.00316405041137991,0.213,9/15,13.40%,RRP15;MAK16;EIF6;PES1;FTSJ3;MPHOSPH6;RPF1;NOL9;WDR12
gsea,tRNA export from nucleus (GO:0006409),0.6366465119368226,1.9991451072110684,0.0,0.001824694002045033,0.185,19/28,16.25%,NDC1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;SEH1L
gsea,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6366465119368226,1.9991451072110684,0.0,0.001824694002045033,0.185,19/28,16.25%,NDC1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;SEH1L
gsea,regulation of microtubule-based process (GO:0032886),0.6332276639940867,1.9950344795342887,0.0,0.001910234733230923,0.193,9/21,18.21%,AURKA;ROCK1;MACF1;CLASP2;CLASP1;GSK3B;HDAC6;BICD2;TAOK1
gsea,histone modification (GO:0016570),0.4956380705029836,1.99194944927818,0.0,0.0019758471436332027,0.198,28/68,25.76%,AURKB;CCNA2;INCENP;EZH2;BRD8;UHRF1;CREBBP;PARP2;SIN3A;BAZ1B;RPS6KA5;HUWE1;TBL1X;TAF6;HDAC6;EP300;TRRAP;KAT6A;MTA1;KAT6B;HDAC5;SIRT1;HDAC9;EYA3;EHMT2;CDK2;TAF6L;MIER3
gsea,histone acetylation (GO:0016573),0.5297645721710373,1.9884978236680289,0.0,0.0020470488425028675,0.209,25/46,24.93%,BRD8;BRCA2;TAF5;CREBBP;PER1;NAA40;TAF9;ATF2;TAF6;HAT1;EP300;TRRAP;KAT2B;EP400;KAT6A;ING5;KAT6B;LEF1;SPI1;BRPF1;KAT7;JADE1;BRPF3;MAP3K7;TAF6L
gsea,DNA integrity checkpoint signaling (GO:0031570),0.6239439750890676,1.9826959294654913,0.0,0.0021989266598498544,0.22,11/28,17.44%,CLSPN;BRIP1;CDC45;RHNO1;DOT1L;CHEK2;CDC6;ATR;CDT1;RAD9A;HINFP
gsea,NIK/NF-kappaB signaling (GO:0038061),-0.58486487482047,-1.982673665316497,0.003952569169960474,0.0040725947342990215,0.259,22/42,19.19%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;AKT1;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;PSMD2;CUL1;PSMD11;PSMB7;PSME3
gsea,regulation of immune response (GO:0050776),0.5235985632913999,1.9790098899651292,0.0,0.002286867645606453,0.231,22/70,16.77%,ITGB1;SLAMF6;SELL;BIRC3;CRTAM;BCL6;IRF1;FOXP1;CLEC2D;ITGB7;IRF4;IFITM1;CD81;JAML;SAMHD1;CD33;SH2D1A;ULBP1;IRF7;CD200;CD40LG;PLSCR1
gsea,protein transmembrane import into intracellular organelle (GO:0044743),-0.6858308876402831,-1.9775365636065525,0.0019723865877712033,0.004340008854541349,0.271,7/18,11.13%,TOMM20;TIMM23;HSPD1;TIMM17A;CHCHD4;PEX2;GRPEL1
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.5189800207658954,-1.9773089987345145,0.0,0.004290123695293748,0.271,28/59,23.04%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;VCP;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;LRRK1;PSMD7;PSMC1;PSMC5;RUVBL1;PSMD2;HHEX;PSMD11;PSMB7;PSME3;JUP;NRARP;TMEM9;PSMC2
gsea,secondary alcohol biosynthetic process (GO:1902653),-0.6931041856704446,-1.9732498285054632,0.0,0.004483736420503433,0.28,12/21,11.05%,FDPS;IDI1;DHCR24;DHCR7;PMVK;MSMO1;SQLE;MVD;HMGCR;HMGCS1;LSS;HSD17B7
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.5088416256930253,-1.9730689918559952,0.0,0.0044333573595989,0.28,29/67,19.19%,TMSB4X;EIF5A;PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;TNFRSF9;PSMA6;PSMD3;PSMB6;PSMD6;TNFRSF4;PSMD1;TNFSF4;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;TNFSF13B;EDARADD;PSMD2;TNFSF12;TNFRSF1A;PSMD11;PSMB7;PSME3
gsea,response to UV (GO:0009411),0.4911720694810431,1.9730523735686578,0.0,0.0024730427219206083,0.252,20/65,16.65%,AURKB;PCLAF;CDKN2D;RHNO1;USP1;FEN1;TAF1;POLH;ZRANB3;CREBBP;CDC25A;ATF4;SDF4;ATR;FMR1;BCL3;WRN;DTL;EP300;USP47
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5129948998240209,1.9724149699378135,0.0019646365422396855,0.0024907843791398343,0.254,25/42,30.93%,PLK1;FZR1;CDC20;TAF1;RNF19A;STUB1;SOCS5;GSK3B;SUMO2;SIRT6;NFE2L2;TRIB2;HSPA1B;DVL1;SMAD7;DAB2;ZYG11B;ZER1;TRIB1;USP5;TRIB3;MDM2;RNF19B;HSPA1A;CBFA2T3
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.543411727396754,1.9722331505055768,0.0,0.0024838078465510504,0.254,12/35,19.25%,CDK1;CCNB1;NFKB1;MED4;ATF7IP;MED14;PAXIP1;TRIM28;MED30;MED13;MED12;LEF1
gsea,mRNA transport (GO:0051028),0.5185572802634115,1.9721517077046562,0.0,0.002476904366659531,0.254,34/79,16.25%,ZFP36L1;NDC1;NUP133;NUP107;NUP37;UPF3B;NUP160;ALYREF;NUP35;SMG6;AAAS;NXT1;GLE1;NUP205;SLBP;NUP85;NUP155;ARC;NUP62;NXF1;THOC2;FMR1;POM121;SRSF4;NUP153;SRSF3;NUP93;NUP88;NUP214;CASC3;NUP98;CPSF1;NUP43;SEH1L
gsea,intracellular protein transmembrane transport (GO:0065002),-0.6387144822567601,-1.9708641408694298,0.001976284584980237,0.004466128769972466,0.282,10/22,17.18%,HSPA5;TOMM20;TIMM23;HSPD1;TIMM17A;CHCHD4;PEX2;GRPEL1;DNAJC15;SEC61A1
gsea,histone lysine methylation (GO:0034968),0.6075498407951762,1.9675583306309836,0.004140786749482402,0.0026339351212268467,0.271,11/22,17.91%,EZH2;SUV39H1;SMYD3;SUV39H2;DOT1L;KMT2A;SETD1B;PAXIP1;KMT2D;SETDB2;KMT2B
gsea,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6170339582588995,1.9657011680937775,0.0,0.0026987756720729316,0.278,6/22,7.49%,CDKN2D;CDKN2C;E2F7;RBL1;KLF4;WEE1
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.5322988112842106,1.9656842235005565,0.002173913043478261,0.002684864457268432,0.278,18/46,25.34%,UBB;ANKLE1;RFC4;FEN1;RFC5;DXO;RAD50;ZC3H12A;RFC1;RPA3;RPA2;POLD3;DNASE1L3;MUS81;CHD1L;OGG1;RPA1;CUL4B
gsea,renal system development (GO:0072001),0.7059512355071068,1.9624285415537135,0.0,0.0027965836494500715,0.286,2/15,7.86%,CENPF;STAT1
gsea,hemopoiesis (GO:0030097),0.5288266429634687,1.9617400325713632,0.0017730496453900709,0.0028060958387339154,0.287,19/46,19.49%,MELK;ZFP36L2;TOX;ZFPM1;ATF4;KMT2A;SH2B3;RUNX1;CSF2;HIPK1;ETV6;IL3;PLD4;KAT6A;TGFBR3;TET2;SNRK;FLT1;TNFRSF13B
gsea,DNA replication (GO:0006260),0.565287880582556,1.95947212151031,0.002066115702479339,0.002874660857937256,0.296,42/89,18.67%,CDK1;PCLAF;CLSPN;DBF4;TICRR;BRCA1;BRIP1;CDC45;RHNO1;BLM;BARD1;MCM10;POLA1;PIF1;RFC4;FEN1;MCM8;RBBP8;EXO1;RFC5;POLE;FAM111A;CDC6;RMI2;RAD50;RECQL4;ATR;CDC7;TOP3A;ORC6;TOPBP1;REV3L;WRN;RFC1;RPA3;RAD9A;POLA2;WDHD1;RNASEH2A;RPA2;ING5;HELB
gsea,chaperone-mediated protein complex assembly (GO:0051131),-0.7346169108369791,-1.958079221804549,0.0019723865877712033,0.00529144612957267,0.327,5/15,5.80%,HSP90AB1;CCT2;HSPD1;NDUFAF1;HSPA4
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5653039049087464,1.9571286840106605,0.0,0.00293664823458667,0.303,12/30,23.12%,UBB;SPRY1;STUB1;SKIL;PMEPA1;PDPK1;BAMBI;SPRY2;SMAD7;SIRT1;SKI;PIN1
gsea,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5948785618992771,1.9569778446631114,0.002036659877800407,0.002921891208282214,0.303,2/23,0.47%,FBXO5;PLK1
gsea,negative regulation of endopeptidase activity (GO:0010951),-0.6414623698885205,-1.9554175391684916,0.0,0.005376592909192673,0.338,4/18,3.20%,GAPDH;MT3;SERPINE2;AKT1
gsea,purine ribonucleotide metabolic process (GO:0009150),-0.5602653304631271,-1.9530618449474033,0.0,0.0055392933526189105,0.345,12/29,25.09%,RAN;HINT1;GIMAP7;DBI;AMPD2;RHOQ;TPST1;ENPP1;EFL1;ACLY;AK4;OPA1
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5406013587180856,-1.950702245298385,0.0038684719535783366,0.0056025384352802665,0.348,30/78,11.35%,RPS26;RPS17;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;RPL5;RPS8;RPS25;NCBP2;RPL10A;RPL14;RPL23A;UPF1;RPS15;RPL4;RPL3;MRTO4;ETF1;RPS27A;RPL41;RPLP0;PELO;GSPT2;MAGOHB;RPL8;RPL7
gsea,Fc receptor signaling pathway (GO:0038093),-0.49184330198227455,-1.9484739954495356,0.0,0.005698991384239838,0.355,25/64,19.19%,PSME2;PSMA4;PSMA3;FCER1G;PSMB2;PSMB5;PSMA5;LAT2;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;LYN;PSMD2;PLCG2;CUL1;PSMD11;PSMB7;PSME3
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),0.6663971097754311,1.9455782157564776,0.0016863406408094434,0.0034316411865126916,0.339,10/18,19.89%,HIF1A;PDCD4;PER1;GBP5;ZC3H12A;NLRC3;PLD4;IL17RA;TNF;STAT3
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.5369343684990433,1.9445535910821117,0.0021231422505307855,0.003449351723513251,0.341,14/40,14.25%,BRCA1;POLQ;HMGB2;NSD2;BARD1;POLA1;HMGB1;PIAS4;RAD50;PAXIP1;HERC2;MDC1;SMC5;RNF168
gsea,Fc-gamma receptor signaling pathway (GO:0038094),-0.538857238461532,-1.94392440268141,0.002012072434607646,0.006007057127469344,0.367,14/37,18.90%,ACTB;ACTG1;HSP90AB1;FCER1G;MYO10;ACTR2;MYO1G;LYN;CYFIP1;PLCG2;PRKCE;MYO1C;BAIAP2;LIMK1
gsea,positive regulation of cytoskeleton organization (GO:0051495),0.5129753287281528,1.9439055841096589,0.0,0.0034380442555120515,0.341,10/41,9.51%,PLK4;SPAG5;CCR7;GPSM2;NUMA1;NTRK3;EVL;SYNPO;NRP1;NUP62
gsea,positive regulation of mRNA catabolic process (GO:0061014),0.5579069917275116,1.9430911992135036,0.003929273084479371,0.0034383284195824977,0.343,15/27,26.28%,ZFP36L1;BTG2;ZFP36L2;ROCK1;ROCK2;CELF1;CNOT1;ZC3H12A;TOB1;EIF4ENIF1;METTL14;FTO;AGO2;KHSRP;TNRC6A
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5145591380763865,1.942047128304046,0.0,0.0034614577033634467,0.344,17/38,27.39%,UBB;NFKBIA;BIRC3;REL;ROCK1;ROCK2;RELB;BCL3;NLRC3;MAP3K14;PRDX4;TRAF2;TNF;TLR7;MAP3K7;TAB3;CARD11
gsea,IRE1-mediated unfolded protein response (GO:0036498),-0.5790347842276572,-1.9419412989262081,0.0,0.006055067072102371,0.374,11/26,16.65%,PDIA6;HSPA5;XBP1;DNAJB11;SERP1;MYDGF;HYOU1;HDGF;EDEM1;SYVN1;ERN1
gsea,"negative regulation of gene expression, epigenetic (GO:0045814)",0.6600435392780226,1.9408399142607222,0.0019880715705765406,0.0034786772224866744,0.345,10/17,20.06%,EZH2;SUZ12;RBBP4;DNMT1;JARID2;MTF2;TASOR;PHF19;RBBP7;SPI1
gsea,rRNA modification (GO:0000154),-0.6924002360762812,-1.9389671165135305,0.005870841487279843,0.006210913770486492,0.38,12/17,23.05%,NHP2;DKC1;GAR1;NOP10;FBL;FTSJ3;THUMPD1;MTERF4;NSUN3;DIMT1;BUD23;TSR3
gsea,cellular protein-containing complex assembly (GO:0034622),0.46841472456452066,1.9372191546553645,0.0,0.003620173008996856,0.357,23/79,19.90%,CENPF;CENPE;DLGAP5;ANLN;NDC1;MIS12;TESPA1;NUP107;CENPT;NSG2;DNAAF2;NUP205;CENPA;TIAM1;NUP153;HOPX;NUP93;NUP98;HIP1;IMMP2L;TRAF2;CENPW;AIFM1
gsea,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6939784407852734,1.9362975656386516,0.0,0.0036758637743375534,0.362,9/20,17.21%,UBB;RFC4;RFC5;POLE;XRCC1;RFC1;RPA3;RPA2;POLD3
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.5641886567657475,-1.9289050785965276,0.0,0.006943628774094482,0.409,8/27,18.06%,ACTB;S100A6;AFG3L2;MFSD2A;RYK;NEFH;BAIAP2;APBB1
gsea,positive regulation of DNA repair (GO:0045739),0.571252530971822,1.9283864214988833,0.0,0.004083953286156053,0.394,15/31,22.15%,FOXM1;BRCA1;SMCHD1;HMGB1;XRCC1;SPIDR;TRIM28;ZCWPW1;RNF168;FAM168A;MGMT;DDX11;SIRT1;ABRAXAS1;EYA3
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.6004023836602034,-1.9276778743984893,0.002079002079002079,0.006948020329285736,0.414,8/21,9.04%,S100A10;CALR;C1QBP;NEDD9;FLNA;CAPRIN1;CDKL3;P4HB
gsea,fatty acid metabolic process (GO:0006631),-0.47368575496681564,-1.9269617339971115,0.002331002331002331,0.006927959298257955,0.416,26/55,35.53%,GPX1;ACSL5;NUDT19;XBP1;MSMO1;FASN;AOAH;NDUFAB1;PEX2;ACSL4;ABCD3;ACLY;NAAA;ELOVL4;LPIN2;ACOX1;ALOX5;ACSL1;ACAD9;PON3;SLC27A2;OXSM;ACADM;PPARG;GNPAT;CBR4
gsea,cellular response to chemical stress (GO:0062197),-0.48447899156687463,-1.9264534629164805,0.0,0.006892207123408888,0.417,18/60,14.85%,PPIA;EIF2S1;GPX1;PRDX1;MT3;CYCS;PARK7;TXNRD1;SRXN1;SELENOS;SLC25A24;PYCR2;KEAP1;GSR;PARP1;PRDX3;ERMP1;PNPT1
gsea,T cell receptor signaling pathway (GO:0050852),-0.46550149591014256,-1.921274005797481,0.002,0.007231465089798888,0.43,32/74,23.93%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;TXK;PSMD3;PSMB6;UBE2N;PSMD6;PSMD1;TNFRSF21;PSMD14;EIF2B3;PSMD12;PSMD7;PSMC1;PSMC5;EIF2B5;PSMD2;PLCG2;CUL1;PSMD11;PSMB7;PSME3;THEMIS;STOML2;RIPK2;PSMC2;EIF2B1
gsea,cellular response to growth factor stimulus (GO:0071363),0.4692593955398186,1.9208454442037386,0.003766478342749529,0.0044546856776527255,0.42,25/73,21.29%,XCL1;ZFP36L1;NR4A1;ZFP36L2;NTRK3;CD44;KNSTRN;KLF4;CPNE3;NRP1;PDPK1;HTRA2;PTPN11;NOTCH1;PRKD2;EGR3;SETX;STAT5B;SHC1;PLCG1;SPRY2;FLT1;ACVRL1;RAPGEF1;SMAD7
gsea,regulation of cell population proliferation (GO:0042127),0.38094414519189823,1.920831072759908,0.0,0.004433472888711522,0.42,145/339,31.66%,PRC1;FBXO5;BIRC5;SHCBP1;CDC25B;KIF20B;KIF14;FOXM1;SAPCD2;TTK;EZH2;CDKN2D;CDKN2C;E2F7;ZFP36L1;CTCF;HMGB2;JUNB;BTG2;PBRM1;RBBP4;NTRK3;PIM2;NR4A3;BCL6;IRF1;RGCC;BIRC6;KLF4;STAT4;IL7R;PHIP;ITGAX;UHRF1;MDM4;JAK2;IER5;BCL2;CCAR1;IFITM1;JUN;STAT1;CD81;DOT1L;CXCL10;CD33;CDC6;TIAM1;NUP62;CELF1;BAMBI;CDC7;SH2B3;ETS1;CDKN3;RUNX1;CSF2;LMNA;IRS2;ITGA1;NOTCH1;PDS5B;TOB1;LIF;GATA3;ENG;STAT5B;SHC1;STAT2;ARID2;KMT2D;AR;AXIN2;STAT6;IL1B;JUND;IL3;KAT2B;IL9R;CD200;HGS;PLPP1;SULT2B1;PRKRA;ING5;DERL2;FLT1;LEF1;MATK;TCIRG1;PTPRK;STAT3;ACVRL1;SMARCA2;HSPA1B;TSC1;CCDC88A;CTSH;PML;BAP1;RPRD1B;SIRT1;CCPG1;CD86;PTPN6;SKI;IFIT3;CX3CL1;PTPRJ;IL2;NACC1;CDKN1A;CUL3;CDK2;CHERP;ARHGEF2;CLCF1;HCK;CSF1R;SGK1;KANK2;KIT;IL13RA1;THBS1;EPCAM;OSGIN1;IL6ST;MDM2;KSR1;KLF11;HSF1;TMEM127;PF4;PGF;TIMP1;LGMN;PAK1;INSM1;HSPA1A;CBFA2T3;SOX4;FOSL1;STAT5A;WWTR1;CIAO1
gsea,regulation of fibroblast proliferation (GO:0048145),-0.5629634498781954,-1.919974957904258,0.0021413276231263384,0.007272358032423768,0.433,10/27,20.67%,MIF;S100A6;CDK6;MYC;PEX2;E2F1;CTNNB1;PDGFB;PDGFA;DAB2IP
gsea,positive regulation of vasculature development (GO:1904018),0.5056196014044915,1.9174654960560837,0.0,0.004594702994357147,0.427,28/51,26.82%,BRCA1;ITGB1;SP1;PRKCA;HIF1A;ITGAX;PDPK1;SERPINE1;PIK3CD;ETS1;RUNX1;ZC3H12A;HIPK1;NINJ1;PRKD2;PLCG1;IL1B;PRKCB;FLT1;PIK3R6;AGO2;CTSH;SIRT1;CD40;ITGB8;F3;THBS1;ECM1
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5789906669296685,1.917235624791319,0.0,0.004584022727282546,0.428,11/23,24.91%,SOCS1;ITPKB;PIK3CD;SOCS5;CISH;SOCS3;PIK3CA;PI4KA;PIK3R2;PIK3CG;PIK3R1
gsea,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6026855566716149,1.9141152292262986,0.0,0.0047375615031763725,0.442,6/22,7.49%,CDKN2D;CDKN2C;E2F7;RBL1;KLF4;WEE1
gsea,positive regulation of telomere maintenance (GO:0032206),0.6328439047053808,1.9137861906574816,0.0020408163265306124,0.0047317585501793465,0.445,7/19,9.69%,AURKB;NEK2;ATRX;RTEL1;NEK7;PPP1R10;RAD50
gsea,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.6362844040779101,1.9054927914673407,0.0019083969465648854,0.005202946324558273,0.469,2/17,3.87%,UBB;BIRC3
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5608227064238454,-1.9052551422457233,0.00199203187250996,0.008671841868226421,0.481,23/41,13.12%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;EPAS1;HIGD1A;PSMA6;PSMD3;PSMB6;ELOC;PSMD6;PSMD1;PSMD14;PSMD12;RPS27A;PSMD7;CITED2;PSMC1;PSMC5;EGLN1;PSMD2
gsea,post-translational protein modification (GO:0043687),-0.40784812258997477,-1.9025126941267883,0.0,0.008891843975796163,0.489,73/168,29.55%,LGALS1;HSP90B1;PSME2;PDIA6;SPP1;PSMA4;PSMA3;RCN1;PSMB2;PSMB5;PSMA5;EPAS1;PSMA6;PSMD3;STT3A;PSMB6;ELOC;PSMD6;PSMD1;ASB2;PSMD14;PSMD12;UCHL3;PSMD7;PSMC1;PSMC5;FBXO31;P4HB;KEAP1;LAMC1;CST3;DCAF13;FBXL20;RABGGTB;FBXO21;PSMD2;PRKCSH;COPS5;KLHL5;DDB1;CUL5;KLHL9;WDR5;FBXW4;CUL1;UBE2M;AFP;COPS4;PSMD11;PSMB7;COPS2;PSME3;DCUN1D1;IGFBP7;PSMC2;KLHL21;ZBTB16;SUMF2;CKAP4;FBXW9;SOCS6;ERCC8;ASB4;DCAF4;CAND1;GPS1;RBBP5;COPS3;KLHL42;ASB7;VCAN;FBXO44;PSMC6
gsea,regulation of DNA binding (GO:0051101),0.5933808041019147,1.9011781204506637,0.0,0.005389249741127742,0.484,11/24,12.79%,HJURP;HMGB2;NFKBIA;HMGB1;JAK2;JUN;DOT1L;PLAUR;CDT1;BCL3;CPNE1
gsea,maturation of SSU-rRNA (GO:0030490),-0.612208797211091,-1.8968003044452493,0.0018726591760299626,0.009353060059946152,0.502,16/24,24.71%,RPS8;TSR1;NOB1;WDR3;DCAF13;RIOK2;NOP14;SNU13;HEATR1;SRFBP1;UTP4;UTP6;PWP2;TSR2;TSR3;NOL10
gsea,regulation of organelle assembly (GO:1902115),0.5139209795724565,1.8964809869978485,0.0,0.005761778525076664,0.503,17/36,25.94%,STIL;ADPRH;CEP295;CENPJ;ATXN2L;TBC1D10B;ATXN2;MTMR3;CEP76;ALMS1;TBC1D5;IFT140;RABGAP1;PLK2;HCK;TBC1D1;SDCCAG8
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4983181621508093,1.8952417510322865,0.0,0.00583690624082469,0.505,21/47,26.10%,INCENP;CALM2;EZH2;TNFSF11;RGCC;ETAA1;ATP2B4;DDX3X;IL1B;PIH1D1;PSRC1;FLT1;TNF;PIK3R5;PIK3R6;RASGRP1;SIRT1;CD40;PIK3CG;CSF1R;KIT
gsea,steroid metabolic process (GO:0008202),-0.6105866303718104,-1.8948194985909974,0.0019646365422396855,0.009524703193104545,0.513,8/19,11.18%,FDX2;FDX1;DHCR24;MSMO1;HSD17B10;LSS;HSD17B7;HSD11B1
gsea,positive regulation of DNA recombination (GO:0045911),0.6052629813231758,1.8944622044010013,0.0020408163265306124,0.005911347858712003,0.51,10/21,15.08%,RAD51AP1;FANCB;MRNIP;WDR48;FUS;KMT5C;PAXIP1;ZCWPW1;MMS19;ARID2
gsea,regulation of endothelial cell apoptotic process (GO:2000351),0.5882792986745538,1.8943573192467775,0.0,0.0058950712156021386,0.512,11/26,19.45%,TNFAIP3;RGCC;PDCD4;PDPK1;SERPINE1;GATA3;PLCG1;CD40LG;NFE2L2;ANO6;TNF
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5165331702984789,1.8938117706322957,0.0,0.005905304840467722,0.514,14/39,24.31%,UBB;SPRY1;STUB1;SKIL;PMEPA1;PDPK1;BAMBI;NOTCH1;SPRY2;SMAD7;SIRT1;SKI;PIN1;TRIM33
gsea,stress-activated protein kinase signaling cascade (GO:0031098),0.6246241492793299,1.893550378868417,0.006036217303822937,0.005894450897771078,0.516,8/17,23.93%,UBB;NFKB1;MAP3K5;BTRC;TAOK2;MAP3K8;KAT7;MAP3K7
gsea,protein monoubiquitination (GO:0006513),0.6213607652053911,1.8920019005681492,0.004149377593360996,0.005988200415302283,0.526,6/19,14.70%,UBE2T;RAD18;UHRF1;RNF40;HUWE1;DTL
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.4574418260433939,-1.891117794426042,0.0,0.00987381548695654,0.528,15/59,12.45%,CTSD;RPS27L;DAP;HSPD1;CYCS;VCP;BID;MYC;BAX;HSPE1;IFT57;RACK1;REST;F2R;CASP1
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),-0.4770523589597994,-1.8906405744265067,0.0,0.00984371239095972,0.53,25/64,19.19%,PSME2;PSMA4;PSMA3;FCER1G;PSMB2;PSMB5;PSMA5;LAT2;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;LYN;PSMD2;PLCG2;CUL1;PSMD11;PSMB7;PSME3
gsea,positive regulation of biomineral tissue development (GO:0070169),0.6588620305799943,1.8893778634894605,0.0017271157167530224,0.006159142561288848,0.532,3/17,8.51%,FBXO5;GPM6B;CCN1
gsea,histone H3 acetylation (GO:0043966),0.5552976646322348,1.8863954869357333,0.002061855670103093,0.006261240059602104,0.543,16/26,24.93%,BRCA2;TAF5;PER1;TAF9;KAT2B;KAT6A;ING5;KAT6B;LEF1;SPI1;BRPF1;KAT7;JADE1;BRPF3;MAP3K7;TAF6L
gsea,DNA geometric change (GO:0032392),0.6114648548912328,1.8840284271131011,0.010080645161290322,0.006403681586683239,0.554,11/21,16.62%,BLM;HMGB2;PIF1;HMGB1;ZRANB3;RTEL1;RAD50;RECQL4;HMGB3;WRN;DDX11
gsea,protein dephosphorylation (GO:0006470),0.45078361342075884,1.8830588822179326,0.0,0.006514068742937116,0.56,33/63,32.96%,DUSP4;SSH2;DUSP1;PPP1R15A;UBLCP1;PPP3CB;PPP2R5D;PTPN11;PGP;MTMR3;BTRC;SBF1;PTPN13;SSH1;DUSP6;PTPRK;DUSP2;RPRD1B;CTDSP2;PTPN6;CTDP1;EYA3;TIMM50;PTPRJ;CTDSP1;PTPN3;PPP2R3A;DUSP5;MTMR4;PPP4R1;DUSP16;PPTC7;PPP1CB
gsea,response to endoplasmic reticulum stress (GO:0034976),-0.4688991878764038,-1.8826510059042043,0.0,0.01061229053559922,0.554,24/61,25.03%,HSP90B1;PDIA3;HSPA5;EIF2S1;BAK1;GORASP2;VCP;PDIA4;TMEM33;BAX;FLOT1;SELENOS;HYOU1;P4HB;ATP2A2;EIF2B5;CREB3L1;SYVN1;ERN1;CCDC47;DAB2IP;UBQLN1;UFL1;HERPUD1
gsea,DNA damage checkpoint signaling (GO:0000077),0.5993731901725136,1.8815168190851548,0.002109704641350211,0.006613266159335512,0.571,8/22,17.44%,CLSPN;BRIP1;RHNO1;DOT1L;CHEK2;ATR;RAD9A;HINFP
gsea,cellular response to oxidative stress (GO:0034599),-0.4487525165212071,-1.8813468581702333,0.0,0.0105907798492022,0.556,21/70,17.96%,PPIA;EIF2S1;GPX1;PRDX1;MT3;CYCS;AKT1;PARK7;TXNRD1;SRXN1;SELENOS;SLC25A24;PYCR2;KEAP1;GSR;PARP1;TPM1;PRDX3;ERMP1;PNPT1;HMOX1
gsea,histone H4 acetylation (GO:0043967),0.5399980556440944,1.8804985217233037,0.0019801980198019802,0.006650536444379991,0.573,15/32,22.40%,BRD8;BRCA2;PER1;NAA40;KMT2A;HCFC1;ATF2;HAT1;EP300;TRRAP;EP400;ING5;LEF1;KAT7;JADE1
gsea,antigen receptor-mediated signaling pathway (GO:0050851),-0.4342995963353939,-1.8773067972188622,0.0,0.010903581129219396,0.563,35/90,23.93%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;LAT2;PSMA6;TXK;PSMD3;PSMB6;UBE2N;PSMD6;PSMD1;TNFRSF21;PSMD14;EIF2B3;PSMD12;PSMD7;PSMC1;PSMC5;EIF2B5;PSMD2;PLCG2;PLEKHA1;CUL1;CD38;PSMD11;PSMB7;PSME3;THEMIS;STOML2;RIPK2;PSMC2;EIF2B1
gsea,cellular response to hormone stimulus (GO:0032870),0.5157562132062763,1.8752198755341236,0.003745318352059925,0.007057320695079619,0.595,14/39,21.01%,BRD8;ZFP36L1;NR4A3;ARID5A;TRIM24;NCOA1;NCOA2;STAT5B;KLF9;AR;NCOA3;STAT3;RAMP3;CTSH
gsea,kidney development (GO:0001822),0.6212302577429427,1.8745785668633677,0.0017482517482517483,0.007082257294061869,0.597,1/20,0.22%,CENPF
gsea,protein import into nucleus (GO:0006606),0.5231688519752767,1.8744686171232943,0.0021008403361344537,0.007056752922911909,0.597,21/47,20.76%,KPNA2;NUP133;CSE1L;NUP107;NUP35;NXT1;NUP85;NUP155;PPP1R10;NUP62;FAM53B;POM121;NUP153;E2F3;NUP93;EIF4ENIF1;NUP88;NUP214;IPO5;STAT3;RANBP2
gsea,termination of RNA polymerase I transcription (GO:0006363),-0.5921993978839694,-1.8695760176013347,0.001976284584980237,0.011678614919976337,0.589,14/22,24.00%,POLR2F;POLR2L;POLR1B;CDK7;UBTF;POLR2H;POLR1E;GTF2H2;POLR1A;POLR1C;TAF1A;TAF1D;GTF2H4;GTF2H1
gsea,error-prone translesion synthesis (GO:0042276),0.6612903429363624,1.8661570453162308,0.0,0.00768160315728775,0.623,8/18,17.10%,UBB;RFC4;RFC5;POLH;REV3L;RFC1;RPA3;RPA2
gsea,RNA biosynthetic process (GO:0032774),0.6414693531366844,1.865863412158552,0.002079002079002079,0.007678653823810559,0.624,11/17,19.78%,TTF2;POLA1;POLR2A;PRIM2;TAF5;PRIM1;TAF6;SETX;POLA2;HELB;TBP
gsea,protein stabilization (GO:0050821),-0.4375691168926788,-1.8658532355282218,0.0,0.012104912990912061,0.606,33/99,23.77%,PFN1;GAPDH;HSP90AB1;CALR;CCT5;MT3;CCT7;RPL5;GTPBP4;CCT2;CCT6A;PHB;CCT8;HSPD1;PHB2;PARK7;TCP1;CCT4;CCT3;FLNA;FLOT1;CDK7;BAG2;ZSWIM7;USP36;SYVN1;CRTAP;BAG3;TBRG1;NAA15;TESC;WDR81;MSX1
gsea,mRNA export from nucleus (GO:0006406),0.4985872482336982,1.8647196951045095,0.004246284501061571,0.007750106815763229,0.628,32/77,16.25%,NDC1;NUP133;NUP107;NUP37;UPF3B;NUP160;ALYREF;NUP35;SMG6;AAAS;NXT1;GLE1;IWS1;NUP205;SLBP;NUP85;NUP155;NUP62;NXF1;THOC2;POM121;SRSF4;NUP153;SRSF3;NUP93;NUP88;NUP214;CASC3;NUP98;CPSF1;NUP43;SEH1L
gsea,positive regulation of cellular process (GO:0048522),0.3836639927221336,1.8637255725274389,0.0,0.007791329447090771,0.63,112/277,31.99%,PRC1;FBXO5;BIRC5;CDC25B;KIF20B;KIF14;FOXM1;SPAG5;SAPCD2;TTK;EZH2;ANKLE1;CCR7;ZFP36L1;RAD18;NUMA1;DOCK2;ACTN4;DNPH1;NTRK3;PRKCA;FAF1;SMC6;HDGFL2;NSMCE4A;IL7R;PHIP;NSMCE1;ITGAX;IER5;BCL2;CCAR1;CD81;DOT1L;CDC6;TIAM1;CELF1;BAMBI;CDC7;ETS1;FMR1;HCFC1;CSPP1;CSF2;LMNA;IRS2;ZC3H12A;EIF4G2;NOTCH1;SMC5;LIF;P2RX4;PRKD2;SHC1;KMT2D;DDX3X;AR;AXIN2;IL1B;IL3;USP47;PRSS2;DERL2;FLT1;LEF1;MATK;TNF;TCIRG1;EGR2;TGM2;TFE3;RAMP3;CTSH;RPRD1B;SIRT1;CCPG1;CD86;PTPN6;CX3CL1;PTPRJ;IL2;NACC1;DYNC1H1;CUL3;CDK2;CAMK1D;CLCF1;HCK;BCLAF1;CSF1R;EXOSC4;IL13RA1;THBS1;LRP1;EPCAM;SIRPA;IL6ST;MDM2;HSF1;RPTOR;GAS6;PRR7;PGF;TIMP1;LGMN;PAK1;INSM1;SOX4;FOSL1;WWTR1;CIAO1;BTC
gsea,organic hydroxy compound biosynthetic process (GO:1901617),-0.6118722558432006,-1.8605441468262451,0.0038684719535783366,0.012658222111938146,0.626,9/20,10.33%,PARK7;DHCR7;PMVK;MSMO1;SC5D;SQLE;HMGCR;PNPO;HSD17B10
gsea,protein secretion (GO:0009306),-0.5844701150505416,-1.8587278973932528,0.0,0.01280944625233861,0.633,12/21,24.54%,CANX;PARK7;ANXA1;PDIA4;TVP23B;NAGPA;MIA2;SNX19;MAFA;CAMK2G;RAB3D;ARFGAP3
gsea,regulation of DNA repair (GO:0006282),0.5710470156348387,1.8565780464962205,0.002136752136752137,0.008422200758628642,0.655,14/26,22.15%,BRCA1;SMCHD1;DEK;USP1;POLH;UBR5;TRIM28;RNF168;AXIN2;PML;SIRT1;KAT7;ABRAXAS1;EYA3
gsea,cellular response to hypoxia (GO:0071456),-0.45913653232703766,-1.851952119256406,0.0,0.013743657766191643,0.656,42/77,23.04%,PSME2;PGK1;PSMA4;ADAM8;HILPDA;PSMA3;PSMB2;MT3;PSMB5;PSMA5;EPAS1;HIGD1A;PSMA6;PSMD3;PSMB6;ELOC;PSMD6;PSMD1;PSMD14;MYC;PSMD12;RPS27A;PSMD7;PSMC1;HYOU1;PSMC5;P4HB;EGLN1;PSMD2;MGARP;PLK3;HMOX1;PSMD11;PSMB7;BNIP3;PSME3;TIGAR;UBQLN1;HP1BP3;AK4;NDRG1;PSMC2
gsea,tRNA modification (GO:0006400),-0.49500662859769695,-1.8505248417967817,0.0,0.013772925320124314,0.659,27/45,32.40%,NSUN2;PUS1;SSB;PUS7;PUS3;METTL1;THUMPD1;PUSL1;CTU1;WDR4;TRMT61B;TYW5;TRMT13;QTRT1;TRMT5;WDR6;TRMT61A;DTWD1;TRMT6;ALKBH8;TYW3;ADAT2;TARBP1;LCMT2;THG1L;TRUB1;CTU2
gsea,positive regulation of GTPase activity (GO:0043547),0.42030770133169315,1.849592169309305,0.0,0.009003706812567718,0.676,46/110,25.69%,ECT2;EZH2;ARHGAP11A;XCL1;ITGB1;CCR7;RANGAP1;RGS10;ADPRH;MAP4K4;TBC1D4;NTRK3;SRGAP2;RGS16;CORO1C;DOCK11;ITGA6;TIAM1;TBC1D10B;TBCK;GSK3B;NET1;CCL1;SCRIB;RAB3GAP1;ARHGAP24;TBC1D5;TGM2;RASGRP1;TSC1;RAPGEF1;RABGAP1;SIPA1L1;CX3CL1;NF1;RALGAPA2;PIN1;PKP4;TAX1BP3;AFDN;CD40;GRTP1;SYDE2;RALGAPB;TBC1D1;RAP1GDS1
gsea,nucleosome organization (GO:0034728),0.5321591309242313,1.8493296675061288,0.006072874493927126,0.00899528736617047,0.676,19/39,18.90%,CTCF;ANP32E;HMGB2;LIN54;ATRX;BRD2;ARID1A;SMARCC2;BPTF;SMARCC1;SART3;ASF1A;SRCAP;ANP32B;SETD2;ARID2;NASP;KAT6B;CHAF1A
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5167388127105719,-1.8477834022427586,0.00408997955010225,0.014075141536795878,0.669,16/36,25.30%,ACTB;ACTG1;HSP90AB1;MYO10;ACTR2;MYO1G;LYN;CYFIP1;PLCG2;PRKCE;MYO1C;BAIAP2;LIMK1;NCKAP1;ELMO2;NCKIPSD
gsea,peptidyl-lysine trimethylation (GO:0018023),0.6050655519484212,1.840520808765162,0.00205761316872428,0.009870580832173601,0.701,10/17,20.16%,SUV39H1;SUV39H2;KMT2A;SETD1B;KMT5C;SETD2;KMT2D;TET3;TET2;ATPSCKMT
gsea,regulated exocytosis (GO:0045055),-0.44533994038089797,-1.8392151046959055,0.0,0.015206230642508714,0.7,21/70,17.82%,TMSB4X;ALDOA;MANF;ANXA5;SYNGR2;LGALS3BP;FLNA;SYNGR3;PLEK;ITGB3;LYN;SYNGR1;SCCPDH;TAGLN2;CD9;TOR4A;PDGFB;VAMP7;ENDOD1;OLA1;PDGFA
gsea,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.599065299229532,1.8375929082606348,0.0056925996204933585,0.010143901273420212,0.709,4/18,15.59%,UBB;BIRC3;TNIP3;IRF7
gsea,cellular response to tumor necrosis factor (GO:0071356),-0.4269260286410166,-1.8361304018562188,0.0,0.015485020243429123,0.709,39/104,20.67%,TMSB4X;EIF5A;PSME2;PSMA4;PSMA3;PSMB2;CCL4;PSMB5;PSMA5;TNFRSF9;YBX3;CCL3;PSMA6;AKT1;PSMD3;PSMB6;NPNT;PSMD6;TNFRSF4;PSMD1;TNFSF4;TNFRSF21;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;TNFSF13B;CCL5;EDARADD;PSMD2;TNFSF12;TANK;TNFRSF1A;GBP3;PSMD11;PSMB7;PSME3;DAB2IP
gsea,ephrin receptor signaling pathway (GO:0048013),-0.5293179281973379,-1.834911576197252,0.002386634844868735,0.01556587040684281,0.715,6/28,16.72%,ACTB;ACTG1;HRAS;ACTR2;LYN;PSEN2
gsea,positive regulation of protein secretion (GO:0050714),-0.49504433152129507,-1.8305791144075396,0.0024813895781637717,0.016121725199441425,0.724,10/38,18.06%,PPIA;ADAM8;PPID;EXPH5;EZR;AACS;ACSL4;UNC13B;FRMD4A;APBB1
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4933966521898988,1.8282172870101432,0.006382978723404255,0.011156481259944586,0.744,37/74,24.83%,NDC1;NUP133;NUP107;NUP37;UPF3B;NUP160;ALYREF;NUP35;SMG6;AAAS;NXT1;GLE1;NUP205;SLBP;NUP85;NUP155;NUP62;NXF1;THOC2;POM121;SRSF4;NUP153;SRSF3;NUP93;NUP88;NUP214;CASC3;NUP98;CPSF1;NUP43;SEH1L;UPF2;RANBP2;RNPS1;SRRM1;SYMPK;U2AF1
gsea,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.563278506788167,-1.8277428683729462,0.002105263157894737,0.016655561365503845,0.735,6/22,9.51%,PRELID1;GPX1;AKT1;BID;BAX;MLLT11
gsea,cotranslational protein targeting to membrane (GO:0006613),-0.7103615397854285,-1.8276791589756953,0.00998003992015968,0.01654290554591842,0.735,25/32,11.35%,RPS26;RPS17;RPS2;RPS6;RPL31;RPL15;RPS18;RPL7A;RPL10;SSR2;RPL5;RPS8;RPS25;RPL10A;RPL14;RPL23A;RPS15;RPL4;RPL3;RPS27A;RPL41;RPLP0;RPL8;SRP72;RPL7
gsea,activation of protein kinase activity (GO:0032147),0.45871216604056586,1.8261307447623172,0.0017857142857142857,0.011297584153128204,0.747,22/54,23.93%,TPX2;ECT2;KIF14;CLSPN;BORA;MAP4K4;NTRK3;JAK2;PDPK1;ZFP91;TNIK;TAOK2;PINK1;MALT1;TAOK1;TRAF2;ABL1;CCDC88A;CD86;AXIN1;RICTOR;MAP3K7
gsea,base-excision repair (GO:0006284),0.5514290764540263,1.8248886454074467,0.0020408163265306124,0.01137067224955707,0.75,16/37,17.21%,NEIL3;POLQ;RFC4;FEN1;RFC5;POLE;XRCC1;HUWE1;TDG;MBD4;WRN;RFC1;RPA3;USP47;RPA2;POLD3
gsea,muscle organ development (GO:0007517),0.6374336252580531,1.8238477142267673,0.0,0.0114717002763156,0.757,6/18,14.18%,UTRN;SMTN;CHD2;TCF12;CXCL10;EGR3
gsea,negative regulation of mitochondrion organization (GO:0010823),-0.5970657202149884,-1.8228959972254413,0.0,0.017220037555314052,0.748,8/19,19.25%,PRELID1;GPX1;SLC25A5;AKT1;VAT1;TFRC;BNIP3;SLC35F6
gsea,positive regulation of histone methylation (GO:0031062),0.6395861267909254,1.820931428359415,0.0020242914979757085,0.011808744983196185,0.76,9/15,21.45%,BRCA1;DNMT1;KMT2A;JARID2;MTF2;PAXIP1;MYB;PHF19;SIRT1
gsea,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6109784926577241,-1.819970503563031,0.004024144869215292,0.01756615603100299,0.752,13/21,25.22%,RPS8;TSR1;RRS1;DCAF13;NOP14;HEATR1;UTP4;UTP6;PWP2;TSR2;RPP40;NOL10;UTP20
gsea,stress-activated MAPK cascade (GO:0051403),0.5156967967029871,1.818578741752056,0.006276150627615063,0.012039273740547541,0.762,10/30,24.38%,UBB;ZFP36L1;NFKB1;MAP3K5;BTRC;TAOK2;MAP3K8;SH2D3C;MAP3K7;TRIB1
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5012424428459096,-1.8165984901380237,0.006072874493927126,0.017938703265437582,0.763,14/38,18.90%,ACTB;ACTG1;HSP90AB1;FCER1G;MYO10;ACTR2;MYO1G;LYN;CYFIP1;PLCG2;PRKCE;MYO1C;BAIAP2;LIMK1
gsea,platelet degranulation (GO:0002576),-0.4560727712374013,-1.8156981433996664,0.0,0.017971085185546975,0.766,17/57,17.82%,TMSB4X;ALDOA;MANF;ANXA5;LGALS3BP;FLNA;PLEK;ITGB3;LYN;SCCPDH;TAGLN2;CD9;TOR4A;PDGFB;ENDOD1;OLA1;PDGFA
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),0.5186260521503369,1.8142477499090872,0.0034542314335060447,0.012531062824400772,0.77,14/37,22.75%,EZH2;RGCC;SPRY1;TIAM1;CLASP2;BAMBI;CLASP1;GATA3;AXIN2;IL1B;SPRY2;LEF1;SMAD7;DAB2
gsea,positive regulation of hydrolase activity (GO:0051345),0.4302418480473753,1.8139999586303521,0.0,0.012555612335131429,0.77,30/81,24.13%,CALM2;ECT2;EZH2;ARHGAP11A;XCL1;ITGB1;HMGB2;RGS10;MAP4K4;SRGAP2;RGS16;DOCK11;ITGA6;GSK3B;NET1;CCL1;WRN;PINK1;CD200;RAB3GAP1;TGM2;RASGRP1;RAPGEF1;CTSH;CX3CL1;NF1;PIN1;PKP4;AFDN;CD40
gsea,positive regulation of histone acetylation (GO:0035066),0.5984033182223453,1.8121221460704522,0.0019267822736030828,0.01273377755049599,0.773,7/18,21.56%,BRCA1;RPS6KA5;PAXIP1;LIF;IL1B;PIH1D1;KAT7
gsea,transcription by RNA polymerase II (GO:0006366),0.38524579841432116,1.8110008725024518,0.0,0.012826959866252569,0.776,63/172,24.77%,TRIP13;NR4A1;TTF2;PMF1;DEK;NFKB1;TAF1;E2F2;NR4A3;SP1;POLR2A;MED4;TAF5;SRRT;IWS1;MLLT3;POU2F1;SLBP;CREBBP;ATF4;NELFE;IRF9;HDAC7;ELOF1;TRIM24;PKNOX1;POU2F2;NFYA;INTS1;MAML2;RBMX;TAF9;GTF2I;SSRP1;GMEB2;E2F3;RORA;NOTCH1;TBL1X;TAF6;SETX;INTS6;SETD2;CPSF1;AR;KAT2B;RXRA;CSTF1;ELP4;GTF2A1;TBP;LSM11;POLR2B;HDAC5;RPRD1B;HDAC9;CTDP1;INTS3;PCF11;NELFCD;CSTF3;SYMPK;CCNK
gsea,pre-replicative complex assembly (GO:0036388),-0.572254826570349,-1.8092280581454956,0.013358778625954198,0.01886711541600613,0.787,22/42,8.70%,PSME2;MCM2;MCM6;MCM3;PSMA4;PSMA3;PSMB2;MCM4;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;RPS27A;PSMD7;PSMC1;PSMC5;MCM5
gsea,positive regulation of osteoblast differentiation (GO:0045669),0.6312968103302097,1.8090308606177858,0.003289473684210526,0.013081241971386,0.782,4/18,14.98%,FBXO5;IFITM1;CCN1;CCN4
gsea,positive regulation of establishment of protein localization (GO:1904951),-0.6691254662320052,-1.8079668653101326,0.005660377358490566,0.018972761319191934,0.791,9/16,4.65%,CCT5;CCT7;CCT2;CCT6A;CCT8;DKC1;TCP1;CCT4;CCT3
gsea,mRNA destabilization (GO:0061157),0.5466594448473774,1.8076492238030455,0.0041928721174004195,0.013227582742458176,0.789,11/22,20.20%,ZFP36L1;ZFP36L2;ROCK1;ROCK2;CELF1;CNOT1;ZC3H12A;METTL14;ZC3H12D;FTO;PLEKHN1
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3627461701564592,1.8075157437471125,0.0,0.01318926835985721,0.789,96/228,30.08%,CENPF;BIRC5;FOXM1;EZH2;BRCA1;XCL1;CTCF;GMNN;HMGB2;SUV39H1;CBX5;ID3;FOXN3;BCL6;IRF1;FOXP1;KLF4;ATF7IP;PDCD4;POU2F1;ARID5B;SUV39H2;ATXN1;JUN;SMARCC2;SIN3A;PER1;BHLHE40;RBM15;CIC;PIAS4;ILF3;ARID5A;JARID2;RPS6KA5;CSF2;BCL3;NOTCH1;TRIM28;ELK3;MYB;GATA3;CBX4;SHC1;HDAC6;DDIT3;BTRC;SETDB2;USP47;TFDP2;KAT6A;HINFP;GZF1;ZEB1;HEXIM1;FOXO1;KAT6B;MDFIC;ARNTL;LEF1;ZHX2;TNF;PTPRK;NONO;SPI1;SMARCA2;PML;HDAC5;RB1;BAP1;SIRT1;KAT7;IKZF1;HDAC9;SMARCA4;KMT5A;NACC1;CBX3;ZBTB21;L3MBTL2;TRIM33;BCLAF1;SOX8;EED;TRIB3;DAXX;TBX21;PHC1;MBTD1;MDM2;SBNO2;GAS6;KDM8;EHMT1;LANCL2;SPINDOC
gsea,regulation of angiogenesis (GO:0045765),0.4288367630616123,1.8054826316518937,0.0,0.01334317688953302,0.793,48/95,29.23%,BRCA1;ITGB1;TNFAIP3;SP1;PRKCA;HIF1A;RGCC;KLF4;ITGAX;ROCK1;STAT1;PDPK1;CXCL10;SERPINE1;ROCK2;PIK3CD;ETS1;RUNX1;GTF2I;ZC3H12A;HIPK1;ATF2;ATP2B4;NINJ1;PRKD2;PLCG1;IL1B;SPRY2;HGS;PRKCB;FLT1;PIK3R6;FOXJ2;AGO2;CTSH;PML;SIRT1;PDE3B;NF1;CD40;ITGB8;GLUL;F3;THBS1;ECM1;PF4;SPRED1;PGF
gsea,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.6068899447390552,1.804054431862886,0.007407407407407408,0.013532296858422953,0.797,5/18,8.65%,CALM2;XCL1;CAMK2D;PDPK1;CXCL10
gsea,cellular response to alcohol (GO:0097306),0.5655312224104593,1.8039501427919036,0.004098360655737705,0.013488710047201624,0.797,5/21,8.03%,RAD51;BRCA1;BLM;GRAMD1B;SPIDR
gsea,ncRNA export from nucleus (GO:0097064),0.5616543143769867,1.8034035751680642,0.004073319755600814,0.013549339386870501,0.799,21/31,20.76%,NDC1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;SEH1L;TSC1;RANBP2
gsea,regulation of translation (GO:0006417),-0.43604903977812404,-1.7999614005236815,0.0,0.020236353605726093,0.807,47/115,27.69%,GZMB;GAPDH;RPS27L;CALR;VIM;YBX1;RPL10;RPL5;NCBP2;EIF5B;UPF1;EIF3D;SYNCRIP;NOLC1;PKP3;PUS7;PUM3;EIF6;ETF1;NPM1;EIF2A;RACK1;SHFL;CAPRIN1;NCL;EIF3B;PIWIL2;EIF3C;GEMIN5;CYFIP1;MRPL13;EIF4G1;HNRNPD;EIF2AK2;NSUN3;IMPACT;EIF4E;LARP1;RIDA;IGF2BP3;EIF4H;MTG2;IGF2BP2;SHMT1;GSPT1;EIF2AK4;METAP1
gsea,negative regulation of cellular protein localization (GO:1903828),0.5578176819704684,1.7996432987946156,0.009689922480620155,0.014014411306365786,0.813,11/21,28.18%,RIPOR2;GPM6B;SIN3A;ROCK2;GSK3B;DNAJA1;CDT1;SPI1;TAX1BP3;MFHAS1;OTUD7B
gsea,rRNA methylation (GO:0031167),-0.6106083950794531,-1.7976534496612642,0.0019120458891013384,0.020624046669865233,0.813,11/18,22.68%,NOP2;FBL;FTSJ3;MRM3;MTERF4;EMG1;NSUN3;DIMT1;METTL16;MRM1;BUD23
gsea,amyloid fibril formation (GO:1990000),0.5815939232678127,1.7963395312110813,0.0055762081784386614,0.014453497226725127,0.819,1/21,0.24%,UBB
gsea,positive regulation of ATP metabolic process (GO:1903580),-0.5917333515797174,-1.7919548554435414,0.008928571428571428,0.021704778185498843,0.832,3/18,3.29%,TMSB4X;ENO1;VCP
gsea,regulation of cellular response to stress (GO:0080135),0.4419476863260186,1.790970558295625,0.00202020202020202,0.015228523033643348,0.838,40/87,21.45%,NDC1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;CAMK2D;NUP205;NUP85;NUP155;ATF3;CREBBP;ATF4;DNAJB1;SLC38A2;NUP62;ROCK2;ATR;POM121;GSK3B;NUP153;BAG4;NUP93;NUP88;NUP214;RPA3;NUP98;NUP43;EP300;SEH1L;PINK1;RPA2;USP19;ARNTL;AJUBA;ABL1;HSPA1B;RANBP2;SIRT1
gsea,regulation of embryonic development (GO:0045995),0.6220134143913926,1.7902763285550756,0.0057692307692307696,0.015290481213119187,0.839,6/15,12.20%,CDK1;RACGAP1;CCSAP;CLASP2;CLASP1;TDG
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.4706451080013759,-1.789233748231523,0.00205761316872428,0.022124226133603098,0.84,12/42,12.45%,RPS27L;DAP;HSPD1;CYCS;VCP;BID;BAX;HSPE1;IFT57;RACK1;F2R;CASP1
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.47849561678030217,-1.7864289358024235,0.005825242718446602,0.022513600115576977,0.843,28/53,20.25%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;EPAS1;HIGD1A;PSMA6;PSMD3;PSMB6;ELOC;PSMD6;PSMD1;PSMD14;PSMD12;RPS27A;PSMD7;PSMC1;PSMC5;EGLN1;PSMD2;HMOX1;PSMD11;BAG3;PSMB7;PSME3;IMPACT
gsea,morphogenesis of an epithelium (GO:0002009),-0.6210104504814964,-1.7832086850332522,0.01348314606741573,0.022927052350200264,0.848,5/15,20.45%,ACTB;ACTG1;LRP6;TIMELESS;KDF1
gsea,positive regulation of microtubule polymerization (GO:0031116),0.6370653505091922,1.7831637809369167,0.007407407407407408,0.01627795996210324,0.849,7/15,20.51%,CKAP5;NUMA1;CDK5RAP2;CLASP1;DCTN1;PSRC1;HSPA1B
gsea,protein polyubiquitination (GO:0000209),0.38630361478143177,1.7815809274498204,0.0,0.016503198019718775,0.855,55/139,33.63%,UBB;UBE2C;CCNF;UBE2S;FZR1;BRCA1;TNFAIP3;UBE2T;BARD1;TAF1;DCAF15;RNF19A;STUB1;CDC23;BCL2;CDC27;RNF5;UBR5;ZFP91;SKP2;ZNRF1;HUWE1;ANAPC1;RBBP6;RNF168;ANAPC7;DTL;FBXL8;BTRC;FBXO11;IRF2BP1;TRAF2;DZIP3;FBXW7;UBE4A;TRAF1;RNF213;TMEM129;CUL3;TRIM14;NPEPPS;FBXL14;AREL1;HACE1;RNF8;MDM2;FBXO30;RNF19B;FBXL15;UBE2E2;FBXO32;KLHL3;AKTIP;RC3H2;DDB2
gsea,Golgi to plasma membrane transport (GO:0006893),0.5744105471814321,1.781092785854361,0.012195121951219513,0.01653326182693753,0.856,6/18,23.24%,EXOC4;MACF1;SPTBN1;EXOC2;GGA3;NSF
gsea,interleukin-1-mediated signaling pathway (GO:0070498),-0.500103030541608,-1.7791512561300826,0.006134969325153374,0.02368274449935333,0.853,26/48,23.04%,PSME2;IL1R2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;UBE2N;PSMD6;PSMD1;PSMD14;PSMD12;RPS27A;PSMD7;PSMC1;PSMC5;PSMD2;CUL1;PSMD11;PSMB7;PSME3;RIPK2;PSMC2
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),-0.4030799636704649,-1.779073078692698,0.0,0.023513582038643666,0.853,41/108,26.37%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;TLE5;PSMA6;PSMD3;VCP;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;HDAC1;DKKL1;LRRK1;PSMD7;PSMC1;PSMC5;RUVBL1;FRZB;LRP6;CTNNB1;PSMD2;WNT11;HHEX;TMEM64;PSMD11;PSMB7;PSME3;JUP;NRARP;DAB2IP;TMEM9;PSMC2;CSNK1G1;CTNND2;KREMEN2;FZD6
gsea,regulation of telomere maintenance (GO:0032204),0.5547039585470107,1.7784787401993156,0.012448132780082987,0.016834697626623783,0.861,10/20,14.76%,TINF2;PIF1;ATRX;SMG6;RTEL1;PPP1R10;RAD50;TERF2;SIRT6;YLPM1
gsea,negative regulation of response to stimulus (GO:0048585),0.5461477005951321,1.777906942662325,0.0038240917782026767,0.01685893045852938,0.862,8/26,11.53%,FBXO5;RBL1;KLF4;SH2B3;SOCS5;MCTP1;TERF2;MAP3K3
gsea,chordate embryonic development (GO:0043009),0.5706604336302152,1.7730146220599727,0.0055147058823529415,0.017526474954809138,0.872,9/19,25.93%,STIL;BRCA1;GATA3;XYLT1;HINFP;DVL1;PTCH1;FUT8;SOX8
gsea,fatty acid beta-oxidation (GO:0006635),-0.513304125439158,-1.7712507276205363,0.009433962264150943,0.02520269626337914,0.864,12/28,22.43%,ETFB;ACADL;MTLN;PEX2;HADH;HSD17B10;DECR2;ACOXL;ECHDC1;ECI1;ABCD3;ACAT2
gsea,positive regulation of angiogenesis (GO:0045766),0.448080025572154,1.7705109125902005,0.0,0.017898828437930135,0.875,30/60,26.82%,BRCA1;ITGB1;SP1;PRKCA;HIF1A;KLF4;ITGAX;PDPK1;SERPINE1;PIK3CD;ETS1;RUNX1;ZC3H12A;HIPK1;NINJ1;PRKD2;SIRT6;PLCG1;IL1B;PRKCB;FLT1;PIK3R6;AGO2;CTSH;SIRT1;CD40;ITGB8;F3;THBS1;ECM1
gsea,steroid biosynthetic process (GO:0006694),-0.5586840204395715,-1.7682151791383733,0.009363295880149813,0.025776199934543588,0.872,12/23,21.11%,DHCR7;PMVK;MSMO1;SC5D;SQLE;HMGCR;HSD17B10;LSS;HSD11B1;INSIG1;DHRS11;TM7SF2
gsea,sprouting angiogenesis (GO:0002040),0.5555367326513168,1.7676954624943557,0.007207207207207207,0.01830294947116937,0.88,6/25,14.26%,E2F8;E2F7;NR4A1;NRP1;EGR3;ENG
gsea,regulation of defense response to virus by host (GO:0050691),0.5887253370814297,1.7638474004482774,0.004073319755600814,0.018764285126383937,0.884,4/16,12.15%,TNFAIP3;STAT1;SIN3A;ZC3H12A
gsea,plasma membrane invagination (GO:0099024),0.6252619310399039,1.7622638737191527,0.003590664272890485,0.019025165421580524,0.885,2/17,8.44%,AURKB;ELMO1
gsea,iron ion homeostasis (GO:0055072),-0.5260614786366846,-1.7619285464352186,0.012,0.02723082909084254,0.89,12/26,22.74%,TMEM199;GLRX3;TMPRSS6;MYC;ATP6V0A2;SLC11A1;TFRC;CCDC115;FRRS1;CUL1;HMOX1;ACO1
gsea,epidermal cell differentiation (GO:0009913),-0.5722509649061311,-1.7611781317239021,0.01016260162601626,0.02727528641661756,0.892,6/18,12.76%,ANXA1;ST14;HDAC1;CASP3;HDAC2;CTNNB1
gsea,positive regulation of endothelial cell proliferation (GO:0001938),0.4950007432721765,1.7594956819128416,0.0018050541516245488,0.019497549008986457,0.889,13/37,15.32%,NR4A1;HMGB2;HMGB1;SP1;PRKCA;HIF1A;NRP1;PDPK1;PIK3CD;PRKD2;EGR3;SIRT6;PLCG1
gsea,activation of protein kinase B activity (GO:0032148),-0.5871502653916711,-1.7560276280820968,0.011904761904761904,0.028337445612825998,0.896,6/16,15.10%,PPIA;MT3;AKT1;PARK7;PRR5;PDGFB
gsea,response to calcium ion (GO:0051592),0.48964873204649695,1.7560110865440297,0.0017513134851138354,0.020145098460226565,0.895,9/41,17.96%,CALM2;ECT2;CPNE3;CAMK2D;ITPKB;CPNE1;ALOX5AP;AQP3;KCNMB4
gsea,sterol metabolic process (GO:0016125),-0.5300878595379965,-1.7558768533214302,0.002070393374741201,0.02819392053529445,0.896,8/26,7.43%,FDX2;FDX1;DHCR7;PMVK;MSMO1;SC5D;SQLE;HMGCR
gsea,positive regulation of organelle assembly (GO:1902117),0.5142931645598774,1.755346701650297,0.0,0.020182012003531348,0.896,13/28,20.87%,PLK4;SPAG5;GPSM2;NUMA1;ASAP1;CCP110;NUP62;CNOT1;CSF2;CEP120;RAB3GAP1;TNF;CCDC88A
gsea,error-free translesion synthesis (GO:0070987),0.6188817574432578,1.754599899953438,0.010482180293501049,0.020248211326634274,0.896,7/18,17.10%,UBB;RFC4;RFC5;POLH;RFC1;RPA3;RPA2
gsea,organelle disassembly (GO:1903008),0.5383211821976832,1.754403983755707,0.014989293361884369,0.020200353015432073,0.896,3/21,11.17%,CDK1;RETREG1;VRK1
gsea,mitochondrial gene expression (GO:0140053),-0.5211279971452465,-1.750755693331751,0.005893909626719057,0.029218638366816947,0.905,15/27,27.54%,NOA1;MRPL12;MRPS18B;SLC25A33;MRPS28;MRPS7;MRPL16;TEFM;RARS2;MRPS2;FASTKD2;MRPS18A;GATB;MRPL47;TFAM
gsea,negative regulation of peptidase activity (GO:0010466),-0.5769934544763018,-1.7504409900497275,0.00437636761487965,0.029087726704817914,0.906,6/18,14.29%,GAPDH;SERPINE2;AKT1;PARK7;CST3;SERPINF1
gsea,negative regulation of cellular process (GO:0048523),0.34699939053154427,1.7502370407235706,0.0,0.02094084519282458,0.9,104/250,31.47%,FBXO5;FOXM1;CDKN2D;CDKN2C;E2F7;CTCF;NR4A1;BLM;RAD18;SUZ12;GMNN;BTG2;PBRM1;RBBP4;PIM2;DUSP1;BCL6;IRF1;RGCC;RIPOR2;KLF4;PDCD4;MDM4;JAK2;SRGAP2;ING1;MYBL1;BCL2;IFITM1;CCN1;CD33;CDC6;TXNIP;NUP62;CELF1;SH2B3;ETS1;CDKN3;ORC6;LMNA;HOPX;ITGA1;PLXNC1;HTRA2;NOTCH1;PDS5B;TOB1;TAF6;GATA3;ANP32B;CCN4;ARID2;DDX3X;AR;AXIN2;IL1B;KAT2B;LPXN;CD200;PLSCR1;HGS;PLPP1;TGFBR3;SULT2B1;PRKRA;ING5;PSRC1;RBBP7;SPN;TGFBI;PTPRK;ACVRL1;SMARCA2;HSPA1B;TSC1;PML;RB1;BAP1;SIRT1;PTPN6;SKI;PDE3B;JADE1;IFIT3;PTPRJ;SMARCA4;CDKN1A;KLK8;CHERP;SESN2;GNG4;KANK2;OSGIN1;VPS13C;SIRPA;KLF11;TMEM127;ACTN1;CRYAA;INSM1;HSPA1A;CBFA2T3;SOX4;TCHP
gsea,myeloid leukocyte differentiation (GO:0002573),0.4874722742237917,1.7490855749815637,0.0037313432835820895,0.02104537785182035,0.901,22/39,30.93%,CCR7;TNFSF11;DEK;FOXP1;PIK3CD;RUNX1;CSF2;EP300;RXRA;LEF1;GPR183;SPI1;PML;SIRT1;CDKN1A;CDK2;CSF1R;BATF3;KIT;SBNO2;TYROBP;CBFA2T3
gsea,regulation of cellular component biogenesis (GO:0044087),0.5264974732096327,1.7477555945149232,0.009900990099009901,0.021269849750504933,0.903,10/26,24.47%,HJURP;ROCK1;ROCK2;HCFC1;PTPN11;NOTCH1;PINK1;TRAF2;RAPGEF1;SPTY2D1
gsea,cellular response to cytokine stimulus (GO:0071345),0.37612812937575885,1.745573648716972,0.0,0.021633714263317054,0.905,104/236,29.34%,UBB;BIRC5;TCF7;BRCA1;XCL1;ITGB1;CCR7;ZFP36L1;JUNB;TNFSF11;SOCS1;IL18R1;PIM1;ZFP36L2;FOS;SLA;NFKB1;DUSP1;HIF1A;BCL6;IRF1;RIPOR2;STAT4;ITGAX;IFNAR2;JAK2;IRF4;WNK1;POU2F1;BCL2;STAT1;CXCL10;CXCR4;PIK3CD;NFAT5;SH2B3;GBP5;SOCS5;GSK3B;RBMX;CSF2;ZC3H12A;S1PR1;HTRA2;PTPN11;RORA;CCL1;BAG4;LIF;GATA3;STAT5B;SOCS3;SHC1;STAT2;STAT6;OXSR1;IL1B;LRCH1;ERBIN;IL3;BCL2L11;PIK3CA;NFE2L2;IL16;ZEB1;PTPN13;FOXO1;BCL2L1;LEF1;TNF;STAT3;GRB10;IFNGR2;RAPGEF1;SIRT1;CD86;CSF2RA;PTPN6;EGR1;CX3CL1;PTPRJ;IL2;MAOA;CDKN1A;CBL;CD40;KHSRP;ARHGEF2;PIK3R1;CLCF1;HCK;F3;CSF1R;KIT;IL13RA1;IFITM2;SIRPA;PLP2;IL6ST;SBNO2;PTGS2;PF4;GAS6;TIMP1
gsea,cell morphogenesis involved in differentiation (GO:0000904),0.526088400905688,1.744067114591399,0.0035398230088495575,0.021829715455148828,0.905,14/26,29.64%,KIF14;NRP1;ITGB7;SRGAP2;ATF4;ARL13B;LPXN;UNK;SPI1;RB1;PEAK1;PIK3R1;ACTN1;ATRNL1
gsea,ERBB2 signaling pathway (GO:0038128),0.5992179216287784,1.741639763056896,0.006134969325153374,0.022217852432910166,0.908,7/15,19.32%,PRKCA;CPNE3;STUB1;SHC1;ERBIN;PIK3CA;MATK
gsea,negative regulation of metabolic process (GO:0009892),0.5439542068581441,1.7413059209263397,0.0038022813688212928,0.022192959154746825,0.909,8/22,21.25%,IL18R1;ATF4;NOTCH1;DDIT3;IL1B;ARNTL;TFE3;RB1
gsea,protein destabilization (GO:0031648),0.5867665741755762,1.7398157907827918,0.006198347107438017,0.022425820639230473,0.911,9/18,23.77%,PLK1;CREBBP;EP300;BTRC;PRNP;CTSH;SIRT1;GGA3;CUL3
gsea,proteasomal protein catabolic process (GO:0010498),-0.40854995927728616,-1.7397751768221066,0.005671077504725898,0.03166724478344537,0.918,39/102,29.55%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;VCP;PSMB6;PSMD6;PSMD1;PRPF19;PSMD14;RAD23B;PSMD12;KCTD17;PSMD7;PSMC1;PSMC5;NEDD4;CTNNB1;PSMD2;SYVN1;DDB1;NSFL1C;CCDC47;PSMD11;PSMB7;PSME3;IFI27;PSMC2;HECTD3;SOCS6;BIRC2;ERCC8;KLHL42;FBXO44;PSMC6
gsea,positive regulation of signal transduction (GO:0009967),0.3987008068365815,1.7396528093035413,0.0,0.022375928617103427,0.911,51/119,30.01%,DEPDC1B;TNFAIP3;TEDC1;TNFSF11;ASXL1;NTRK3;PRKCA;HIF1A;IL7R;PHIP;NRP1;JAK2;KLF2;CREBBP;MACF1;FAS;MGAT5;MAML2;PTPN11;NOTCH1;GATA3;PRKD2;UCHL5;EP300;AAK1;IL1B;KAT2B;C1QTNF12;TEDC2;PRKCB;ING5;PIH1D1;STAT3;FGFBP3;TMEM108;GRB10;CD226;SIRT1;SKI;ARNT;SMARCA4;PIK3R1;F3;PRKCZ;TUBD1;IL6ST;P2RY6;GAS6;CD74;CD180;LANCL2
gsea,global genome nucleotide-excision repair (GO:0070911),0.559378434935215,1.7396332710147289,0.01417004048582996,0.02230202378982178,0.911,4/18,25.34%,UBB;USP45;CHD1L;CUL4B
gsea,cell-cell junction assembly (GO:0007043),-0.5333910023269269,-1.739135940637175,0.009900990099009901,0.03160378550408679,0.918,10/21,21.42%,ACTB;ACTG1;PKP3;CTNNB1;CD9;CTNNA1;JUP;GJB2;RHOC;FSCN1
gsea,JNK cascade (GO:0007254),0.5542872456723714,1.7357176784818171,0.021739130434782608,0.023159208347008402,0.917,8/18,31.63%,UBB;MAP3K5;SH2D3C;MAP3K7;TRIB1;TAB3;PTGER4;MAP3K11
gsea,regulation of Ras protein signal transduction (GO:0046578),0.4703204682112617,1.7341167619831919,0.0017921146953405018,0.023413727295785128,0.917,24/45,33.26%,KIF14;FOXM1;SPRY1;JAK2;NUP62;MYO9B;MADD;IRS2;NOTCH1;SHC1;ERBIN;SPRY2;SHOC2;RASGRP1;RAPGEF1;RASGEF1A;ARHGEF2;ARHGEF18;KANK2;DENND4C;NOTCH2;EPS8;DENND4A;SYNGAP1
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.473115575703046,1.7335468195206125,0.01,0.023469605023617626,0.918,23/36,30.93%,PLK1;TAF1;RNF19A;STUB1;SOCS5;GSK3B;SUMO2;TRIB2;HSPA1B;FBXW7;DVL1;SMAD7;DAB2;AXIN1;ZYG11B;ZER1;TRIB1;USP5;TRIB3;MDM2;RNF19B;HSPA1A;CBFA2T3
gsea,supramolecular fiber organization (GO:0097435),0.38567813010596913,1.7333025753591682,0.0032520325203252032,0.023453021813901874,0.918,57/149,34.41%,UBB;KIF2C;KIF18B;CKAP5;KIF14;KIF18A;STMN1;FIGNL1;MARCKSL1;EVL;KIF24;TRIOBP;FGF13;CENPJ;KLHL24;CORO1C;ELMO1;ITGA6;MPRIP;PLEC;USP9X;HOOK3;DCTN1;HDGFL3;KATNB1;HIP1;SLK;TUBGCP6;PCM1;TGFBI;CCDC88A;TUBGCP4;GGA3;CORO7;NF1;HIP1R;PIN1;TUBGCP3;DYNC1H1;CAMSAP2;ARHGEF2;CD2AP;MYO5A;COL27A1;MARCKS;NCKAP5L;MDM2;ACTN1;P4HA2;ARHGAP25;NEFL;HOOK1;MFGE8;FBLN5;RND3;CD151;P3H2
gsea,nucleotide-excision repair (GO:0006289),0.4447274437911489,1.732209987886044,0.002066115702479339,0.023656032925142727,0.918,27/72,26.33%,UBB;BRIP1;HMGN1;POLA1;RFC4;RFC5;POLR2A;POLE;BRCA2;XRCC1;MMS19;RFC1;RPA3;EP300;RPA2;FANCC;POLD3;USP45;POLR2B;CHD1L;SIRT1;UVSSA;OGG1;SLX4;RPA1;CUL4B;USP7
gsea,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5817968683001021,1.731841213050764,0.012345679012345678,0.02363494969949058,0.919,1/16,0.24%,UBB
gsea,RNA modification (GO:0009451),-0.47729861321917066,-1.7297282160404783,0.007476635514018692,0.03393147218208301,0.93,27/42,32.40%,NSUN2;NOP2;SSB;PUS7;PUS3;NOP10;METTL1;FTSJ3;THUMPD1;CTU1;WDR4;RBM15B;JMJD6;TYW5;QTRT1;NSUN3;TRMT61A;PUS7L;DTWD1;TSR3;TRMT6;ADAT2;NAT10;LCMT2;THG1L;TRUB1;CTU2
gsea,monocarboxylic acid metabolic process (GO:0032787),-0.4251348660237534,-1.7289961017021054,0.0,0.03396188710323987,0.931,26/61,35.31%,LDHA;MSMO1;FASN;BSG;AOAH;PTGR1;VDAC1;GOT2;DLAT;ACSL4;AASDHPPT;MCCC2;CKM;CKB;DLD;PDHA1;ALDH1A3;NAAA;HLCS;GRHPR;MCCC1;ALDH4A1;PPARG;UGT1A9;MTHFD1L;GNPAT
gsea,hexose metabolic process (GO:0019318),-0.5652930249834266,-1.7285900880986735,0.01782178217821782,0.03390075895862653,0.932,11/18,24.25%,ALDOA;GALK1;ALDOC;PMM1;PGM1;GAA;ADPGK;SLC37A4;DCXR;SORD;FUOM
gsea,peptidyl-asparagine modification (GO:0018196),-0.6187411149566115,-1.727407054321921,0.018711018711018712,0.03382320746807719,0.933,7/15,11.31%,DDOST;RPN1;STT3A;RPN2;LMAN1;MCFD2;MAGT1
gsea,protein N-linked glycosylation via asparagine (GO:0018279),-0.6187411149566115,-1.727407054321921,0.018711018711018712,0.03382320746807719,0.933,7/15,11.31%,DDOST;RPN1;STT3A;RPN2;LMAN1;MCFD2;MAGT1
gsea,cellular response to calcium ion (GO:0071277),0.5331775334400004,1.727214159809725,0.0018484288354898336,0.02456126541332496,0.926,6/25,14.83%,ECT2;CPNE3;CAMK2D;ITPKB;CPNE1;ALOX5AP
gsea,regulation of chromosome organization (GO:0033044),0.5898133378242241,1.727140072017421,0.008350730688935281,0.02450170674793615,0.926,7/15,14.76%,BUB1;PIF1;SMG6;RMI2;TERF2;CDT1;YLPM1
gsea,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5751459661183294,1.7249146411794773,0.01606425702811245,0.0249346295546407,0.926,1/16,0.24%,UBB
gsea,regulation of Wnt signaling pathway (GO:0030111),0.46278302697622703,1.7247947214395543,0.0,0.024874214839384755,0.926,15/45,23.40%,DEPDC1B;TNFAIP3;NFATC1;TIAM1;MACF1;FAM53B;RUNX1;BTRC;HMGXB4;MDFIC;GRB10;SKI;AXIN1;SMARCA4;TAX1BP3
gsea,cellular response to unfolded protein (GO:0034620),-0.5701793086436275,-1.7232967452673842,0.0099601593625498,0.03478427215074709,0.938,10/20,20.67%,HSPA5;BAK1;HSPD1;HSPA9;BAX;ABCB10;ERN1;BAG3;HSPA2;DAB2IP
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.47356626916174815,-1.7229779085005086,0.01020408163265306,0.0346933387876712,0.938,25/48,19.19%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;PSMD7;PSMC1;PSMC5;FBXO31;FBXL20;PSMD2;CUL5;FBXW4;CUL1;PSMD11;PSMB7;PSME3
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),0.40903869058024833,1.7221425884097044,0.0076481835564053535,0.025263879976365925,0.931,23/68,21.92%,NR4A1;TAF1;E2F2;NR4A3;POLR2A;TAF5;CREBBP;HDAC7;MAML2;TAF9;E2F3;RORA;NOTCH1;TBL1X;TAF6;AR;KAT2B;RXRA;GTF2A1;TBP;POLR2B;HDAC5;HDAC9
gsea,regulation of microtubule polymerization (GO:0031113),0.5528960616065266,1.72176254544835,0.005545286506469501,0.02528850515786164,0.932,14/21,31.84%,STMN1;NUMA1;CDK5RAP2;DYRK1A;CLASP1;DCTN1;PSRC1;ABL1;CAMSAP2;ARL2;PRUNE1;MAP2;PAK1;GBA2
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5038823429634275,1.7214638838870597,0.008561643835616438,0.025262472300032313,0.933,13/36,26.61%,EMB;ITGB1;SELL;CRTAM;JAML;ALCAM;CLDN10;MILR1;MPZL2;ADGRL1;SELP;PECAM1;CADM1
gsea,negative regulation of organelle assembly (GO:1902116),0.5365323387398286,1.7208529308013099,0.002004008016032064,0.025337264653447836,0.934,15/22,36.13%,BRCA1;CDK5RAP2;MDM1;CCP110;ODF2L;KAT2B;PINK1;TRIM37;CEP97;PHF23;TCHP;NUPR1;TBC1D30;YAP1;EVI5L
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.5727858527284359,-1.720680656450517,0.00784313725490196,0.034994707100565924,0.94,11/19,21.76%,NDUFAF4;NDUFA12;NDUFAF1;NDUFAB1;ECSIT;NDUFA5;NDUFAF5;NDUFAF6;FOXRED1;NDUFS1;TMEM126B
gsea,NADH dehydrogenase complex assembly (GO:0010257),-0.5727858527284359,-1.720680656450517,0.00784313725490196,0.034994707100565924,0.94,11/19,21.76%,NDUFAF4;NDUFA12;NDUFAF1;NDUFAB1;ECSIT;NDUFA5;NDUFAF5;NDUFAF6;FOXRED1;NDUFS1;TMEM126B
gsea,positive regulation of protein metabolic process (GO:0051247),0.43887296988152313,1.720390817869907,0.0038684719535783366,0.025303525901067287,0.934,23/49,27.58%,FZR1;TNFAIP3;BARD1;NFKBIA;KLF4;UHRF1;KLF2;ROCK2;GSK3B;HUWE1;DTL;IL1B;FOXO1;TNF;RASGRP1;CD86;AXIN1;NSF;PLK2;SLC6A9;ATG7;AREL1;HACE1
gsea,positive regulation of cell differentiation (GO:0045597),0.4071951090336414,1.7156154488262225,0.0,0.026419870285646296,0.943,29/96,22.87%,FBXO5;ECT2;EZH2;ZFP36L1;NFKB1;RGCC;RIPOR2;IFITM1;SIN3A;CCN1;CREB1;TIAM1;BAMBI;MMD;CSF2;ZC3H12A;CPNE1;TCF3;CCN4;AR;AXIN2;IL1B;ZEB1;ARNTL;LEF1;ABL1;ACVRL1;DAB2;LPL
gsea,positive regulation of transport (GO:0051050),-0.45017709472914846,-1.7149730766761002,0.006550218340611353,0.03664732092217713,0.944,14/49,12.26%,ACTB;ANXA2;CALR;FCER1G;BAK1;CHCHD10;ANXA1;BID;BAX;FLOT1;SYNGR3;IL15RA;SMPD1;SLC11A1
gsea,regulation of mRNA catabolic process (GO:0061013),-0.4508119761657555,-1.7121261882258598,0.007736943907156673,0.03734700405058734,0.947,40/75,24.49%,PSME2;VIM;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;AKT1;PSMD3;SERBP1;PSMB6;SET;UPF1;PSMD6;PSMD1;PSMD14;PKP3;PSMD12;APEX1;RPS27A;PSMD7;PSMC1;PSMC5;EXOSC1;PSMD2;PCBP4;EIF4G1;HNRNPD;PNPT1;MAPKAPK2;PSMD11;PSMB7;PSME3;PABPC1;EXOSC2;PSMC2;IGF2BP3;DIS3;EXOSC5
gsea,substrate adhesion-dependent cell spreading (GO:0034446),0.5912891589229691,1.7103011013472305,0.005597014925373134,0.027594031924878103,0.946,4/15,6.97%,KIF14;NRP1;ITGB7;SRGAP2
gsea,regulation of viral entry into host cell (GO:0046596),-0.5909448072713946,-1.7097527521115816,0.007936507936507936,0.03782031267905255,0.949,5/16,17.62%,LGALS1;LY6E;P4HB;TRIM21;TRIM25
gsea,positive regulation of histone modification (GO:0031058),0.5770785857104413,1.7088688067466475,0.011406844106463879,0.027893247574637937,0.948,6/17,15.71%,BRCA1;SART3;FMR1;RPS6KA5;PAXIP1;IL1B
gsea,prostaglandin metabolic process (GO:0006693),-0.5705542599483395,-1.7081781177707158,0.011235955056179775,0.037980826899065956,0.952,2/15,8.95%,MIF;PTGR1
gsea,cellular response to interleukin-1 (GO:0071347),-0.4297396915057778,-1.7075725798444186,0.0021413276231263384,0.03800433269639836,0.952,33/75,23.04%,PSME2;IL1R2;PSMA4;PSMA3;PSMB2;CCL4;PSMB5;PSMA5;CCL3;PSMA6;PSMD3;PSMB6;UBE2N;UPF1;PSMD6;PSMD1;PSMD14;PSMD12;RPS27A;PSMD7;PSMC1;PSMC5;CCL5;PSMD2;TANK;CUL1;GBP3;PSMD11;PSMB7;PSME3;DAB2IP;RIPK2;PSMC2
gsea,regulation of insulin receptor signaling pathway (GO:0046626),0.5461910645159019,1.7069690858510775,0.007692307692307693,0.028274283220543,0.952,9/20,21.45%,SOCS1;NUCKS1;PTPN11;SIK2;IL1B;C1QTNF12;PRKCB;GRB10;SIRT1
gsea,establishment of protein localization to organelle (GO:0072594),0.4589502694028457,1.7037523617217356,0.010330578512396695,0.028869184633166727,0.955,24/48,24.48%,NUP133;CSE1L;NUP107;NXT1;LAMP1;NUP85;NUP155;PPP1R10;NUP62;FAM53B;POM121;NUP153;E2F3;CD68;NUP93;EIF4ENIF1;NUP88;NUP214;PINK1;ZDHHC15;IPO5;STAT3;IPO11;KPNB1
gsea,regulation of epidermal cell differentiation (GO:0045604),0.5801997391324664,1.702872674022151,0.01609657947686117,0.029006232197421124,0.955,7/16,21.14%,ZFP36L1;ROCK1;ROCK2;RUNX1;AQP3;SULT2B1;ERRFI1
gsea,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.6026708726128152,1.7022048892800228,0.006688963210702341,0.029082056505608078,0.955,7/18,23.12%,TTK;PMEPA1;ENG;ACVRL1;SMAD7;DAB2;PIN1
gsea,regulation of cardiac muscle contraction (GO:0055117),0.6006433666846227,1.7007348282547656,0.0075046904315197,0.02936036947023455,0.956,8/16,25.23%,CALM2;ZC3H12A;P2RX4;RGS2;SMAD7;ATP1B1;PIK3CG;PLN
gsea,protein ubiquitination (GO:0016567),0.3484634276090699,1.6999297073077442,0.0,0.02947952860915483,0.957,83/216,33.63%,UBB;UBE2C;PLK1;CCNF;UBE2S;BRCA1;TRAIP;UBE2T;RAD18;BARD1;RFWD3;TAF1;HIF1A;DCAF15;BIRC6;RNF19A;UHRF1;STUB1;CDC23;RNF157;BCL2;CDC27;KLHL24;UBR5;TRIM24;SKP2;RNF40;ZNRF1;HUWE1;RNF38;HERC2;USP9X;RBBP6;RNF168;ANAPC7;DTL;FBXL8;BTRC;PINK1;NFE2L2;FBXO45;FBXO11;IRF2BP1;TRAF2;HLTF;DZIP3;UBR3;FBXW7;SIRT1;UBE4A;RNF213;UVSSA;TMEM129;CUL3;TRIM14;CBL;TRIM33;NPEPPS;USP5;CUL4B;ZSWIM8;FBXL14;USP7;AREL1;ISG15;PHC1;HACE1;RNF8;MDM2;TRIM37;FBXO30;RNF19B;FBXL15;DTX1;MEFV;UBE2E2;FBXO32;MGRN1;KLHL3;AKTIP;NFX1;RC3H2;DDB2
gsea,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5455375460877491,1.6997119220024408,0.01440329218106996,0.02942239047858929,0.957,8/19,28.22%,AUNIP;SMCHD1;MRNIP;KMT5C;PARP3;WRAP53;KDM4D;HSF1
gsea,'de novo' posttranslational protein folding (GO:0051084),-0.5498340903612605,-1.6991161456652417,0.007827788649706457,0.04054316896377602,0.956,7/24,11.72%,HSPA5;CCT2;SDF2L1;HSPA9;CHCHD4;HSPE1;DNAJB4
gsea,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5665363102162992,1.698301854380132,0.010416666666666666,0.029682057291088155,0.957,2/19,2.41%,EMB;ITGB1
gsea,tRNA transport (GO:0051031),0.5369490879121105,1.6976147281985028,0.01417004048582996,0.0297656547933108,0.957,19/30,16.25%,NDC1;NUP133;NUP107;NUP37;NUP160;NUP35;AAAS;NUP205;NUP85;NUP155;NUP62;POM121;NUP153;NUP93;NUP88;NUP214;NUP98;NUP43;SEH1L
gsea,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.548637650186573,1.6964809505950582,0.014336917562724014,0.029941201135778937,0.958,9/23,22.75%,EZH2;RGCC;TIAM1;BAMBI;NOTCH1;AXIN2;IL1B;LEF1;DAB2
gsea,positive regulation of myeloid cell differentiation (GO:0045639),0.5401556178107165,1.6936505737889618,0.015037593984962405,0.030465946877316047,0.959,9/21,22.99%,HMGB2;HIF1A;STAT1;ETS1;STAT5B;STAT3;HSPA1B;RAB7B;ARNT
gsea,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.5241363222256846,1.69148297224807,0.014799154334038054,0.030950623460002106,0.96,10/29,25.34%,UBB;RFC4;RFC5;RFC1;RPA3;RPA2;POLD3;CHD1L;RPA1;CUL4B
gsea,regulation of cellular amide metabolic process (GO:0034248),-0.5127945103123752,-1.6889077943759898,0.005802707930367505,0.043693827791599325,0.96,10/24,21.26%,RPL10;PGAM1;NOLC1;PKP3;PUM3;EIF2A;GEMIN5;CYFIP1;EIF4E;TIGAR
gsea,glutathione metabolic process (GO:0006749),-0.5602809026156526,-1.6871549170894098,0.012072434607645875,0.04405110415275787,0.961,7/17,18.01%,GPX1;PARK7;GGCT;GSR;GSTM5;GCLC;GSS
gsea,peptidyl-tyrosine dephosphorylation (GO:0035335),0.544261391902553,1.6853690139440842,0.0275049115913556,0.03254619493503084,0.962,9/19,22.66%,DUSP4;DUSP1;PTPN11;PGP;PTPN13;DUSP6;DUSP2;PTPN6;PTPRJ
gsea,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5628966635650023,1.683324841804481,0.009191176470588236,0.03299574203955394,0.964,11/20,29.06%,XCL1;SLAMF6;CRTAM;LAMP1;KLRC2;SPI1;RASGRP1;CD226;AP1G1;CADM1;TYROBP
gsea,positive regulation of protein localization to cell periphery (GO:1904377),0.4844628361479895,1.682338612098648,0.010224948875255624,0.033191223912418494,0.964,13/30,26.74%,ITGB1;GPSM2;NUMA1;PDPK1;EPB41L2;ATP2B4;EPB41;SPTBN1;TNF;RAMP3;PLS1;PIK3R1;LRP1
gsea,tRNA aminoacylation for protein translation (GO:0006418),-0.541990501938588,-1.6821754516007728,0.016563146997929608,0.04549299025127565,0.961,10/22,22.45%,EEF1E1;PPA1;AIMP2;FARSA;YARS2;NARS2;RARS2;EARS2;FARSB;PPA2
gsea,positive regulation of response to DNA damage stimulus (GO:2001022),0.47986827009858773,1.6816134982423543,0.014583333333333334,0.033247546268578926,0.964,16/34,28.60%,BRCA1;ANKLE1;SMCHD1;NSMCE4A;NSMCE1;ATR;FMR1;TRIM28;RNF168;SIRT1;ABRAXAS1;EYA3;WRAP53;BCLAF1;RNF8;SPRED1
gsea,regulation of complement activation (GO:0030449),-0.6374404779943454,-1.6811900827628974,0.02295918367346939,0.04559755138100375,0.961,4/16,4.53%,C1QBP;PHB;PHB2;CD55
gsea,regulation of protein catabolic process (GO:0042176),0.44693716766367153,1.680457263961563,0.0081799591002045,0.03343741319994651,0.965,23/45,28.00%,FZR1;MAD2L1;FAM83D;TNFAIP3;BARD1;FAF1;MDM4;CHEK2;GSK3B;HUWE1;DTL;HGS;FOXO1;TNF;AXIN1;PIN1;NSF;PLK2;AZIN1;ATG7;AREL1;HACE1;MDM2
gsea,tRNA processing (GO:0008033),-0.46655927146187237,-1.680241704524425,0.007590132827324478,0.04571053307821638,0.961,24/42,32.40%,NSUN2;SSB;POP1;PUS3;ELAC2;METTL1;TRNT1;THUMPD1;CTU1;WDR4;TRMT10C;TYW5;POP5;QTRT1;TRMT61A;TSEN54;RPP40;DTWD1;TRMT6;ADAT2;LCMT2;THG1L;TRUB1;CTU2
gsea,receptor-mediated endocytosis (GO:0006898),-0.41043035266380046,-1.6801506695592592,0.004246284501061571,0.045481597065637966,0.961,23/68,28.21%,HSP90B1;CALR;M6PR;FCER1G;CANX;SNX9;HYOU1;NEDD4;RABEPK;LRP6;TFRC;CD9;PIKFYVE;ITGAM;DNM3;CAV2;AP1G2;LDLR;PDLIM7;SCARB1;CLN3;RAMP2;DLL1
gsea,adherens junction organization (GO:0034332),-0.5542445303878191,-1.6794128745778998,0.019148936170212766,0.04551286208669022,0.961,4/17,19.39%,ACTB;CTNNB1;CTNNA1;JUP
gsea,response to estrogen (GO:0043627),0.5513507308991115,1.679189697335236,0.014314928425357873,0.03367661038134212,0.966,7/17,15.50%,BRCA1;ARID5A;TRIM24;GATA3;KMT2D;EP300;AR
gsea,actin filament bundle organization (GO:0061572),-0.5401768164086389,-1.6786486943853376,0.028888888888888888,0.04551531562660036,0.962,6/19,22.96%,LCP1;NEDD9;EZR;BAIAP2;FSCN1;USH1C
gsea,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5805504085107721,1.6784153528316885,0.015180265654648957,0.033788456001264684,0.967,4/15,15.71%,BRCA1;RPS6KA5;PAXIP1;IL1B
gsea,"nucleotide-excision repair, DNA incision (GO:0033683)",0.5128109538559621,1.6777873056080381,0.023157894736842106,0.03391036943140868,0.967,11/30,25.34%,UBB;RFC4;RFC5;RFC1;RPA3;RPA2;POLD3;CHD1L;OGG1;RPA1;CUL4B
gsea,protein deubiquitination (GO:0016579),0.3675518963920603,1.6765114847611535,0.002066115702479339,0.034210253206654696,0.968,52/144,28.18%,CCNA2;CDK1;UBB;CLSPN;CDC20;BRCA1;TNFAIP3;BARD1;NFKBIA;BIRC3;ASXL1;USP1;HIF1A;MDM4;CCP110;CDC25A;SKP2;USP34;WDR48;TNIP3;HCFC1;ZC3H12A;USP2;OTUD1;USP9X;GATA3;USP42;UCHL5;EP300;AR;TRRAP;KAT2B;USP47;HGS;USP45;USP11;USP19;TRAF2;USP8;MBD6;TNIP1;USP15;SMAD7;BAP1;ABRAXAS1;USP33;MAP3K7;USP5;MCRS1;USP7;MDM2;OTUD7B
gsea,protein K63-linked ubiquitination (GO:0070534),0.5115012912259848,1.6762659767593253,0.01616161616161616,0.03418403026143544,0.969,8/23,22.32%,UBE2S;UBE2T;STUB1;RNF5;ZFP91;RNF168;TRAF2;TRAF1
gsea,liver development (GO:0001889),0.5652845328948475,1.6756070040956892,0.01092896174863388,0.03429651746924668,0.969,8/18,22.64%,AURKA;E2F8;E2F7;ARID5B;PCK2;TGFBR3;PHF2;NF1
gsea,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4346519867720647,1.6755822537560079,0.011811023622047244,0.03420289805311467,0.969,16/46,28.74%,KIF14;CDKN2D;CDKN2C;E2F7;RBL1;RGCC;KLF4;WEE1;DDX3X;LSM11;RB1;PTPN6;JADE1;CDKN1A;KANK2;RPTOR
gsea,carboxylic acid metabolic process (GO:0019752),-0.5538896746921461,-1.674195406982986,0.015590200445434299,0.04693206745785633,0.962,6/17,19.99%,MIF;SLC2A3;GSTO1;SLC2A1;LIPT2;GNE
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.45156133263070974,1.6736496142048805,0.007889546351084813,0.03462184682179034,0.969,14/41,20.68%,SHCBP1;ZFP36L1;NR4A1;ZFP36L2;CEP57;CD44;POLR2A;HNRNPH1;PTPN11;EGR3;SETX;SHOC2;KIF16B;POLR2B
gsea,protein modification by small protein removal (GO:0070646),0.36273298651550495,1.6729955477046186,0.002061855670103093,0.03468622696126832,0.97,54/152,28.18%,CCNA2;CDK1;UBB;CLSPN;CDC20;BRCA1;TNFAIP3;BARD1;NFKBIA;BIRC3;ASXL1;USP1;HIF1A;MDM4;CCP110;CDC25A;SKP2;USP34;WDR48;TNIP3;HCFC1;ZC3H12A;USP2;OTUD1;USP9X;GATA3;SENP7;USP42;UCHL5;EP300;AR;TRRAP;KAT2B;USP47;HGS;USP45;USP11;USP19;TRAF2;USP8;MBD6;TNIP1;USP15;SMAD7;BAP1;ABRAXAS1;USP33;MAP3K7;SENP1;USP5;MCRS1;USP7;MDM2;OTUD7B
gsea,regulation of gene expression (GO:0010468),0.324664315888135,1.6706274727765933,0.0,0.035209998959943666,0.971,211/453,36.12%,AURKA;TCF7;EZH2;BRCA1;AFF3;ZFP36L1;CTCF;MYBL2;NSD2;LIN54;NFKBID;TCF19;REL;RBL1;NUP107;ATRX;NFKB1;TAF1;NTRK3;SP1;FOXN3;HIF1A;BCL6;POLR2A;RGCC;FOXP1;KLF4;TOB2;BRCA2;NFYB;NUP35;TAF5;SAP30;ITGAX;SRRT;ROCK1;MYBL1;IRF2;HMG20B;CCAR1;ATXN1;CREBBP;UBR5;ATF4;PER1;BHLHE40;DNMT1;SLC38A2;CALCOCO1;NFKBIZ;CHEK2;KDM6B;ROCK2;CELF1;PIK3CD;SART3;ETS1;MTF2;CRABP2;FUS;NAB2;RPS6KA5;HCFC1;NFYA;TERF2;RUNX1;GSK3B;CSF2;MLF1;HNRNPH1;ZC3H12A;TDG;SSBP2;RORA;NOTCH1;ATF2;ATP2B4;CPNE1;NFKB2;TOB1;MYB;CHD3;JMJD1C;GATA3;ENG;FLOT2;NCOA2;TCF3;HDAC6;CCN4;HMG20A;KMT2D;DDX3X;EP300;AR;TRRAP;DDIT3;IL1B;SETDB2;UBAP2;NFATC2;PINK1;SPRY2;PUM2;PLSCR1;HGS;SNRNP70;PHF19;NFE2L2;HINFP;MTA1;NOS1AP;GZF1;KAT6B;ARNTL;MYADM;LEF1;PRDM10;TNF;AJUBA;ABL1;STAT3;NONO;SPI1;XDH;ACVRL1;SMARCA2;HSPA1B;RAMP3;GON4L;AGO2;FBXW7;CTSH;PML;HDAC5;ASCC1;AIRE;DVL1;RB1;SIRT1;HNRNPH3;KAT7;METTL4;NPAT;CLK2;AFF1;EGR1;OGG1;ATP1B1;PIN1;COQ7;TRIM14;AFDN;CDK2;KHSRP;SPTY2D1;ITGB8;NFYC;TAF6L;F3;DAXX;TNRC6A;TBX21;WNT3;ZNHIT3;SIRPA;WNT6;POFUT1;SBNO2;PF4;PRDM2;GAS6;CD74;TYROBP;TTN;MARF1;LGMN;MYOM1;HFE;INSM1;NOTCH2;NLK;HSPA1A;TULP3;ZC3H10;SOX4;ACTA2;SRSF10;WWTR1;SOX15;KDM4A;MEFV;WNT4;APOE;SETDB1;DENND4A;NFX1;AMH;CREM;PRKAA1;PID1;PARP14;MBNL3;YAP1;RELA;CDH1;CPSF4;TSKU;VPS35;SMAD1;TGIF2
gsea,glycosaminoglycan catabolic process (GO:0006027),0.530368806264947,1.6662736130780411,0.014736842105263158,0.03629050178734571,0.976,2/19,5.02%,HMMR;CD44
gsea,cellular response to epidermal growth factor stimulus (GO:0071364),0.581487456180529,1.6650309184221983,0.01016260162601626,0.03660398658935896,0.976,7/17,15.32%,ZFP36L1;ZFP36L2;KNSTRN;PDPK1;PTPN11;STAT5B;PLCG1
gsea,regulation of protein polymerization (GO:0032271),-0.530703625763256,-1.664890991870611,0.012024048096192385,0.050057621249075646,0.971,5/18,30.43%,PFN1;HAX1;CAMSAP1;PFN2;ABITRAM
gsea,negative regulation of apoptotic process (GO:0043066),0.3386007803842973,1.6634613640802776,0.001893939393939394,0.037016471638616495,0.976,96/228,36.02%,CDK1;UBB;ARL6IP1;PLK1;BIRC5;KIF14;MAD2L1;CDKN2D;STIL;ITGB1;BARD1;NFKBIA;FIGNL1;PIM1;TPT1;BIRC3;MAP4K4;NFKB1;PIM2;PRKCA;CD44;BIRC6;KLF4;PHIP;KDM2B;RNF157;BCL2;PLAUR;NUP62;FAS;RETREG1;GSK3B;TAF9;DNAJA1;ZC3H12A;BCL3;NOTCH1;BAG4;EGR3;SETX;CBX4;ARHGAP10;SHC1;DDX3X;PIDD1;NAA16;MGMT;AHI1;PINK1;USP47;SPRY2;CD40LG;FNIP1;PIK3CA;MALT1;FOXO1;BCL2L1;LEF1;TNF;HSPA1B;CTSH;RB1;CX3CR1;SIRT1;RNF213;IFIT3;CX3CL1;DAB2;IL2;PLK2;CBL;FHL2;APIP;PIK3R1;CLCF1;HCK;SOX8;THBS1;AREL1;ANKLE2;IL6ST;GAS6;CD74;CRYAA;LGMN;NOTCH2;HSPA1A;APOE;PIM3;NUPR1;PRKAA1;FSTL1;YAP1;RELA;RHBDD1;CSNK2A2
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4892939162358673,1.662980524012693,0.016666666666666666,0.03705195896667232,0.976,15/28,34.22%,TRAIP;TNFAIP3;BIRC3;MADD;HIPK1;CPNE1;TRAF2;TNF;HSPA1B;TRAF1;GAS6;HSPA1A;SYK;FADD;F2RL1
gsea,negative regulation of cell junction assembly (GO:1901889),0.6166717941080216,1.6593896581268497,0.0125,0.03801735562030605,0.978,7/15,20.28%,ROCK1;CORO1C;ROCK2;CLASP2;IL1B;TNF;ACVRL1
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),0.5247832572688584,1.65854978286682,0.007722007722007722,0.03813930586028863,0.978,7/21,21.25%,IL18R1;ATF4;NOTCH1;DDIT3;ARNTL;TFE3;RB1
gsea,negative regulation of cellular protein metabolic process (GO:0032269),-0.42008548346989505,-1.657688268078538,0.006578947368421052,0.05261165978653093,0.975,21/51,27.46%,GZMB;GAPDH;CALR;YBX1;SERPINE2;AKT1;SYNCRIP;PUS7;RACK1;CAPRIN1;NCL;CST3;MRPL13;EIF2AK2;DAB2IP;LARP1;RIDA;IGF2BP3;IGF2BP2;SHMT1;CLN3
gsea,positive regulation of protein phosphorylation (GO:0001934),0.35882472391001236,1.6530328261775338,0.0,0.039680139686887446,0.979,63/159,30.22%,CENPE;PLK1;CALM2;TTK;CCR7;NTRK3;CD44;NRP1;JAK2;CD81;CCN1;PLAUR;RAD50;ROCK2;FAS;MRNIP;MMD;FMR1;RPS6KA5;PTPN11;ATP2B4;LIF;PRKD2;ENG;LCP2;HDAC6;DDX3X;AXIN2;IL1B;TNIK;TAOK2;IL3;PINK1;SPRY2;FNIP1;PRNP;TNF;ABL1;SH2D3C;ACVRL1;RASGRP1;RAMP3;CX3CR1;SIRT1;TNKS1BP1;CX3CL1;PTPRJ;DAB2;AXIN1;PIN1;CDKN1A;CD40;ARHGEF2;CSF1R;PECAM1;DAXX;RPTOR;GAS6;CD74;PGF;RAP2C;HFE;PAK1
gsea,positive regulation of Wnt signaling pathway (GO:0030177),-0.4189498149587796,-1.6517865512092536,0.02127659574468085,0.05447410331607371,0.978,29/67,24.83%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;VCP;PSMB6;PSMD6;PSMD1;PSMD14;PSMD12;LRRK1;PSMD7;PSMC1;PSMC5;RUVBL1;PSMD2;HHEX;PSMD11;PSMB7;PSME3;JUP;NRARP;TMEM9;PSMC2;CSNK1G1
gsea,inorganic anion transport (GO:0015698),0.5464686506163547,1.650951596790917,0.023890784982935155,0.040224880261759174,0.981,6/21,19.40%,RACGAP1;SLC25A10;SLC26A11;XPR1;TTYH3;ANO6
gsea,cellular response to light stimulus (GO:0071482),0.47083660326270527,1.6508478588394264,0.00784313725490196,0.04014109009053029,0.981,12/36,19.88%,AURKB;RHNO1;TAF1;CREBBP;CDC25A;ATF4;ATR;FMR1;EP300;USP47;TRPM1;PTPRK
gsea,positive regulation of erythrocyte differentiation (GO:0045648),0.5729115609823568,1.6470761642154121,0.033962264150943396,0.041267325977265186,0.982,8/15,22.99%,HMGB2;HIF1A;STAT1;ETS1;STAT5B;STAT3;HSPA1B;ARNT
gsea,glial cell development (GO:0021782),-0.5786074982097956,-1.6469752482112743,0.021231422505307854,0.05605293717754826,0.983,5/15,16.64%,MT3;CDK6;EIF2B3;EIF2B5;NRROS
gsea,regulation of transport (GO:0051049),-0.5441437512981859,-1.6463241719634514,0.022675736961451247,0.05603766997982098,0.983,5/17,17.65%,ACTB;ACTG1;YRDC;WWC1;ICA1
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.4217542815653697,1.6447587916551971,0.0017699115044247787,0.041870618901205206,0.982,18/59,29.11%,CCR7;ODF2;STMN1;MNS1;BTG2;HMGB1;GPM6B;ROCK1;GSK3B;GPRIN3;HDGFL3;KIFAP3;TMEM108;RB1;UNC5A;CSF1R;MAP2;MAP4
gsea,negative regulation of programmed cell death (GO:0043069),0.34332062233853483,1.6431941787186541,0.00186219739292365,0.042324748909736726,0.984,78/188,35.64%,CDK1;UBB;ARL6IP1;PLK1;BIRC5;KIF14;MAD2L1;STIL;BARD1;NFKBIA;FIGNL1;PIM1;TPT1;BIRC3;MAP4K4;NFKB1;PIM2;CD44;BIRC6;PHIP;RNF157;BCL2;PLAUR;NUP62;FAS;GSK3B;TAF9;DNAJA1;BCL3;BAG4;EGR3;SETX;CBX4;ARHGAP10;SHC1;DDX3X;PIDD1;NAA16;MGMT;AHI1;USP47;SPRY2;CD40LG;MALT1;FOXO1;BCL2L1;LEF1;HSPA1B;CTSH;SIRT1;IFIT3;CX3CL1;DAB2;IL2;PLK2;CBL;FHL2;APIP;PIK3R1;HCK;SOX8;KANK2;THBS1;AREL1;ANKLE2;IL6ST;GAS6;CD74;CRYAA;NOTCH2;HSPA1A;PIM3;NUPR1;PRKAA1;FSTL1;MET;RELA;RHBDD1
gsea,RNA export from nucleus (GO:0006405),0.44737719374476376,1.642933168932513,0.028017241379310345,0.04227975135726569,0.984,38/77,24.83%,NDC1;NUP133;NUP107;NUP37;UPF3B;NUP160;ALYREF;NUP35;SMG6;AAAS;NXT1;GLE1;NUP205;SLBP;NUP85;NUP155;NUP62;NXF1;THOC2;POM121;SRSF4;NUP153;SRSF3;NUP93;NUP88;NUP214;CASC3;NUP98;CPSF1;NUP43;SEH1L;UPF2;RANBP2;RNPS1;SRRM1;XPO5;SYMPK;U2AF1
gsea,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5255973051793528,1.6429115837322859,0.025477707006369428,0.04216092329897091,0.984,10/19,19.45%,SOCS1;JAK2;CENPJ;DOT1L;SH2B3;BCL3;NOTCH1;SOCS3;HGS;TNF
gsea,nucleosome assembly (GO:0006334),0.5492809973086068,1.6412900966407467,0.02826086956521739,0.042543129508745135,0.985,12/23,18.90%,ASF1B;HMGB2;RBBP4;ATRX;BRD2;SART3;ASF1A;ANP32B;HAT1;NASP;KAT6B;CHAF1A
gsea,response to retinoic acid (GO:0032526),0.515050279338415,1.6397555799295473,0.021922428330522766,0.04291309393121662,0.985,10/24,27.49%,CDKN2D;ASXL1;CREB1;HTRA2;SETX;AQP3;RXRA;CTSH;WNT3;WNT6
gsea,negative regulation of cell-substrate adhesion (GO:0010812),0.551336699726187,1.6391197142248533,0.018148820326678767,0.043017172563890545,0.985,4/18,12.58%,MAP4K4;ACTN4;CORO1C;NOTCH1
gsea,regulation of TOR signaling (GO:0032006),0.44313823520850854,1.6389197548765726,0.006134969325153374,0.042974168746549433,0.985,17/35,28.92%,FAM83D;TNFAIP8L1;TBCK;SEH1L;FNIP1;PIK3CA;PIH1D1;ARNTL;SLC38A9;TSC1;SIRT1;TTI1;RICTOR;DEPDC5;TMEM127;RPTOR;GAS6
gsea,mRNA modification (GO:0016556),-0.5485037959805483,-1.6388093589089339,0.033073929961089495,0.059039487974482954,0.983,10/18,23.42%,NSUN2;DKC1;PUS1;PUS7;PUS3;TRMT10C;TRMT61B;TRMT61A;METTL16;TRMT6
gsea,protein N-linked glycosylation (GO:0006487),-0.452495728847773,-1.6385002140782252,0.008565310492505354,0.058885522603931706,0.983,14/36,19.04%,DDOST;RPN1;STT3A;RPN2;LMAN1;ALG2;PGM3;PMM1;MCFD2;MAGT1;ALG3;MGAT4B;ALG10B;DOLPP1
gsea,cellular amino acid catabolic process (GO:0009063),-0.4348534068623463,-1.6379437668231107,0.012345679012345678,0.05881437865825704,0.985,21/47,32.92%,GLDC;GCSH;BLMH;MTRR;HSD17B10;GOT2;GOT1;FAH;DBT;MCCC2;BCAT2;BCAT1;ALDH7A1;DLD;IL4I1;SHMT1;ACAD8;IDO1;MCCC1;ALDH4A1;GLS2
gsea,response to unfolded protein (GO:0006986),-0.49952580428926396,-1.637670603275969,0.033203125,0.05858712247260634,0.985,13/35,20.67%,HSP90AB1;HSPA5;BAK1;HSPD1;HSPA9;HSPA4;BAX;HSPE1;DNAJB4;ERN1;BAG3;HSPA2;DAB2IP
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),-0.44781547391648624,-1.6364683858461868,0.009541984732824428,0.05876357473969206,0.986,15/37,32.76%,HSP90B1;HSPA5;VCP;FOXRED2;SELENOS;EDEM1;SYVN1;TRIM25;UBQLN1;HERPUD1;ECPAS;FBXO44;PSMC6;RHBDD2;NCCRP1
gsea,positive regulation of cell motility (GO:2000147),0.37912200655725875,1.6358337614672998,0.0016474464579901153,0.043960542124902476,0.986,34/104,26.66%,GTSE1;ITGB1;CCR7;ARHGEF39;MAP4K4;ACTN4;NTRK3;PRKCA;CPNE3;ITGAX;SUN2;CCAR1;CCN1;ITGA6;TIAM1;ROCK2;MGAT5;PIK3CD;NOTCH1;IL1B;SPRY2;MYADM;FLT1;LEF1;SYNE2;STAT3;CTSH;ELP5;DAB2;F3;CSF1R;PECAM1;KIT;THBS1
gsea,cellular protein modification process (GO:0006464),0.3064051847970004,1.6348700793753552,0.0,0.04418986166726918,0.986,213/480,41.99%,AURKB;CDK1;PLK1;BIRC5;CDC25B;CCNF;UBE2S;PLK4;AURKA;MELK;LRR1;NEK2;HASPIN;DUSP4;PIM1;ADPRH;MAP4K4;SSH2;DCAF7;TAF1;PIM2;DUSP1;PRKCA;HIF1A;CDK19;BIRC6;BRD2;CAMK2D;CCNE1;TRIOBP;JAK2;ROCK1;WNK1;STK10;PASK;PARP2;PDPK1;MAST2;UBLCP1;CCN1;ST8SIA4;NEK7;ILF3;PPP3CB;CHEK2;PPP2R5D;CREB1;BCKDK;DYRK1A;ROCK2;SKP2;SEPHS1;PIK3CD;ST8SIA1;SOCS5;CISH;TBCK;ST3GAL1;RPS6KA5;VRK1;GSK3B;MAP3K5;HIPK1;DCLK1;MAP3K1;GRK2;SIK2;PHKA2;PRKD2;METAP1D;SIRT6;DTL;ST3GAL4;SOCS3;MACROD1;MTMR3;FBXL8;AAK1;OXSR1;TNIK;BTRC;TAOK2;PARP3;PINK1;BTBD6;PDK2;ART3;SERPINC1;PRKCB;FBXO11;SBF1;TAOK1;ERG;PTPN13;SSH1;SNRK;TRIB2;RBBP7;MATK;DCAF6;DUSP6;ABL1;TGM2;PTPRK;NEK1;DYRK2;ACVRL1;FBXW7;DUSP2;PARP8;BAP1;SIRT1;CTDSP2;CLK2;PTPN6;CTDP1;TIMM50;PEAK1;CTH;PTPRJ;CTDSP1;PLK2;PTPN3;CUL3;CDK2;TRIB1;MAP4K1;ATG10;CUL4B;HCK;SGK1;MCRS1;ATG7;FBXL14;THBS1;CHM;ISG15;GOLGA2;PRKCZ;OARD1;PPP2R3A;DUSP5;SRPK1;JMJD7;MEX3B;GAS6;TIMP1;FBXO30;PAK1;HIPK2;NLK;TLK2;FBXL15;MTMR4;PPP4R1;KLHL11;STK3;DUSP16;LATS2;SYK;MAP3K11;UST;UBE2E2;FBXO32;APOE;KLHL3;PPP1CB;MFGE8;PIM3;SIRT5;DDB2;PRKAA1;B3GNT5;MIA3;ST3GAL5;FSTL1;PARP14;PDP1;DAPK1;KTN1;RHBDD1;BTK;ABCA7;KLHL25;LMTK2;FBXW10;OGFOD1;COG3;CDK12;FGR;ANO8;FEM1B;PPM1M;TULP4;FBXL12;LOXL2;FN1;LTBP1;MAP3K13;NPC1;PPM1L;CPE;MTOR;ANKRD9;MAN2A1;LMO7;ULK1;PPP2CB;STK38L;STRADA;RARA;GCNT2;MAP3K20
gsea,regulation of osteoblast differentiation (GO:0045667),0.4678391451879721,1.6342537337929253,0.011686143572621035,0.0442594352830814,0.986,8/36,14.98%,FBXO5;IFITM1;ATF4;CCN1;HDAC7;BAMBI;NOTCH1;CCN4
gsea,receptor signaling pathway via STAT (GO:0097696),0.5646014939058349,1.6303240714427347,0.025341130604288498,0.04546423418809367,0.988,9/17,25.16%,STAT4;IFNAR2;JAK2;STAT1;STAT5B;STAT2;STAT6;STAT3;CLCF1
gsea,positive regulation of transferase activity (GO:0051347),0.4225147878413005,1.6290747509990908,0.02099236641221374,0.04576943944592934,0.989,34/68,37.58%,AURKB;PLK1;NEK2;CHTF18;RFC4;NTRK3;RFC5;KLF4;NEK7;RAD50;PINK1;CD200;FLT1;FBXW7;AXIN1;PIN1;CHTF8;WRAP53;CSF1R;MAP3K4;TRIB3;KIT;PARN;VAC14;RFC2;CD74;DSCC1;RFC3;ARRDC3;MET;DRD4;LMTK2;HSP90AA1;POLG2
gsea,regulation of cell motility (GO:2000145),-0.3957008677144603,-1.6261793555455832,0.008456659619450317,0.06302192982554526,0.989,18/54,40.64%,TMSB4X;TMSB10;SERPINE2;CDK6;AKT1;PLXND1;FLNA;ADGRG3;CEACAM1;TMSB15A;AMOTL1;CCDC125;NEXN;PLXNA1;ENPP2;AMOT;RHOB;HBEGF
gsea,receptor signaling pathway via JAK-STAT (GO:0007259),0.553233808279104,1.6244765362877756,0.023391812865497075,0.04732654844030733,0.989,9/18,25.16%,STAT4;IFNAR2;JAK2;STAT1;STAT5B;STAT2;STAT6;STAT3;CLCF1
gsea,regulation of nervous system development (GO:0051960),0.5535202105646386,1.6235108986773739,0.01744186046511628,0.047517115743107075,0.989,9/16,27.16%,KIF14;HMGB2;BHLHE40;IL1B;ARNTL;CX3CR1;CX3CL1;WNT3;PRUNE1
gsea,generation of neurons (GO:0048699),0.42696412623231256,1.6230714891701494,0.004878048780487805,0.04757642365457599,0.989,23/65,27.49%,RACGAP1;CIT;HMGB2;NRP1;TUBB2A;FGF13;BHLHE40;THOC2;RUNX1;MYEF2;USP9X;IL1B;ACSL3;TUBB2B;ARNTL;CX3CR1;CX3CL1;PIN1;ATP2B2;SDCCAG8;WNT3;PRUNE1;WNT6
gsea,glycoprotein biosynthetic process (GO:0009101),-0.43409383672193147,-1.6186504803377717,0.010224948875255624,0.06618485297989808,0.991,16/36,25.25%,DDOST;NUS1;SERP1;FUT4;ALG3;CHST10;B4GALT5;TMEM106A;SERP2;B3GALNT2;ALG10B;ST3GAL6;B3GALT5;B3GNT3;FUT7;MPI
gsea,negative regulation of cell population proliferation (GO:0008285),0.3352416150130507,1.6177539250158384,0.001834862385321101,0.049511475149386475,0.99,68/163,31.02%,CDKN2D;CDKN2C;E2F7;TNFAIP3;CTCF;TINF2;BTG2;PBRM1;RBBP4;PIM2;IRF1;RGCC;KLF4;KDM2B;MDM4;JAK2;IFITM1;CD33;CDC6;NUP62;CELF1;SH2B3;ETS1;CDKN3;LMNA;ITGA1;E2F3;NOTCH1;NLRC3;PDS5B;TOB1;GATA3;ARID2;AR;AXIN2;IL1B;KAT2B;CD200;HGS;PLPP1;TGFBR3;SULT2B1;PRKRA;ING5;PTPRK;ACVRL1;SMARCA2;HSPA1B;TSC1;PML;BAP1;PTPN6;SKI;IFIT3;NF1;PTPRJ;CDKN1A;CHERP;TRIB1;KANK2;KLF11;TMEM127;CD300A;PAK1;INSM1;HSPA1A;CBFA2T3;SOX4
gsea,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5568175501004915,1.6152321976009534,0.02040816326530612,0.050289953890631664,0.99,5/17,17.22%,TNFAIP3;PDPK1;SERPINE1;GATA3;NFE2L2
gsea,negative regulation of fat cell differentiation (GO:0045599),0.5158432114344694,1.614190901212459,0.017208413001912046,0.05052830153334651,0.99,10/20,21.45%,ASXL1;ZFP36L2;ZFPM1;RORA;GATA3;FOXO1;ARNTL;TRIB2;TNF;SIRT1
gsea,fatty acid catabolic process (GO:0009062),-0.45397206022630554,-1.6132837113976326,0.023255813953488372,0.06865594591395302,0.992,21/31,37.12%,ACADL;NUDT19;MTLN;PEX2;HADH;HSD17B10;AIG1;ECHDC1;ALDH3A2;ECI1;ABCD3;ACAT2;LPIN2;ACOX1;ECHDC2;SLC27A2;ACADM;PECR;MMUT;ABCD1;MCAT
gsea,negative regulation of transferase activity (GO:0051348),0.5282372767143301,1.612055356218767,0.017130620985010708,0.05122563558626662,0.99,6/16,21.29%,FBXO5;PIF1;GSK3B;IRS2;ABL1;SMAD7
gsea,neurogenesis (GO:0022008),0.5107842448316187,1.610879612302654,0.015384615384615385,0.05157886372746068,0.992,8/19,16.59%,CIT;CDK5RAP2;WDR62;CXCR4;THOC2;METTL14;TRAK1;BTBD6
gsea,aerobic electron transport chain (GO:0019646),-0.612134958351132,-1.6099125893096584,0.03571428571428571,0.0694919219980847,0.992,7/15,12.82%,NDUFA12;CYCS;NDUFAF1;SDHD;UQCRC1;NDUFAB1;NDUFA5
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.612134958351132,-1.6099125893096584,0.03571428571428571,0.0694919219980847,0.992,7/15,12.82%,NDUFA12;CYCS;NDUFAF1;SDHD;UQCRC1;NDUFAB1;NDUFA5
gsea,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5113916693090313,-1.6092158012784792,0.029880478087649404,0.06952769488772603,0.992,7/20,18.32%,RPS27L;HINT1;DDIT4;MYBBP1A;MSH2;AEN;RRP8
gsea,regulation of protein kinase activity (GO:0045859),0.39436387104275744,1.6079247665712095,0.007633587786259542,0.05254158360625461,0.993,26/59,32.76%,CENPE;ECT2;CCR7;PDPK1;CCN1;CEP85;MRNIP;MMD;LCP2;TRIB2;TNF;PRKRIP1;DVL1;RB1;SIRT1;NF1;CDKN1A;TRIB1;TRIB3;DAXX;SPRED1;GAS6;TTN;RAP2C;WWTR1;TARBP2
gsea,regulation of BMP signaling pathway (GO:0030510),0.4939395764785466,1.606987701175769,0.027726432532347505,0.05272964855932286,0.993,15/26,35.98%,NUMA1;SKIL;CCN1;BAMBI;NOTCH1;ENG;ACVRL1;SMAD7;SKI;TRIM33;HIPK2;FBXL15;FSTL1;CRIM1;SMAD1
gsea,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.5026263813013052,-1.606773544562471,0.022044088176352707,0.07021590483411887,0.992,15/23,24.00%,POLR2F;POLR2L;POLR1B;CDK7;UBTF;POLR2H;POLR1E;GTF2H2;RRN3;POLR1A;POLR1C;TAF1A;TAF1D;GTF2H4;GTF2H1
gsea,cellular response to organic substance (GO:0071310),0.41602386427538707,1.6066310727998854,0.011406844106463879,0.052681090217953475,0.993,24/56,25.59%,CCR7;IL18R1;KLF4;CPNE3;CXCR4;NFAT5;HTRA2;PTPN11;NCOA1;NCOA2;STAT5B;SHC1;HDAC6;NCOA3;IL1B;PTPN13;LEF1;TNF;STAT3;ACVRL1;RAMP3;PTPN6;KHSRP;CSF1R
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4229665080773847,1.6061670330037878,0.016697588126159554,0.05273757313506549,0.993,24/46,31.57%,UBB;SPRY1;STUB1;SKIL;PMEPA1;CREBBP;PDPK1;BAMBI;ENG;EP300;SPRY2;TGFBR3;SMAD7;SIRT1;SKI;DAB2;PIN1;TRIM33;THBS1;SPRED1;HIPK2;HSPA1A;MTMR4;LATS2
gsea,regulation of cell-cell adhesion (GO:0022407),-0.538963500894393,-1.6060003437211356,0.026530612244897958,0.07023044456709891,0.993,8/17,24.03%,ADAM8;GTPBP4;CITED2;FUT4;ZDHHC2;CEACAM1;FUT7;ADA
gsea,regulation of protein binding (GO:0043393),0.3935714465121273,1.6053525332749667,0.007827788649706457,0.05291407310457444,0.993,29/64,31.28%,AURKB;PLK1;AURKA;TAF1;ROCK1;ZFPM1;TIAM1;BAMBI;GSK3B;EPB41;DDX11;TMC8;HDAC5;DVL1;HIP1R;DAB2;PIN1;USP33;CDKN1A;SYMPK;TRIB3;CTSZ;LRP1;SLPI;GOLGA2;HFE;IDE;HIPK2;STK3
gsea,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5356289483467876,1.6042325493206278,0.027985074626865673,0.05320645653747092,0.993,8/18,21.13%,HMGB1;RGCC;KLF4;NOTCH1;ATP2B4;TNF;ACVRL1;HDAC5
gsea,regulation of cell adhesion (GO:0030155),0.40042636725511455,1.6028973328204486,0.007532956685499058,0.05350985674302496,0.993,28/60,24.60%,KIF14;CCR7;CXCR3;DUSP1;PRKCA;RIPOR2;ROCK1;CXCR4;ROCK2;C2CD4B;PLXNC1;PTPN11;PRKD2;LPXN;PRSS2;MYADM;TNF;SPN;ABL1;TGFBI;CYTH1;TGM2;TFE3;ACVRL1;PDE3B;PTPRJ;PKP4;PIK3CG
gsea,regulation of intracellular transport (GO:0032386),0.5032284242953188,1.6027188533033658,0.03,0.05343158248477607,0.993,9/21,29.35%,SPAG5;NUMA1;AAAS;LAMP1;NUP214;ATPSCKMT;DYNC1H1;MAP2;CRYAA
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5085459413197824,-1.6011780189751554,0.027253668763102725,0.07225522912189777,0.993,6/19,9.04%,S100A10;CALR;C1QBP;NEDD9;FLNA;P4HB
gsea,regulation of telomerase activity (GO:0051972),0.4890345273659743,1.6005439613720251,0.03909465020576132,0.054096101731633886,0.993,6/27,8.96%,AURKB;NEK2;PIF1;KLF4;SMG6;NEK7
gsea,positive regulation of response to stimulus (GO:0048584),0.4583165478294787,1.5989210365135245,0.01761252446183953,0.054578991219327744,0.993,11/28,25.49%,ANKLE1;YPEL3;NSMCE4A;NSMCE1;IER5;FMR1;TAF9;GATA3;SIRT1;RSAD2;BCLAF1
gsea,regulation of cell cycle G1/S phase transition (GO:1902806),0.5046120718935541,1.5987393780790697,0.02109704641350211,0.054498486181128174,0.993,8/20,23.71%,KIF14;FAM83D;EZH2;TAF1;ATP2B4;FBXW7;PTPN6;CDKN1A
gsea,brain development (GO:0007420),0.41248405584371534,1.5981331837154547,0.007326007326007326,0.054642137195088335,0.993,24/54,35.07%,CENPF;CDK5RAP2;ATXN1;BPTF;CIC;CXCR4;SMG9;PTPN11;PBX2;RAB3GAP1;EGR2;PHF8;CX3CR1;NF1;PTCH1;ROGDI;SYNJ1;SETD1A;SYNJ2;BBS4;SCYL2;B3GNT5;SPEF2;MKKS
gsea,regulation of macrophage activation (GO:0043030),-0.5253242034241401,-1.5976627646366444,0.02575107296137339,0.0739589232947923,0.994,3/16,14.43%,MIF;HSPD1;GPR137B
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4215692759428828,1.5931820278978412,0.02631578947368421,0.056495700276457006,0.994,23/42,30.93%,PLK1;TAF1;RNF19A;STUB1;SOCS5;FMR1;GSK3B;SUMO2;TRIB2;HSPA1B;FBXW7;DVL1;SMAD7;DAB2;ZYG11B;ZER1;TRIB1;USP5;TRIB3;MDM2;RNF19B;HSPA1A;CBFA2T3
gsea,Wnt signaling pathway (GO:0016055),0.43632243180770736,1.5931283850205367,0.014778325123152709,0.05635820763049581,0.994,21/45,40.69%,UBB;TCF7;USP34;GSK3B;DDX3X;BTRC;LEF1;DVL1;AXIN1;WNT3;WNT6;WNT10A;WNT4;RARG;STRN;VPS35;BCL9L;TCF7L2;DVL3;NR4A2;CPE
gsea,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5617369653937709,-1.5924832481267834,0.03162055335968379,0.07628035760054386,0.995,4/15,8.12%,PPIA;AKT1;PARK7;REST
gsea,positive regulation of cell population proliferation (GO:0008284),0.3420602670093168,1.5923503855505254,0.0,0.05652354254444059,0.994,90/205,36.88%,PRC1;FBXO5;BIRC5;CDC25B;KIF20B;KIF14;FOXM1;SAPCD2;TTK;EZH2;PIM1;NTRK3;NR4A3;FOXP1;IL7R;TOX;PHIP;ITGAX;BCL2;CCAR1;STAT1;CD81;DOT1L;CCN1;TIAM1;BAMBI;CDC7;CSF2;MAP3K3;IRS2;NOTCH1;LIF;SIRT6;SHC1;CCN4;KMT2D;AR;IL1B;IL3;TGFBR3;DERL2;FLT1;LEF1;MATK;TNF;TCIRG1;CTSH;RPRD1B;SIRT1;CCPG1;CD86;PTPN6;CX3CL1;IL2;NACC1;CDKN1A;CUL3;CDK2;CLCF1;HCK;CSF1R;SOX8;IL13RA1;THBS1;EPCAM;IL6ST;MDM2;HSF1;GAS6;CD74;PGF;TIMP1;LGMN;PAK1;INSM1;SOX4;FOSL1;WWTR1;CIAO1;BTC;SOX15;PID1;ASH2L;YAP1;RELA;LIFR;C5AR1;ESM1;CDC123;FXN
gsea,interferon-gamma-mediated signaling pathway (GO:0060333),0.4684448020348671,1.5917714019832951,0.028056112224448898,0.056617291012118584,0.994,14/30,25.44%,CD44;IRF1;CAMK2D;JAK2;IRF4;IRF2;STAT1;IRF9;IRF7;MID1;IFNGR2;PML;OAS3;HCK
gsea,positive regulation of multicellular organismal process (GO:0051240),-0.3317744535682659,-1.5904132997938654,0.0026455026455026454,0.07698352283984401,0.996,58/149,36.07%,CFL1;GAPDH;PLAC8;ENO1;MIF;NME2;HILPDA;C1QBP;EPAS1;ACADL;TXK;XBP1;TNFSF4;FABP5;VAMP8;ADRB1;CCR2;TRPV2;FLOT1;AGPAT2;REST;KAT2A;HADH;GLIPR2;F2R;B4GALT5;SLC11A1;TFRC;CTNNB1;RBM19;GADD45G;PDGFB;VAMP7;GLMN;EIF2AK2;SLC27A1;PPARGC1B;GHSR;TBXA2R;SMTNL2;ZBTB16;IL10;TGFB3;TMEM119;HCAR2;VEGFA;IL33;DIO2;ACSL1;OLFM1;ELOVL6;IFNG;ACHE;MED1;IL21;HAP1;CCDC88B;BATF
gsea,water-soluble vitamin metabolic process (GO:0006767),-0.4333607026037625,-1.58993525892265,0.012396694214876033,0.07688422402143837,0.996,21/40,26.66%,SLC2A3;GSTO1;MMADHC;SLC52A3;SLC25A19;PNPO;SLC2A1;MTRR;ACP5;MTHFD2L;ENPP1;ABCC1;AASDHPPT;MCCC2;PDXK;SLC19A1;SLC25A32;MTHFD1;CD320;SHMT1;HLCS
gsea,positive regulation of viral genome replication (GO:0045070),0.5116322654934935,1.589077252960994,0.021696252465483234,0.05758141202782175,0.995,6/19,32.76%,TOP2A;DDX3X;ADAR;PPIH;SRPK1;TARBP2
gsea,regulation of megakaryocyte differentiation (GO:0045652),0.44796496948960146,1.5846638309014571,0.018975332068311195,0.05923166616240107,0.996,17/32,28.47%,HMGB2;NR4A3;ZFPM1;SIN3A;RBM15;KMT2A;KMT2C;RUNX1;KMT2D;EP300;KAT2B;KMT2B;RAB7B;TNRC6A;THBS1;PF4;SETD1A
gsea,epithelial cell migration (GO:0010631),0.5264357521927565,1.5845351818905329,0.036231884057971016,0.05912541544207105,0.996,9/19,26.10%,ANLN;NRP1;ROCK1;STAT1;LPXN;PIK3CA;ABL1;KANK2;KIT
gsea,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5654045108123027,1.5817072386526216,0.026929982046678635,0.060215386847166895,0.996,10/16,21.35%,JAK2;IRS2;NOTCH1;SHC1;ERBIN;SHOC2;TGM2;RASGRP1;RAPGEF1;RASGEF1A
gsea,cytoplasmic microtubule organization (GO:0031122),0.46729907143581206,1.5808602056493595,0.01195219123505976,0.06035899020313734,0.996,14/29,24.48%,FIGNL1;NUMA1;CLASP1;HOOK3;DCTN1;SLK;TUBGCP6;PCM1;CCDC88A;TUBGCP4;TUBGCP3;DYNC1H1;CAMSAP2;KPNB1
gsea,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4942952777064648,1.5792625267746172,0.044989775051124746,0.06091043933461329,0.996,6/21,25.34%,UBB;RPA3;RPA2;CHD1L;RPA1;CUL4B
gsea,protein methylation (GO:0006479),-0.514124527972733,-1.5781212926297286,0.03469387755102041,0.08296310632532339,0.996,14/23,16.20%,SNRPD3;PRMT3;PRMT5;FAM98A;ETF1;PRMT2;METTL22;PRMT6;N6AMT1;ETFBKMT;PRMT1;SNRPB;PRMT7;CARM1
gsea,gene expression (GO:0010467),-0.3803883162667474,-1.5761854161020712,0.04030710172744722,0.08363445590459873,0.996,88/203,26.64%,RPS26;RPS17;RPS2;RPS6;RPL31;RPL15;RPS18;HNRNPA2B1;RPL7A;RPL10;RPL5;RPS8;RSL24D1;RPS25;HSPD1;NCBP2;DKC1;RPL10A;SRSF6;RPL14;RPL23A;RRBP1;PTMA;HNRNPU;HNRNPK;UPF1;DNAJB11;SYNCRIP;RPS15;MPHOSPH10;RPL4;MRPL42;POLR2F;HNRNPF;SRSF2;RPL3;POLR2L;MRPS18B;RPS27A;SARNP;DDX54;RPL41;E2F1;MRPL3;RPLP0;GSPT2;MAGOHB;MRPL11;MRPS7;BICD1;RPL8;YARS2;NUFIP1;RPL7;EEF1A1;RNASEL;POLR2H;MRRF;PABPC4;PWP1;NOL9;MRPL13;COPS5;EIF4G1;MRPL44;HNRNPD;RBM15B;HHEX;CPSF3;MRPL35;SRSF7;FASTKD2;MRPS18A;RAE1;TESC;FARSB;ABCF1;EIF4E;U2AF2;THOC6;MRPS5;IGF2BP3;SRSF9;DHPS;MAGOH;GSPT1;DRG1;RPSA
gsea,DNA modification (GO:0006304),0.5240242836944656,1.5760735762339453,0.03225806451612903,0.062129196987620816,0.996,9/17,22.69%,NEIL3;TINF2;PARP2;TERF2;TDG;MBD4;PARP3;MUTYH;OGG1
gsea,actin cytoskeleton reorganization (GO:0031532),-0.44502688475955754,-1.575448912101247,0.006711409395973154,0.08371257079145329,0.996,10/31,28.62%,NEDD9;ANXA1;EZR;GPR65;FLNA;RAP2A;PLEK;RALA;ANTXR1;PLEK2
gsea,neuron projection morphogenesis (GO:0048812),0.3951511368536354,1.5740462346210427,0.0136986301369863,0.0629261430769348,0.996,19/53,30.22%,UBB;KIF20B;MAP4K4;ROCK1;SRGAP2;PACSIN1;ARC;ALCAM;DCLK1;CPNE1;TNIK;TAOK2;TAOK1;DVL1;FARP1;KLK8;SGK1;MAP2;PAK1
gsea,regulation of cilium assembly (GO:1902017),0.4501146459560397,1.5726948080156413,0.02631578947368421,0.06334658388944411,0.996,19/29,36.13%,CCP110;TBC1D10B;ODF2L;CEP120;TBC1D5;IFT140;CCDC88A;RABGAP1;TBC1D1;SDCCAG8;CEP97;TBC1D14;IFT88;BBS4;TCHP;TBC1D30;YAP1;HTT;EVI5L
gsea,positive regulation of signaling (GO:0023056),-0.5350307805047443,-1.5717092848746375,0.023109243697478993,0.08534482318397582,0.997,2/15,20.02%,ANXA2;CD80
gsea,epithelium development (GO:0060429),0.4218731656564055,1.5716308746880898,0.013559322033898305,0.06362107983148037,0.996,22/44,32.14%,CDK1;STIL;DNPH1;JAK2;BDH2;STAT1;AHI1;PIH1D1;VCL;ERRFI1;DVL1;HNRNPH3;PTCH1;PTER;SOX8;KANK2;WNT3;CNN3;PPP2R3A;DHRS9;CPT1A;WNT4
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3142783471491878,1.5709412176301616,0.0,0.06378361938938047,0.996,129/277,36.35%,CENPF;BIRC5;FOXM1;TYMS;EZH2;BRCA1;XCL1;CTCF;GMNN;HMGB2;SUV39H1;BTG2;CBX5;ID3;FOXN3;BCL6;IRF1;FOXP1;KLF4;ATF7IP;PDCD4;POU2F1;ARID5B;SUV39H2;ATXN1;PASK;JUN;SMARCC2;SIN3A;PER1;BHLHE40;RBM15;CIC;PIAS4;ILF3;ARID5A;CDC6;JARID2;DHFR;ATR;FMR1;RPS6KA5;CNOT1;GSK3B;CSF2;BCL3;NOTCH1;TRIM28;ELK3;TOB1;MYB;PDS5A;EIF4ENIF1;GATA3;CBX4;CNOT10;SHC1;HDAC6;DDX3X;DDIT3;BTRC;SETDB2;USP47;TFDP2;KAT6A;HINFP;GZF1;ZEB1;HEXIM1;FOXO1;KAT6B;MDFIC;ARNTL;CDAN1;LEF1;ZHX2;TNF;PTPRK;NONO;SPI1;ACVRL1;SMARCA2;TSC1;PML;HDAC5;RB1;BAP1;SIRT1;KAT7;IKZF1;HDAC9;PAIP2B;SMARCA4;KMT5A;NACC1;CDKN1A;CBX3;ZBTB21;L3MBTL2;TRIM33;BCLAF1;SOX8;EED;TRIB3;DAXX;TBX21;PHC1;MBTD1;MDM2;SBNO2;GIGYF2;GAS6;KDM8;EHMT1;LANCL2;SPINDOC;CBFA2T3;SAMD1;KDM4A;WNT4;EIF4A3;KDM5C;RBFOX2;WWP1;RELA;DAPK1;BAHD1;NKRF;BCOR
gsea,positive regulation of ion transport (GO:0043270),-0.4902833275216097,-1.5698895140217353,0.027906976744186046,0.08605126467179723,0.997,8/22,15.38%,CCL4;CCL3;VAMP8;SCN1B;CCL5;F2R;CCR1;VAMP7
gsea,positive regulation of cell migration (GO:0030335),0.35123086069682447,1.568312921050718,0.0016286644951140066,0.06472314972160768,0.997,45/134,27.69%,FBXO5;KIF20B;GTSE1;ITGB1;ARHGEF39;MAP4K4;ACTN4;NTRK3;PRKCA;HIF1A;CPNE3;ITGAX;NRP1;SUN2;CCAR1;CCN1;ITGA6;TIAM1;ROCK2;CLASP2;MGAT5;PIK3CD;CLASP1;NOTCH1;HDAC6;CCN4;PLCG1;IL1B;SPRY2;MYADM;FLT1;LEF1;SYNE2;STAT3;AGO2;CTSH;ELP5;DAB2;ARHGEF2;F3;CSF1R;PECAM1;KIT;THBS1;DOCK1
gsea,apoptotic mitochondrial changes (GO:0008637),-0.4946236157878654,-1.5677610305164609,0.025793650793650792,0.08677499174198236,0.997,11/21,24.56%,BAK1;HSPD1;BID;BAX;GGCT;AIFM2;SFN;BNIP3;NDUFS1;SOD2;IFIT2
gsea,ERAD pathway (GO:0036503),-0.4112854105318594,-1.5672697421070678,0.013257575757575758,0.08662306059070844,0.997,16/45,32.76%,HSP90B1;HSPA5;VCP;FOXRED2;SELENOS;EDEM1;SYVN1;TRIM25;CCDC47;UBQLN1;HERPUD1;ECPAS;FBXO44;PSMC6;RHBDD2;NCCRP1
gsea,histone H3-K4 methylation (GO:0051568),0.534478744766802,1.566867419810688,0.046370967741935484,0.06514066123942269,0.997,8/16,18.20%,KMT2A;SETD1B;KMT2C;PAXIP1;KMT2D;TET3;KMT2B;TET2
gsea,negative regulation of Ras protein signal transduction (GO:0046580),0.49808894090979217,1.565853323868887,0.029876977152899824,0.0654730281458402,0.997,8/22,26.01%,STMN1;SPRY1;RIPOR2;HEG1;SPRY2;ARHGAP24;CUL3;SCAI
gsea,positive regulation of catabolic process (GO:0009896),0.4679593050371756,1.5650181872713225,0.01890359168241966,0.06569132404989952,0.997,15/27,27.58%,FZR1;TNFAIP3;BARD1;GSK3B;HUWE1;DTL;IL1B;FOXO1;TNF;AXIN1;NSF;PLK2;ATG7;AREL1;HACE1
gsea,positive regulation of cell cycle (GO:0045787),0.41703402474316126,1.564033616397531,0.01937984496124031,0.06593211452026276,0.997,14/39,33.47%,CCNB1;CDC25B;PRKCA;RGCC;HCFC1;USP2;USP19;PSRC1;CCPG1;MDM2;HSF1;LGMN;TTL;NUPR1
gsea,phospholipid biosynthetic process (GO:0008654),-0.46679911339754054,-1.563344781333988,0.02186878727634195,0.08837733002712861,0.997,11/25,28.64%,FDPS;IDI1;NUS1;MVD;CRLS1;LPCAT1;DOLPP1;FAR1;AGPAT5;CLN3;AGPAT4
gsea,regulation of protein autophosphorylation (GO:0031952),0.4877990897851592,1.562992540261856,0.029880478087649404,0.06621582687665714,0.997,8/19,22.10%,CALM2;PPP2R5D;RAD50;ENG;DDX3X;TAOK2;ERRFI1;TNKS1BP1
gsea,striated muscle contraction (GO:0006941),-0.5031645574835812,-1.5626306221888027,0.02511415525114155,0.08829873728039678,0.997,5/19,15.72%,ALDOA;SCN1B;TPM1;TNNT1;GAA
gsea,chromatin assembly (GO:0031497),0.4913896761903092,1.5624096749426735,0.042283298097251586,0.06631906754756965,0.997,15/25,26.11%,CTCF;HMGB2;LIN54;RBBP4;ATRX;BRD2;SART3;ASF1A;ANP32B;KAT6B;CHAF1A;CDAN1;SIRT1;SPTY2D1;DAXX
gsea,regulation of actin filament bundle assembly (GO:0032231),-0.5067974714133663,-1.5612801267710268,0.035269709543568464,0.08863700283759907,0.997,8/19,28.79%,PFN1;ACTG1;PLEK;SYNPO2;LIMK1;RDX;ASAP3;PFN2
gsea,cytokine-mediated signaling pathway (GO:0019221),-0.31522417072872727,-1.5608431575847286,0.002183406113537118,0.08848298525784146,0.997,137/311,45.10%,TMSB4X;HSP90B1;ANXA2;CFL1;PPIA;EIF5A;MIF;PSME2;IL1R2;VIM;PSMA4;PSMA3;HNRNPA2B1;FCER1G;LCP1;PSMB2;MT3;CCR5;CCL4;PSMB5;PSMA5;TNFRSF9;IRF8;CANX;CCL3;PSMA6;AKT1;PSMD3;PSMB6;TCP1;MTAP;GSTO1;ANXA1;UBE2N;PSMD6;TNFRSF4;SNRPA1;PSMD1;TNFSF4;HSPA9;PSMD14;CCR2;MYC;PSMD12;HNRNPF;CASP3;RPS27A;PSMD7;PSMC1;IL15RA;PSMC5;RPLP0;TNFSF13B;P4HB;BST2;JAGN1;IL12RB1;CCL5;EDARADD;RNASEL;CASP1;PSMD2;TNFSF12;IL2RA;IRF5;CCR1;OSM;PDGFB;TNFRSF1A;CUL1;ITGAM;CEACAM1;TRIM21;SLC27A1;TRIM25;HMOX1;PSMD11;ICAM1;PSMB7;IL10RA;ISG20;PSME3;IFI27;RALA;CD80;FSCN1;RIPK2;CAMK2G;SOD2;PSMC2;IL10;TYK2;IFIT2;BRWD1;SOCS6;BIRC2;VEGFA;IL33;RIPK1;ALOX5;PSMC6;OSMR;CHUK;IL17RC;IFI30;SDC1;LRP8;CIITA;IRAK3;IKBKG;INPPL1;IFNG;CSF1;IP6K2;TRIM5;IL21;IL12RB2;CCND1;BATF;TNIP2;NOS2;CD4;NCAM1;MUC1;PSMC4;PSMA8;LTBR;SOCS2;ADAM17;PTK2B;TRAF5;TEC;GBP2;CTR9;CTSG;GRAP2;HNRNPDL
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.4247837923564916,1.560725160498418,0.037815126050420166,0.06686973466649877,0.997,17/53,28.69%,UBB;HMGN1;RFC4;RFC5;POLR2A;XRCC1;RFC1;RPA3;EP300;RPA2;POLD3;POLR2B;UVSSA;RPA1;CUL4B;USP7;RFC2
gsea,regulation of heart contraction (GO:0008016),0.455042221547122,1.5599996551696438,0.006611570247933884,0.06705551083440173,0.997,13/36,29.40%,CALM2;CAMK2D;ATP2A3;ITPR2;ATP2B4;P2RX4;TMEM65;SMAD7;ATP1B1;ATP2B2;PLN;CELF2;FXYD1
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),-0.402055558909373,-1.5573497151680926,0.009478672985781991,0.09006133354185077,0.997,15/45,33.16%,PLAC8;EPAS1;ACADL;FABP5;ADRB1;CCR2;TRPV2;HADH;GADD45G;PPARGC1B;VEGFA;DIO2;ACSL1;ELOVL6;ACHE
gsea,regulation of postsynapse organization (GO:0099175),-0.5421412166271398,-1.5564148497602786,0.04090909090909091,0.09026137389599455,0.997,1/15,0.17%,CFL1
gsea,zymogen activation (GO:0031638),-0.5444241297939638,-1.5550225640082882,0.041304347826086954,0.09073554640308411,0.997,5/15,21.98%,PGK1;BAK1;ASPH;VSIR;RIPK2
gsea,regulation of mRNA stability (GO:0043488),-0.4020980109870603,-1.5544217599815504,0.030534351145038167,0.09062870739821485,0.997,48/94,24.49%,PSME2;VIM;PSMA4;PSMA3;YBX1;PSMB2;PSMB5;PSMA5;PSMA6;AKT1;PSMD3;SERBP1;PSMB6;HNRNPU;SET;PSMD6;PSMD1;PSMD14;PSMD12;APEX1;NPM1;RPS27A;PSMD7;PSMC1;E2F1;PSMC5;EXOSC1;TBRG4;SLC11A1;PSMD2;PCBP4;EIF4G1;HNRNPD;MAPKAPK2;PSMD11;PSMB7;PSME3;METTL16;PABPC1;LARP1;EXOSC2;NOCT;FASTKD1;RIDA;PSMC2;IGF2BP3;DIS3;EXOSC5
gsea,intraciliary transport involved in cilium assembly (GO:0035735),0.4710103766269952,1.5543267772367435,0.03625954198473282,0.0693115778868391,0.997,10/22,23.92%,IFT80;SSX2IP;IFT74;PCM1;KIFAP3;KIF3B;IFT81;IFT140;DYNC2H1;IFT46
gsea,regulation of protein metabolic process (GO:0051246),0.4615023913355729,1.550885138203053,0.036585365853658534,0.07083283773794155,0.997,9/25,18.68%,FAM83D;FAF1;KLF4;KLF2;PLAUR;CHEK2;ROCK2;HGS;SSH1
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),0.39297225152945947,1.5501150264938135,0.02495201535508637,0.07107403719373523,0.997,20/52,31.63%,CCR7;GADD45B;HMGB1;RELL1;MAP3K5;ZC3H12A;IL1B;TAOK2;MID1;TAOK1;TRAF2;SPI1;XDH;RASGRP1;TRAF1;AXIN1;MAP3K4;MFHAS1;HIPK2;MAP3K11
gsea,regulation of cell-matrix adhesion (GO:0001952),0.43252701250850223,1.5483275288812453,0.016632016632016633,0.07173329586353062,0.997,16/36,22.64%,CCR7;UTRN;MAP4K4;GPM6B;ROCK1;CORO1C;MACF1;ROCK2;CLASP1;GSK3B;SLK;VCL;TSC1;PEAK1;CX3CL1;NF1
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.48629110403368186,-1.5445707869554284,0.05533596837944664,0.0960493689477838,0.998,23/35,19.19%,PSME2;PSMA4;PSMA3;PSMB2;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;PSMD14;PINX1;PSMD12;PSMD7;PSMC1;PSMC5;PSMD2;CUL1;AVEN;PSMD11;PSMB7;PSME3
gsea,negative regulation of neuron projection development (GO:0010977),-0.4914397832432017,-1.544550334704685,0.03529411764705882,0.09561203978493316,0.998,5/19,25.93%,MT3;ARHGDIA;HDAC2;CRMP1;PAQR3
gsea,regulation of interleukin-1 beta production (GO:0032651),0.47244692184089954,1.5414843214607075,0.03169014084507042,0.07489860170061825,0.998,14/33,22.87%,CCR7;TNFAIP3;FOXP1;JAK2;CD33;GBP5;ZC3H12A;MALT1;TNF;STAT3;CX3CR1;EGR1;CX3CL1;LPL
gsea,heart morphogenesis (GO:0003007),0.5543260631197248,1.537431609783236,0.047377326565143825,0.07684275319908694,0.998,6/15,20.28%,MDM4;ZFPM1;NOTCH1;ENG;TGFBR3;ACVRL1
gsea,positive regulation of apoptotic process (GO:0043065),0.31815241226479285,1.5338159978217625,0.0018450184501845018,0.07843005068608591,0.998,69/160,35.65%,TOP2A;UBB;MELK;ECT2;ITGB1;BARD1;GADD45B;HMGB1;BCL6;FAF1;ARHGEF3;CCAR1;JUN;DDX20;ATF4;ITGA6;TIAM1;FAS;DNAJA1;MAP3K5;ZC3H12A;HTRA2;NET1;PLEKHG2;SCRIB;DDX3X;DDIT3;PIDD1;BCL2L11;ING5;PRNP;FOXO1;QRICH1;ANO6;TNF;DUSP6;ABL1;TGM2;AIFM1;PLEKHN1;FAM162A;SIRT1;ATF6;RNPS1;NF1;HIP1R;ITGB3BP;JMY;ARHGEF11;ARHGEF2;ARHGEF18;GZMA;BCLAF1;ATG7;KLF11;PRR7;SOX4;STK3;LATS2;MAP3K11;FOXO3;FADD;NUPR1;SPHK2;RARG;PREX1;PXT1;DAPK1;HTT
gsea,regulation of apoptotic process (GO:0042981),0.2945685153177952,1.533350218404352,0.0037243947858473,0.07844921025653298,0.998,169/379,37.99%,TOP2A;CDK1;UBB;ARL6IP1;PLK1;BIRC5;MELK;ECT2;KIF14;MAD2L1;STIL;ITGB1;ANP32E;BARD1;NFKBIA;FIGNL1;PIM1;TPT1;BIRC3;MAP4K4;ACTN4;GADD45B;HMGB1;NFKB1;PIM2;CD44;BCL6;FAF1;BIRC6;PHIP;ARHGEF3;JAK2;RNF157;BCL2;CCAR1;JUN;CREBBP;STAT1;DDX20;ATF4;PLAUR;CXCL10;ITGA6;TIAM1;NUP62;TRIM24;FAS;SKP2;MADD;GSK3B;TAF9;DNAJA1;MAP3K5;HTRA2;BCL3;NET1;BAG4;WRN;PLEKHG2;ANP32B;EGR3;SETX;CBX4;ARHGAP10;SHC1;SCRIB;DDX3X;USP42;PIDD1;TNFSF9;NAA16;MGMT;AHI1;BCL2L11;PINK1;HIP1;USP47;SPRY2;CD40LG;SLK;MALT1;FBXO11;ING5;TRAF2;FOXO1;QRICH1;ANP32A;BCL2L1;DDX42;LEF1;ANO6;TNF;DUSP6;ABL1;TGM2;AIFM1;PLEKHN1;HSPA1B;FAM162A;CTSH;SIRT1;PTPN6;ATF6;RNPS1;IFIT3;CX3CL1;LANCL1;NF1;HIP1R;DAB2;ITGB3BP;IL2;JMY;PLK2;ARHGEF11;CBL;FHL2;APIP;TNFRSF25;ARHGEF2;PERP;PIK3R1;ARHGEF18;GZMA;HCK;BCLAF1;SGK1;SOX8;DAXX;ATG7;THBS1;OSGIN1;CHM;AREL1;ANKLE2;IL6ST;KLF11;GAS6;CD74;PRR7;ACTN1;CRYAA;NOTCH2;HSPA1A;SOX4;STK3;LATS2;MAP3K11;FOXO3;FADD;PIM3;NUPR1;PRKAA1;SPHK2;RARG;PREX1;PXT1;FSTL1;RELA;DAPK1;RHBDD1;HTT;SOS2;HSP90AA1;FXN;RBM25;ARHGEF19;RPS6KA3;VAV2
gsea,regulation of cellular localization (GO:0060341),0.46370760017026713,1.5325832946083775,0.031067961165048542,0.07859679537670136,0.998,9/23,32.05%,SPAG5;MAD1L1;NUMA1;CAMK2D;PINK1;DVL1;DYNC1H1;MAP2;TTL
gsea,internal peptidyl-lysine acetylation (GO:0018393),0.508766295010026,1.5320867753976017,0.036468330134357005,0.07865818864880504,0.998,10/18,24.93%,BRD8;CREBBP;TAF6;EP300;TRRAP;KAT2B;KAT6A;KAT6B;KAT7;TAF6L
gsea,positive regulation of metabolic process (GO:0009893),-0.3851616472286594,-1.530848132736028,0.004651162790697674,0.10372525777543834,0.998,19/54,33.16%,PLAC8;EPAS1;ACADL;FABP5;ADRB1;FASN;CCR2;TRPV2;HADH;GADD45G;PPARGC1B;ACLY;BEND3;VEGFA;DIO2;ACSL1;ELOVL6;IFNG;ACHE
gsea,positive regulation of secretion by cell (GO:1903532),-0.4251537589028135,-1.5270276079593255,0.020460358056265986,0.10588446958809722,0.998,10/35,26.01%,PPIA;ADAM8;PPID;EXPH5;EZR;UNC13B;FRMD4A;APBB1;TGFB3;RAB27A
gsea,response to cytokine (GO:0034097),0.37739048980291606,1.526959908877477,0.03473491773308958,0.08124871277487666,0.998,39/84,29.34%,AFF3;CCR7;IL18R1;REL;PRKCA;GCH1;IFNAR2;JAK2;BCL2;IFITM1;STAT1;CXCR4;NFAT5;TAF9;RELB;PTPN11;TIMP2;SETD2;IL1B;PLSCR1;YTHDC2;PTPN13;BCL2L1;LEF1;STAT3;ADAR;PML;PTPN6;CD274;CD40;KHSRP;SELP;CSF1R;IFITM3;IFITM2;ISG15;IL6ST;CD74;TIMP1
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.4185297560578521,1.526469024410272,0.047325102880658436,0.08128917923462332,0.998,15/45,25.92%,CDK1;PLK1;ECT2;GTSE1;UBR5;MEPCE;ZC3H12A;TRIM28;LIF;IPO5;KAT7;PIK3R2;SESN2;PIK3R1;MCRS1
gsea,positive regulation of programmed cell death (GO:0043068),0.318329775129923,1.525539300803515,0.0055658627087198514,0.08158682093010336,0.998,67/154,35.65%,TOP2A;UBB;MELK;ECT2;ITGB1;BARD1;GADD45B;HMGB1;BCL6;FAF1;ARHGEF3;CCAR1;JUN;DDX20;ATF4;ITGA6;TIAM1;FAS;DNAJA1;MAP3K5;HTRA2;NET1;PLEKHG2;HDAC6;SCRIB;DDX3X;PIDD1;BCL2L11;ING5;FOXO1;QRICH1;ANO6;TNF;DUSP6;ABL1;TGM2;AIFM1;PLEKHN1;FAM162A;SIRT1;ATF6;RNPS1;NF1;HIP1R;ITGB3BP;JMY;ARHGEF11;ARHGEF2;ARHGEF18;GZMA;BCLAF1;ATG7;KLF11;PRR7;SOX4;STK3;LATS2;SYK;MAP3K11;FOXO3;FADD;SPHK2;RARG;PREX1;PXT1;DAPK1;HTT
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4496901049604479,1.5234024147182001,0.019834710743801654,0.08254887451130971,0.998,15/32,30.75%,TTK;NUMA1;JAK2;CREBBP;CCN1;NOTCH1;NUP93;ENG;EP300;ACVRL1;DAB2;THBS1;HFE;HIPK2;FBXL15
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.40296838952597136,1.5226800659064474,0.04216867469879518,0.08274915387865549,0.998,16/55,25.99%,FBXO5;AURKA;CDKN2D;CDKN2C;E2F7;ZFP36L1;RBL1;ZFP36L2;RGCC;KLF4;WEE1;USP47;RB1;JADE1;CDKN1A;KANK2
gsea,peptide metabolic process (GO:0006518),-0.4391992682921426,-1.5215595794705066,0.0371900826446281,0.1091427281688898,0.998,9/30,16.79%,GPX1;SPCS3;ERAP1;ABCB9;GSR;NLN;GSTM5;PSEN2;CLN5
gsea,phosphatidylinositol biosynthetic process (GO:0006661),0.3668907924921634,1.5206627024126322,0.008565310492505354,0.08366726866095707,0.998,36/65,38.70%,INPP4B;SOCS1;ITPKB;PIK3CD;SOCS5;CISH;MTMR14;MTMR12;SOCS3;MTMR3;PIK3CA;SBF1;PTPN13;PIGA;PIK3R5;PIK3R6;PI4KA;PIGF;PIK3R2;PIK3CG;PIK3R1;SYNJ1;VAC14;PIP5K1C;PIGN;TTC7B;SYNJ2;MTMR4;PITPNM2;PIGV;PGAP3;PGAP2;INPP5F;PIK3C2A;FAM126B;FGF2
gsea,calcium ion transmembrane import into cytosol (GO:0097553),0.5204731353652547,1.520414384334361,0.0364963503649635,0.08363420934022459,0.998,4/17,12.75%,XCL1;CCR7;ITPR2;ATP2B4
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.40495041579649743,-1.5199146827117724,0.045174537987679675,0.10976717666539984,0.998,13/41,33.89%,MIF;HAVCR2;ADAM8;CCL3;CCR2;TMEM106A;CD14;PLCG2;IL33;RIPK1;TLR4;IFNG;HSPB1
gsea,neurotransmitter transport (GO:0006836),0.4621973074949077,1.5178635537027825,0.036608863198458574,0.08478331785368168,0.998,11/24,29.18%,SLC29A1;SLC38A2;PDZD11;SLC1A2;PPFIA1;GLS;DVL1;STXBP3;GLUL;SYNJ1;PPFIA4
gsea,cellular response to reactive oxygen species (GO:0034614),0.4140518501838431,1.5176879899733622,0.034552845528455285,0.08468920581169574,0.998,13/36,21.45%,ECT2;TNFAIP3;FOS;JUN;MAP3K5;NET1;SETX;HDAC6;NFE2L2;PDK2;ABL1;PTPRK;SIRT1
gsea,cellular senescence (GO:0090398),-0.5015380629137519,-1.5176023571166233,0.0613107822410148,0.11103767508280439,0.998,5/18,6.93%,CALR;ID2;HMGA1;CDKN2A;HRAS
gsea,positive regulation of JNK cascade (GO:0046330),0.40726650208094056,1.5159146682829163,0.029880478087649404,0.08540203588997837,0.998,18/39,38.89%,CCR7;GADD45B;HMGB1;MAP3K5;IL1B;TAOK2;TAOK1;TRAF2;RASGRP1;TRAF1;AXIN1;MFHAS1;HIPK2;MAP3K11;F2RL1;FCGR2B;PJA2;UNC5CL
gsea,positive regulation of gene expression (GO:0010628),-0.3074059593683439,-1.5149318039319326,0.0023094688221709007,0.11241594124054721,0.998,90/227,36.39%,ACTB;GAPDH;ACTG1;MIF;RPS27L;VIM;HILPDA;ID2;MT3;RPL5;PHB;FUBP1;CCL3;TXK;AKT1;PARK7;MYBBP1A;EIF3D;TNFSF4;EZR;PKP3;EIF6;MYC;POLR2F;FAM98A;POLR2L;FLOT1;NPM1;AGPAT2;DDX21;CITED2;POLR1B;E2F1;KAT2A;OSR2;ZPR1;POLR2H;PIWIL2;EIF3C;SLC11A1;TFRC;POLR1E;PLCG2;WNT11;HNRNPD;PDGFB;GLMN;EIF2AK2;MYO1C;ERN1;POLR1A;DNMT3B;VSIR;POLR1C;TAF1A;TAF1D;TESC;SERPINB9;U2AF2;ATM;RDX;IL10;HMGN5;RAB27A;TMEM119;RAMP2;VEGFA;IL33;RIPK1;OLFM1;NAT10;TLR4;BMP7;DLL4;SFRP4;PPM1F;IFNG;CSF1;ZCCHC4;EIF2AK3;MED1;IL21;LARP4;POLR2E;DNAJA4;CCDC88B;ERCC6;BATF;MOV10;CAMK2N1
gsea,RNA metabolic process (GO:0016070),-0.38639672942574493,-1.5137502082960672,0.04809619238476954,0.11269417492531224,0.998,34/83,21.90%,HNRNPA2B1;PCBP1;HNRNPA1;NCBP2;DKC1;PTBP1;HNRNPU;HNRNPK;HNRNPM;SYNCRIP;MPHOSPH10;POLR2F;HNRNPF;POLR2L;HNRNPC;DDX54;BICD1;NUFIP1;TBRG4;RNASEL;WDR74;POLR2H;PABPC4;NOL9;MRPL44;HNRNPD;PNPT1;PPP1R8;GTF2F2;FASTKD2;ISG20;RNASEH2B;FASTKD1;HNRNPA3
gsea,endothelial cell migration (GO:0043542),0.4884635029137615,1.5136716883184167,0.04946996466431095,0.08640000794759338,0.998,7/20,19.58%,NR4A1;NRP1;STAT1;EGR3;LPXN;PIK3CA;ABL1
gsea,regulation of MAP kinase activity (GO:0043405),0.39496541270530655,1.5127100324423879,0.022641509433962263,0.08675664538005987,0.998,24/48,28.95%,EZH2;TNFSF11;DUSP1;SPRY1;SH2B3;RGS2;IL1B;SPRY2;HGS;TRIB2;FLT1;TNF;PIK3R5;PIK3R6;RASGRP1;NF1;PTPRJ;CD40;TRIB1;PIK3CG;TRIB3;KIT;KSR1;CD300A
gsea,regulation of protein secretion (GO:0050708),-0.3692680956208428,-1.5108407468438614,0.0079155672823219,0.11418189061300538,0.998,21/58,33.16%,PPIA;ADAM8;PPID;EXPH5;EZR;HMGCR;SLC2A1;HADH;CCL5;UNC13B;RHBDF2;FRMD4A;APBB1;DISP1;ITPR3;TGFB3;P3H1;ALOX5;CACNA1A;IFNG;ACHE
gsea,regulation of erythrocyte differentiation (GO:0045646),0.46422373359011393,1.509133851867574,0.048638132295719845,0.08864684190555398,0.998,11/23,22.99%,ZFP36L1;HMGB2;HIF1A;STAT1;ZFPM1;ETS1;STAT5B;STAT3;SPI1;HSPA1B;ARNT
gsea,tRNA aminoacylation (GO:0043039),-0.4885252497085197,-1.5089820603759292,0.05622489959839357,0.11496470229994923,0.998,9/19,25.44%,EEF1E1;PPA1;AIMP2;FARSA;YARS2;RARS2;FARSB;PPA2;GATB
gsea,transcription by RNA polymerase I (GO:0006360),-0.4573810066269968,-1.5072833668079801,0.04921259842519685,0.11554277144611985,0.998,15/25,24.00%,POLR2F;POLR2L;POLR1B;CDK7;UBTF;POLR2H;POLR1E;GTF2H2;RRN3;POLR1A;POLR1C;TAF1A;TAF1D;GTF2H4;GTF2H1
gsea,positive regulation of intracellular protein transport (GO:0090316),0.36612584714310376,1.5068580225993478,0.01764705882352941,0.08969617829959001,0.998,35/71,37.69%,KIF20B;ECT2;GTSE1;PCNT;BCL2;CD81;UBR5;C2CD5;GSK3B;HUWE1;ZC3H12A;HTRA2;TRIM28;ANP32B;IL1B;SAE1;PINK1;TFDP2;PCM1;IPO5;PRNP;FBXW7;BAP1;PIK3R2;NPEPPS;PIK3R1;XPO4;GAS6;CDH1;BCAS3;CSNK2A2;CEP290;SEC16A;VPS11;TCF7L2
gsea,regulation of protein localization (GO:0032880),-0.43236714954748906,-1.5037171752242828,0.032015065913371,0.11755215504507936,0.998,9/30,17.62%,CTSD;HSP90AB1;RSL1D1;RACK1;ITGB3;PARP1;TRIM46;TRIM21;TRIM25
gsea,organophosphate biosynthetic process (GO:0090407),-0.48596998157686494,-1.503218960256144,0.056133056133056136,0.11739861119955797,0.998,10/19,35.31%,TPI1;TKT;PNPO;LPCAT1;AGPAT5;AGPAT4;PCYT2;IP6K2;IPPK;GNPAT
gsea,response to lipid (GO:0033993),0.39523397259974435,1.5028384940406503,0.01971326164874552,0.09191130461105365,0.998,19/46,27.00%,CDKN2D;HMGB2;ASXL1;FOXP1;GCH1;JAK2;ABCG1;PCK2;STAT5B;IL1B;ERBIN;AQP3;RXRA;FOXO1;STAT3;CTSH;TRIB1;SELP;SLPI
gsea,regulation of protein export from nucleus (GO:0046825),0.5300212619223609,1.500223957149652,0.06133828996282528,0.09323864722240056,0.998,6/15,15.71%,GTSE1;RANGAP1;BARD1;GSK3B;ANP32B;IL1B
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.41323751637839307,1.5000994013372444,0.03314917127071823,0.09309910122523732,0.998,25/41,35.65%,BRCA1;TNFAIP3;BIRC6;PHIP;BCL2;SERPINE1;ITGA6;FAS;GSK3B;CSF2;DDX3X;AR;IL1B;TRAF2;BCL2L1;TNF;HSPA1B;EYA3;ARHGEF2;THBS1;PF4;HSPA1A;FADD;RELA;HTT
gsea,epidermis development (GO:0008544),-0.45826686682018625,-1.5000359546545197,0.0334075723830735,0.11930622782214947,0.998,11/22,29.89%,YBX1;FABP5;HDAC1;HDAC2;ATP2A2;ALDH3A2;DSP;LAMC2;DLL1;COL7A1;COL17A1
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),-0.39934306543008974,-1.4995956751461468,0.0365296803652968,0.11911035906985107,0.998,17/42,27.51%,CALR;MT3;CCL3;SLC39A6;CCR2;SLC39A7;ATP2A2;CCL5;SLC11A1;SLC39A14;CCR1;SLC39A10;STOML2;RMDN3;ATP13A1;SLC39A4;TNNI3
gsea,actin filament organization (GO:0007015),-0.34536888203901206,-1.4994639410071546,0.02027027027027027,0.11868694419565808,0.998,33/81,32.85%,ALDOA;CAPG;LCP1;CORO1A;TPM3;NEDD9;NEBL;SH3BP1;FLNA;MYO1G;NEB;TPM1;TMOD1;MYO1C;SPIRE1;BAIAP2;MYO1F;TPM4;RHOC;DSTN;GHSR;ERMN;FLII;ELMO2;ABI2;PLS3;SPIRE2;GAS2L1;GAS2;CDC42EP2;SPTA1;INPPL1;TMOD4
gsea,regulation of JNK cascade (GO:0046328),0.38186797362042263,1.498239550311652,0.03076923076923077,0.09403539810343482,0.998,25/52,39.33%,CCR7;MAP4K4;GADD45B;HMGB1;PER1;MAP3K5;IL1B;TAOK2;PINK1;TGFBR3;TAOK1;TRAF2;RASGRP1;TRAF1;AXIN1;SIRPA;MFHAS1;AIDA;HIPK2;MAP3K11;F2RL1;FCGR2B;PJA2;UNC5CL;PHLPP1
gsea,cellular response to UV (GO:0034644),0.4026376681434326,1.497253632203603,0.03762376237623762,0.09442281360029924,0.998,14/45,25.34%,AURKB;RHNO1;TAF1;CREBBP;CDC25A;ATF4;ATR;FMR1;EP300;USP47;PTPRK;SIRT1;CDKN1A;CUL4B
gsea,regulation of filopodium assembly (GO:0051489),0.49221540557575044,1.4972248149388379,0.059813084112149535,0.0942162947246257,0.998,5/18,10.81%,CCR7;RIPOR2;NRP1;DOCK11;FMR1
gsea,histone methylation (GO:0016571),0.49717290099462336,1.4967179476411265,0.04132231404958678,0.0943332106792698,0.998,5/18,7.84%,EZH2;SUV39H1;SMYD3;SUV39H2;CREBBP
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3899816736523279,-1.4950649828189513,0.04017857142857143,0.12145215146715628,0.998,17/43,39.93%,PRELID1;GPX1;SLC25A5;NOC2L;AKT1;PARK7;LGALS3;PSME3;SLC35F6;CAAP1;HERPUD1;OPA1;RIPK1;PPIF;MPV17L;ACVR1;SH3RF1
gsea,porphyrin-containing compound biosynthetic process (GO:0006779),-0.5132028827573939,-1.4937043410748383,0.07066381156316917,0.12149064574474712,0.998,8/15,31.71%,ALAD;CPOX;ABCB10;ALAS1;HMBS;PGRMC1;UROS;COX10
gsea,heme biosynthetic process (GO:0006783),-0.5132028827573939,-1.4937043410748383,0.07066381156316917,0.12149064574474712,0.998,8/15,31.71%,ALAD;CPOX;ABCB10;ALAS1;HMBS;PGRMC1;UROS;COX10
gsea,regulation of lipid metabolic process (GO:0019216),-0.40726182036183317,-1.4931463530537727,0.03550295857988166,0.12146563705311206,0.998,21/45,36.54%,FDPS;ID2;IDI1;DHCR7;PMVK;FASN;SC5D;SQLE;MVD;HMGCR;LACTB;HMGCS1;LSS;CARM1;TM7SF2;MVK;ELOVL6;SREBF2;MED1;PPARG;FDFT1
gsea,visual perception (GO:0007601),0.4565899212608867,1.4928284770559168,0.019834710743801654,0.09646104797827638,0.998,10/28,22.15%,RGS16;OPA3;OAT;MYO9A;RDH12;CRYBG3;TRPM1;DHRS3;ATF6;EYA3
gsea,histone monoubiquitination (GO:0010390),0.5212458523661975,1.4916889528083312,0.060784313725490195,0.09696064086302249,0.998,4/15,14.25%,KDM2B;UHRF1;RNF40;RNF168
gsea,negative regulation of T cell activation (GO:0050868),-0.4496577415424521,-1.4915559446394209,0.054,0.1220262765729761,0.998,10/24,24.15%,HAVCR2;TNFRSF21;DUSP3;PDCD1LG2;LGALS3;GLMN;CEACAM1;CD80;IL4I1;IL10
gsea,long-chain fatty acid metabolic process (GO:0001676),-0.4228013049165585,-1.489652719171518,0.04050632911392405,0.12286139894489692,0.998,13/29,36.22%,GPX1;ACSL5;ACADL;ACSL4;AIG1;ACOX1;ALOX5;ACSL1;ACAD9;ELOVL6;SLC27A2;ELOVL2;ABCD1
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.4380664562586922,-1.4889025449829187,0.027906976744186046,0.12292822472411068,0.998,9/28,21.98%,CTSD;BAK1;CYCS;MYC;REST;F2R;CASP1;ASPH;RIPK2
gsea,tRNA methylation (GO:0030488),-0.43610766149074337,-1.4881018072889216,0.032818532818532815,0.12304986610794974,0.998,15/27,30.20%,NSUN2;METTL1;HSD17B10;TRMT10C;TRMT61B;TRMT13;TRMT5;WDR6;TRMT61A;PRORP;TRMT1L;ALKBH8;TYW3;TARBP1;LCMT2
gsea,granulocyte chemotaxis (GO:0071621),-0.44440869158322405,-1.4867261808983583,0.0392156862745098,0.12349447302804159,0.998,9/32,14.74%,PPIA;FCER1G;CCL4;CCL3;ANXA1;BSG;LGALS3;CCL5;PIKFYVE
gsea,mRNA stabilization (GO:0048255),-0.49657164068646475,-1.486705755505239,0.07142857142857142,0.12299492103557937,0.998,12/22,21.47%,YBX1;YBX3;HNRNPU;SYNCRIP;HNRNPC;E2F1;SLC11A1;MAPKAPK2;TARDBP;PABPC1;LARP1;NOCT
gsea,beta-catenin-TCF complex assembly (GO:1904837),0.45976289669414316,1.4853426492529862,0.04056795131845842,0.10075182376035528,0.999,10/23,23.05%,TCF7;CREBBP;KMT2D;EP300;AXIN2;TRRAP;TLE4;LEF1;PYGO2;SMARCA4
gsea,small GTPase mediated signal transduction (GO:0007264),0.3757740211710994,1.4846149175890297,0.019400352733686066,0.10096268390353348,0.999,28/56,39.15%,CCNA2;JUN;DNMT1;TIAM1;ARHGAP31;TRIM28;SHC1;GRAP;SHOC2;USP8;RASGRP1;CCDC88A;RB1;NF1;PLK2;CDKN1A;CDK2;ARHGEF18;KSR1;RASGRP2;KSR2;SETDB1;RIN2;CNKSR1;RHEBL1;RRAD;FGF2;MAPKAPK5
gsea,regulation of amyloid-beta formation (GO:1902003),0.4792433564503254,1.4845480633915018,0.06273062730627306,0.10077076657917838,0.999,9/21,23.12%,SP1;ROCK1;ROCK2;RTN3;ABCG1;PRNP;TNF;GGA3;PIN1
gsea,positive regulation of ATPase activity (GO:0032781),-0.49767060701313387,-1.4842429755796493,0.05343511450381679,0.12438624351798824,0.998,6/19,12.03%,PFN1;HNRNPU;DNAJB11;MSH2;MSH6;TPM1
gsea,negative regulation of cell-matrix adhesion (GO:0001953),0.5185451432331573,1.483487445845876,0.06076388888888889,0.1011997672688039,0.999,6/16,26.66%,MAP4K4;CORO1C;SERPINE1;CLASP2;ACVRL1;THBS1
gsea,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.4961381072818605,-1.4829545764859786,0.05719921104536489,0.12485380851064783,0.998,8/16,24.77%,PHB;PHB2;XBP1;TNFRSF4;TNFSF4;LACC1;IL10;SCIMP
gsea,protein-DNA complex assembly (GO:0065004),-0.41502866332057164,-1.482250496955001,0.0755813953488372,0.12490057523061049,0.998,42/82,24.00%,PSME2;MCM2;MCM6;MCM3;PSMA4;PSMA3;PSMB2;MCM4;PSMB5;PSMA5;PSMA6;PSMD3;PSMB6;PSMD6;PSMD1;NAP1L3;PSMD14;RAD23B;PSMD12;NPM1;RPS27A;PSMD7;PSMC1;PSMC5;CDK7;MCM5;GRWD1;CENPV;CHAF1B;PARP1;PSMD2;DDB1;TCF4;GTF2H2;NAP1L4;PSMD11;PSMB7;PSME3;GTF2H4;PSMC2;NAP1L1;GTF2H1
gsea,negative regulation of innate immune response (GO:0045824),0.493254387866074,1.4812778540454692,0.05671077504725898,0.10246407312873561,0.999,8/19,26.98%,TNFAIP3;SAMHD1;NLRC3;STAT2;TRAFD1;USP15;OAS3;ISG15
gsea,nervous system development (GO:0007399),0.3318702128004282,1.480296518514989,0.009787928221859706,0.1028100981097774,0.999,63/137,38.70%,ECT2;STIL;CDK5RAP2;MARCKSL1;EVL;WDR62;GPM6B;LRCH4;ARHGAP26;FGF13;ATXN1;ST8SIA4;PPP2R5D;CXCR4;DYRK1A;JARID2;NAB2;MBP;DCLK1;NINJ1;ADORA2A;DCTN1;EP300;TRAK1;IL3;AHI1;BTBD6;EGR2;STAT3;IGSF8;DVL1;RPS6KA6;FARP1;NF1;CHERP;ROGDI;SOX8;MTR;MARCKS;ANKLE2;NOTCH2;PRPS1;ATN1;SPOCK2;WWTR1;GBA2;NAV1;B3GNT5;RBFOX2;CHAC1;MET;YAP1;WWP1;CRIM1;CDH1;GFRA4;SOX10;ZEB2;ATXN3;RPS6KA3;EFNB3;BTD;FGF2
gsea,mismatch repair (GO:0006298),0.4785621762565555,1.4801019700634117,0.05179282868525897,0.10269004197980672,0.999,11/24,23.94%,EXO1;PMS1;TDG;RPA3;SETD2;RNASEH2A;RPA2;POLD3;ABL1;MUTYH;RPA1
gsea,sensory perception of light stimulus (GO:0050953),0.45342027896527715,1.479400441582612,0.0411663807890223,0.10284860095648009,0.999,10/27,22.15%,RGS16;OPA3;OAT;MYO9A;RDH12;CRYBG3;TRPM1;DHRS3;ATF6;EYA3
gsea,polyol metabolic process (GO:0019751),0.4729635071455547,1.47918422329957,0.06958250497017893,0.10276599383792671,0.999,10/21,27.02%,INPP4B;ITPKB;NUDT4;INPP5B;PLCG1;PLD4;PLCH1;PLCB4;PPIP5K1;SYNJ1
gsea,regulation of GTPase activity (GO:0043087),0.33257860619169977,1.474880739916169,0.00929368029739777,0.10531478471741275,1.0,45/104,39.80%,ECT2;EZH2;ARHGAP11A;XCL1;ITGB1;RGS10;MAP4K4;SRGAP2;WNK1;RGS16;DOCK11;ITGA6;TBC1D10B;GSK3B;PLXNC1;NET1;CCL1;LRCH1;RAB3GAP1;TGM2;RASGRP1;RAPGEF1;ARFGEF1;RABGAP1;SIPA1L1;CX3CL1;NF1;PIN1;PKP4;AFDN;CD40;ARL2;RAP1GDS1;SNX13;RASGRP2;CCL22;F2RL1;TBC1D30;BCAS3;EVI5L;VAV2;RGP1;DVL3;PICALM;CCL17
gsea,regulation of cell differentiation (GO:0045595),0.3571660552480779,1.4740573695659769,0.02578268876611418,0.10560575333123676,1.0,23/63,22.64%,ZFP36L1;SUZ12;CDK5RAP2;BCL6;KLF4;ROCK1;CREBBP;ATF4;TIAM1;CLASP2;CLASP1;RUNX1;CSF2;HOPX;LIF;GATA3;ANP32B;FLOT2;AR;PRKCB;TNF;SMAD7;NF1
gsea,positive regulation of cellular component biogenesis (GO:0044089),-0.37366356716848587,-1.4730950325878598,0.03300970873786408,0.13115835306102813,0.998,25/50,33.52%,PFN1;BAK1;VCP;PARK7;BID;MTLN;BAX;FLOT1;RACK1;PLEK;LGALS3;SYNPO2;TFRC;LIMK1;RHOC;DAB2IP;SLF1;ICE1;VEGFA;PFN2;BMP7;SDC1;CDC42EP2;IFNG;GNL3L
gsea,epithelial cell differentiation (GO:0030855),0.3963061803489921,1.4729359269594224,0.03551401869158879,0.10609486731669349,1.0,16/44,31.26%,CDK1;E2F8;E2F7;DNPH1;BDH2;KDM6B;GATA3;PCK2;SCRIB;PIH1D1;HNRNPH3;DAB2;PTER;CNN3;DHRS9;CPT1A
gsea,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5035616088642141,1.4724958094146543,0.05405405405405406,0.1061209228101714,1.0,10/16,37.54%,BRCA1;CNOT1;RUNX1;KMT2D;AXIN1;KANK2;PAK1;YAP1;UFSP2;VPS11
gsea,positive regulation of binding (GO:0051099),0.3925572664421751,1.4694491516287465,0.046263345195729534,0.10785292379759753,1.0,27/49,35.57%,GMNN;HMGB2;STMN1;HMGB1;TAF1;PLAUR;TIAM1;BAMBI;GSK3B;CDT1;EPB41;DDX11;SKI;HIP1R;PIN1;USP33;TRIB3;LRP1;KDM4D;HFE;IDE;HIPK2;STK3;APOE;AKTIP;MET;NCBP1
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.4903251684118619,-1.4694149935020413,0.06932773109243698,0.13354569238596073,0.998,3/17,3.63%,HSP90AB1;RPL5;PARK7
gsea,regulation of endothelial cell proliferation (GO:0001936),0.4168417756334822,1.4690372211109686,0.03804347826086957,0.10787232289139952,1.0,21/39,32.36%,NR4A1;HMGB2;PRKCA;HIF1A;RGCC;NRP1;STAT1;PIK3CD;PRKD2;EGR3;XDH;ACVRL1;SIRT1;NF1;ARNT;F3;THBS1;ECM1;PGF;STAT5A;APOE
gsea,negative regulation of supramolecular fiber organization (GO:1902904),0.4060088595876809,1.4668327261626737,0.05835010060362173,0.10912190330080758,1.0,17/34,24.49%,TPX2;STMN1;SSH2;FGF13;DYRK1A;CLASP2;CLASP1;HDGFL3;KATNB1;PIK3CA;TAOK1;SSH1;MYADM;ARFGEF1;HIP1R;CAMSAP2;ARHGEF2
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4871721601189023,1.4658186651040437,0.06808510638297872,0.10961590588852275,1.0,9/16,20.62%,CALM2;MASTL;PPP6R3;PPP1R15A;GSK3B;ITGA1;PPP6R1;PPP6R2;TSC1
gsea,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.46743496874925017,1.465745042867064,0.06545454545454546,0.10943446128986938,1.0,11/24,23.05%,FOS;HIF1A;KLF4;JUN;ETS1;GATA3;TNF;STAT3;SPI1;EGR1;SMARCA4
gsea,negative regulation of angiogenesis (GO:0016525),0.4078225559243247,1.4653777288873835,0.03860294117647059,0.10942176102906502,1.0,21/42,28.60%,E2F2;RGCC;KLF4;ROCK1;KLF2;STAT1;CXCL10;SERPINE1;ROCK2;GTF2I;ATF2;ATP2B4;SPRY2;HGS;TNF;FOXJ2;PML;PDE3B;THBS1;PF4;SPRED1
gsea,negative regulation of intracellular signal transduction (GO:1902532),0.3285063692718545,1.4643008463967166,0.017716535433070866,0.1098937756349167,1.0,53/102,35.04%,CIT;TNFAIP3;TRIM59;TNFAIP8L1;DUSP1;RNF157;BCL2;STAT1;PER1;PLAUR;HDAC7;SH2B3;TNIP3;ZC3H12A;RORA;NLRC3;ATP2B4;CPNE1;DDX3X;DDIT3;PINK1;FNIP1;ARNTL;MYADM;BCL2L1;AJUBA;TNIP1;SPI1;XDH;TSC1;SIRT1;PIK3R2;PDE3B;PIK3IP1;NF1;PTPRJ;PDE10A;DGKD;DEPDC5;CD2AP;TRIB3;THBS1;MDM2;OTUD7B;TMEM127;SPRED1;ARHGAP25;THEM4;MGRN1;PRKAA1;UBR1;ITPR1;RELA
gsea,negative regulation of binding (GO:0051100),0.3726438548399787,1.463433470162836,0.028629856850715747,0.110271104183476,1.0,23/50,27.12%,AURKB;AURKA;NFKBIA;JAK2;ROCK1;JUN;ZFPM1;GSK3B;CPNE1;DDX11;LEF1;TMC8;DVL1;DAB2;PIN1;USP33;CDKN1A;SYMPK;PLN;GZMA;CTSZ;SLPI;GOLGA2
gsea,response to molecule of bacterial origin (GO:0002237),0.4479001434120116,1.462895623314593,0.051418439716312055,0.11037727592199001,1.0,10/30,27.00%,TNFAIP3;HMGB2;FOXP1;GCH1;JAK2;IL1B;ERBIN;TRIB1;SELP;SLPI
gsea,inositol phosphate metabolic process (GO:0043647),0.4645412488703769,1.462668175697502,0.06627680311890838,0.11027810304850688,1.0,10/21,27.02%,INPP4B;ITPKB;NUDT4;INPP5B;PLCG1;PLD4;PLCH1;PLCB4;PPIP5K1;SYNJ1
gsea,T cell differentiation (GO:0030217),0.45854889508421204,1.460203512556245,0.06457564575645756,0.11175602094759633,1.0,10/21,33.00%,TCF7;ZFP36L1;ZFP36L2;PIK3CD;GATA3;SPI1;IL2;KIT;SOX4;FADD
gsea,positive regulation of phospholipase C activity (GO:0010863),-0.47101868739289965,-1.457829773310855,0.06372549019607843,0.14275391887787708,0.999,4/17,6.93%,PHB;PHB2;TXK;HRAS
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3936046191447582,-1.4573765816710038,0.058365758754863814,0.14255376175932521,0.999,16/38,37.54%,TMSB4X;HAVCR2;DAP;ANXA4;CDKN2A;PRMT2;TRIM21;DAB2IP;UFL1;IL10;BMP7;CHUK;IRAK3;PARP10;NFKBIB;ARRB1
gsea,positive regulation of immune effector process (GO:0002699),-0.47086012624765605,-1.4551324019050813,0.07341269841269842,0.14381318409774924,0.999,8/18,32.49%,PHB;XBP1;TNFSF4;CCR2;IL12RB1;IL10;DHX58;IFNG
gsea,neuron development (GO:0048666),0.36526680751580876,1.4540311723634125,0.026515151515151516,0.11563954982996816,1.0,22/60,32.36%,STMN1;BTG2;HMGB1;TDP2;GPM6B;ROCK1;WNK1;THOC2;RUNX1;GSK3B;PBX2;GPRIN3;HDGFL3;UNK;TMEM108;RB1;UNC5A;MAP2;MAP4;INSM1;GBA2;APOE
gsea,regulation of MAPK cascade (GO:0043408),0.3527635390021423,1.4536169105465924,0.026515151515151516,0.11567201202897334,1.0,31/70,31.58%,FAM83D;MAP4K4;HMGB1;NTRK3;DUSP1;ROCK1;CCN1;ROCK2;FAS;LIF;SHC1;IL1B;TNIK;TAOK2;TGFBR3;TAOK1;FLT1;RASGRP1;PTPN6;PIK3R2;CX3CL1;NF1;PTPRJ;APIP;KIT;KSR1;SPRED1;CD74;PAK1;STK3;SYK
gsea,protein glycosylation (GO:0006486),-0.34058966112102274,-1.4533759225257512,0.031914893617021274,0.14465229512145514,0.999,32/72,31.79%,DDOST;NUS1;RPN1;STT3A;RPN2;SERP1;ALG2;FUT4;PGM3;PMM1;MAGT1;ALG3;B4GALT5;SERP2;B3GALNT2;MGAT4B;ALG10B;GALNT18;ST3GAL6;DOLPP1;B3GALT5;B3GNT3;FUT7;GFPT1;MPI;PLOD2;GALNT1;OGA;POMGNT1;ST3GAL3;ALG9;PLOD3
gsea,cellular response to hydrogen peroxide (GO:0070301),0.43447802715614464,1.4530057887545214,0.053742802303262956,0.11582872693337778,1.0,9/24,21.45%,ECT2;TNFAIP3;MAP3K5;NET1;SETX;HDAC6;NFE2L2;ABL1;SIRT1
gsea,sensory organ development (GO:0007423),0.46838907506472227,1.4529307820926523,0.0663265306122449,0.1156301212377241,1.0,9/23,30.54%,SMCHD1;SMG9;HIPK1;PBX2;GATA3;AHI1;ATF6;WNT10A;HIPK2
gsea,"transcription, DNA-templated (GO:0006351)",0.3301651884521248,1.4519244400941156,0.035164835164835165,0.11611989592890118,1.0,53/124,40.65%,TRIP13;TTF2;PMF1;DEK;NFKB1;TAF1;POLR2A;MED4;TAF5;IWS1;MLLT3;ATF4;NELFE;GTF3C2;IRF9;TRIM24;PKNOX1;NFYA;RBMX;TAF9;MLF1;SSRP1;GMEB2;BCL3;TAF6;MMS19;SETX;GTF2A1;TBP;POLR2B;CTDP1;RNPS1;NELFCD;GTF3C1;CCNK;HSF1;MLLT1;GTF2E2;TTF1;NFIX;DTX1;MED16;FOXO3;NFX1;POLRMT;NCBP1;TAF1B;SMARCA5;MBD1;BRF2;NR4A2;BAZ2A;ELOA
gsea,negative regulation of secretion by cell (GO:1903531),-0.4814814783972218,-1.4513308964904514,0.07857142857142857,0.14584046313098922,0.999,6/16,16.67%,ANXA1;VAMP8;HMGCR;OSM;TNFRSF1A;RHBDF2
gsea,cellular calcium ion homeostasis (GO:0006874),-0.35844700886236347,-1.4511466735485774,0.02643171806167401,0.1454178819141843,0.999,24/57,27.51%,CALR;BAK1;YWHAE;CCL3;CCR2;BAX;KCTD17;AFG3L2;SLC35G1;ATP2A2;MCUB;CCL5;CCR1;CCDC47;CAV2;TRPC1;CDH23;STOML2;RMDN3;ATP13A1;HERPUD1;CALCA;CLN3;TNNI3
gsea,axon guidance (GO:0007411),0.3650764255503692,1.4502870076803493,0.02936096718480138,0.11707415209250849,1.0,28/68,39.53%,EMB;PRKCA;EVL;NRP1;CXCR4;PIK3CD;ALCAM;RPS6KA5;IRS2;PLXNC1;PTPN11;NOTCH1;SPTBN1;SHC1;PLCG1;PIK3CA;GRB10;UNC5A;USP33;PIK3R1;NOTCH2;SPTAN1;GFRA4;KIF5B;NRP2;SEMA4B;EFNB3;ENAH
gsea,cell chemotaxis (GO:0060326),0.41356272785203774,1.450043102695777,0.04660194174757282,0.11701507989667123,1.0,16/30,34.16%,CCR7;NR4A1;CCR6;HMGB2;CXCR3;NRP1;CXCR4;CXCR5;EGR3;LEF1;CX3CR1;CX3CL1;KIT;CCR8;CCR4;CCR9
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4600416786521081,1.449645004897971,0.0775347912524851,0.11701653352170936,1.0,8/21,19.45%,ARL6IP1;CDKN2D;CD44;KLF4;DDX3X;USP47;FNIP1;TNF
gsea,embryonic organ development (GO:0048568),0.4722853280687923,1.4496260897456725,0.0466786355475763,0.11678493225714258,1.0,9/21,19.45%,STIL;ZFPM1;ATF4;KMT2A;SH2B3;PBX2;GATA3;IL3;TNF
gsea,positive regulation of cellular metabolic process (GO:0031325),0.3789703282692785,1.4492449415791924,0.040776699029126215,0.11683688395972333,1.0,19/49,33.89%,CDK1;CCNB1;NFKBIA;KLF4;UHRF1;FMR1;ZC3H12A;GATA3;SCRIB;AHI1;TBC1D5;XDH;RAMP3;NSF;CDKN1A;THBS1;APOE;SCYL2;PID1
gsea,positive regulation of chemokine production (GO:0032722),0.4431949419694017,1.445917043898204,0.07442748091603053,0.11892217462209123,1.0,16/28,34.22%,HMGB1;HIF1A;MBP;DDX3X;IL1B;IL17RA;TNF;AIRE;TLR7;EGR1;LPL;OAS3;CSF1R;CD74;SYK;F2RL1
gsea,cellular response to metal ion (GO:0071248),0.37792277781985206,1.445010246867656,0.050816696914700546,0.11928554670717903,1.0,27/48,44.08%,ECT2;FOS;CPNE3;CAMK2D;ITPKB;JUN;CPNE1;P2RX4;ALOX5AP;PRNP;DAXX;HSF1;LGMN;RASGRP2;HFE;CPNE7;PRKAA1;CDH1;CPNE9;SLC41A1;SLC12A2;NCF1;GLRA1;SYT11;DLG2;DMTN;MAPK8
gsea,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4629380373973814,1.443238550892944,0.07692307692307693,0.12026353193997043,1.0,7/21,32.24%,FAM83D;EZH2;RGCC;DDX3X;LSM11;RPTOR;UBE2E2
gsea,defense response to Gram-positive bacterium (GO:0050830),-0.4977614929394819,-1.4431878238594713,0.07789473684210527,0.1517605008587668,0.999,3/15,13.99%,PGLYRP1;PGLYRP2;GBP7
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.38050190383353744,1.4406738871103997,0.0410958904109589,0.12186460346194043,1.0,19/45,32.36%,PLK1;DUSP1;SPRY1;SH2B3;RGS2;HEG1;IL1B;SPRY2;IPO5;HEXIM1;ABL1;RB1;SIRT1;NF1;PTPRJ;CD300A;PKIG;LATS2;APOE
gsea,mitochondrial membrane organization (GO:0007006),-0.4718152460658774,-1.4374083716762835,0.076,0.15625591342289966,0.999,9/21,28.66%,SLC25A5;BAK1;HSPA9;SAMM50;BNIP3;RCC1L;MTX1;OPA1;PPIF
gsea,neural tube closure (GO:0001843),0.4635310051523722,1.43680612235242,0.060109289617486336,0.12437424788464566,1.0,8/20,30.96%,STIL;KDM2B;SCRIB;DVL1;SKI;PHACTR4;MTHFR;BBS4
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3395635415414116,-1.4363336302093597,0.04821802935010482,0.15662072695827053,0.999,27/70,37.54%,TMSB4X;HAVCR2;DAP;ID2;PHB2;ANXA4;EOMES;TNFRSF4;CDKN2A;TNFSF4;FLNA;HDAC2;KEAP1;PRMT2;EGLN1;ADGRG3;TRIM21;DAB2IP;UFL1;FZD6;EIF2AK4;BMP7;CHUK;IRAK3;PARP10;SFRP4;ARRB1
gsea,BMP signaling pathway (GO:0030509),0.4575634237286593,1.4360085877331594,0.07330827067669173,0.12459708402872978,1.0,13/21,37.18%,PDCD4;HIVEP1;USP9X;ENG;TGFBR3;ACVRL1;USP15;SMAD7;ZFYVE16;HFE;AMH;SMAD1;RGMB
gsea,organic substance transport (GO:0071702),0.35808638944605353,1.4359446337220525,0.03543307086614173,0.12437554502271472,1.0,20/50,44.81%,CENPF;NDC1;TXNIP;ABCG1;CHKA;RAMP3;ABCA1;GM2A;NME4;ARRDC3;MIA3;TCN2;CEP290;ABCA7;LMAN2L;MYH9;ABCA2;SLC19A2;RUFY1;HIKESHI
gsea,regulation of neurogenesis (GO:0050767),0.4227617298814093,1.4339725033504263,0.05668016194331984,0.12559551569128352,1.0,13/26,27.16%,HMGB2;BHLHE40;NOTCH1;HOOK3;IL1B;PCM1;ARNTL;TNF;TGM2;CX3CR1;CX3CL1;WNT3;PRUNE1
gsea,ERBB signaling pathway (GO:0038127),0.4049899689543708,1.4333619575236596,0.044859813084112146,0.12580456078486668,1.0,15/34,24.91%,PRKCA;CPNE3;STUB1;PDPK1;RPS6KA5;PTPN11;SHC1;PLCG1;ERBIN;PIK3CA;KIF16B;MATK;DGKD;CBL;PIK3R1
gsea,negative regulation of cellular amide metabolic process (GO:0034249),-0.37274285276872055,-1.4323603805945853,0.06086956521739131,0.1594274482216951,0.999,20/49,35.71%,GZMB;GAPDH;CALR;YBX1;SYNCRIP;PUS7;RACK1;CAPRIN1;NCL;MRPL13;EIF2AK2;LARP1;RIDA;IGF2BP3;IGF2BP2;SHMT1;NANOS3;EIF2AK3;GRB7;HAP1
gsea,regulation of p38MAPK cascade (GO:1900744),0.438055718367224,1.4316273342645105,0.07,0.1268230121910538,1.0,11/23,27.45%,GADD45B;DUSP1;PER1;RELL1;ZC3H12A;IL1B;SPI1;XDH;RASGRP1;MAP3K4;MFHAS1
gsea,regulation of regulatory T cell differentiation (GO:0045589),0.48454197765839935,1.431616770788127,0.08061420345489444,0.1265571358552235,1.0,7/17,22.98%,SOCS1;BCL6;IRF1;FANCA;RUNX1;NFATC2;IL2
gsea,negative regulation of MAP kinase activity (GO:0043407),0.41670444460556877,1.4315549708453907,0.06463878326996197,0.1263191871924719,1.0,13/28,32.36%,DUSP1;SPRY1;PDCD4;SH2B3;DNAJA1;RGS2;IL1B;SPRY2;NF1;PTPRJ;CD300A;AIDA;APOE
gsea,positive regulation of cellular amide metabolic process (GO:0034250),-0.3864253032972208,-1.4314984586195967,0.043010752688172046,0.1595196111251342,0.999,18/47,34.89%,RPS27L;VIM;RPL5;EIF3D;EIF6;CASP3;NPM1;RACK1;PIWIL2;EIF3C;GSAP;HNRNPD;TNFRSF1A;PLA2G6;NAT10;IFNG;ZCCHC4;LARP4
gsea,positive regulation of telomerase activity (GO:0051973),0.47152421990822757,1.4313336267510717,0.10323886639676114,0.12622819153298082,1.0,4/21,8.96%,AURKB;NEK2;KLF4;NEK7
gsea,chaperone cofactor-dependent protein refolding (GO:0051085),-0.480851208057965,-1.431019885731741,0.09161793372319688,0.15930023366021212,0.999,7/20,24.36%,HSPA5;SDF2L1;HSPA9;HSPE1;DNAJB4;HSPA2;DNAJB13
gsea,RNA transport (GO:0050658),0.4025443349185451,1.4301262415468856,0.08520179372197309,0.12682215539459255,1.0,30/53,36.45%,CKAP5;ZFP36L1;UPF3B;ALYREF;SLBP;NUP155;ARC;NUP62;NXF1;THOC2;FMR1;POM121;SRSF4;NUP153;RFTN1;SRSF3;ATXN2;NUP214;CASC3;RNPS1;SRRM1;SIDT1;XPO5;U2AF1;DDX39B;SRSF1;NUP188;EIF4A3;NCBP1;RBM8A
gsea,cellular response to chemokine (GO:1990869),0.44619943552028457,1.4300715702378755,0.06216696269982238,0.1266020976440235,1.0,10/31,15.78%,XCL1;DUSP1;RIPOR2;WNK1;CXCL10;SH2B3;ZC3H12A;CCL1;OXSR1;LRCH1
gsea,aggrephagy (GO:0035973),0.4925452025954145,1.42903000435328,0.0691699604743083,0.1271710635336027,1.0,4/15,14.93%,UBB;PCNT;ARL13B;HDAC6
gsea,apoptotic process (GO:0006915),-0.30330458445264363,-1.4272035846143407,0.016129032258064516,0.1620829167357116,0.999,56/126,39.76%,PRF1;GZMB;PPIA;GAPDH;MCM2;DAP;BAK1;HSPD1;DDIT4;AKT1;DHCR24;BID;TNFRSF21;MYC;BAX;CASP3;IFT57;MRPS30;VDAC1;AIFM2;PARP1;DAPK2;CASP1;CD14;TNFSF12;IL2RA;CASP7;AKAP1;PRKCE;PLK3;FASTKD2;BNIP3;DLC1;IFI27;NDUFS1;IER3;ZBTB16;NCKAP1;IFIT2;PAK6;PLSCR3;BNIP1;GADD45A;EGLN3;RNF152;RIPK1;ERCC3;THOC1;IKBKG;PAWR;IFNG;ATCAY;ERCC2;CASP12;LIG4;RHOB
gsea,protein targeting to membrane (GO:0006612),0.38916200241647014,1.425514853764641,0.04721030042918455,0.12946985691113486,1.0,10/31,42.08%,ARL6IP1;TAOK2;PXMP2;ZDHHC15;RTP4;CHM;ZDHHC14;RAB3IP;NCF1;SGTB
gsea,positive regulation of cell-substrate adhesion (GO:0010811),-0.40264187445496197,-1.4205321373987991,0.06779661016949153,0.16753070077262877,0.999,13/33,32.55%,S100A10;CALR;C1QBP;CDK6;NEDD9;NPNT;FLNA;P4HB;PDGFB;JUP;DOCK5;PPM1F;CSF1
gsea,regulation of cellular protein localization (GO:1903827),-0.42015986049208104,-1.4202268947846663,0.07514450867052024,0.16719425141775185,0.999,9/27,23.13%,HSP90AB1;LCP1;VCP;KCNAB2;PARP1;CTNNB1;TRIM46;SUMO3;RALB
gsea,nitrogen compound transport (GO:0071705),0.3469415581919834,1.4200567416703378,0.034926470588235295,0.1333746019248317,1.0,25/59,46.74%,CENPF;NDC1;SLC38A2;TXNIP;LRRC8D;SLC7A1;RAMP3;SLC15A2;SLC44A1;SLC3A1;ARRDC3;MIA3;TCN2;CEP290;LMAN2L;SLC7A8;MYH9;SLC12A2;SLC6A6;SLC52A2;SLC19A2;RUFY1;HIKESHI;SLC43A2;FLVCR1
gsea,synapse organization (GO:0050808),-0.3829391879004039,-1.4183202268769057,0.06304347826086956,0.16836218728166139,0.999,15/40,35.17%,CHCHD10;PLXND1;REST;NEDD4;RYK;RAB39B;F2R;DSCAM;CYFIP1;DNM3;UNC13B;CTNND2;NLGN2;ACHE;LRRK2
gsea,response to tumor necrosis factor (GO:0034612),0.3768506548540708,1.4180524084108688,0.054307116104868915,0.13459880222778467,1.0,18/52,24.49%,BRCA1;XCL1;AFF3;ZFP36L1;ZFP36L2;GCH1;JAK2;ZC3H12A;CCL1;BAG4;GATA3;ERBIN;YTHDC2;NFE2L2;SIRT1;CX3CL1;CD40;ARHGEF2
gsea,fat cell differentiation (GO:0045444),0.42366214471619174,1.4177122988373945,0.05514705882352941,0.13459038336923848,1.0,14/27,39.57%,NR4A1;NR4A3;KLF4;SDF4;EP300;FOXO1;EGR2;SIRT1;SOX8;BBS4;PID1;MKKS;TCF7L2;NR4A2
gsea,positive regulation of cell-matrix adhesion (GO:0001954),0.45093603048821185,1.4176409822659715,0.08064516129032258,0.134371441794547,1.0,10/21,22.66%,CCR7;UTRN;MAP4K4;NRP1;ROCK1;GSK3B;ABL1;TSC1;CX3CL1;PTPRJ
gsea,negative regulation of kinase activity (GO:0033673),-0.3923748380597908,-1.417417209061728,0.072,0.16845885710186784,0.999,15/31,36.39%,PPIA;AKT1;PARK7;HNRNPU;LRP6;PRDX3;CEACAM1;SFN;AKT1S1;YWHAG;DUSP19;PPM1F;HSPB1;SMCR8;CAMK2N1
gsea,histone lysine demethylation (GO:0070076),0.45349385240803736,1.41738227632738,0.07827788649706457,0.1343086040934662,1.0,13/20,33.61%,KDM2B;KDM6B;KDM3A;KDM7A;JMJD1C;PHF8;PHF2;KDM3B;KDM4D;KDM4B;KDM8;KDM4A;KDM5C
gsea,negative regulation of protein ubiquitination (GO:0031397),0.4117396424878986,1.4162487224435871,0.07910750507099391,0.1349132383102545,1.0,12/28,31.02%,FBXO5;TNFAIP3;TAF1;DNAJA1;SPRY2;ABL1;HSPA1B;SMAD7;ISG15;PRR7;HSPA1A;SOX4
gsea,regulation of epithelial cell proliferation (GO:0050678),-0.39463089895458353,-1.416214891071567,0.04691358024691358,0.1690150388959248,0.999,16/37,33.04%,NME1;NME2;GPX1;CDK6;SRSF6;MYC;HRAS;PEX2;LAMC1;OSR2;RUNX3;DAB2IP;VEGFA;CDKN2B;TGFA;GRN
gsea,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4283769794591688,1.4139540459412192,0.05595667870036101,0.13636198947854253,1.0,15/32,27.87%,SOCS1;JAK2;SH2B3;CSF2;LIF;SOCS3;IL3;TNF;STAT3;IL2;CD40;CLCF1;CSF1R;KIT;IL6ST
gsea,lipid biosynthetic process (GO:0008610),-0.38827666682462003,-1.4136122179238655,0.05702647657841141,0.17073975284965973,0.999,25/37,37.12%,ACSL5;XBP1;MVD;HMGCR;NDUFAB1;LSS;LPCAT1;DOLPP1;DHRS11;ABCD3;ACLY;MVK;AGPAT5;ELOVL4;AGPAT4;ALOX5;ACSL1;FDXR;OXSM;PCYT2;PDSS2;GNPAT;CBR4;FDFT1;MCAT
gsea,positive regulation of signaling receptor activity (GO:2000273),0.43073927236448806,1.4114390366521004,0.05935251798561151,0.13809911672195277,1.0,9/27,20.90%,ITGB1;TAF1;HIF1A;NRP1;JAK2;ARC;HDAC6;NCOA3;FBXW7
gsea,cellular response to BMP stimulus (GO:0071773),0.4552768551064562,1.4093457901369206,0.07918968692449356,0.13950234596875685,1.0,13/22,37.18%,PDCD4;HIVEP1;USP9X;ENG;TGFBR3;ACVRL1;USP15;SMAD7;ZFYVE16;HFE;AMH;SMAD1;RGMB
gsea,determination of heart left/right asymmetry (GO:0061371),0.47825637341176125,1.4087441388750963,0.09242144177449169,0.139383370807738,1.0,5/15,16.42%,STIL;NOTCH1;ENG;SETDB2;AHI1
gsea,heart looping (GO:0001947),0.47825637341176125,1.4087441388750963,0.09242144177449169,0.139383370807738,1.0,5/15,16.42%,STIL;NOTCH1;ENG;SETDB2;AHI1
gsea,negative regulation of multicellular organismal process (GO:0051241),0.3303874271755639,1.4085267110665802,0.041811846689895474,0.13926892413195718,1.0,36/88,33.38%,IL18R1;RGCC;EVL;SPRY1;BRCA2;ROCK1;ATF4;CORO1C;ROCK2;RPS6KA5;GSK3B;NOTCH1;ATP2B4;GATA3;RGS2;DDIT3;IL1B;PARP3;SPRY2;ARNTL;TNF;SPI1;TFE3;RB1;SMAD7;HDAC9;RPS6KA6;PTCH1;TIFAB;SPRED1;GAS6;TIMP1;PTGER4;ABHD6;USF3;ARRDC3
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3347096413018122,1.4084387870958435,0.051587301587301584,0.13903747490373283,1.0,33/77,28.77%,UBB;NFKBIA;TNFSF11;IL18R1;NFKB1;IL18RAP;RPS6KA5;NFKB2;PRKD2;FLOT2;EP300;AR;IL1B;PIDD1;CD40LG;MALT1;PRKCB;TRAF2;TNF;STAT3;HSPA1B;CX3CR1;RAB7B;TRAF1;CX3CL1;TRIM14;MAP3K7;CD40;ARHGEF2;TAB3;CARD11;PRKCZ;TRIM37
gsea,nucleobase-containing small molecule interconversion (GO:0015949),0.5077954726170285,1.4081157824761321,0.11022044088176353,0.13902968966192134,1.0,3/18,1.84%,RRM2;TYMS;RRM1
gsea,cellular response to organonitrogen compound (GO:0071417),-0.38075355622455614,-1.4074467429454387,0.047619047619047616,0.17594082282617177,0.999,13/38,23.68%,ACTB;HSP90B1;XBP1;EZR;CAPN2;PDXP;CTNNB1;CTNNA1;JUP;IMPACT;LARP1;RRAGB;GABRB1
gsea,negative regulation of protein-containing complex assembly (GO:0031333),0.4248275627834695,1.4068479114950418,0.0677361853832442,0.1397589870997764,1.0,14/26,32.13%,KIF14;HMGB1;PMEPA1;GSK3B;NLRC3;HDAC6;DDX3X;EP300;TMC8;PRKCZ;HSF1;AIDA;PTGER4;MEFV
gsea,regulation of kinase activity (GO:0043549),0.4087482521164725,1.405379906258244,0.0774526678141136,0.14070019591709682,1.0,18/32,39.06%,ECT2;RBL1;NTRK3;RAD50;IRS2;FLT1;RB1;CSF1R;KIT;VAC14;CD74;TTN;MET;DRD4;LMTK2;SLAMF8;SMG8;FGR
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.4253347424124879,-1.4053041268100617,0.072,0.1772518286851398,0.999,7/24,21.09%,GZMB;YWHAE;BID;E2F1;USP36;SFN;YWHAG
gsea,TOR signaling (GO:0031929),-0.4572048651665691,-1.4046860252811828,0.08431372549019608,0.17720841012585165,0.999,5/18,28.19%,RPS6;AKT1;PRR5;LARP1;PRR5L
gsea,cell-matrix adhesion (GO:0007160),0.40621917639623384,1.4024213402967995,0.07787610619469026,0.14277491724992428,1.0,17/37,30.45%,ITGB1;CD44;ITGB7;TIAM1;ITGA1;PPFIA1;TAOK2;PTPRK;VCL;TSC1;PEAK1;ITGB8;ITGA7;ITGA10;ACTN1;BCAM;VCAM1
gsea,DNA duplex unwinding (GO:0032508),0.40867175554485313,1.4008010388270418,0.10560344827586207,0.14379705647945784,1.0,13/38,25.98%,UBB;RAD51;BLM;PIF1;RTEL1;RAD50;RECQL4;WRN;DDX11;CHD1L;RPA1;CUL4B;RECQL5
gsea,dephosphorylation (GO:0016311),0.3382540439446851,1.400764437046314,0.058027079303675046,0.1435361413770286,1.0,29/65,32.96%,DUSP4;SSH2;DUSP1;UBLCP1;PPP3CB;PPP2R5D;PGP;MTMR3;BTRC;PLPP1;SBF1;PTPN13;SSH1;DUSP6;PTPRK;DUSP2;CTDSP2;PTPN6;CTDP1;TIMM50;PTPRJ;CTDSP1;PTPN3;PPP2R3A;DUSP5;MTMR4;PPP4R1;DUSP16;PPP1CB
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3440029880251008,-1.3993049138105742,0.05203619909502263,0.18169084375049188,0.999,29/65,31.81%,TMED2;AREG;BCAP29;COPB2;CD55;LMAN1;CAPZA2;HYOU1;MIA2;SEC24D;RANGRF;MCFD2;ARCN1;VAMP7;COPZ2;LMAN2;STX17;SEC31A;USO1;KDELR2;SEC24A;PGAP1;ARFGAP3;KDELR3;TICAM2;COL7A1;TGFA;COPA;SPTA1
gsea,regulation of supramolecular fiber organization (GO:1902903),-0.4884209638057758,-1.397728075254532,0.10505050505050505,0.18265351157280174,0.999,3/15,24.09%,GPX1;PARK7;CAMSAP1
gsea,protein complex oligomerization (GO:0051259),0.36595772855573955,1.3975038341333177,0.06365503080082136,0.1459496049392424,1.0,21/43,38.59%,ECT2;POLQ;BLM;EHD3;ARC;LRRC8D;FUS;ATL2;RBMX;ZC3H12A;NINJ1;ATL3;RNF213;MCU;CARD11;KCNC1;CPSF6;SHMT2;TIFA;HOMER1;HGSNAT
gsea,regulation of stress fiber assembly (GO:0051492),-0.3577199850277472,-1.396169984245602,0.05150214592274678,0.1834565481536979,0.999,19/41,39.06%,PFN1;ACTG1;S100A10;GPR65;TPM1;WNT11;LIMK1;DLC1;RHOC;ARHGEF5;SORBS3;TGFB3;ARAP1;ASAP3;PFN2;PHLDB2;PPM1F;ARHGEF10L;TJP1
gsea,purine-containing compound biosynthetic process (GO:0072522),-0.4973411927921514,-1.3956549742053754,0.12835249042145594,0.1832783796248905,0.999,11/18,26.33%,APRT;ADSL;PPAT;GMPS;AMPD2;PAICS;GART;PRPSAP1;MTHFD1;ADA;SHMT1
gsea,regulation of telomere maintenance via telomerase (GO:0032210),0.42325725875710063,1.3956256612697415,0.10084033613445378,0.1471674401637689,1.0,10/34,11.34%,AURKB;NEK2;TINF2;PIF1;CTC1;SMG6;NEK7;ATR;XRN1;TERF2
gsea,embryonic heart tube morphogenesis (GO:0003143),0.4723936949084496,1.3942130056249515,0.09925093632958802,0.14796511807313142,1.0,8/16,35.07%,STIL;NOTCH1;ENG;SETDB2;AHI1;TBX21;BBS4;MKKS
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.4065380424553101,-1.3935095061323577,0.08216432865731463,0.18474214472480124,1.0,13/28,23.07%,RPL5;GTPBP4;AKT1;PARK7;PRMT3;PINX1;BAG2;CTNNB1;CRY1;TRIM21;U2AF2;NXN;UFL1
gsea,mesenchymal cell differentiation (GO:0048762),0.4419943492307717,1.3923619478657479,0.08058608058608059,0.1491672479357118,1.0,10/22,19.25%,FAM83D;HIF1A;ROCK1;ROCK2;GSK3B;NOTCH1;TRIM28;ENG;TGFBR3;LEF1
gsea,purine ribonucleotide biosynthetic process (GO:0009152),-0.48398146081129584,-1.3921430418446703,0.09689922480620156,0.1854019800694362,1.0,9/15,26.82%,ADSL;IMPDH1;GMPS;AMPD2;SLC26A2;COASY;PPCS;NPPC;IMPDH2
gsea,neutrophil chemotaxis (GO:0030593),-0.41938062140966387,-1.3919837094871395,0.07542579075425791,0.18489713011761766,1.0,8/31,14.74%,PPIA;FCER1G;CCL4;CCL3;BSG;LGALS3;CCL5;PIKFYVE
gsea,regulation of cellular metabolic process (GO:0031323),0.44799614562059936,1.3910461462203438,0.08300395256916997,0.15001299423344477,1.0,8/19,23.33%,FOXM1;STUB1;ABCG1;PINK1;PDK2;SSH1;KIF16B;COQ7
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),0.37114373969691516,1.389973507088018,0.07222222222222222,0.1506466763133882,1.0,24/45,37.11%,TNFAIP3;SOCS1;BIRC3;IFNAR2;JAK2;STAT1;MADD;RUNX1;HIPK1;PTPN11;SOCS3;IL3;TRAF2;TNF;IFNGR2;PTPN6;TRAF1;GAS6;CD74;SYK;USP18;FADD;LIFR;SIGIRR
gsea,regulation of protein ubiquitination (GO:0031396),0.35001283602644345,1.3894751668986944,0.07465618860510806,0.1507284414402768,1.0,24/51,31.02%,UBB;BRCA1;TNFAIP3;BIRC3;STUB1;FANCI;DNAJA1;HUWE1;PAXIP1;PINK1;SPRY2;MALT1;HSPA1B;FBXW7;SMAD7;AXIN1;CENPS;CUL3;DAXX;ISG15;PRR7;PHF23;HSPA1A;SOX4
gsea,regulation of response to biotic stimulus (GO:0002831),0.45115413777955243,1.3887276335281242,0.09611451942740286,0.15110462390227164,1.0,5/19,22.49%,BIRC3;IRF1;FOXP1;SAMHD1;CX3CL1
gsea,protein import (GO:0017038),0.3683796465541233,1.388069179322617,0.0823045267489712,0.15139040157125755,1.0,26/52,33.84%,NUP133;CSE1L;NUP107;NXT1;NUP85;NUP155;PPP1R10;NUP62;FAM53B;POM121;NUP153;E2F3;NUP93;EIF4ENIF1;NUP88;NUP214;PXMP2;IPO5;STAT3;IPO11;KPNB1;IPO9;SYK;NUP188;APOE;RPAIN
gsea,negative regulation of BMP signaling pathway (GO:0030514),0.4914280494184701,1.3877267784283043,0.08627450980392157,0.15136782106520527,1.0,11/16,38.63%,SKIL;BAMBI;NOTCH1;SMAD7;SKI;TRIM33;HIPK2;FSTL1;CRIM1;SMAD1;LEMD3
gsea,regulation of interleukin-4 production (GO:0032673),-0.4587950997297576,-1.3869473529648275,0.08559498956158663,0.1892968645888054,1.0,3/17,4.98%,HAVCR2;FCER1G;TNFSF4
gsea,mRNA catabolic process (GO:0006402),0.40936261781498234,1.3844671410681004,0.09221311475409837,0.15383481501190346,1.0,11/25,30.68%,LSM2;ZFP36L2;THRAP3;DXO;XRN1;CNOT10;NBAS;ZC3H12D;HSPA1B;EXOSC4;HSPA1A
gsea,epithelial to mesenchymal transition (GO:0001837),0.4307367283481493,1.3838364582868161,0.0998185117967332,0.15405240378950238,1.0,11/23,19.25%,FAM83D;HIF1A;ROCK1;ROCK2;GSK3B;NOTCH1;TRIM28;TASOR;ENG;TGFBR3;LEF1
gsea,carbohydrate derivative biosynthetic process (GO:1901137),0.48204634204949,1.3836779961215777,0.1026694045174538,0.15390260504497885,1.0,6/15,19.81%,RRM2;RRM1;ALG8;ST3GAL4;ALG6;TNIP1
gsea,response to interferon-beta (GO:0035456),0.4919068024305182,1.3828556069087197,0.10633946830265849,0.15434052495584188,1.0,8/15,26.67%,IRF1;IFNAR2;IFITM1;STAT1;HTRA2;PLSCR1;IFITM3;IFITM2
gsea,lysosome organization (GO:0007040),-0.4267397320664273,-1.3819257360256834,0.09368191721132897,0.19365565216166547,1.0,9/21,35.17%,CORO1A;ARSB;NAGPA;GAA;CLN5;CLN3;GRN;ACP2;LRRK2
gsea,protein localization to Golgi apparatus (GO:0034067),0.4699141008310754,1.3804835500476966,0.12219959266802444,0.1561042715542887,1.0,10/15,33.99%,ARL5C;GBP5;BICD2;ZDHHC15;ARL5B;GBF1;VPS13D;VPS13C;GAK;OPTN
gsea,Golgi organization (GO:0007030),0.34293921485439033,1.3803933455507231,0.07100591715976332,0.1558906426213722,1.0,26/58,38.86%,CDK1;ZW10;CLASP2;CLASP1;ATL2;VRK1;HUWE1;ATL3;GBF1;ARFGEF1;DYNC2H1;DYM;GOLGA2;HACE1;SYNE1;GAK;OPTN;LMAN1L;HTT;BCAS3;PLEKHM2;GOLGB1;COG3;SEC16A;LMAN2L;STX16
gsea,"DNA-templated transcription, termination (GO:0006353)",-0.3815068347243389,-1.3797235944175394,0.09980806142034548,0.19521579627506533,1.0,24/47,25.60%,SNRPF;NCBP2;SNRPD3;POLR2F;PRMT5;POLR2L;POLR1B;CDK7;SMN1;UBTF;POLR2H;SNRPB;POLR1E;CPSF3;GTF2H2;POLR1A;CSTF2T;SNRPE;POLR1C;TAF1A;TAF1D;GTF2H4;GTF2H1;POLR3K
gsea,Notch signaling pathway (GO:0007219),0.39856346495440037,1.3788519940674377,0.0992063492063492,0.1568116477297614,1.0,11/26,31.43%,DLGAP5;CREBBP;STAT1;GMDS;MAML2;NOTCH1;EP300;KAT2B;POFUT1;NOTCH2;DTX1
gsea,posttranscriptional regulation of gene expression (GO:0010608),-0.39361784400644284,-1.3786916998897514,0.08080808080808081,0.19557122933182308,1.0,19/32,34.89%,RPL10;NOLC1;PKP3;PUM3;EIF2A;GEMIN5;CYFIP1;METTL16;TDRD7;EIF4E;LARP1;METAP1;ZC3H7B;DDX25;NANOS3;ATG14;PARP9;EIF2B4;LARP4
gsea,negative regulation of DNA metabolic process (GO:0051053),0.4678024319730579,1.3780942468071933,0.10576923076923077,0.15718906511055622,1.0,7/15,23.71%,BLM;ZRANB3;RTEL1;KMT2A;TERF2;ACVRL1;CDKN1A
gsea,negative regulation of protein binding (GO:0032091),0.3619151586993748,1.3770304986907222,0.07442748091603053,0.1577998715506636,1.0,19/43,30.19%,AURKB;AURKA;ROCK1;ZFPM1;ATP2A3;GSK3B;DDX11;TMC8;DVL1;DAB2;PIN1;USP33;CDKN1A;SYMPK;CTSZ;SLPI;GOLGA2;MAP2;HFE
gsea,neutrophil migration (GO:1990266),-0.4116233646656803,-1.3764552086409654,0.07416267942583732,0.1972548949710031,1.0,8/32,14.74%,PPIA;FCER1G;CCL4;CCL3;BSG;LGALS3;CCL5;PIKFYVE
gsea,positive regulation of organelle organization (GO:0010638),-0.45797874360371926,-1.3747298422465235,0.11439842209072978,0.1983707978810219,1.0,9/17,39.72%,ANXA2;ANXA1;LMAN1;MGARP;SORBS3;RAB3GAP2;SMCR8;LIG4;ADRB2
gsea,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4611068613696435,1.373418351544072,0.09516129032258064,0.16062944304528115,1.0,7/20,28.21%,NR4A3;PDCD4;JUN;DNMT1;FOXJ2;CDKN1A;P2RY6
gsea,regulation of programmed cell death (GO:0043067),-0.3009645920140802,-1.3721579240069812,0.056338028169014086,0.20037521100586014,1.0,101/101,99.49%,LGALS1;PRELID1;NME1;CALR;NME2;RSL1D1;PHB;AKT1;VCP;IKZF3;BID;BAX;IFT57;APEX1;PSMC5;AIFM2;RABGGTB;USP36;DAPK2;CASP1;RIPK3;TARDBP;AKT1S1;BNIP3;HAX1;TIGAR;DNAJA3;NDRG1;ATM;RTKN;PLSCR3;BIRC2;RIPK1;LRP8;GLS2;LRRK2;ACER3;TM7SF3;OMA1;BCAR1;CIDEA;ACTN2;DFFA;ALPK2;BEX2;FBXO10;TNFRSF10B;APAF1;NF2;NAE1;FLT3;PMAIP1;MAGED1;PHLPP1;RBM25;HSP90AA1;DAPK1;RARG;ACTN1;CHM;OSGIN1;DAXX;KANK2;SGK1;PERP;TNFRSF25;PTPN6;SIRT1;TGM2;ABL1;TNF;DDX42;ANP32A;TRAF2;FBXO11;MALT1;SLK;HIP1;PINK1;BCL2L11;TNFSF9;PIDD1;USP42;ANP32B;WRN;BCL3;MADD;SKP2;FAS;TRIM24;NUP62;CXCL10;STAT1;CREBBP;JAK2;BCL6;ACTN4;BIRC3;TPT1;ANP32E;BIRC5
gsea,cellular response to type I interferon (GO:0071357),0.4417814246087837,1.3700888284114616,0.11578947368421053,0.16290055283115853,1.0,18/31,26.98%,IRF1;IFNAR2;IRF4;IRF2;IFITM1;STAT1;SAMHD1;IRF9;STAT2;IRF7;ADAR;EGR1;IFIT3;RSAD2;OAS3;IFITM3;IFITM2;ISG15
gsea,type I interferon signaling pathway (GO:0060337),0.4417814246087837,1.3700888284114616,0.11578947368421053,0.16290055283115853,1.0,18/31,26.98%,IRF1;IFNAR2;IRF4;IRF2;IFITM1;STAT1;SAMHD1;IRF9;STAT2;IRF7;ADAR;EGR1;IFIT3;RSAD2;OAS3;IFITM3;IFITM2;ISG15
gsea,phosphatidylinositol metabolic process (GO:0046488),0.3450315950435447,1.370076952297939,0.08823529411764706,0.16260580263969138,1.0,32/53,38.70%,INPP4B;LCLAT1;PIK3CD;MTMR14;MTMR12;INPP5B;MTMR3;PLCG1;PIK3CA;PLA2G4F;PLBD1;SBF1;PTPN13;PIK3R5;PIK3R6;PI4KA;PIK3R2;PIK3CG;PIK3R1;PLA2G4A;CSF1R;SYNJ1;VAC14;PIP5K1C;SYNJ2;MTMR4;PITPNM2;PGAP3;PLCB2;INPP5F;PIK3C2A;FGF2
gsea,sulfur compound biosynthetic process (GO:0044272),-0.35969107450100546,-1.3688581372295605,0.0734341252699784,0.20331411422917575,1.0,24/43,35.26%,GSTO1;CHPF;MAT2A;GGCT;CHSY1;DSEL;B4GALT5;GSTM5;GCLC;ST3GAL6;GSS;B4GALT4;METTL16;B3GNT3;SLC26A2;GGTA1;MGST3;SLC35D2;VCAN;CHPF2;ST3GAL3;CHSY3;CHAC2;CHST2
gsea,substantia nigra development (GO:0021762),-0.4700495021313441,-1.3686255498495816,0.10728744939271255,0.20282003627283557,1.0,9/15,19.35%,ACTB;HSPA5;YWHAE;BASP1;SYNGR3;PADI2;GNB4;S100A1;CKB
gsea,positive regulation of proteolysis (GO:0045862),0.39605182458308885,1.3685429872443506,0.08598130841121496,0.1636590702395619,1.0,13/32,24.86%,PLK1;STUB1;TNP2;WDR48;ZC3H12A;CLN6;IL1B;BTRC;PINK1;TNF;TNIP1;CTSH;PERP
gsea,selective autophagy (GO:0061912),0.38742577192431993,1.367794643878343,0.0891089108910891,0.16406933629043616,1.0,10/29,32.64%,UBB;PCNT;RETREG1;ARL13B;HDAC6;DYNC1H1;AMBRA1;ATG2A;IFT88;KLHL3
gsea,negative regulation of TOR signaling (GO:0032007),0.41009714044471607,1.3662391120832722,0.09036144578313253,0.16511804929624754,1.0,13/23,34.20%,SESN3;TNFAIP8L1;CASTOR1;FNIP1;ARNTL;TSC1;SIRT1;DEPDC5;SESN2;SESN1;TMEM127;PRKAA1;UBR1
gsea,intracellular protein transport (GO:0006886),0.29203657337701505,1.3648495042069972,0.03488372093023256,0.1659381191430547,1.0,71/158,36.13%,ANKLE1;NUP133;ADPRH;CSE1L;TBC1D4;NUP107;ARL5C;NXT1;NUP85;NUP155;XPO1;AP3B1;C2CD5;ARL4D;PPP1R10;NUP62;FAM53B;TBC1D10B;TBCK;POM121;NUP153;E2F3;HERC2;ARL4C;NUP93;EIF4ENIF1;NUP88;NUP214;HDAC6;TRAK1;KATNB1;NAPB;CCHCR1;IPO5;DNAJC27;RANBP3;ARL5B;TBC1D5;EGR2;STAT3;GGA3;RABGAP1;SNX27;NSF;IPO11;GRTP1;XPO5;KPNB1;ARHGEF2;AP4E1;STXBP3;RAB5B;TBC1D1;AP4M1;IPO9;CLTC;XPO4;SNX13;CD74;TBC1D14;TBC1D9;SYK;NUP188;TBC1D25;SCG5;RPAIN;TBC1D30;XPO6;AP3D1;VPS35;EVI5L
gsea,protein localization to nucleus (GO:0034504),0.3448216644698823,1.3644769727382084,0.07112970711297072,0.16593502701147383,1.0,33/69,33.84%,PLK1;NUP133;CSE1L;NUP107;NXT1;NUP85;NUP155;PPP1R10;NUP62;FAM53B;POM121;NUP153;LMNA;E2F3;BCL3;NUP93;EIF4ENIF1;WRN;NUP88;NUP214;IPO5;STAT3;PML;DVL1;IPO11;KPNB1;ARL2;IPO9;MDM2;BBS4;SYK;NUP188;RPAIN
gsea,signal transduction by p53 class mediator (GO:0072331),0.4364785575438502,1.3643529457563115,0.09725158562367865,0.16572566995458163,1.0,8/18,24.84%,E2F7;ATRX;MDM4;PAXIP1;BCL3;PDK2;JMY;SESN2
gsea,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.45124234886409836,1.364322211176455,0.10453648915187377,0.16544262952503264,1.0,11/17,31.98%,MED4;JUN;MED14;PAXIP1;SETX;MED30;MED13;MED12;BCLAF1;FOSL1;MED16
gsea,histone mRNA metabolic process (GO:0008334),-0.4621173567594527,-1.363374944336203,0.1470019342359768,0.20786581359849926,1.0,10/19,22.75%,SNRPF;NCBP2;SNRPD3;UPF1;SSB;SNRPB;CPSF3;TUT1;SNRPE;ATM
gsea,regulation of nitric-oxide synthase activity (GO:0050999),0.42096450681036246,1.3615102149930485,0.10358565737051793,0.1677862741776064,1.0,9/20,19.45%,HIF1A;GCH1;DHFR;TERF2;ATP2B4;IL1B;NOS1AP;GLA;TNF
gsea,regulation of cell growth (GO:0001558),0.3102111276335334,1.3613979238075562,0.05762081784386617,0.16756153390888073,1.0,58/104,40.95%,KIF14;CDKN2D;CDKN2C;DNPH1;BCL6;HDGFL2;CAMK2D;ING1;BCL2;CISH;EIF4G2;NET1;DDX3X;TAOK2;USP47;PRSS2;PSRC1;DERL2;RBBP7;ACVRL1;SMARCA2;HSPA1B;PML;TMC8;RB1;BAP1;SIRT1;JADE1;PTPRJ;IL2;SMARCA4;CDKN1A;ARHGEF11;SESN2;GNG4;SGK1;EXOSC4;OSGIN1;RPTOR;NUBP1;RASGRP2;HSPA1A;TMEM97;TCHP;SPHK2;NCBP1;DCBLD2;FXN;EBAG9;RPS6KA3;EI24;PPP1R9B;URI1;CCAR2;INO80;SPHK1;ST7L;MTOR
gsea,negative regulation of cell differentiation (GO:0045596),0.31913397509858055,1.361064371662167,0.05517241379310345,0.16751187576262072,1.0,39/82,35.79%,SUZ12;NFKBIA;ASXL1;ZFP36L2;SPRY1;PDCD4;ZFPM1;HDAC7;BAMBI;HOPX;PTPN11;RORA;NOTCH1;MYB;ABCG1;GATA3;ANP32B;METTL14;SPRY2;FOXO1;ARNTL;TRIB2;TNF;XDH;RB1;SMAD7;SIRT1;SKI;PTCH1;SOX8;TRIB3;SPRED1;ABCA1;DTX1;WWTR1;USF3;YAP1;CRIM1;TSKU
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3492673965296863,-1.3610296335344214,0.06952965235173825,0.20958615457759047,1.0,18/47,34.41%,MIF;HSP90AB1;DDIT4;AKT1;PARK7;RACK1;TFRC;EIF4G1;OSM;HAX1;RIPK2;PAQR3;VEGFA;PFN2;PPM1F;GPD1L;CAMK1;TERF2IP
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.41192511309441193,1.3609161012399025,0.08745247148288973,0.1673319652377343,1.0,10/27,38.08%,UBB;HMGB1;TLR7;MAP3K7;CTSS;TAB3;LGMN;TIFA;RPS6KA3;CTSL
gsea,cellular response to mechanical stimulus (GO:0071260),0.4145404958154717,1.360342358842491,0.10211946050096339,0.16750425064839294,1.0,13/25,33.00%,NFKB1;IRF1;TNFSF14;FAS;MAP3K1;MAP3K14;IL1B;TLR7;PIEZO1;CD40;CASP8AP2;PTGER4;FADD
gsea,7-methylguanosine mRNA capping (GO:0006370),-0.4466926930312288,-1.3599365107020571,0.11650485436893204,0.2092477254574812,1.0,10/20,24.00%,NCBP2;POLR2F;POLR2L;CDK7;RNMT;POLR2H;GTF2H2;GTF2F2;GTF2H4;GTF2H1
gsea,7-methylguanosine RNA capping (GO:0009452),-0.4466926930312288,-1.3599365107020571,0.11650485436893204,0.2092477254574812,1.0,10/20,24.00%,NCBP2;POLR2F;POLR2L;CDK7;RNMT;POLR2H;GTF2H2;GTF2F2;GTF2H4;GTF2H1
gsea,peptidyl-proline modification (GO:0018208),-0.466735392238984,-1.3589509410442642,0.13473684210526315,0.20960476320518007,1.0,6/18,30.51%,PPIA;PPID;PPIE;NTMT1;PPIF;PPIL1
gsea,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4689477530701896,-1.357358520677143,0.11545988258317025,0.21062582288388007,1.0,4/15,22.03%,HSP90AB1;EPAS1;UBQLN1;DCUN1D1
gsea,regulation of interferon-beta production (GO:0032648),0.38359494450520765,1.357007516247288,0.08333333333333333,0.17017315469121136,1.0,11/32,27.13%,REL;IRF1;RELB;PTPN11;NLRC3;DDX3X;IRF7;TLR7;OAS3;ISG15;SIRPA
gsea,negative regulation of endothelial cell migration (GO:0010596),0.45217892858866376,1.3569380504441722,0.11233885819521179,0.1698985099154543,1.0,10/19,38.70%,HMGB1;RGCC;NOTCH1;ATP2B4;TNF;ACVRL1;THBS1;APOE;SP100;FGF2
gsea,RNA stabilization (GO:0043489),-0.45609446322137154,-1.356835083470544,0.14864864864864866,0.21047037883208283,1.0,10/19,21.47%,YBX1;NSUN2;DKC1;HNRNPU;E2F1;SLC11A1;NAF1;PABPC1;LARP1;NOCT
gsea,response to interferon-gamma (GO:0034341),-0.3852949104623732,-1.3566405666697758,0.10513447432762836,0.20996242518499056,1.0,14/46,17.21%,GAPDH;CCL4;IRF8;CCL3;SYNCRIP;SHFL;BST2;IL12RB1;CCL5;SLC11A1;CASP1;GBP7;GBP3;TRIM21
gsea,Rho protein signal transduction (GO:0007266),-0.4075714583658301,-1.3563974800377543,0.10123456790123457,0.20952561700895023,1.0,8/24,32.70%,CFL1;ADGRG1;ARHGDIA;LIMK1;RTKN;CDC42EP1;CDC42EP2;RIPOR1
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4454355559306794,1.3562879454051333,0.11864406779661017,0.17021613536722263,1.0,14/22,41.41%,TRAIP;SAMHD1;SH2B3;STAT2;OAS3;ISG15;GAS6;USP18;F2RL1;PARP14;SIGIRR;IL1RN;CACTIN;METTL3
gsea,positive regulation of Notch signaling pathway (GO:0045747),0.424387253751429,1.354264885497927,0.11796733212341198,0.1716396753242658,1.0,8/23,27.87%,CREBBP;MAML2;NOTCH1;EP300;AAK1;KAT2B;STAT3;IL6ST
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.3711015716670142,-1.3525980450108723,0.10211946050096339,0.21300793510837296,1.0,18/38,35.17%,PPIA;ENO1;YBX3;NOC2L;AKT1;PARK7;XBP1;SELENOS;HYOU1;CREB3L1;SYVN1;SOD2;HERPUD1;OPA1;CREB3;PPIF;HSPB1;LRRK2
gsea,protein catabolic process (GO:0030163),-0.3852601079897507,-1.3521436060655811,0.11293634496919917,0.21276809174509836,1.0,13/32,29.24%,CTSD;VCP;PRPF19;UCHL3;DDB1;CEACAM1;CLN5;DENND3;DAB2IP;SOCS6;RIPK1;OGA;FBXO44
gsea,T cell activation (GO:0042110),0.3797846062475243,1.352130781131952,0.08249496981891348,0.17328370136018234,1.0,18/35,31.02%,CCR7;CRTAM;CD44;TNFSF14;IRF4;JAML;PPP3CB;PIK3CD;NLRC3;GATA3;SCRIB;RASGRP1;IL2;PIK3CG;KIT;CD74;TREML2;SOX4
gsea,regulation of T cell activation (GO:0050863),-0.4125116021395171,-1.3520579896426248,0.1026694045174538,0.2121532073013076,1.0,8/24,22.85%,PRELID1;HSPD1;CCR2;DUSP3;KAT2A;LGALS3;CCL5;IL4I1
gsea,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4853214491718063,1.3513708359321241,0.11962616822429907,0.17363625645457573,1.0,4/15,24.38%,TNFAIP3;PDCD4;CDKN1A;TRIB1
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.414275605793513,1.3505742777701633,0.09533073929961089,0.17409461494818737,1.0,10/24,19.45%,ARL6IP1;CDKN2D;CD44;KLF4;PLAUR;DDX3X;USP47;FNIP1;PIH1D1;TNF
gsea,regulation of viral genome replication (GO:0045069),-0.36704678635916904,-1.3496532877559808,0.124,0.21407293740622432,1.0,15/40,25.43%,PPIA;PPID;SHFL;PPIE;BST2;HACD3;CCL5;RNASEL;DDB1;EIF2AK2;BANF1;ISG20;PABPC1;LARP1;LTF
gsea,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4181190594424585,1.3493233256039,0.12350597609561753,0.17498317969288435,1.0,12/24,26.66%,BRCA1;TNFAIP3;SERPINE1;FAS;MADD;GSK3B;DDX3X;TRAF2;BCL2L1;TMC8;ARHGEF2;THBS1
gsea,regulation of cellular senescence (GO:2000772),0.41666840115749165,1.3488854742250553,0.1120162932790224,0.17502123404410894,1.0,7/21,21.45%,FBXO5;YPEL3;RBL1;TERF2;MAP3K3;ARNTL;SIRT1
gsea,RNA-dependent DNA biosynthetic process (GO:0006278),-0.4570757319488832,-1.3488455250457843,0.125,0.2142309963283669,1.0,8/24,13.51%,PPIA;HSP90AB1;NHP2;DKC1;GAR1;PINX1;NOP10;SHQ1
gsea,regulation of neuron death (GO:1901214),0.3574880311916613,1.3481007103460851,0.09859154929577464,0.1754234208931779,1.0,15/43,29.06%,UBB;KIF14;FOS;GSK3B;MAP3K5;HTRA2;CD200;PRNP;TRAF2;TSC1;EGR1;LANCL1;DAXX;CTSZ;TYROBP
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.42669156588387014,1.3477512110571204,0.12110091743119267,0.17542225858879368,1.0,11/25,23.05%,FOS;HIF1A;KLF4;JUN;ETS1;GATA3;TNF;STAT3;SPI1;EGR1;SMARCA4
gsea,membrane organization (GO:0061024),0.30406453001369277,1.3476285335401836,0.05605786618444846,0.1752300770453464,1.0,51/101,44.70%,UBB;CEP55;KIF20A;REEP4;IL7R;NEMP1;SUN2;NUP155;CORO1C;TMEM43;HUWE1;EPS15L1;NUP93;SPTBN1;AAK1;HIP1;HGS;RTP4;MYADM;REEP1;CCDC88A;TIMM50;HIP1R;DAB2;CBL;SGIP1;SYNJ1;HACE1;CLTC;PIP5K1C;SYNJ2;REPS1;BTC;EPS15;CLTB;GAK;AP3D1;SPAG4;FNBP1L;PIK3C2A;AP2B1;LEMD3;PICALM;NPC1;CTTN;HSPA8;ITSN1;CPTP;SYP;STAM;REPS2
gsea,blood vessel morphogenesis (GO:0048514),0.4343511635582784,1.3475352008681007,0.1092896174863388,0.1750068149842225,1.0,8/19,31.58%,NRP1;ENG;TGFBR3;FLT1;SMAD7;NF1;ITGB8;SYK
gsea,import into nucleus (GO:0051170),0.36692689343535057,1.347500695580712,0.11823647294589178,0.17472514950182574,1.0,30/54,33.84%,NUP133;BACH2;CSE1L;NUP107;NXT1;GEMIN6;NUP85;NUP155;DDX20;PPP1R10;NUP62;FAM53B;POM121;NUP153;E2F3;NUP93;EIF4ENIF1;NUP88;NUP214;IPO5;STAT3;GEMIN2;IPO11;KPNB1;GEMIN8;IPO9;SNUPN;SYK;NUP188;RPAIN
gsea,RNA methylation (GO:0001510),-0.35567191561285205,-1.3465173702426845,0.08984375,0.21599270381532884,1.0,22/45,30.20%,NSUN2;NOP2;METTL1;FBL;FTSJ3;TRMT10C;TRMT61B;RBM15B;MTERF4;TRMT13;TRMT5;WDR6;NSUN3;DIMT1;TRMT61A;METTL16;BUD23;TRMT6;ALKBH8;TYW3;TARBP1;LCMT2
gsea,positive regulation of leukocyte chemotaxis (GO:0002690),0.4174662800411547,1.3456962825731604,0.09876543209876543,0.17607204530267287,1.0,13/27,29.59%,XCL1;CCR7;CCR6;HMGB1;CXCL10;SERPINE1;CCL1;ANO6;CSF1R;THBS1;GAS6;PGF;LGMN
gsea,positive regulation of immunoglobulin production (GO:0002639),-0.44287109537053815,-1.345599402666034,0.1293634496919918,0.21628364828582108,1.0,7/18,24.15%,PHB;PHB2;XBP1;TNFRSF4;TNFSF4;TFRC;IL10
gsea,cellular component assembly (GO:0022607),-0.30182732571731086,-1.3444679552565943,0.0502283105022831,0.21683602355961326,1.0,110/110,99.57%,ACTB;ACTG1;CAPG;LCP1;PPID;NIFK;CHCHD10;NOC2L;GORASP2;NEDD9;NDUFAF1;SH3BP1;EZR;FLNA;TFAP4;AFG3L2;SNX9;CAPZA2;SLC2A1;TLCD2;RHOQ;LAMC1;CCDC40;CHAF1B;GEMIN5;CYFIP1;TSPAN4;NEFH;BAIAP2;PDGFA;TLCD1;FSCN1;USH1C;NCKAP1;DNAJB13;TOGARAM1;SPAG16;PLS3;ST13;GAS8;IKBKG;PKP2;PAWR;NLGN2;SYCE2;MYO1B;MATN1;PTK2B;KPNA3;CFAP74;MDN1;GSN;BAIAP2L1;MITF;LIMA1;LLGL1;ADD1;PARVB;AIF1;VIL1;SCIN;REPS2;SHANK1;SPG7;DMTN;ESPN;PICALM;TUBGCP2;CEP290;YAP1;LIN7A;EPS8;HFE;CD74;GAS6;SYCE1;MDM2;CD2AP;LRGUK;PLS1;CD40;MICAL1;PPIH;TRAF1;DVL1;PML;TUBGCP4;CDAN1;CHAF1A;KIFAP3;TRAF2;FANCC;LPXN;SPTBN1;MYO9A;WIPF1;RTN3;FANCA;FAS;KMT2A;CREBBP;MDM4;ZW10;GPM6B;RBBP4;TINF2;KNTC1;TRIP13;RAD21;ARL6IP1
gsea,cellular response to topologically incorrect protein (GO:0035967),-0.4096572319247591,-1.3436870509455894,0.1311787072243346,0.21688432761837306,1.0,8/23,20.67%,HSPA5;BAK1;HSPA9;BAX;ERN1;BAG3;HSPA2;DAB2IP
gsea,negative regulation of translation (GO:0017148),-0.3507888387157941,-1.3435986518648984,0.10772357723577236,0.2162537159288607,1.0,21/50,35.20%,GZMB;GAPDH;CALR;YBX1;SYNCRIP;PUS7;RACK1;CAPRIN1;NCL;MRPL13;EIF2AK2;METTL16;LARP1;RIDA;IGF2BP3;IGF2BP2;SHMT1;EIF2AK4;NANOS3;EIF2AK3;GRB7
gsea,regulation of immune effector process (GO:0002697),-0.5084394892609256,-1.3434723385351508,0.13953488372093023,0.21568975436780868,1.0,3/16,4.53%,C1QBP;PHB2;CD55
gsea,metal ion transport (GO:0030001),-0.3765033278256217,-1.341108366743827,0.09956709956709957,0.21747944446594755,1.0,16/34,35.76%,MT3;CCR5;CCL3;CCL5;MAGT1;SLC11A1;CCR1;PSEN2;TRPC1;CDH23;CACNA1S;RAMP2;CACNA1A;CACNA1B;CALCRL;KCNN4
gsea,"DNA-templated transcription, initiation (GO:0006352)",0.31062831344490777,1.3399576233568429,0.06796116504854369,0.18107626274524702,1.0,46/86,42.67%,NR4A1;TAF1;E2F2;NR4A3;POLR2A;TAF5;CREBBP;HDAC7;MAML2;TAF9;E2F3;RORA;NOTCH1;TBL1X;TAF6;AR;KAT2B;RXRA;GTF2A1;TBP;POLR2B;HDAC5;HDAC9;GTF3C1;GTF2E2;NOTCH2;WWTR1;TFB1M;POLRMT;RARG;TBL1XR1;YAP1;CAVIN1;TAF1B;SMARCA5;NR2F6;MAZ;BRF2;MED23;NR4A2;HDAC10;RORB;MAML3;MED7;RARA;TAF15
gsea,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.45235019557400014,-1.3397288574217614,0.12474849094567404,0.2182805445290309,1.0,10/16,35.17%,PARK7;XBP1;SELENOS;CREB3L1;SYVN1;HERPUD1;OPA1;CREB3;EIF2AK3;LRRK2
gsea,positive regulation of macromolecule metabolic process (GO:0010604),0.2872195543801241,1.3386509887866833,0.049403747870528106,0.1820387497688062,1.0,91/164,44.08%,BRCA1;CTCF;NTRK3;SP1;HIF1A;RGCC;KLF4;ATF7IP;ITGAX;ROCK1;KLF2;UBR5;ATF4;DNMT1;SLC38A2;CALCOCO1;ROCK2;CELF1;PIK3CD;ETS1;FMR1;HCFC1;TERF2;GSK3B;CSF2;ZC3H12A;NOTCH1;ATF2;TRIM28;TASOR;SCRIB;DDX3X;AR;IL1B;SETDB2;AHI1;SPRY2;PLSCR1;HGS;NFE2L2;HINFP;NOS1AP;RESF1;LEF1;TNF;TBC1D5;STAT3;HSPA1B;RAMP3;AGO2;CTSH;EGR1;NSF;AFDN;ITGB8;F3;TNRC6A;WNT3;WNT6;PF4;GAS6;CD74;TYROBP;TTN;MYOM1;HFE;HSPA1A;ACTA2;SETDB1;SCYL2;AMH;PRKAA1;PID1;YAP1;VPS35;SMAD1;INPP5F;FGF2;MAZ;MED23;FN1;IL13;MTOR;RNF207;GABPA;PIK3CB;LGALS7;TADA3;APP;CD36;MAPK8
gsea,regulation of neuron differentiation (GO:0045664),0.3903472834197541,1.3380744734025878,0.09195402298850575,0.18220834235549882,1.0,10/28,24.49%,ECT2;CDK5RAP2;ROCK1;SIN3A;TIAM1;MMD;CPNE1;TCF3;ZEB1;ARHGEF2
gsea,dicarboxylic acid metabolic process (GO:0043648),-0.3791917907154539,-1.336631880212335,0.10874200426439233,0.2209267942433345,1.0,17/35,28.95%,MDH2;MTRR;GOT2;GOT1;MTHFD2L;GCLC;IDH1;ASS1;SDHAF3;SLC19A1;SLC25A32;ACLY;MTHFD1;SDHA;SHMT1;ALDH18A1;L2HGDH
gsea,hippo signaling (GO:0035329),-0.4542563491841337,-1.3358052577476325,0.1275626423690205,0.22111358535706416,1.0,5/15,25.70%,YWHAE;CASP3;WWC1;SAV1;AMOTL1
gsea,positive regulation of p38MAPK cascade (GO:1900745),0.4511766980146824,1.335796982892487,0.1115702479338843,0.18405812532171995,1.0,8/16,27.45%,GADD45B;RELL1;ZC3H12A;IL1B;SPI1;XDH;MAP3K4;MFHAS1
gsea,regulation of TORC1 signaling (GO:1903432),0.43943347679193817,1.3356359840478,0.12830957230142567,0.18385529176534976,1.0,7/17,26.60%,SESN3;CASTOR1;SEH1L;PIH1D1;DEPDC5;SESN2;SESN1
gsea,neuron migration (GO:0001764),0.4407720106139458,1.3351222375808955,0.13257575757575757,0.18399148162018136,1.0,10/18,39.57%,NRP1;TUBB2A;FGF13;USP9X;TUBB2B;SDCCAG8;NAV1;CEP85L;TUBGCP2;NR4A2
gsea,protein localization to lysosome (GO:0061462),-0.4433342886935516,-1.3339967504306915,0.13389121338912133,0.22233590237224954,1.0,6/15,19.33%,M6PR;NAGPA;AP3M1;NEDD4;RNF128;NCOA4
gsea,positive regulation of developmental process (GO:0051094),0.32315395867469837,1.3338168221878275,0.055248618784530384,0.1848817781907239,1.0,33/73,40.56%,FBXO5;AURKA;CDC20;NUMA1;PACSIN1;CORO1C;CLASP2;FMR1;CLASP1;LMNA;KMT5C;PAXIP1;AR;NCOA3;PINK1;ZDHHC15;TNF;AGO2;DVL1;SIRT1;DDHD1;ADGRL1;SOX8;MCU;INSM1;APOE;VPS35;RPS6KA3;DLG5;DVL3;SLC6A6;KMT5B;MAP3K13
gsea,positive regulation of Ras protein signal transduction (GO:0046579),0.3884334482023754,1.3336094725483794,0.09225092250922509,0.1847264186363311,1.0,14/32,24.60%,MAP4K4;ARHGEF3;JAK2;IRS2;NOTCH1;NET1;SHC1;ERBIN;GPR174;SHOC2;RASGRP1;RAPGEF1;RASGEF1A;PIK3CG
gsea,positive regulation of actin filament bundle assembly (GO:0032233),-0.37771838525652685,-1.3335789671172122,0.11836734693877551,0.22206413737376612,1.0,14/28,32.07%,PFN1;S100A10;GPR65;PLEK;SYNPO2;TPM1;WNT11;LIMK1;RHOC;ARHGEF5;SORBS3;TGFB3;PFN2;PPM1F
gsea,neuron differentiation (GO:0030182),-0.332719474755621,-1.3322912380081473,0.057057057057057055,0.2227551410499027,1.0,26/54,36.90%,ID2;MANF;DDIT4;XBP1;EPOP;CASP3;RYK;LRP6;CTNNB1;ACSL4;WNT11;RUNX3;FOXA1;NIF3L1;HS6ST1;VEGFA;SRF;LHX5;ERCC3;WNT2B;PBX3;BHLHA15;ERCC6;WNT10B;ERCC2;WNT1
gsea,regulation of keratinocyte differentiation (GO:0045616),0.46136916776746606,1.3319223937917646,0.11394891944990176,0.18599856850932486,1.0,8/16,21.14%,ZFP36L1;NUMA1;ROCK1;ROCK2;RUNX1;NCOA3;AQP3;ERRFI1
gsea,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.41911057715484074,1.3314909061946374,0.13358778625954199,0.18612168183584263,1.0,10/21,29.03%,ZFP36L1;TNFSF11;PRKCA;RUNX1;LIF;LEF1;TNF;HSF1;PF4;CD74
gsea,cytoskeleton organization (GO:0007010),0.33292899205969767,1.3304373968131742,0.08843537414965986,0.1867907595935975,1.0,21/60,36.29%,DIAPH3;TNFAIP3;SYNE3;PHIP;PACSIN1;ARC;MAST2;FMNL3;ARHGAP10;TNIK;ZMYM3;AJUBA;MAST3;MICAL1;STRIP1;MICAL3;APOE;DIAPH1;ZMYM4;RND3;PPP2R3C
gsea,nucleobase-containing compound catabolic process (GO:0034655),-0.4172098024618144,-1.3302145903987148,0.13009708737864079,0.2243943039659635,1.0,12/23,33.20%,ENTPD1;NUDT16;PABPC4;HNRNPD;PNPT1;PPP1R8;NUDT1;ISG20;RNASEH2B;NUDT5;EXOSC7;ENTPD7
gsea,DNA replication initiation (GO:0006270),0.46388661884985066,1.3290856482866713,0.1868583162217659,0.18771985105572805,1.0,21/34,26.18%,DBF4;CDC45;GMNN;MCM10;POLA1;MCM8;POLE;PRIM2;PRIM1;CDC6;CDC7;ORC6;TOPBP1;CDT1;RPA3;POLA2;RPA2;ORC1;RPA1;CDK2;ORC5
gsea,regulation of ion transport (GO:0043269),0.4625849704945572,1.3281742108119503,0.13013698630136986,0.18823936536597077,1.0,7/16,33.74%,WNK1;PER1;CLDN10;P2RX4;NKAIN1;HFE;KCNJ14
gsea,positive regulation of epithelial cell proliferation (GO:0050679),-0.3478241193372149,-1.3277442348845263,0.06516290726817042,0.22651880397192653,1.0,20/46,36.78%,NME1;NME2;AREG;SRSF6;AKT1;XBP1;MYC;MYDGF;HRAS;LAMC1;NRAS;OSR2;ITGB3;TNFSF12;PDGFB;NRARP;VEGFA;TGFA;GRN;VEGFB
gsea,"base-excision repair, gap-filling (GO:0006287)",0.4565299714201371,1.3275763228969437,0.15843621399176955,0.1884770561742889,1.0,14/26,23.94%,RFC4;FEN1;RFC5;POLE;XRCC1;TDG;MBD4;RFC1;RPA3;RPA2;POLD3;MUTYH;OGG1;RPA1
gsea,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.40862685147327826,1.3267246997210063,0.1264591439688716,0.1889440800608393,1.0,13/21,36.41%,BCL2;PPP1R15A;ATF4;ATP2A3;MAP3K5;DDIT3;TRAF2;QRICH1;AIFM1;TRIB3;CHAC1;ITPR1;DNAJC10
gsea,heterotypic cell-cell adhesion (GO:0034113),0.4612509069597031,1.3264242055623876,0.1434108527131783,0.18891505173628867,1.0,5/17,16.61%,ITGB1;ITGAX;ITGB7;NINJ1;CD200
gsea,regulation of signal transduction (GO:0009966),0.31026171267067576,1.3246006550965772,0.06525911708253358,0.19026025229628613,1.0,37/72,37.75%,NUCKS1;RGS16;CREBBP;NUP62;SOCS5;RUNX1;RORA;GRK2;SIK2;GATA3;RGS2;CASTOR1;IL3;PLSCR1;PRNP;MDFIC;IGFBP2;IFT81;TMEM108;DHRS3;SIRT1;CX3CL1;AXIN1;USP33;PTCH1;GNG4;RIC8B;RGS12;POFUT1;TIMP1;TULP3;DTX1;WWTR1;USP20;LIFR;HOMER1;SP100
gsea,positive regulation of tumor necrosis factor production (GO:0032760),-0.35844736301843605,-1.323576126086281,0.11410788381742738,0.23032288805364676,1.0,12/39,33.89%,MIF;HAVCR2;CCL3;CCR2;TMEM106A;CD14;PLCG2;IL33;RIPK1;TLR4;IFNG;HSPB1
gsea,snRNA metabolic process (GO:0016073),0.4524853457162709,1.3233156125706174,0.1419624217118998,0.1911366798657038,1.0,7/15,27.76%,ZCCHC8;MEPCE;INTS1;INTS6;MTREX;INTS3;INTS11
gsea,MAPK cascade (GO:0000165),-0.281269652664603,-1.3221890847334532,0.03982300884955752,0.23125385888005962,1.0,142/142,99.84%,PSME2;PSMA4;PSMA3;PSMB2;MT3;CCR5;PSMB5;PSMA5;YWHAE;CCL3;AREG;PSMA6;PSMD3;PSMB6;PEBP1;PSMD6;PSMD1;PSMD14;MYC;PSMD12;HRAS;RPS27A;PSMD7;PSMC1;PSMC5;NRAS;CCL5;PTPN7;PSMD2;IL2RA;PDGFB;MAPKAPK2;CUL1;PDGFA;PSMD11;PSMB7;PSME3;DAB2IP;DUSP7;PSMC2;GFRA2;MRAS;PAQR3;CAMKK2;PPP5C;PSMC6;CHUK;TGFA;IKBKG;SPTA1;RALGDS;RASA4;LRRK2;TNIP2;NCAM1;PSMC4;PSMA8;HBEGF;RASGRF1;ICMT;ACTN2;RGL1;IGF1;MEF2C;PSME4;RASA1;CCL2;ABHD17C;FNTB;RAPGEF2;MINK1;CSF2RB;GRIN1;MAPK13;FLT3;MAPK8;MEN1;SOS1;DLG2;RET;PIK3CB;MAP3K20;ZFP36;FGF2;GFRA4;MET;SPTAN1;SYNGAP1;RASAL2;PPP1CB;BTC;PTGER4;NEFL;PAK1;SPRED1;HSF1;KSR1;DUSP5;KIT;ARL2;RASA2;PIK3R1;MAP3K7;CUL3;PTPN3;IL2;NF1;PIK3R2;CSF2RA;RASGEF1A;CTSH;RASGRP1;DUSP6;TNF;BCL2L1;TAOK1;SHOC2;MAP3K8;PIK3CA;IL3;TAOK2;BTRC;TNIK;IL1B;SHC1;PDE6D;SETX;SPTBN1;IRS2;MAP3K5;MBP;MAP3K3;CSF2;FGF13;JAK2;RASA3;NFKB1;ZFP36L2;MAP4K4;ZFP36L1;UBB;CDK1
gsea,DNA methylation (GO:0006306),0.4436562329375981,1.3218900841949233,0.11041666666666666,0.19214064282714682,1.0,7/17,29.92%,ATRX;FOS;ATF7IP;DNMT1;METTL4;EHMT2;EHMT1
gsea,inositol lipid-mediated signaling (GO:0048017),0.4314438470273359,1.3204188527230536,0.11192660550458716,0.1931859124742491,1.0,14/20,38.19%,PIK3CD;IRS2;PIK3CA;PI4KA;PLCH1;PLCB4;PIK3R2;PIK3CG;PIK3R1;CSF1R;PITPNM2;PLCB2;INPP5F;PIK3C2A
gsea,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4092939810607496,-1.3202727649478738,0.13975903614457832,0.232876424162033,1.0,9/20,43.33%,ANXA2;HNRNPK;BICD1;VEGFA;SFRP4;ARRB1;CD63;PICK1;C3
gsea,carbohydrate homeostasis (GO:0033500),-0.41531853217530745,-1.3189681132127784,0.13711583924349882,0.23368139885988878,1.0,7/20,34.38%,RPS6;PARK7;CRY1;PYGL;ALOX5;KLF7;PPARG
gsea,axonogenesis (GO:0007409),-0.29714125628009835,-1.3176262478212128,0.06888888888888889,0.2345124297697548,1.0,35/84,46.28%,ACTB;S100A6;HSP90AB1;EZR;BSG;SCN1B;AFG3L2;DOK2;SEMA4A;RYK;B4GALT5;DSCAM;CYFIP1;NEFH;BAIAP2;APBB1;SEMA6D;GFRA2;ACTBL2;PDLIM7;SPTA1;KLF7;NEXN;GRB7;FEZ1;DAG1;SEMA4C;NCAM1;L1CAM;EFNB2;SEMA7A;TUBB3;SHTN1;NRCAM;LGR6
gsea,positive regulation of wound healing (GO:0090303),-0.42421660421386775,-1.315512763641731,0.11954022988505747,0.23601361425275538,1.0,7/18,16.56%,ACTG1;ANXA1;XBP1;HRAS;F2R;PRKCE;ENPP4
gsea,chromatin remodeling (GO:0006338),0.32514627784883593,1.314283043645619,0.10337552742616034,0.19882546537985962,1.0,42/70,40.51%,PBRM1;RBBP4;ATRX;ARID1A;SATB1;SUV39H2;SMARCC2;BPTF;GATAD2B;BAZ1B;SMARCC1;KDM6B;JARID2;HCFC1;SRCAP;ARID1B;MYB;CHD3;KAT2B;PIH1D1;SMARCA2;HDAC5;RB1;CHD1L;SIRT1;SMARCA4;CBX3;TAF6L;DAXX;KDM4D;KDM4B;POLE3;PAK1;KDM4A;CHD4;KDM5C;BAHD1;SMARCA5;CHD8;BAZ2A;INO80;MBD3
gsea,Ras protein signal transduction (GO:0007265),0.3186580426439871,1.3126708592206715,0.074487895716946,0.20015183283792815,1.0,35/75,32.47%,CCNA2;GPSM2;ARHGEF3;ROCK1;JUN;ELMO1;DNMT1;TIAM1;ROCK2;MYO9B;TRIM28;SHC1;GRAP;SHOC2;USP8;RASGRP1;RAPGEF1;RB1;NF1;TAX1BP3;PLK2;CDKN1A;ARHGEF11;CDK2;PHACTR4;KPNB1;HACE1;KSR1;ARHGAP5;RAP2C;RASGRP2;CDC42EP3;KSR2;EPS8;SETDB1
gsea,regulation of cytokine production (GO:0001817),-0.31397031856572244,-1.3124391769798402,0.09930715935334873,0.23877451521079787,1.0,32/70,37.43%,GAPDH;MIF;HILPDA;IRF8;TXK;ANXA1;TNFSF4;CCR2;FLOT1;AGPAT2;KAT2A;LYN;SLC11A1;RIPK3;MAPKAPK2;GLMN;EIF2AK2;TRIM21;ZBP1;IGF2BP3;IL10;LTF;IGF2BP2;IL33;ALOX5;IFNG;IL21;CCDC88B;BATF;BTNL9;NOS2;TRIM56
gsea,regulation of response to external stimulus (GO:0032101),-0.318228927250874,-1.3120755662752213,0.07474747474747474,0.23844258919846922,1.0,31/64,42.16%,TMSB4X;PSMA6;PARK7;ANXA1;CD55;TNFSF4;METAP2;CCR2;ERAP1;F2R;CASP1;TKFC;ZMPSTE24;LACC1;ZBP1;GNAT1;UFL1;PIK3AP1;BIRC2;METAP1;ALOX5;LRP8;DHX58;GRN;TRIM5;NMT1;CASP12;EFNB2;SPATA2;SETD6;SEMA7A
gsea,regulation of macromolecule metabolic process (GO:0060255),0.31338340673774456,1.312028792194126,0.07454545454545454,0.20050694162600646,1.0,36/83,32.36%,AFF3;ZFP36L1;CTCF;NFKBID;TCF19;HIF1A;FOXP1;TOB2;HMG20B;NFKBIZ;KDM6B;ROCK2;SART3;ZC3H12A;TOB1;HMG20A;MTMR3;UBAP2;HINFP;KIF16B;PRDM10;NPAT;AFF1;ATP1B1;PIN1;COQ7;TRIM14;CDK2;KHSRP;SIRPA;PRDM2;MARF1;INSM1;MTMR4;MEFV;APOE
gsea,regulation of B cell proliferation (GO:0030888),-0.3786341828081923,-1.3119546721852573,0.1111111111111111,0.23785126411333274,1.0,11/31,25.92%,MIF;IKZF3;TNFRSF4;TNFRSF21;TNFSF13B;LYN;TFRC;CD38;ATM;IL10;CD320
gsea,regulation of activated T cell proliferation (GO:0046006),0.46207429073159856,1.3107306096251021,0.14335664335664336,0.2014272550579385,1.0,8/16,22.98%,CRTAM;HMGB1;SCRIB;TNFSF9;PRNP;IGFBP2;CD274;IL2
gsea,regulation of cell death (GO:0010941),0.3451988733620678,1.3095387069821203,0.11538461538461539,0.20217474170547775,1.0,17/41,31.02%,UBB;RAD18;FAF1;SRGAP2;CCN1;CELF1;ZC3H12A;CCN4;AXIN2;HSPA1B;TSC1;RAMP3;CTSZ;LRP1;PRR7;HSPA1A;SOX4
gsea,regulation of neuron projection development (GO:0010975),-0.3193197873176091,-1.3070868285951998,0.0821917808219178,0.24258157903017716,1.0,28/62,44.56%,CFL1;MT3;AKT1;ARSB;SCN1B;HDAC2;MFSD2A;LYN;DAB2IP;CAMK2G;CRMP1;KIF13B;ABI2;PAQR3;P3H1;CAMK1;KNDC1;LRRK2;KIF1A;PDLIM5;PRKCI;EFNB2;PTPRS;PTK2B;ADCY6;NDNF;GFI1;ABI3
gsea,modulation of chemical synaptic transmission (GO:0050804),0.36414258662365695,1.3060002973067137,0.125,0.2053267359521629,1.0,16/35,38.83%,ITGB1;ARC;FMR1;MCTP1;IL1B;KCNMB4;TNF;TMEM108;CX3CR1;DGKI;BAIAP3;SLC4A8;HOMER1;KCTD13;SYN1;SLC12A2
gsea,calcium ion transmembrane transport (GO:0070588),-0.3628666878077056,-1.304155869188534,0.11529933481152993,0.2452572151403919,1.0,12/33,31.60%,PHB;PHB2;TRPV2;AFG3L2;SLC35G1;ATP2A2;MCUB;TRPC1;STOML2;PMPCB;PARL;CACNA1A
gsea,regulation of ion transmembrane transporter activity (GO:0032412),-0.41614078770406737,-1.3034943057709532,0.12244897959183673,0.24524202451832441,1.0,12/20,41.09%,PHB2;YWHAE;SCN1B;NEDD4;RANGRF;RIPK1;PPIF;FXYD2;GPD1L;SCN4B;STK39;TCAF1
gsea,negative regulation of macromolecule metabolic process (GO:0010605),-0.2935334104951932,-1.3014252198019023,0.06787330316742081,0.24690805550184514,1.0,97/97,98.72%,MIF;HAVCR2;HSP90AB1;SUB1;ID2;ANXA7;TLE5;CCL3;PARK7;PTRH2;HDAC1;HRAS;RACK1;CITED2;REST;RBL2;CREB3L1;CCR1;PDGFB;TARDBP;TIPARP;NOCT;DIP2A;LDLR;APLN;VEGFA;OLFM1;PARP10;DLL4;IFNG;APOBEC1;PARP9;SMCR8;MOV10;NOS2;VDR;OVOL2;SLC7A5;IGF1;STC2;MEF2C;TCEAL1;DICER1;TET1;WDR54;MSR1;YY1;AGO1;TGFB2;APP;PICALM;FGF2;YAP1;PARP14;OPTN;PRKAA1;SETDB1;APOE;WNT4;KDM4A;NOTCH2;LGMN;TNRC6A;ITGB8;SIRT1;RB1;FBXW7;AGO2;ACVRL1;XDH;SPI1;TNF;MYADM;HINFP;PINK1;SETDB2;FLOT2;ATXN2;ENG;TRAT1;CPNE1;ATP2B4;NOTCH1;ZC3H12A;RUNX1;TERF2;CELF1;ROCK2;DNMT1;KLF4;FOXP1;HIF1A;TAF1;NFKB1;RBL1;REL;AURKA
gsea,positive regulation of type I interferon production (GO:0032481),-0.33686703599968915,-1.3006198168523804,0.11568627450980393,0.24699388806208852,1.0,22/54,30.84%,GAPDH;HSPD1;G3BP1;POLR2F;POLR3D;POLR2L;POLR3E;FLOT1;POLR2H;CTNNB1;CD14;IRF5;POLR3G;DHX33;POLR1C;POLR3H;ZBP1;RIPK2;POLR3K;TLR4;CHUK;DHX58
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.281266276083332,1.296399795327883,0.07532956685499058,0.21485957367774075,1.0,59/126,40.90%,UBB;NFKBIA;TNFSF11;IL18R1;NFKB1;TAF1;RGCC;ARID5B;IL18RAP;RPS6KA5;ATF2;NFKB2;PRKD2;FLOT2;TCF3;EP300;AR;DDIT3;IL1B;PIDD1;CD200;CD40LG;MALT1;PRKCB;TRAF2;TNF;STAT3;HSPA1B;HDAC5;CX3CR1;RAB7B;TRAF1;CX3CL1;SMARCA4;JMY;TRIM14;NFAM1;MAP3K7;CD40;ARHGEF2;CAMK1D;KIT;TAB3;CARD11;PRKCZ;HSF1;TRIM37;HIPK2;HSPA1A;STK3;RELA;BTK;RHEBL1;TRIM41;BEX1;ERC1;SPHK1;MAP3K13;MBTPS2
gsea,regulation of JUN kinase activity (GO:0043506),0.4141011204291932,1.2963482079111188,0.14620938628158844,0.21452729789650005,1.0,10/19,31.63%,PDCD4;DNAJA1;MAP3K5;TRAF2;TNF;MAP3K7;MAP3K4;PAK1;AIDA;MAP3K11
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2974036471489597,-1.2958575921224136,0.07297830374753451,0.251938143077725,1.0,36/76,40.32%,LGALS1;GAPDH;S100A4;LITAF;UBE2N;FLNA;DDX21;BST2;F2R;CASP1;TFRC;TMEM106A;TNFRSF1A;TRIM21;TRIM25;HMOX1;MTDH;RHOC;RIPK2;MID2;LTF;NEK6;BIRC2;TICAM2;RIPK1;PPP5C;CHUK;IKBKG;WLS;TNFSF10;TRIM5;TERF2IP;TNIP2;CD4;IKBKE;LTBR
gsea,regulation of peptide hormone secretion (GO:0090276),0.4023594612178703,1.294899073278188,0.13435374149659865,0.2156562296744602,1.0,12/27,37.05%,PRKCA;PASK;PPP3CB;ITPR2;IL1B;GLP1R;ARNTL;TNF;HFE;RAPGEF4;ITPR1;CACNA2D2
gsea,regulation of protein localization to plasma membrane (GO:1903076),-0.3457426434993205,-1.294409260736479,0.13664596273291926,0.2529337383392701,1.0,18/41,42.28%,ACTB;AKT1;VAMP8;TMBIM1;RHOQ;LGALS3;RANGRF;ZDHHC2;PRKCE;ITGA3;CLN3;CLIP3;IFNG;NKD2;MMP14;PRKCI;CNPY4;ZDHHC8
gsea,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.419611887370866,1.2942915247996445,0.15737051792828685,0.21591635918359395,1.0,6/18,25.49%,UBB;BCL2;DDIT3;BCL2L11;BCL2L1;BCLAF1
gsea,positive regulation of nucleocytoplasmic transport (GO:0046824),0.36983243131357263,1.2936084493771856,0.14481409001956946,0.21627753010530504,1.0,14/32,30.97%,ECT2;GTSE1;UBR5;GSK3B;ZC3H12A;TRIM28;ANP32B;IL1B;IPO5;PIK3R2;PIK3R1;XPO4;GAS6;CPSF6
gsea,response to metal ion (GO:0010038),0.36762684786380134,1.2935800192787121,0.14446529080675422,0.21593712106027715,1.0,16/29,44.84%,CALM2;HIF1A;BCL2;GPHN;PLSCR1;AQP3;THBS1;TTN;HFE;HOMER1;FXN;D2HGDH;LOXL2;PPP2CB;AHCYL1;ADAM9
gsea,cellular response to glucose starvation (GO:0042149),-0.37935253292313864,-1.2934649842292616,0.13953488372093023,0.25331303275994344,1.0,13/26,39.67%,HSPA5;HNRNPA1;MYBBP1A;XBP1;ASNS;RRP8;IMPACT;PIK3R4;ATG14;BHLHA15;EIF2AK3;NUAK2;ITFG2
gsea,cellular defense response (GO:0006968),-0.390443520123385,-1.2923790417772076,0.1301518438177874,0.2538097018332687,1.0,8/25,42.10%,PRF1;CCR5;LGALS3BP;KLRG1;ADORA2B;NCF2;NCR1;PTK2B
gsea,cellular protein catabolic process (GO:0044257),-0.36823443210293283,-1.2906318332986293,0.12320328542094455,0.25515101380244176,1.0,8/29,28.32%,GZMB;PSMA6;CAPN2;PISD;BNIP3;DENND3;DAB2IP;RIPK1
gsea,regulation of mRNA processing (GO:0050684),0.4275485183927557,1.2901902581056526,0.1565217391304348,0.21919718254087076,1.0,10/18,38.47%,ZFP36L1;IWS1;SAFB;SAFB2;SRSF3;SRPK1;SRSF10;CPSF4;NCBP1;SLTM
gsea,erythrocyte differentiation (GO:0030218),-0.38326709279100335,-1.28951771867799,0.1511111111111111,0.25575560801476643,1.0,10/24,28.11%,ID2;SLC25A5;HSPA9;CASP3;LYN;ABCB10;UFL1;ALAS1;LYAR;VEGFA
gsea,positive regulation of biosynthetic process (GO:0009891),-0.39163631175974856,-1.2893692149214622,0.12043010752688173,0.25521504525276395,1.0,11/22,33.27%,VIM;AKT1;HDAC2;CCL5;F2R;CREB3L1;PLCG2;TGFB3;RAB27A;TLR4;SIRT4
gsea,positive regulation of protein localization to membrane (GO:1905477),-0.3314760414157073,-1.2867833155767021,0.13671875,0.25744411775636095,1.0,23/47,42.28%,GZMB;YWHAE;AKT1;BID;HRAS;E2F1;LGALS3;RANGRF;PRKCE;ITGAM;MYO1C;SFN;ITGA3;YWHAG;CLIP3;IFNG;NMT1;NKD2;PRKCI;CNPY4;TCAF1;TFDP1;ZDHHC8
gsea,extracellular matrix organization (GO:0030198),-0.2947544431722695,-1.2858981635942435,0.08595988538681948,0.2576852056036661,1.0,47/105,44.03%,SPP1;CAPG;ADAM8;LCP1;NPNT;TMPRSS6;COLGALT1;BSG;CAPN2;ADAMTS14;FLOT1;P4HB;LAMC1;ITGB3;CREB3L1;PDGFB;ITGAM;CRTAP;APLP1;JAM2;ITGA4;PDGFA;ICAM1;ITGA3;COL16A1;LAMC2;PLOD2;P3H1;P4HA1;GFOD2;VCAN;COL7A1;COL17A1;ST7;DST;PLOD3;DAG1;CTSK;MMP14;ADAM19;COL5A3;MATN1;SH3PXD2B;NDNF;ITGAE;EXOC8;COL12A1
gsea,negative regulation of DNA biosynthetic process (GO:2000279),0.4228114504860722,1.2857408550547225,0.15447154471544716,0.2236809571551401,1.0,7/17,23.71%,TINF2;PIF1;CTC1;XRN1;TERF2;ACVRL1;CDKN1A
gsea,positive regulation of MAP kinase activity (GO:0043406),0.36915434380538675,1.2841310430191268,0.09908256880733946,0.22511227925534996,1.0,16/31,31.63%,EZH2;TNFSF11;MAP3K5;TRAF2;FLT1;TNF;PIK3R5;PIK3R6;RASGRP1;MAP3K7;CD40;PIK3CG;MAP3K4;KIT;PAK1;MAP3K11
gsea,cellular metal ion homeostasis (GO:0006875),-0.3446678541177671,-1.2818022691629876,0.10093896713615023,0.26191621013975963,1.0,11/41,27.51%,CALR;MT3;CCL3;CCR2;ATP2A2;CCL5;CCR1;STOML2;RMDN3;ATP13A1;TNNI3
gsea,spliceosomal snRNP assembly (GO:0000387),-0.4334514625135029,-1.2801864383226076,0.19038461538461537,0.2632192091843557,1.0,13/27,19.47%,SNRPF;SNRPD3;STRAP;PRPF19;WDR77;PRMT5;SMN1;CLNS1A;SNRPD1;SNRPB;GEMIN5;PRMT7;SNRPE
gsea,protein localization to membrane (GO:0072657),0.28996324368417864,1.2797510937559542,0.09392265193370165,0.22963415784249283,1.0,44/90,40.69%,NDC1;SYNE3;ARL5C;EHD3;ITGB7;ROCK1;FGF13;PACSIN1;NUP155;CD81;C2CD5;ROCK2;PDZD11;CLASP2;RFTN1;SPTBN1;FLOT2;SCRIB;TNIK;HGS;ZDHHC15;MYADM;ARL5B;TNF;RAMP3;DVL1;ATP1B1;PTCH1;MYO5A;AP4M1;DENND4C;GAS6;TTC7B;CACNB3;GAK;LIN7A;CDH1;AP3D1;MADCAM1;SEC16A;FAM126B;TSPAN32;NPC1;CPE
gsea,positive regulation of DNA biosynthetic process (GO:2000573),0.38507532025306057,1.2792349304288553,0.18936170212765957,0.22982591902961536,1.0,21/42,39.15%,AURKB;NEK2;CHTF18;RFC4;RFC5;RGCC;KLF4;NEK7;ATR;PRKD2;CHTF8;WRAP53;MAP3K4;PARN;RFC2;DSCC1;RFC3;HSP90AA1;POLG2;FGF2;MAPKAPK5
gsea,tube closure (GO:0060606),0.4363661709456651,1.2778083127203084,0.1527001862197393,0.2306984346128412,1.0,6/17,30.96%,STIL;SCRIB;SKI;PHACTR4;MTHFR;BBS4
gsea,primary neural tube formation (GO:0014020),0.4363661709456651,1.2778083127203084,0.1527001862197393,0.2306984346128412,1.0,6/17,30.96%,STIL;SCRIB;SKI;PHACTR4;MTHFR;BBS4
gsea,positive regulation of protein dephosphorylation (GO:0035307),0.4444908904560244,1.2774681031770923,0.17695473251028807,0.2306886263367102,1.0,9/15,28.95%,CALM2;CDCA2;PPP1R15A;ITGA1;PPP1R7;PIN1;SYMPK;ANKLE2;CD300A
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3935006586453703,1.277012614820402,0.17543859649122806,0.23075155602766392,1.0,11/23,30.73%,CCR7;TBC1D10B;FMR1;P2RX4;TBC1D5;IFT140;RABGAP1;TBC1D1;SDCCAG8;TBC1D14;IFT88
gsea,organic anion transport (GO:0015711),-0.36861308046493024,-1.2769082204201467,0.13821138211382114,0.2663839043563472,1.0,10/27,27.00%,SLC35B1;SLC52A3;SLC25A19;SLC25A24;SLCO2A1;SLC19A1;SLC35C2;SLCO4A1;SLC17A9;SLC35A1
gsea,anion transmembrane transport (GO:0098656),-0.3558107472007715,-1.275828972723372,0.13429752066115702,0.26694031703196736,1.0,12/31,27.00%,SLC25A5;SLC35B1;SFXN1;SLC25A19;SLC6A13;ABCC1;SLC27A1;SFXN2;SLC19A1;SLC35C2;SLC25A22;SLC35A1
gsea,regulation of histone acetylation (GO:0035065),0.40326374026205275,1.2758239747161177,0.16536964980544747,0.23162052795866217,1.0,8/21,21.13%,BRCA1;IWS1;KMT2A;RPS6KA5;PAXIP1;IL1B;SPI1;HDAC5
gsea,negative regulation of gene expression (GO:0010629),0.2746182683424849,1.2744522024115101,0.07272727272727272,0.232741169924086,1.0,86/176,41.53%,AURKA;TYMS;EZH2;SUZ12;BTG2;LSM2;REL;RBBP4;RBL1;ZFP36L2;NFKB1;TAF1;HIF1A;RGCC;FOXP1;KLF4;DNMT1;ILF3;DXO;ROCK2;CELF1;JARID2;DHFR;MTF2;FMR1;RPS6KA5;CNOT1;TERF2;RUNX1;ZC3H12A;NOTCH1;ATP2B4;CPNE1;TOB1;TASOR;EIF4ENIF1;ENG;FLOT2;CNOT10;DDX3X;ZC3H12D;SETDB2;KAT2B;PINK1;PHF19;HINFP;MYADM;RBBP7;TNF;SPI1;XDH;ACVRL1;HSPA1B;TSC1;AGO2;FBXW7;RB1;SIRT1;HDAC9;PAIP2B;ITGB8;EED;TNRC6A;GIGYF2;LGMN;NOTCH2;AEBP2;HSPA1A;ZC3H10;PTGER4;KDM4A;WNT4;APOE;SETDB1;EIF4A3;PRKAA1;PARP14;YAP1;DAPK1;FCGR2B;DIS3L2;FGF2;PICALM;ZFP36;METTL3;SYT11
gsea,regulation of toll-like receptor signaling pathway (GO:0034121),0.4456679295620286,1.2742694298198123,0.18125,0.2325383547832369,1.0,4/15,15.59%,BIRC3;IRF1;FLOT2;IRF7
gsea,protein maturation (GO:0051604),-0.3364098262136047,-1.2739910082990968,0.1232876712328767,0.2682218043205335,1.0,21/46,42.83%,GCSH;HSPD1;GLRX3;DNAJB11;METAP2;AFG3L2;NDUFAB1;PCSK4;PSEN2;LIPT2;NAA15;TESC;NAA50;CLN3;TSPAN5;XPNPEP3;MMP14;ADAM19;ADAM17;TSPAN33;AEBP1
gsea,monocarboxylic acid biosynthetic process (GO:0072330),-0.39040862727931525,-1.2714586732655722,0.1746031746031746,0.2705862823703222,1.0,14/23,37.12%,PARK7;XBP1;NDUFAB1;HSD17B10;ABCD3;ACLY;ALDH1A3;ELOVL4;ALOX5;SLC27A2;OXSM;OSBPL2;CBR4;MCAT
gsea,response to organic cyclic compound (GO:0014070),-0.3790956605503172,-1.2700790971871896,0.14383561643835616,0.2715608897063221,1.0,9/26,26.66%,SPP1;GLDC;CCL3;ANXA1;CCL5;CTNNB1;TIPARP;FOXA1;HLCS
gsea,negative regulation of cellular metabolic process (GO:0031324),0.43191178240307854,1.269463248438636,0.16515426497277677,0.23736413609245716,1.0,9/17,33.99%,BRCA1;NFKB1;TRAT1;ATXN2;PINK1;TRAP1;APOE;SIRT5;OPTN
gsea,negative regulation of protein kinase activity (GO:0006469),-0.3334944427789262,-1.2674472280811675,0.12863070539419086,0.27415602492365887,1.0,19/42,36.39%,PPIA;AKT1;PARK7;DUSP3;NPM1;MVP;LRP6;CEACAM1;SFN;AKT1S1;DAB2IP;YWHAG;GADD45A;DUSP19;PPM1F;IFNG;HSPB1;SMCR8;CAMK2N1
gsea,negative regulation of type I interferon production (GO:0032480),0.3896301139617704,1.2654464264115663,0.17234468937875752,0.24135732800688658,1.0,7/22,27.13%,TNFAIP3;REL;RELB;NLRC3;PIN1;ISG15;SIRPA
gsea,gland development (GO:0048732),-0.3738425442164026,-1.2654355857202417,0.1405152224824356,0.27582244746398826,1.0,11/25,33.88%,ANXA1;XBP1;EZR;CITED2;RIPK3;PRKCSH;WNT11;FOXE1;TGFB3;SIX3;ZBTB1
gsea,positive regulation of cell-cell adhesion (GO:0022409),0.3910902743897157,1.263579640038327,0.16888045540796964,0.24307867730987973,1.0,9/22,23.96%,TNFSF11;CD44;PLAUR;IL1B;TNF;SMAD7;CX3CL1;PIEZO1;AFDN
gsea,response to peptide hormone (GO:0043434),0.37080507761697706,1.2626164046594706,0.14489795918367346,0.24379606378476756,1.0,13/26,21.45%,ZFP36L1;STAT4;ROCK1;STAT1;CREB1;ROCK2;STAT5B;STAT2;STAT6;TGFBR3;STAT3;TSC1;SIRT1
gsea,positive regulation of cell growth (GO:0030307),0.33717208131080634,1.2625744965292565,0.14311270125223613,0.24344082295129713,1.0,20/47,40.56%,DNPH1;HDGFL2;RNF157;BCL2;MACF1;EIF4G2;DDX3X;USP47;PRSS2;DERL2;IL2;EXOSC4;RPTOR;NCBP1;FXN;CPNE9;RPS6KA3;INO80;SPHK1;MAP3K13
gsea,defense response to Gram-negative bacterium (GO:0050829),0.44772399121928214,1.2624532200163892,0.17625899280575538,0.2431738652159897,1.0,7/15,36.26%,HMGB2;SERPINE1;MPEG1;SELP;RNASE6;OPTN;IL23A
gsea,protein acylation (GO:0043543),0.3727066519265235,1.2621865575095337,0.14341846758349705,0.2430430616076799,1.0,13/24,40.48%,CREBBP;EP300;KAT2B;KAT6A;ING5;ZDHHC15;FOXO1;NAA10;GLUL;ZDHHC14;NAT9;ZDHHC13;SPHK1
gsea,cellular response to interleukin-6 (GO:0071354),0.43965158587784453,1.2614888418710593,0.19662921348314608,0.24342779034741308,1.0,13/16,35.04%,NFKB1;JAK2;STAT1;PTPN11;SOCS3;STAT3;SPI1;CBL;IL6ST;SBNO2;PID1;YAP1;RELA
gsea,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4290000132784131,-1.261239939760281,0.20703125,0.28045757219311135,1.0,13/23,22.75%,CCT5;HNRNPA2B1;CCT7;CCT2;CCT6A;CCT8;HNRNPA1;TCP1;CCT4;CCT3;CTNNB1;NAF1;ATM
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.34285764123834644,-1.2611209784085196,0.13855421686746988,0.2797659148176576,1.0,16/38,42.59%,MIF;HSP90AB1;AKT1;PARK7;TFRC;EIF4G1;OSM;HAX1;RIPK2;VEGFA;PFN2;IFNG;CAMK1;TERF2IP;LATS1;NOS1
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),0.38084751687565976,1.260352580785926,0.16573556797020483,0.24427541850971288,1.0,11/25,33.89%,FOXM1;BRCA1;ZC3H12A;PINK1;XDH;COQ7;CDKN1A;THBS1;SIRT5;SPHK2;PID1
gsea,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.40919531657959834,1.2599232205628075,0.14416058394160583,0.24434149758427454,1.0,8/21,34.08%,UTRN;CAMK2D;WNK1;FGF13;NETO1;PTPN3;FXYD1;FXYD3
gsea,macroautophagy (GO:0016236),-0.3315276647910333,-1.259784339325044,0.1482889733840304,0.28071176168458883,1.0,15/44,34.66%,TOMM5;TOMM20;VCP;VAMP8;VDAC1;VPS33B;VAMP7;STX17;PIK3R4;UBQLN1;SNX14;TOMM40;CLN3;ATG14;PLAA
gsea,regulation of autophagosome assembly (GO:2000785),0.41788351793486667,1.2596159046959243,0.16793893129770993,0.24425378487443625,1.0,8/18,33.47%,ADPRH;MTMR3;PINK1;RAB3GAP1;TBC1D14;PHF23;IFT88;NUPR1
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3711434475447464,-1.257216359198137,0.1951219512195122,0.2830800153621188,1.0,21/44,26.22%,C1QBP;HNRNPA1;SRSF6;PTBP1;HNRNPU;HNRNPK;RBMXL1;DAZAP1;REST;NCL;PCBP4;RBM15B;JMJD6;SRSF7;METTL16;CWC22;U2AF2;LARP7;SRSF9;CELF4;MAGOH
gsea,positive regulation of cytokine production (GO:0001819),0.26874898580954837,1.2565376596650553,0.09845559845559845,0.24740144375264547,1.0,86/179,36.68%,BRCA1;XCL1;CCR7;SLAMF6;IL18R1;CRTAM;HMGB1;NFKB1;HIF1A;IRF1;RGCC;FOXP1;IRF4;CREBBP;ZFPM1;ATF4;SERPINE1;ROCK2;PIK3CD;GBP5;POU2F2;RUNX1;CSF2;MBP;RFTN1;PTPN11;RORA;LTB;CCL1;NFKB2;GATA3;PRKD2;SPTBN1;SCRIB;EP300;STAT6;IRF7;DDIT3;IL1B;CD200;CD40LG;IL17RA;MALT1;POU2AF1;IL16;TRAF2;TNF;STAT3;RASGRP1;HSPA1B;CD226;AIRE;TLR7;CD86;RAB7B;EGR1;CD274;LPL;IL2;ARNT;NFAM1;MAP3K7;CD40;ARHGEF2;PIK3CG;F3;CSF1R;CADM1;ISG15;CARD11;PRKCZ;IL6ST;PTGS2;CD74;TYROBP;HSPA1A;PTGER4;SYK;FADD;PDE4B;SPHK2;F2RL1;CGAS;RELA;IL23A;EBI3
gsea,fatty acid oxidation (GO:0019395),-0.37343320154485926,-1.2562650346485325,0.17391304347826086,0.2834168859230486,1.0,17/26,37.12%,ACADL;MTLN;PEX2;HADH;HSD17B10;ECHDC1;ALDH3A2;ECI1;ABCD3;ACAT2;ACOX1;ECHDC2;SLC27A2;ACADM;PECR;ABCD1;MCAT
gsea,response to glucose (GO:0009749),-0.38435482152238337,-1.2557953927123726,0.17173913043478262,0.2832370759904057,1.0,11/22,23.93%,XBP1;EIF2B3;RACK1;SELENOS;PFKL;EIF2B5;SLC39A14;UNC13B;ERN1;MAFA;EIF2B1
gsea,positive regulation of RNA splicing (GO:0033120),0.40413626493400445,1.2548888390234885,0.19591836734693877,0.24890857305234698,1.0,10/20,35.57%,POLR2A;THRAP3;SLC38A2;DYRK1A;RBMX;SETX;NUP98;PIK3R1;HSPA1A;NCBP1
gsea,protein-containing complex subunit organization (GO:0043933),0.32372566906075256,1.254797175018652,0.1350844277673546,0.24859221747847263,1.0,27/58,30.19%,KNTC1;NDC1;NUP133;NUP35;ZW10;MDM4;NUP205;CREBBP;KMT2A;FAS;FANCA;WIPF1;NUP98;SEH1L;LPXN;FANCC;TRAF2;KIFAP3;TUBGCP4;PML;TRAF1;PPIH;CD40;CD2AP;MDM2;CD74;HFE
gsea,regulation of protein localization to cell surface (GO:2000008),-0.4138388552129672,-1.2542521963969804,0.17829457364341086,0.28443172579573567,1.0,6/17,32.80%,HSP90AB1;KCNAB2;RANGRF;CTNNB1;TM9SF4;GPD1L
gsea,regulation of interferon-alpha production (GO:0032647),-0.4093451563388204,-1.2536534933158594,0.1854043392504931,0.2843832617714963,1.0,7/18,29.70%,HAVCR2;HSPD1;IRF5;RIPK2;IL10;TLR4;CHUK
gsea,toll-like receptor signaling pathway (GO:0002224),0.3346686180383608,1.2532744503903321,0.16666666666666666,0.24994180300711094,1.0,16/44,38.08%,UBB;BIRC3;HMGB1;TNIP3;RFTN1;MAP3K1;TNIP1;TLR7;MAP3K7;CTSS;TAB3;LGMN;FADD;BTK;RPS6KA3;CTSL
gsea,regulation of monocyte chemotaxis (GO:0090025),0.4359445996480027,1.2505946241492603,0.19195612431444242,0.2526673724241709,1.0,6/16,19.40%,HMGB1;DUSP1;CXCL10;SERPINE1;CCL1;ANO6
gsea,lipid transport (GO:0006869),-0.32928132193177295,-1.2503494172828324,0.16393442622950818,0.2875766933609897,1.0,24/43,40.38%,PRELID1;FABP5;MFSD2A;GOT2;SLCO2A1;CEACAM1;SLC27A1;PRELID3B;ABCD3;LDLR;PRELID3A;PCTP;PLTP;SCARB1;CLN3;ACSL1;PLEKHA8;OSBPL2;PRELID2;ABCD1;OSBPL5;ABCC4;ATP8A1;PITPNB
gsea,regulation of cell migration (GO:0030334),-0.2566091661860252,-1.2497576973493831,0.0707070707070707,0.2875056517285004,1.0,185/185,98.60%,TMSB4X;TMSB10;ACTG1;MIF;HSPA5;SERPINE2;GTPBP4;CCL3;AKT1;NEDD9;ANXA1;XBP1;PLXND1;ARSB;FLNA;HRAS;DUSP3;RACK1;CITED2;RAP2A;BST2;SEMA4A;CCL5;F2R;TPM1;WNT11;CCR1;PDGFB;ADGRG3;MYO1C;CEACAM1;TMSB15A;PDGFA;DLC1;VSIR;SEMA6D;RHOC;ATM;SOD2;RDX;AMOTL1;LAMC2;CLN3;VEGFA;PRR5L;PLAU;PPM1F;CSF1;RIPOR1;NEXN;GRN;PLXNA1;ENPP2;GRB7;SMIM22;CXCL16;AMOT;DAG1;SEMA4C;MMP14;FUZ;TJP1;FAM110C;ELP3;RHOB;GPNMB;ACVR1;ELP6;HBEGF;ADAM17;TCAF1;PLET1;PTK2B;BCAR1;SEMA7A;IGSF10;ABI3;SINHCAF;CARMIL2;LGR6;TTBK2;DUSP22;IGF1;DDX58;COL1A1;ADRA2A;RUFY3;CCL7;TBCCD1;MMP9;RAP2B;RCC2;MINK1;EDN1;APPL2;MITF;NF2;LMO4;AIF1;VIL1;CLIC4;ADAM9;PLXNB2;KIF2A;RET;DUSP10;GCNT2;SPHK1;CASS4;FGR;MAZ;FGF2;DLG5;SEMA4B;CDH1;MIA3;CD151;F2RL1;LIMCH1;FOXO3;AMOTL2;PAK1;RAP2C;SPATA13;CD74;HACE1;OSGIN1;THBS1;KIT;SCAI;SGK1;PECAM1;CSF1R;F3;AFDN;DAB2;PTPRJ;NF1;CX3CL1;ELP5;SRGAP3;SMAD7;CTSH;VCL;ACVRL1;STAT3;PTPRK;SYNE2;LEF1;FLT1;MYADM;SLK;SPRY2;IL1B;ARID2;ZMYND8;ENG;NOTCH1;PLXNC1;LMNA;MCTP1;PIK3CD;MGAT5;ROCK2;MACF1;TIAM1;ITGA6;SERPINE1;CCN1;CORO1C;IFITM1;CCAR1;SUN2;SRGAP2;ROCK1;ITGAX;CPNE3;PRKCA;NTRK3;ACTN4;MAP4K4;ARHGEF39;ITGB1;GTSE1;KIF14
gsea,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4273340742389056,1.2485701837888556,0.19136960600375236,0.2547282435729723,1.0,7/16,26.81%,CCR7;FLT1;PIK3R2;PIK3IP1;PIK3R1;KIT;AMBRA1
gsea,positive regulation of cellular protein metabolic process (GO:0032270),0.32419014880752234,1.2485496367036932,0.15660377358490565,0.25433425241904234,1.0,27/56,41.41%,PLK1;NFKBIA;UPF3B;FAF1;KLF4;UHRF1;STUB1;PASK;FMR1;BCL3;CLN6;METTL14;DDX3X;BTRC;ATG10;PERP;ATG7;THBS1;SOX4;FADD;EIF4A3;NSUN5;VPS35;HSP90AA1;VPS11;MTOR;METTL3
gsea,cellular response to amino acid starvation (GO:0034198),0.3475852727613086,1.2474580865176046,0.17169811320754716,0.25521667857786223,1.0,16/35,31.41%,DAPL1;SESN3;ATF4;FAS;MAP3K5;ATF2;CASTOR1;SEH1L;TCIRG1;SLC38A9;CDKN1A;DEPDC5;SESN2;SESN1;RPTOR;ATP6V1G3
gsea,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4183387325429295,1.247448981454017,0.20121951219512196,0.2548080406736154,1.0,7/16,32.66%,TINF2;PIF1;CTC1;XRN1;TERF2;SLX4;TENT4B
gsea,regulation of proteolysis (GO:0030162),0.39403874540991385,1.2473050891141422,0.19591836734693877,0.25455936663247913,1.0,7/20,24.86%,PLK1;STUB1;PLAUR;CLN6;HDAC6;BTRC;PERP
gsea,regulation of interleukin-8 production (GO:0032677),-0.34189086495747756,-1.2470724979201644,0.16352201257861634,0.29032926682282095,1.0,36/36,95.35%,TMSB4X;PARK7;ANXA1;ANXA4;F2R;CD14;IL10;RIPK1;TLR4;NOS2;ARRB1;TLR2;DDX58;MAVS;HYAL2;CACTIN;RELA;F2RL1;FADD;SYK;HSPA1A;CD74;OTUD7B;F3;TLR7;HSPA1B;STAT3;TNF;IL1B;DDIT3;PRKD2;BCL3;CD33;SERPINE1;KLF4;HMGB1
gsea,defense response to bacterium (GO:0042742),-0.33747895308911874,-1.2468851310075324,0.1643835616438356,0.2897517538854467,1.0,18/42,44.81%,PGLYRP1;FCER1G;PGLYRP2;SLC11A1;GBP7;LTF;PLA2G6;ANXA3;TLR4;GBP4;STAB1;NOS2;MR1;MPO;ADAM17;GBP2;CTSG;CHGA
gsea,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3502853431855238,-1.2465428696375223,0.1532258064516129,0.2893433906677931,1.0,13/31,40.30%,RPS27L;BAK1;DDIT4;CRIP1;BAX;MSH2;E2F1;MSH6;AEN;SFN;ATM;IKBKE;PRKDC
gsea,ATP-dependent chromatin remodeling (GO:0043044),0.3786595278014072,1.2463076300725204,0.2080808080808081,0.2553409840611361,1.0,15/30,27.95%,ANP32E;PBRM1;RBBP4;ARID1A;SMARCC2;GATAD2B;SMARCC1;SRCAP;ARID1B;CHD3;NASP;SMARCA2;SMARCA4;SPTY2D1;RNF8
gsea,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.413430512847205,1.2451274803001016,0.20997920997921,0.25634220643525446,1.0,9/18,24.49%,BRCA1;TNFAIP3;SERPINE1;FAS;GSK3B;DDX3X;TRAF2;BCL2L1;ARHGEF2
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.31520170893212696,1.2439562739118566,0.13125,0.2573514756067525,1.0,27/53,30.93%,PLK1;TAF1;RNF19A;STUB1;XPO1;SOCS5;GSK3B;TAF9;SUMO2;UCHL5;TRIB2;HSPA1B;DVL1;SMAD7;DAB2;ZYG11B;ZER1;TRIB1;USP5;TRIB3;USP7;MDM2;RNF19B;HFE;TLK2;HSPA1A;CBFA2T3
gsea,protein homooligomerization (GO:0051260),0.3121734907406737,1.2437092567017185,0.13636363636363635,0.25723728467979046,1.0,25/57,34.27%,ECT2;TK1;POLQ;BLM;EHD3;ARC;SAMHD1;GBP5;SLC1A2;FUS;ATL2;RBMX;CLYBL;NINJ1;ALOX5AP;ATL3;GLS;CTH;RNF213;APIP;TRPA1;GOLGA2;CARD11;SHMT2;TIFA
gsea,regulation of myeloid cell differentiation (GO:0045637),0.3375903916715295,1.2419577141589417,0.1614785992217899,0.25892565376570387,1.0,19/42,28.47%,NR4A3;CREBBP;ZFPM1;SIN3A;RBM15;KMT2A;KMT2C;RUNX1;CSF2;KMT2D;EP300;KAT2B;PRKCB;KMT2B;SPI1;TNRC6A;THBS1;PF4;SETD1A
gsea,regulation of nitric oxide biosynthetic process (GO:0045428),0.37712071053670715,1.2402279507734129,0.1896551724137931,0.2605599729944088,1.0,15/25,28.27%,KLF4;JAK2;KLF2;ROCK2;ZC3H12A;ATP2B4;P2RX4;IL1B;NOS1AP;GLA;TNF;CX3CR1;KHSRP;SIRPA;PTGS2
gsea,cellular respiration (GO:0045333),-0.41723979741091033,-1.240222227581234,0.2076923076923077,0.29663719386921733,1.0,8/18,23.79%,ETFB;MDH2;CYCS;MTLN;UQCRC1;NDUFA5;NDUFS1;SDHA
gsea,vesicle cytoskeletal trafficking (GO:0099518),0.4117992856562866,1.2400638387727483,0.1949317738791423,0.26034221826370935,1.0,11/20,44.54%,NDE1;ACTN4;TRAK1;MYO5A;TANC2;HTT;KIF5B;FNBP1L;MYO1E;BICDL1;MYO5B
gsea,regulation of interleukin-2 production (GO:0032663),0.36176504680321375,1.2394387842335648,0.19444444444444445,0.26065464685244405,1.0,15/27,27.39%,XCL1;TNFAIP3;IRF4;HDAC7;RUNX1;PRKD2;SPTBN1;IL1B;MALT1;PRNP;TRAF2;CD86;MAP3K7;TBX21;CARD11
gsea,cellular glucose homeostasis (GO:0001678),0.3926694504023127,1.2383170318140928,0.199203187250996,0.2615952341314665,1.0,12/21,33.77%,NUCKS1;HIF1A;ZBTB20;LRRC8D;PCK2;FOXO1;SIRT1;PIK3R2;PIK3R1;GAS6;SOX4;PRKAA1
gsea,hematopoietic progenitor cell differentiation (GO:0002244),0.42676353353720076,1.238236493433753,0.22404371584699453,0.26130067402975743,1.0,7/16,26.10%,MLLT3;MLF1;PLD4;FLT1;TNFRSF13B;CSF1R;KIT
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2721821218657768,1.2379694201655513,0.1285444234404537,0.26120744415803027,1.0,47/105,35.04%,ECT2;CCR7;TNFAIP3;TRIM59;BIRC3;REL;PIM2;STAT1;PDPK1;PER1;NUP62;TNIP3;MAP3K3;ZC3H12A;RORA;NLRC3;CPNE1;MAP3K14;CXXC5;IL1B;PIDD1;PINK1;MALT1;PRKCB;SLC20A1;TRAF2;CC2D1A;TNF;TNIP1;SIRT1;TRAF1;CX3CL1;PLK2;TRIM14;MAP3K7;CD40;ECM1;TAB3;CARD11;OTUD7B;CD74;FADD;SPHK2;OPTN;F2RL1;TIFA;RELA
gsea,regulation of cell development (GO:0060284),0.3979839213575065,1.2378834482678989,0.17636363636363636,0.26091258463977046,1.0,13/21,37.50%,HMGB2;BHLHE40;IL1B;FOXO1;ARNTL;CX3CR1;HDAC9;CX3CL1;WNT3;PRUNE1;NOTCH2;YAP1;SLAMF8
gsea,regulation of mitochondrial membrane potential (GO:0051881),-0.38602120252484545,-1.237786829183292,0.21398305084745764,0.29899588977456987,1.0,12/23,22.45%,PRELID1;BAK1;AKT1;VCP;PARK7;MTLN;BAX;SLC25A33;PRDX3;NDUFS1;STOML2;PPA2
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.3228816301162152,1.2366664112306822,0.17584745762711865,0.26192447339016106,1.0,18/47,28.34%,SP1;POLR2A;TAF5;SRRT;POU2F1;POU2F2;INTS1;TAF9;TAF6;INTS6;GTF2A1;TBP;POLR2B;RPRD1B;INTS3;CCNK;INTS11;GTF2E2
gsea,regulation of type I interferon production (GO:0032479),-0.3145840046413712,-1.2365842703426178,0.1534090909090909,0.2997099665181596,1.0,26/54,40.30%,GAPDH;IRF8;G3BP1;POLR2F;POLR3D;POLR2L;POLR3E;POLR2H;CTNNB1;CD14;IRF5;POLR3G;DHX33;TRIM21;TRIM25;POLR1C;POLR3H;ZBP1;POLR3K;DHX58;POLR2E;XRCC6;TRIM56;UBE2L6;IKBKE;PRKDC
gsea,positive regulation of endothelial cell migration (GO:0010595),0.3311196180535823,1.2358815706358754,0.16304347826086957,0.26243640303615123,1.0,28/47,39.92%,HMGB1;SP1;PRKCA;HIF1A;FOXP1;NRP1;PDPK1;ROCK2;PIK3CD;ETS1;ZC3H12A;P2RX4;GATA3;PRKD2;PLCG1;ABL1;SIRT1;CD40;PIK3CG;THBS1;LGMN;STAT5A;RIN2;MET;BCAS3;NRP2;FGF2;SPARC
gsea,lymphocyte differentiation (GO:0030098),0.3390607846444377,1.2358676313216745,0.15343915343915343,0.26203774921597606,1.0,22/42,35.73%,ITGB1;KLF6;TOX;PIK3CD;RELB;GATA3;TCF3;HDAC5;KAT7;IKZF1;HDAC9;PTPRJ;IL2;NFAM1;CLCF1;KIT;TPD52;LY6D;VCAM1;SOX4;BLNK;DCAF1
gsea,positive regulation of response to external stimulus (GO:0032103),0.31664668297206006,1.2350803830317296,0.1787709497206704,0.26251474756261606,1.0,31/66,36.26%,NFKBIA;PRKCA;PDCD4;AKIRIN2;SERPINE1;NFKBIZ;GBP5;ETS1;MGST2;CCL1;NINJ1;CCN4;IL1B;PUM2;PLSCR1;IL17RA;IL16;TNF;TNIP1;USP15;TLR7;CX3CL1;LPL;IL2;THBS1;CD180;DDX60;PTGER4;OPTN;F2RL1;IL23A
gsea,positive regulation of protein transport (GO:0051222),-0.3337915853221961,-1.2349661739967848,0.15654205607476634,0.30100568591050647,1.0,17/39,33.16%,PPIA;ADAM8;PPID;EXPH5;EZR;RACK1;UNC13B;PLK3;FRMD4A;APBB1;ARHGEF5;TGFB3;CLN3;ICE1;PRR5L;RIPOR1;ACHE
gsea,regulation of RNA metabolic process (GO:0051252),-0.36416470655233674,-1.2343106772815373,0.17346938775510204,0.3010330863641648,1.0,13/28,33.95%,PCBP1;PTBP1;HNRNPF;RRP1B;GRSF1;USP36;PCBP4;IGF2BP3;PTBP2;IGF2BP2;AHNAK;RBM38;MED1
gsea,positive regulation of innate immune response (GO:0045089),-0.42481306791004986,-1.2336839611795938,0.20491803278688525,0.3009946200429092,1.0,6/15,21.69%,ADAM8;POLR3D;CCL5;POLR3G;SLC15A4;ZBP1
gsea,positive regulation of B cell activation (GO:0050871),-0.3406921585054051,-1.2333388535704786,0.17987152034261242,0.30062191445577857,1.0,13/33,42.80%,MIF;XBP1;TNFRSF4;TNFSF4;TNFSF13B;TFRC;CD38;CD320;IL21;TNIP2;MMP14;SHLD2;RIF1
gsea,regulation of protein dephosphorylation (GO:0035304),0.3823309765724966,1.2296936893198365,0.18012422360248448,0.2684488725173021,1.0,12/21,27.50%,CALM2;CDCA2;PPP6R3;PPP1R15A;PPP6R1;PPP6R2;TSC1;PPP1R7;PIN1;SYMPK;MFHAS1;ANKLE2
gsea,response to amino acid starvation (GO:1990928),0.33959874016814207,1.2291272658280274,0.18147448015122875,0.26873627447156434,1.0,16/36,31.41%,DAPL1;SESN3;ATF4;FAS;MAP3K5;ATF2;CASTOR1;SEH1L;TCIRG1;SLC38A9;CDKN1A;DEPDC5;SESN2;SESN1;RPTOR;ATP6V1G3
gsea,second-messenger-mediated signaling (GO:0019932),0.3326760696528067,1.2268057178419878,0.1509433962264151,0.27114256253237357,1.0,24/48,40.48%,CCR7;CCR6;TNFSF11;CXCR3;GUCY1A1;NUDT4;PDPK1;CXCR4;CXCR5;MCTP1;P2RX4;PLCG1;CX3CR1;GUCY1B1;DGKD;MCU;KSR2;APOE;CCR8;CCR4;CCR9;BTK;PPP1R9B;SPHK1
gsea,positive regulation of developmental growth (GO:0048639),0.4247959721103339,1.2259923156693988,0.21561338289962825,0.27167544301525826,1.0,4/15,40.56%,RNF157;MACF1;CPNE9;MAP3K13
gsea,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.4026838887387971,-1.225392416764403,0.1845841784989858,0.3105637173015973,1.0,6/18,23.77%,MIF;EEF1E1;SMYD2;SPRED2;ATM;MSX1
gsea,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3673401897163016,1.2243301825457849,0.21206225680933852,0.27327509701473807,1.0,11/23,34.98%,ARID1A;PMEPA1;UBR5;SAFB;CALCOCO1;KDM3A;AR;PLPP1;DAXX;RBFOX2;YAP1
gsea,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4024136453541435,-1.2243108588469638,0.20773930753564154,0.3111557033169802,1.0,13/20,37.18%,WDR75;WDR43;NCL;UBTF;PWP1;HEATR1;DHX33;LYAR;SMARCB1;EIF2AK3;IPPK;NOL11;UTP15
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.35666532969667586,1.2242206196942327,0.18806509945750452,0.2729914962553948,1.0,17/31,39.41%,SPRY1;SKIL;BAMBI;NOTCH1;ATP2B4;SPRY2;HGS;SMAD7;SKI;TRIM33;THBS1;HIPK2;CRIM1;SMAD1;LEMD3;FGF2;SULF2
gsea,negative regulation of epithelial cell proliferation (GO:0050680),0.3534714449664301,1.223128942437345,0.1793103448275862,0.2738576387033744,1.0,15/34,33.47%,TINF2;RGCC;BRCA2;STAT1;NLRC3;GATA3;KLF9;TGFBR3;PTPRK;XDH;FBXW7;NF1;THBS1;APOE;NUPR1
gsea,positive regulation of protein modification process (GO:0031401),0.28071833925746237,1.2231173191988678,0.11796733212341198,0.27344312866220044,1.0,49/98,40.13%,CALM2;CDCA2;CEP295;NTRK3;CCN1;PLAUR;DYRK1A;ROCK2;FAS;FMR1;ENG;DDX3X;AXIN2;IL1B;TNIK;PINK1;FNIP1;RAB3GAP1;NOS1AP;TAOK1;ARNTL;TNF;ABL1;RASGRP1;SIRT1;PPP1R7;DAB2;AXIN1;PIN1;CD40;SYMPK;ATG10;CSF1R;PECAM1;DAXX;ATG7;GOLGA2;ANKLE2;GAS6;CD74;PGF;PAK1;AKTIP;LIMCH1;HSP90AA1;WDFY2;FGF2;DVL3;FBH1
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3272001615481487,1.222458834268285,0.16793893129770993,0.2738611893373075,1.0,19/41,38.02%,ANLN;CCR7;RIPOR2;NRP1;CCP110;DOCK11;FMR1;CEP120;PIK3CA;CCDC88A;PIK3R1;CDC42EP3;BBS4;EPS8;F2RL1;EPS8L1;HTT;BCAS3;FNBP1L
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.37362549662295935,1.2208737242597982,0.193359375,0.27527465845976884,1.0,10/24,21.54%,ACTN4;TNFSF14;PDCD4;NFAT5;DDX3X;EP300;IL1B;TNF;TLR7;CD86
gsea,regulation of cell-substrate adhesion (GO:0010810),0.37640615329702176,1.2204147754666443,0.16981132075471697,0.275469641375858,1.0,8/23,25.58%,JAK2;CORO1C;NOTCH1;MYADM;TSC1;CX3CL1;NF1;ARL2
gsea,snRNA transcription (GO:0009301),0.3172662311432861,1.2203558919552453,0.18669527896995708,0.27512565927545274,1.0,18/48,28.34%,SP1;POLR2A;TAF5;SRRT;POU2F1;POU2F2;INTS1;TAF9;TAF6;INTS6;GTF2A1;TBP;POLR2B;RPRD1B;INTS3;CCNK;INTS11;GTF2E2
gsea,regulation of defense response (GO:0031347),-0.3231538761635185,-1.2202574584961714,0.16901408450704225,0.31600289103510765,1.0,23/46,42.16%,TMSB4X;PSMA6;PARK7;ANXA1;TNFSF4;CCR2;ERAP1;CASP1;TKFC;ZMPSTE24;LACC1;ZBP1;UFL1;PIK3AP1;BIRC2;ALOX5;LRP8;DHX58;GRN;CASP12;SPATA2;SETD6;SEMA7A
gsea,positive regulation of lymphocyte proliferation (GO:0050671),-0.33387534414469466,-1.2190902368368624,0.204,0.3167422333101998,1.0,13/37,35.90%,MIF;ANXA1;TNFRSF4;TNFSF4;PDCD1LG2;TNFSF13B;CCL5;TFRC;CD38;CD80;CD320;IL21;CCDC88B
gsea,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.42283293970682373,-1.2182976100060343,0.23865877712031558,0.31694703125475515,1.0,11/19,29.25%,RRS1;PES1;FTSJ3;NOP14;NOL9;WDR12;EXOSC2;RPP40;UTP20;URB1;EXOSC7
gsea,positive regulation of protein catabolic process (GO:0045732),0.3326172937040921,1.2179849327442136,0.18687872763419483,0.2776633820268623,1.0,22/41,37.54%,FZR1;TNFAIP3;BARD1;FAF1;GSK3B;HUWE1;DTL;IL1B;FOXO1;TNF;AXIN1;NSF;PLK2;ATG7;AREL1;HACE1;IDE;APOE;WWP1;VPS35;HSP90AA1;VPS11
gsea,phosphate-containing compound metabolic process (GO:0006796),-0.2682964219993362,-1.217900206061595,0.11563169164882227,0.3166371921819255,1.0,48/97,43.47%,ALDOA;PGK1;AKT1;PPA1;GPD2;PSPH;GDE1;DUSP3;AGPAT2;HDHD2;ALDOC;PFKL;PDXP;ISYNA1;NADK;ENPP1;PLCG2;PLPP2;NUDT10;ACYP1;G6PC3;DUSP23;TIGAR;PPA2;COQ8A;GFPT1;NUDT11;NUDT5;DUSP12;HK3;INPPL1;FRA10AC1;IP6K2;ACP2;IPPK;LHPP;PLAA;PFKP;LRRK2;PANK3;AGK;PFKFB3;ACYP2;PFKM;HK1;GFPT2;DUSP18;AGPAT1
gsea,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.42572743313374767,1.2178810787582355,0.23440453686200377,0.27737830640546324,1.0,10/15,30.68%,BCL2;CSF2;HTRA2;IL1B;BCL2L1;TNF;HSPA1B;EYA3;PF4;HSPA1A
gsea,regulation of fat cell differentiation (GO:0045598),0.3312434575840671,1.2175575541523989,0.21621621621621623,0.2773962107326819,1.0,20/38,40.01%,ZFP36L1;ASXL1;ZFP36L2;ZFPM1;CREB1;ZC3H12A;RORA;GATA3;FTO;FOXO1;ARNTL;TRIB2;TNF;SIRT1;LPL;TRIB3;WWTR1;YAP1;WDFY2;ZFP36
gsea,cellular macromolecule biosynthetic process (GO:0034645),0.3141135388924847,1.2163553845856296,0.21703853955375255,0.27846259920891714,1.0,79/183,39.63%,CDK1;PCLAF;TYMS;CLSPN;DBF4;TICRR;BRCA1;BRIP1;CDC45;RHNO1;BLM;BARD1;MCM10;POLA1;PIF1;RFC4;FEN1;MCM8;RBBP8;EXO1;RFC5;POLR2A;POLE;FAM111A;SRBD1;RPLP1;CDC6;RMI2;RAD50;RECQL4;ATR;CDC7;TOP3A;ORC6;MLF1;TOPBP1;BCL3;EIF4G2;MRPL51;EEFSEC;WRN;MMS19;ST3GAL4;RPA3;RAD9A;POLA2;RNASEH2A;RPA2;POLD3;ING5;MRPL18;HELB;TNIP1;POLR2B;AGO2;KAT7;RNPS1;MRPL28;ORC1;RPA1;CDK2;RECQL5;DONSON;ORC5;RFC2;POLE3;MRPS6;ORC2;DTX1;APOE;RFC3;POLD1;RAD1;INHA;MRPS12;TAF1B;TSFM;NR4A2;BAZ2A
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),0.32442911096855703,1.2144911940237038,0.17288801571709234,0.28028401090248023,1.0,23/39,38.08%,UBB;TNFAIP3;STUB1;USP9X;HDAC6;MALT1;CTSH;ZYG11B;ZER1;GZMA;CUL4B;CTSS;CTSZ;ISG15;MDM2;OTUD7B;LGMN;IDE;LONP1;RHBDD1;ATXN3;CLPX;CTSL
gsea,regulation of smoothened signaling pathway (GO:0008589),0.4007367647423259,1.2137639656041799,0.19929453262786595,0.28083434770082427,1.0,12/21,32.41%,TEDC1;CREBBP;RORA;UCHL5;BTRC;TEDC2;IFT81;PTCH1;TUBD1;KCTD21;TULP3;MGRN1
gsea,regulation of protein import into nucleus (GO:0042306),0.3784934786318583,1.2135804137362087,0.2145748987854251,0.2806198692927859,1.0,8/20,24.91%,ECT2;UBR5;ZC3H12A;TRIM28;IPO5;MDFIC;PIK3R2;PIK3R1
gsea,negative regulation of developmental process (GO:0051093),0.34907001201756255,1.2134613070895592,0.21070811744386875,0.28031860993626323,1.0,15/36,33.60%,FOXM1;SUZ12;ROCK1;ROCK2;HUWE1;HOPX;NOTCH1;ANP32B;PARP3;PINK1;SPI1;RPS6KA6;GAS6;BCL11A;GRIN3A
gsea,regulation of focal adhesion assembly (GO:0051893),0.3517658791246661,1.213271843998754,0.2111692844677138,0.2800966674282925,1.0,17/32,26.66%,MAP4K4;GPM6B;NRP1;ROCK1;CORO1C;MACF1;ROCK2;CLASP2;CLASP1;SLK;ABL1;ACVRL1;VCL;TSC1;PEAK1;PTPRJ;THBS1
gsea,positive regulation of defense response (GO:0031349),0.3225002624940697,1.2108241766533752,0.1784313725490196,0.2827342511599557,1.0,21/52,22.98%,NFKBIA;PDCD4;AKIRIN2;SERPINE1;NFKBIZ;GBP5;ETS1;MGST2;CCL1;NINJ1;CCN4;IL1B;PLSCR1;IL17RA;IL16;TNF;TNIP1;TLR7;CX3CL1;LPL;IL2
gsea,positive regulation of epithelial cell migration (GO:0010634),0.32171510509531254,1.2105389868280068,0.18412162162162163,0.2826727211779319,1.0,31/53,45.55%,MAP4K4;PRKCA;HIF1A;FOXP1;NRP1;ROCK2;CLASP2;PIK3CD;ETS1;CLASP1;ZC3H12A;GATA3;PRKD2;HDAC6;PLCG1;ABL1;CTSH;PIK3CG;IQSEC1;THBS1;DOCK1;RIN2;BCAS3;NRP2;FGF2;SPARC;MTOR;PIK3CB;ADAM9;TGFB2;VIL1
gsea,autophagosome assembly (GO:0000045),-0.408465178423543,-1.2098130921571468,0.22012578616352202,0.32703739071857396,1.0,8/16,37.47%,ATG9B;ATP2A2;NSFL1C;STX17;UBQLN1;ATG14;ATG2B;UBXN2B
gsea,regulation of proteasomal protein catabolic process (GO:0061136),-0.3594841905330267,-1.2092953263533899,0.23391812865497075,0.3268346887903174,1.0,16/28,29.73%,PSME2;HSP90AB1;GPX1;PSMD14;RAD23B;ALAD;PSMC5;BAG2;GLMN;UBQLN4;PSME3;DAB2IP;PSMC2;UFL1;PSMC6;DESI1
gsea,negative regulation of blood vessel morphogenesis (GO:2000181),0.35578760183327623,1.208797589787483,0.20170940170940171,0.284390280962722,1.0,18/35,32.14%,RGCC;KLF4;ROCK1;STAT1;CXCL10;ROCK2;GTF2I;ATF2;ATP2B4;SPRY2;HGS;FOXJ2;PML;PDE3B;THBS1;PF4;SPRED1;WNT4
gsea,RNA catabolic process (GO:0006401),0.3485491581219196,1.2080095537621711,0.2068230277185501,0.2848736251068805,1.0,16/31,41.41%,LSM2;FEN1;ZFP36L2;DXO;CNOT10;ZC3H12D;MTREX;RNASEH2A;HSPA1B;RNASE6;SND1;HSPA1A;NCBP1;DIS3L2;ZFP36;METTL3
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.32468995000462736,-1.2075855616228466,0.20162932790224034,0.3284920035269034,1.0,38/38,99.57%,CTSD;GPX1;MT3;YWHAE;CYCS;AKT1;DHCR24;MYC;REST;F2R;CASP1;SFN;VEGFA;PPM1F;TNFSF10;GRAMD4;SH3RF1;NLRP3;PMAIP1;RPS6KA3;DAPK1;SYK;GAS6;THBS1;DELE1;SIRT1;TNF;MALT1;FNIP1;USP47;DDX3X;HTRA2;MAP3K5;KLF4;CD44;HMGB1;CDKN2D;ARL6IP1
gsea,positive regulation of interleukin-10 production (GO:0032733),0.40110385895228234,1.2071383765707622,0.21346153846153845,0.28548988547857207,1.0,11/17,36.26%,XCL1;HMGB1;IRF4;CD40LG;STAT3;CD274;ISG15;PRKCZ;SYK;F2RL1;IL23A
gsea,regulation of actin cytoskeleton reorganization (GO:2000249),0.40476732909186963,1.206161297193827,0.21495327102803738,0.28633026495212316,1.0,8/17,35.74%,NTRK3;NRP1;IQGAP2;ABL1;HCK;CSF1R;NOTCH2;BCAS3
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3498627585443085,-1.2059323368446029,0.21120689655172414,0.3299271074378412,1.0,11/27,33.94%,NOC2L;BID;PTPMT1;BAX;RACK1;P4HB;DAPK2;UBQLN1;HERPUD1;PPIF;EIF2AK3
gsea,regulation of organelle organization (GO:0033043),0.3389185774861514,1.2052903204549859,0.2030360531309298,0.2868860458342818,1.0,15/34,38.51%,ARL6IP1;EHD3;CDT1;EP300;PINK1;TAOK1;CAMSAP2;MYO5A;RHOT2;TBC1D25;DIAPH1;VPS35;ZEB2;VPS11;PDE4DIP
gsea,positive regulation of intracellular signal transduction (GO:1902533),-0.23740074813115844,-1.2052256237138315,0.1136890951276102,0.3299880858333088,1.0,233/233,98.64%,LGALS1;GAPDH;S100A4;MIF;HSP90AB1;ADAM8;C1QBP;CCL4;PHB;LITAF;PHB2;CCL3;AREG;PARK7;UBE2N;BID;RPS15;FLNA;MYDGF;HRAS;BAX;RACK1;DDX21;BST2;NEDD4;CCL5;RYK;LYN;F2R;WWC1;CASP1;TFRC;TMEM106A;CD14;PLCG2;WNT11;OSM;PDGFB;TNFRSF1A;EIF2AK2;PTP4A3;DHX33;TRIM21;TRIM25;PDGFA;HMOX1;MTDH;CAV2;MIOS;RHOC;HAX1;CD80;DAB2IP;RRAGB;RIPK2;MID2;LTF;PIK3AP1;RASD2;NEK6;HPSE;BIRC2;AXL;VEGFA;TICAM2;RIPK1;PPP5C;DUSP19;TRIM44;TLR4;CHUK;TGFA;DHX58;IKBKG;WLS;TNFSF10;TRIM5;TERF2IP;WDR24;SMCR8;TNIP2;EPOR;CD4;IKBKE;JCAD;FAM110C;ADRB2;LTBR;HBEGF;MLST8;TRAF5;MC1R;TLR2;IGF1;MAVS;ADRA2A;ANKRD17;TMEM101;C1QTNF4;FFAR4;GSDME;TNFRSF10B;RAPGEF2;BCAR3;TRIM8;EEF1D;TGFB2;FLT3;TSPAN6;PMAIP1;BBC3;DDX1;RET;APP;PIK3CB;BOK;GCNT2;NCF1;SPHK1;CASS4;FN1;FGR;ZDHHC13;UNC5CL;MAZ;FGF2;DLG5;TCF7L2;HSP90AA1;IL23A;RELA;MET;CGAS;TIFA;STRN;F2RL1;SPHK2;NUPR1;FADD;BTC;DDX60;THEM4;CD74;GAS6;RPTOR;KSR1;MFHAS1;CARD11;TAB3;ECM1;THBS1;KIT;TRIB3;F3;BCLAF1;SELP;PIK3R1;PIK3CG;CD40;CBL;MAP3K7;TRIM14;PLK2;RICTOR;PTPRJ;CX3CL1;PIK3R2;PTPN6;CD86;TLR7;SIRT1;CX3CR1;ICOS;RAMP3;SLC38A9;USP15;PIK3R5;TGM2;TNF;FLT1;CC2D1A;BCL2L1;TRAF2;SLC20A1;HEXIM1;NOS1AP;PRKCB;MALT1;PIK3CA;FNIP1;PUM2;SPRY2;HIP1;PINK1;BCL2L11;SEH1L;IL1B;DDIT3;EP300;DDX3X;SHC1;CXXC5;MAP3K14;ENG;PRKD2;GATA3;TRAT1;P2RX4;LIF;CPNE1;PTPN11;IRS2;MAP3K3;NFAT5;PIK3CD;ROCK2;NUP62;PDPK1;BCL2;ROCK1;JAK2;PDCD4;TNFSF14;PIM2;NTRK3;HMGB1;ACTN4;REL;BIRC3;TNFSF11;CCR7;ITGB1;ECT2
gsea,regulation of interferon-gamma production (GO:0032649),0.32388010732256234,1.2033693424056844,0.17142857142857143,0.28890638262766744,1.0,25/46,36.68%,XCL1;CCR7;SLAMF6;IL18R1;CRTAM;HMGB1;ZFPM1;ZC3H12A;SCRIB;DDIT3;IL1B;PRNP;RASGRP1;CD226;TLR7;CD274;ISG15;SIRPA;GAS6;FADD;PDE4B;F2RL1;INHA;IL23A;EBI3
gsea,negative regulation of cellular component organization (GO:0051129),0.3201168783946504,1.2029799227854083,0.18725868725868725,0.2889627351311488,1.0,23/40,41.53%,RTEL1;DNAJB1;MCTP1;TERF2;GSK3B;HDAC6;DDX3X;EP300;AR;SPRY2;TNF;HSPA1B;TMC8;PRKCZ;HSF1;AIDA;HSPA1A;ABCA7;SACS;TFIP11;TRAF3IP1;ULK1;SYT11
gsea,regulation of protein-containing complex assembly (GO:0043254),0.2869431630279458,1.2029013217794873,0.1811175337186898,0.2886310884638564,1.0,39/67,44.05%,HJURP;FAF1;ATF7IP;SPIDR;MPP7;HCFC1;GSK3B;CDT1;PTPN11;HDAC6;DDX3X;EP300;NAPB;BCL2L11;PINK1;FNIP1;PIH1D1;TRAF2;TNF;AJUBA;TMC8;RB1;SELP;HCK;PRKCZ;HSF1;ABCA1;AIDA;INSM1;SYK;APOE;BIK;HSP90AA1;TFIP11;TRAF3IP1;ULK1;SLF2;HSPA8;CD36
gsea,neuron projection extension (GO:1990138),-0.39293870800005914,-1.2024163953404527,0.2123015873015873,0.3330171651694522,1.0,7/20,27.56%,HSP90AB1;LLPH;CDKL3;CTNNB1;CYFIP1;IMPACT;EIF2AK4
gsea,positive regulation of actin filament polymerization (GO:0030838),-0.3589039251079179,-1.2023223113801504,0.2222222222222222,0.3322841983887194,1.0,10/23,31.18%,PFN1;SNX9;PRKCE;SPIRE1;BAIAP2;NCKAP1;CDC42EP1;SPIRE2;PFN2;CDC42EP2
gsea,positive regulation of interleukin-8 production (GO:0032757),0.36545048379038353,1.2014729128185886,0.21082089552238806,0.2899090005022019,1.0,16/26,35.04%,HMGB1;SERPINE1;PRKD2;DDIT3;IL1B;TNF;STAT3;HSPA1B;TLR7;F3;CD74;HSPA1A;SYK;FADD;F2RL1;RELA
gsea,response to lipopolysaccharide (GO:0032496),0.3006593989900071,1.2011041016215502,0.1828358208955224,0.289902357229498,1.0,40/76,45.80%,TNFAIP3;HMGB2;HMGB1;NFKB1;FOXP1;PDCD4;GCH1;JAK2;CXCL10;SERPINE1;TNIP3;ZC3H12A;CD68;IL1B;ERBIN;CX3CR1;CD86;CD274;TRIB1;SELP;SLPI;SIRPA;SBNO2;PF4;CD180;PDE4B;RELA;CXCL9;LIAS;RPS6KA3;CXCL2;TRIM41;ZFP36;CACTIN;ACOD1;CDC73;MAPK8;CXCL13;ADAM9;NR1H3
gsea,protein localization to plasma membrane (GO:0072659),-0.2891760054958338,-1.2002402227904492,0.16129032258064516,0.33439465244639077,1.0,29/64,45.85%,S100A10;TMED2;GORASP2;EZR;PKP3;FLNA;BSG;FLOT1;RAP2A;LRP6;ZDHHC2;EHD4;TNFRSF1A;JUP;TESC;RDX;RAB3D;FAM126A;RAMP2;PKP2;EHD2;TSPAN5;PLEKHF1;NKD2;TSPAN33;RAB34;SLMAP;RAB13;ACTN2
gsea,positive regulation of protein-containing complex assembly (GO:0031334),-0.28170015062209075,-1.2001760004510358,0.1834319526627219,0.3335881352102174,1.0,39/74,38.51%,CAPG;LCP1;BAK1;VCP;PARK7;BID;MTLN;BAX;RACK1;PLEK;PSMC5;LGALS3;PARP1;TFRC;EIF4G1;DDB1;GTF2H2;UNC13B;DHX33;RHOC;DAB2IP;FSCN1;GTF2H4;ATM;PSMC2;GTF2H1;SLF1;ICE1;VEGFA;TLR4;PSMC6;RASIP1;ERCC3;CDC42EP2;IFNG;GNL3L;ERCC2;GTF2H3;PSMC4
gsea,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.42146324338234425,-1.1996781974807933,0.21395348837209302,0.3334568394460902,1.0,5/15,30.42%,AREG;NEDD9;PDGFB;TGFA;LRP8
gsea,positive regulation of interleukin-1 production (GO:0032732),0.37819350895209214,1.1989956462167257,0.2439516129032258,0.29212140077407817,1.0,11/21,34.22%,HMGB1;JAK2;GBP5;MALT1;IL16;TNF;STAT3;EGR1;LPL;TYROBP;F2RL1
gsea,endoderm formation (GO:0001706),0.4304690612169068,1.1977124602665512,0.2425249169435216,0.29331334049883395,1.0,6/16,27.99%,DUSP4;DUSP1;SETD2;DUSP2;ITGA7;DUSP5
gsea,negative regulation of cellular biosynthetic process (GO:0031327),0.3475630262415359,1.1965921490544897,0.20973782771535582,0.2943345070914112,1.0,16/28,32.14%,BRCA1;NFKB1;ROCK2;ZC3H12A;ATP2B4;PGP;EP300;C1QTNF12;GLA;FBXW7;CLK2;KHSRP;TRIB3;SIRPA;ERLIN2;WNT4
gsea,chemical homeostasis (GO:0048878),0.36242945674358795,1.1962455769556315,0.2019607843137255,0.29429521071227815,1.0,13/26,36.99%,ZBTB20;WNK1;THADA;IRS2;DDX3X;FBXW7;SLC4A7;SLC4A8;PNPLA8;KLHL3;TENT4B;SLC4A2;ABCB4
gsea,regulation of inflammatory response (GO:0050727),0.2859320002194751,1.1952643453314975,0.18213660245183888,0.2950895884354526,1.0,47/101,36.26%,XCL1;TNFAIP3;NFKBIA;BIRC3;BCL6;FOXP1;KLF4;PDCD4;JAK2;SERPINE1;NFKBIZ;CELF1;ETS1;MGST2;RORA;NLRC3;CCL1;NINJ1;GATA3;CCN4;IL1B;CD200;IL17RA;DNASE1L3;IL16;TNF;TNIP1;RB1;TLR7;CX3CL1;LPL;IL2;HCK;AREL1;SIRPA;MFHAS1;SBNO2;PTGS2;TNFAIP8L2;PTGER4;MEFV;USP18;APOE;AKNA;RELA;VPS35;IL23A
gsea,phospholipid transport (GO:0015914),-0.36061321247116923,-1.1950147625291099,0.1970954356846473,0.3389928454636754,1.0,13/25,34.22%,PRELID1;MFSD2A;ABCC1;ATP8B4;PRELID3B;LDLR;PRELID3A;PCTP;PLTP;SCARB1;ATP8B2;OSBPL2;PRELID2
gsea,regulation of stress-activated MAPK cascade (GO:0032872),0.35948597809784666,1.191073139088845,0.21782178217821782,0.299935677194926,1.0,10/22,20.41%,FOXM1;MAP4K4;PER1;FAS;TAOK2;MID1;TGFBR3;TAOK1;FOXO1;RASGRP1
gsea,protein modification process (GO:0036211),0.3284396897643419,1.1900910936558526,0.20488721804511278,0.30079895828316056,1.0,10/34,25.92%,UBE2S;ADPRH;ST8SIA4;SEPHS1;ST3GAL1;PHKA2;FBXO11;ABL1;BAP1;MCRS1
gsea,cellular response to heat (GO:0034605),-0.4024143614706633,-1.1882354319150517,0.24435318275154005,0.34772289638608217,1.0,7/19,22.14%,HSP90AB1;YWHAE;VCP;HMOX1;BAG3;HSBP1L1;CLPB
gsea,organelle organization (GO:0006996),0.23997592526667563,1.1877160394464483,0.12927756653992395,0.30328133662285445,1.0,98/211,50.19%,CDCA8;CEP55;DIAPH3;MTFR2;TNFAIP3;ODF2;MNS1;NUMA1;SYNE3;CENPT;PHIP;ZW10;PACSIN1;ARC;MAST2;FANCG;CLASP2;CLASP1;ATL2;HCFC1;HUWE1;FMNL3;GABPB1;LNPK;ARHGAP10;TNIK;PINK1;RAB3GAP1;ZMYM3;PRM2;ATL3;KIFAP3;CENPW;GBF1;AJUBA;VPS13D;ARFGEF1;DYNC2H1;MAST3;MICAL1;STRIP1;DYM;AGTPBP1;MICAL3;VPS13C;GOLGA2;HACE1;SNX11;ZFYVE16;SYNE1;RHOT2;LONP1;APOE;DIAPH1;EPS15;TFB1M;GAK;SIRT5;POLRMT;ZMYM4;OPTN;MIA3;LMAN1L;HTT;BCAS3;PLEKHM2;GOLGB1;COG3;SEC16A;VPS11;POLG2;LMAN2L;FNBP1L;MTFR1;FMNL2;MAST4;GABPA;CEP78;BAG5;PI4K2B;ADCK1;NECTIN2;TRAPPC11;YME1L1;DMTN;USP6NL;NRF1;KLHL20;CUL7;PEX3;PALLD;KIF5C;RAB30;NPLOC4;SIRT3;CCL2;VPS18;TRAPPC12
gsea,regulation of neuron apoptotic process (GO:0043523),-0.30743320097785626,-1.187257177150322,0.19294605809128632,0.34820199916974665,1.0,22/43,43.44%,ADAM8;MT3;CCL3;PARK7;SET;BAX;MSH2;SIGMAR1;F2R;CTNNB1;BHLHB9;AKT1S1;SOD2;TGFB3;EGLN3;CLN3;GRN;PRKCI;LIG4;FOXQ1;PTK2B;NDNF
gsea,positive regulation of protein import into nucleus (GO:0042307),0.3851869803602361,1.1872331308571862,0.2581967213114754,0.3034327785377395,1.0,7/18,24.91%,ECT2;UBR5;ZC3H12A;TRIM28;IPO5;PIK3R2;PIK3R1
gsea,protein K63-linked deubiquitination (GO:0070536),0.3845775232674482,1.1866502739780134,0.24008350730688935,0.3036958150137825,1.0,10/17,36.30%,TNFAIP3;OTUD1;USP8;ABRAXAS1;USP33;USP7;OTUD7B;SHMT2;USP20;ATXN3
gsea,glycoprotein metabolic process (GO:0009100),0.35722934289549874,1.186620758848652,0.23246492985971945,0.3032833693593053,1.0,9/25,24.81%,HIF1A;ST6GALNAC3;ST8SIA4;ST8SIA1;GANAB;ST3GAL4;MAN1B1;TNIP1;FUT8
gsea,acyl-CoA metabolic process (GO:0006637),-0.4080671228568,-1.1855636545822021,0.232409381663113,0.34963598467141616,1.0,3/15,33.03%,DBI;HMGCS1;OXSM
gsea,positive regulation of neuron death (GO:1901216),-0.3453673290182799,-1.185278387676977,0.21951219512195122,0.3492296227591352,1.0,11/28,40.03%,EIF2S1;DDIT4;CCL3;BAX;REST;CTNNB1;ITGAM;TLR4;IFNG;GRN;EFNB2
gsea,regulation of vesicle-mediated transport (GO:0060627),0.33863396241589494,1.1850598078074914,0.2113970588235294,0.30478155802985296,1.0,18/35,40.48%,NRP1;PACSIN1;HIP1;ABL1;HIP1R;NSF;STXBP5;STON1;HCK;RAB5B;USP7;ZFYVE16;SYK;INPP5F;PICALM;FGR;TSC2;SPHK1
gsea,negative regulation of cell adhesion (GO:0007162),0.3433092591730237,1.184867062164421,0.22482014388489208,0.30458324278288934,1.0,14/30,35.28%,DUSP1;RIPOR2;SERPINE1;PLXNC1;NOTCH1;LPXN;SPN;TGFBI;ACVRL1;PDE3B;CX3CL1;B4GALNT2;MIA3;CDH1
gsea,positive regulation of cell death (GO:0010942),-0.3307308983537767,-1.184168698924128,0.232409381663113,0.349894970004031,1.0,14/35,44.57%,EIF2S1;MT3;PHB;DDIT4;SLC6A13;EIF4G1;ITGAM;BNIP3;RIPK2;RIPK1;IFNG;LRRK2;EFNB2;HEBP2
gsea,negative regulation of GTPase activity (GO:0034260),-0.3996864175745367,-1.1836994439570983,0.24708171206225682,0.34968555679681734,1.0,8/16,35.17%,TMED2;HRAS;RRP1B;DAB2IP;RDX;GPSM1;RASA4;LRRK2
gsea,actin polymerization or depolymerization (GO:0008154),-0.338804514815103,-1.1825807500703727,0.2132701421800948,0.35033356945586575,1.0,29/29,98.76%,CFL1;CAPG;MSRB2;SPIRE1;DSTN;GHSR;FLII;ABI2;SPIRE2;MICAL2;PSTPIP2;CATIP;WASHC5;GSN;AIF1;VIL1;SCIN;VILL;CFL2;ENAH;PREX1;DIAPH1;MICAL3;MICAL1;CORO7;SVIL;JAK2;EVL;DIAPH3
gsea,"regulation of gene expression, epigenetic (GO:0040029)",0.3112376630649833,1.1825776238965255,0.20507399577167018,0.3072146527310406,1.0,26/52,37.23%,EZH2;CTCF;SUZ12;DEK;RBBP4;DNMT1;BAZ1B;JARID2;MTF2;TDG;TASOR;HDAC6;EP300;KAT2B;PHF19;MTA1;RBBP7;TBP;SPI1;PHF2;HDAC5;EED;AEBP2;SPHK2;TAF1B;SMARCA5
gsea,response to peptide (GO:1901652),0.38791332223514957,1.1813633105860408,0.2611218568665377,0.30841814099735465,1.0,10/20,21.56%,STAT4;STAT1;STAT5B;STAT2;STAT6;ERBIN;PRNP;STAT3;RAMP3;KAT7
gsea,negative regulation of transport (GO:0051051),-0.3725906991163834,-1.180500213898389,0.25820568927789933,0.3525385209982284,1.0,8/19,32.53%,RACK1;BST2;LGALS3;ITGB3;YRDC;CRYAB;PPM1F;PACSIN3
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.34023395936020157,1.1801753069228766,0.22117202268431002,0.30952071161233874,1.0,19/32,39.47%,BIRC6;PHIP;ITGA6;FAS;MADD;AR;TRAF2;TNF;PML;TMC8;TRAF1;THBS1;FADD;WWOX;RELA;HTT;TCF7L2;SP100;FEM1B
gsea,leukocyte cell-cell adhesion (GO:0007159),0.4234758095762327,1.175824404507328,0.27734375,0.3149892890521701,1.0,10/15,31.58%,ITGB1;ROCK1;NT5E;CD40LG;TNIP1;SELP;PECAM1;OLR1;VCAM1;SYK
gsea,positive regulation of inflammatory response (GO:0050729),0.322697338548346,1.1755570441265824,0.22137404580152673,0.31488141778128254,1.0,25/49,36.60%,NFKBIA;PDCD4;CD81;SERPINE1;NFKBIZ;ETS1;C2CD4B;MGST2;CCL1;NINJ1;CCN4;IL1B;IL17RA;IL16;TNF;TNIP1;TLR7;CX3CL1;LPL;IL2;IL6ST;PTGER4;NUPR1;IL23A;C2CD4A
gsea,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.41086613195948146,-1.1753756052147963,0.2787524366471735,0.3589095983780962,1.0,12/21,22.75%,CCT5;CCT7;CCT2;CCT6A;CCT8;HNRNPA1;TCP1;CCT4;CCT3;CTNNB1;NAF1;ATM
gsea,regulation of phagocytosis (GO:0050764),-0.35237570721038836,-1.1752050406994727,0.24222222222222223,0.3582648571692669,1.0,10/28,32.49%,CALR;FCER1G;RACK1;IL15RA;SLC11A1;LMAN2;RAB27A;LYAR;SCARB1;IFNG
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3212464579470926,1.174111689071146,0.2265625,0.31640350084024493,1.0,17/38,21.54%,NFKBIA;ACTN4;TNFSF14;PDCD4;HDAC7;NFAT5;ZC3H12A;BCL3;NLRC3;CPNE1;DDX3X;EP300;IL1B;TNF;SPI1;TLR7;CD86
gsea,defense response to virus (GO:0051607),-0.2878243384159889,-1.1740990108959786,0.23408624229979466,0.3590101772731904,1.0,26/70,37.43%,PRF1;NDUFAF4;PHB;PHB2;DDIT4;ABCE1;G3BP1;FLNA;SHFL;BST2;RNASEL;RIPK3;ATAD3A;AKAP1;EIF2AK2;BNIP3;ISG20;IFI27;ZBP1;CLPB;EXOSC5;IFIT2;TRIM5;IL21;MOV10;TRIM56
gsea,positive regulation of cellular biosynthetic process (GO:0031328),-0.2701190485328347,-1.1728073901320974,0.20302375809935205,0.3600258287208047,1.0,95/95,95.42%,RPS27L;HSP90AB1;VIM;RPL5;AKT1;PARK7;EIF3D;EIF6;MYC;NPM1;MFSD2A;CCL5;PIWIL2;EIF3C;PRMT1;STARD4;ABCB10;DDB1;HNRNPD;PDGFB;LPGAT1;ASS1;SLC27A1;EPM2AIP1;LDLR;SCARB1;NAT10;TLR4;GIPC1;IFNG;PAOX;ZCCHC4;DDAH2;LARP4;DUOXA1;SLC25A37;PYM1;PTH1R;PRKDC;EEF2;MID1IP1;TYRP1;IGF1;SORBS1;PCNA;METTL5;EDN1;CTDNEP1;FXR2;DHX9;LARP4B;BCAR3;NR1H3;DNA2;SMAD3;PLXNB2;CD36;METTL3;MTOR;FGF2;HSP90AA1;ZEB2;NSUN5;EIF4A3;SOX4;PTGS2;THBS1;SLC6A9;ARNT;BRPF3;EGR1;KAT7;SIRT1;DYRK2;TNF;NOS1AP;IL1B;DDX3X;METTL14;PRKD2;P2RX4;BCL3;CDT1;IRS2;FMR1;PASK;KLF2;KLF4;RGCC;FAF1;CTC1;HIF1A;SP1;ATAD5;UPF3B
gsea,telomere maintenance via telomere lengthening (GO:0010833),0.3717492538982428,1.1727097676047948,0.2753623188405797,0.31775808023726,1.0,16/27,25.02%,RAD51;TINF2;PIF1;CTC1;PPP6R3;RTEL1;RAD50;TERF2;RFC1;DCLRE1B;ANKRD28;TNKS1BP1;ZBTB48;RPA1;CDK2;WRAP53
gsea,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.36842750581466216,1.1725589655976238,0.2543352601156069,0.3174956939430252,1.0,10/22,35.04%,NR4A1;NRP1;NOTCH1;PRKD2;EGR3;SPRY2;PIK3CA;FLT1;PGF;RELA
gsea,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.37056734467511104,1.1710172556631606,0.2495511669658887,0.3189751605108586,1.0,15/27,36.26%,JAK2;CSF2;LIF;SOCS3;IL3;TNF;STAT3;IL2;CD40;CLCF1;CSF1R;KIT;IL6ST;PARP14;IL23A
gsea,epidermal growth factor receptor signaling pathway (GO:0007173),0.3566174179836648,1.1700433195191993,0.24686940966010734,0.31981612906945805,1.0,18/26,45.55%,PDPK1;RPS6KA5;PTPN11;SHC1;PLCG1;ERBIN;PIK3CA;KIF16B;DGKD;CBL;PIK3R1;BTC;PIK3C2A;GAREM1;NCK2;SOS1;REPS2;VIL1
gsea,sensory perception of mechanical stimulus (GO:0050954),0.3491325728391488,1.1699614737394433,0.22429906542056074,0.3194539529276707,1.0,10/27,39.08%,BIRC5;RIPOR2;TBL1X;CCDC50;P2RX4;GRAP;ATP2B2;USP53;LHFPL4;CDC14A
gsea,RNA processing (GO:0006396),-0.3033083424849784,-1.1698659392149047,0.25793650793650796,0.36342835861737927,1.0,42/108,34.90%,HNRNPA2B1;SNRPF;NCBP2;SNRPD3;DKC1;LUC7L3;PTBP1;HNRNPU;HNRNPK;SNRPA1;SYNCRIP;MPHOSPH10;HNRNPF;SRSF2;HNRNPC;DDX54;MAGOHB;BICD1;SNRPD1;NUFIP1;RNASEL;PIWIL2;PABPC4;SNRPB;NOL9;SFPQ;MRPL44;HNRNPD;TUT1;DHX15;TARDBP;SRSF7;FASTKD2;TSEN54;U2AF2;SRSF9;MAGOH;IVNS1ABP;DDX47;THOC1;APOBEC1;SF3B3
gsea,nucleic acid metabolic process (GO:0090304),0.33424818547790147,1.1695367382512596,0.2719836400817996,0.31957679725915455,1.0,25/49,45.68%,KPNA2;ANKLE1;FEN1;POLR2A;LSM8;NT5E;DXO;RAD50;RBMX;TOPBP1;HNRNPH1;WRN;MMS19;ATXN2;METTL14;DNASE1L3;POLR2B;HNRNPR;RECQL5;RBFOX2;NCBP1;METTL3;POLG;DDX1;DNA2
gsea,regulation of wound healing (GO:0061041),-0.36883419377782545,-1.1694173095107492,0.23779193205944799,0.36318676674945105,1.0,8/18,29.08%,ACTG1;SRSF6;ANXA1;HRAS;F2R;PRKCE;PLAU;ALOX5
gsea,protein ADP-ribosylation (GO:0006471),0.3914770428579985,1.1693120735303457,0.2702169625246548,0.31940629187496195,1.0,10/16,38.16%,PARP2;SIRT6;PARP3;ART3;PARP8;SIRT1;HPF1;SIRT5;PARP14;PARP12
gsea,positive regulation of protein import (GO:1904591),0.3732795289539095,1.168677549926745,0.25773195876288657,0.31974912008800743,1.0,7/19,24.91%,ECT2;UBR5;ZC3H12A;TRIM28;IPO5;PIK3R2;PIK3R1
gsea,regulation of cellular component movement (GO:0051270),0.3614828269854006,1.1681222117943988,0.263671875,0.3199868607880314,1.0,15/24,38.58%,ACTN4;ROCK1;ROCK2;ETS1;HDAC6;TGFBR3;ABL1;ZSWIM8;ACTN1;BTC;DIAPH1;SP100;INPP5F;ZSWIM4;ZSWIM6
gsea,positive regulation of protein kinase B signaling (GO:0051897),-0.27730012503218554,-1.167758585676162,0.18693693693693694,0.3647178510153454,1.0,68/68,97.61%,HSP90AB1;ADAM8;C1QBP;PHB;CCL3;AREG;PARK7;MYDGF;OSM;PDGFB;PDGFA;MTDH;HAX1;CD80;PIK3AP1;RASD2;HPSE;AXL;TGFA;FAM110C;HBEGF;MC1R;FLT3;RET;PIK3CB;GCNT2;CASS4;MAZ;FGF2;TCF7L2;HSP90AA1;MET;STRN;BTC;THEM4;GAS6;MFHAS1;THBS1;KIT;TRIB3;F3;PIK3R1;PIK3CG;RICTOR;PTPRJ;CX3CL1;PIK3R2;CD86;CX3CR1;ICOS;RAMP3;PIK3R5;TNF;PIK3CA;SPRY2;HIP1;PINK1;ENG;GATA3;TRAT1;P2RX4;CPNE1;PTPN11;IRS2;PIK3CD;PDPK1;CCR7;ITGB1
gsea,ameboidal-type cell migration (GO:0001667),0.3685120905580927,1.1673964887030754,0.24485981308411214,0.32046870224192814,1.0,10/21,39.67%,ITGB7;SRGAP2;PDLIM1;CORO1C;PHACTR4;SOX8;AMOTL2;SOX10;SEMA4B;SGPL1
gsea,regulation of sprouting angiogenesis (GO:1903670),0.3670832789366041,1.166989684053577,0.2351851851851852,0.32053563169846316,1.0,10/20,45.66%,E2F2;KLF4;KLF2;PDPK1;GLUL;THBS1;SMAD1;FGF2;PIK3CB;ITGA5
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2852588698122637,1.1665842691221344,0.20137693631669534,0.32057227674139144,1.0,55/97,43.17%,FAM83D;XCL1;CCR7;DUSP4;HMGB1;NTRK3;PRKCA;CD44;SPRY1;NRP1;CCN1;PTPN11;NOTCH1;CCL1;PRKD2;SHC1;IL1B;SPRY2;TGFBR3;TNF;DUSP6;TNIP1;GPR183;RASGRP1;RAMP3;FBXW7;PTPN6;RPS6KA6;CX3CL1;PIN1;APIP;CSF1R;SIRPA;PRKCZ;MFHAS1;HTR2A;P2RY6;SPRED1;GAS6;CD74;NOTCH2;SYK;CCL22;APOE;F2RL1;C5AR1;ABCA7;FGF2;CCL17;GAREM1;FN1;GCNT2;DUSP10;CCL8;APP
gsea,alpha-amino acid metabolic process (GO:1901605),-0.3665122534026591,-1.16648135147493,0.25,0.3657171159930885,1.0,12/21,35.46%,PYCR2;MTRR;GOT2;GOT1;ASS1;ASNS;MTHFD1;ALDH18A1;KYAT3;GLS2;DDAH2;MMUT
gsea,negative regulation of cell migration (GO:0030336),-0.2839255181020103,-1.1654441150385686,0.2012987012987013,0.3664117376760888,1.0,60/60,94.71%,MIF;CALR;GTPBP4;ADGRG1;DUSP3;CITED2;RAP2A;BST2;TPM1;WNT11;HMOX1;DLC1;DAB2IP;PFN2;PHLDB2;DAG1;FUZ;RHOB;TCAF1;PTPN23;SINHCAF;DUSP22;RAP2B;MITF;NF2;HYAL2;CLIC4;DUSP10;FGF2;DLG5;CDH1;MIA3;LIMCH1;FOXO3;RAP2C;TIMP1;CD74;LRP1;SCAI;TRIB1;AFDN;PTPRJ;NF1;CX3CL1;SRGAP3;SMAD7;VCL;ACVRL1;PTPRK;ARID2;ZMYND8;ENG;MCTP1;CLASP1;CLASP2;SERPINE1;CORO1C;IFITM1;SRGAP2;EVL
gsea,protein-containing complex disassembly (GO:0032984),-0.3498787158110056,-1.164179580595523,0.2438095238095238,0.36739760306753033,1.0,14/23,38.83%,VCP;VAMP8;MYC;LRP6;CTNNB1;VPS33B;VAMP7;STX17;UBQLN1;SNX14;CLN3;WNT1;PYM1;VPS33A
gsea,response to hydrogen peroxide (GO:0042542),0.3352038732524431,1.160265117269508,0.22690763052208834,0.3285050922509462,1.0,13/28,36.88%,ECT2;TNFAIP3;MAP3K5;NET1;SETX;HDAC6;NFE2L2;ABL1;SIRT1;SIRPA;APTX;RELA;FXN
gsea,membrane protein proteolysis (GO:0033619),-0.3601705910389989,-1.1600965034279886,0.26614481409001955,0.37230532098556723,1.0,10/21,41.08%,NAPSA;TMPRSS6;ERAP1;AFG3L2;PSEN2;PARL;DAG1;ADAM19;SPPL2B;ADAM17
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),0.28964017260866975,1.1596251989409379,0.24067164179104478,0.3288402959236227,1.0,40/73,49.63%,UPF3B;ATAD5;NFKB1;CTC1;FAF1;RGCC;KLF4;JAK2;PASK;FMR1;IRS2;CDT1;BCL3;PRKD2;METTL14;DDX3X;AR;IL1B;DYRK2;SIRT1;KAT7;BRPF3;SLC6A9;THBS1;SOX4;EIF4A3;NSUN5;FGF2;MTOR;METTL3;PLXNB2;TGFB2;DNA2;BCAR3;LARP4B;HSPH1;DHX9;FXR2;METTL5;CCL2
gsea,protein localization to organelle (GO:0033365),-0.28364978374525107,-1.1584623165611847,0.21458333333333332,0.3738929074364571,1.0,24/61,35.17%,CALR;YBX1;YWHAE;SSB;SERP1;SNX10;ARL1;BICD1;PIKFYVE;HHEX;CCDC47;HMOX1;ALDH3A2;PACSIN2;MSX1;CEP68;CEP250;PAQR3;MTCH2;TTC21B;BMP7;RIPOR1;GCC2;LRRK2
gsea,cortical cytoskeleton organization (GO:0030865),-0.37424531584406706,-1.1583061543526123,0.25740318906605925,0.3732080309422902,1.0,6/20,24.35%,LCP1;EZR;PLEK;RHOQ;RHOC;NCKAP1
gsea,RNA splicing (GO:0008380),-0.33855228848368357,-1.1534233379786225,0.2887189292543021,0.37955836795042575,1.0,23/60,38.66%,SNRPF;NCBP2;SNRPD3;LUC7L3;PTBP1;SNRPA1;SYNCRIP;MPHOSPH10;SRSF2;TXNL4A;HNRNPC;MAGOHB;SNRPD1;SNRPB;SFPQ;DHX15;TARDBP;SRSF7;MAGOH;IVNS1ABP;DDX47;SF3B3;SF3B4
gsea,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.32184911453308895,-1.1532655024625214,0.22505307855626328,0.37886079662526245,1.0,31/31,95.35%,TMSB4X;NUS1;AKT1;ANXA1;PDGFB;HMOX1;MAP2K3;VEGFA;FOXC2;HSPB1;JCAD;ADAM17;FGF2;PIK3C2A;STAT5A;PTGS2;THBS1;CD40;HDAC9;SIRT1;PLCG1;PRKD2;P2RX4;MAP3K3;ETS1;HDAC7;PDPK1;HIF1A;PRKCA;SP1;HMGB1
gsea,regulation of Rho protein signal transduction (GO:0035023),0.3132163328713019,1.1512755399100028,0.2459605026929982,0.33986481579816796,1.0,21/39,36.79%,STMN1;RIPOR2;NRP1;ARHGEF3;MYO9B;NET1;HEG1;GPR174;ABL1;CUL3;ARHGEF2;ARHGEF18;KANK2;SCAI;ABCA1;EPS8;APOE;F2RL1;MET;EPS8L1;KCTD13
gsea,negative regulation of endothelial cell proliferation (GO:0001937),0.41680297672885047,1.150887625725875,0.28596187175043325,0.33993850609078546,1.0,7/16,32.36%,RGCC;STAT1;FLT1;XDH;NF1;THBS1;APOE
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.3054294840133275,1.1493438222975112,0.24855491329479767,0.3416419989892644,1.0,32/57,45.80%,TNFAIP3;HMGB2;HMGB1;NFKB1;PDCD4;CXCL10;SERPINE1;TNIP3;ZC3H12A;CD68;IL1B;CX3CR1;CD86;CD274;SIRPA;SBNO2;PF4;CD180;PDE4B;RELA;FCGR2B;CXCL9;CXCL2;TRIM41;ZFP36;CACTIN;ACOD1;CDC73;MAPK8;CXCL13;ADAM9;NR1H3
gsea,positive regulation of cellular catabolic process (GO:0031331),0.2837746399875388,1.147990427865504,0.24305555555555555,0.3431450570628572,1.0,41/73,46.99%,HMGB1;PIM2;HIF1A;ZBTB20;FAF1;ROCK1;DXO;CNOT1;GSK3B;IRS2;ZC3H12A;IL1B;FOXO1;ZC3H18;TNF;ATF6;PFKFB1;ARNT;PLK2;TRIM14;KHSRP;ZSWIM8;MEFV;APOE;FOXO3;PRKAA1;OPTN;DAPK1;VPS35;HSP90AA1;VPS11;PIK3C2A;SLC4A4;ULK1;PIK3CB;APP;ADAM9;ENTPD5;FURIN;TRIM8;SUPV3L1
gsea,regulation of cellular protein metabolic process (GO:0032268),-0.3168583592919241,-1.1457634759311206,0.2871900826446281,0.3895961870906345,1.0,15/33,33.93%,RPL10;AKT1;NOLC1;PKP3;PUM3;EIF2A;GEMIN5;CYFIP1;EIF4G1;EIF4E;METAP1;DDX25;NANOS3;CSF1;EIF2B4
gsea,positive regulation of phosphorylation (GO:0042327),-0.2542593413934337,-1.1454097364074438,0.20099255583126552,0.3891628650101722,1.0,107/107,95.23%,PPIA;MIF;MT3;AKT1;CDK2AP1;MYDGF;HRAS;FLOT1;RACK1;RAP2A;CCL5;ITGB3;RYK;LYN;DSCAM;TFRC;GLMN;CCND2;RALB;CCND3;TMEM119;FAM20A;CLIP3;AXL;VEGFA;RIPK1;CAMKK2;IFNG;ATG14;KNDC1;LRRK2;CCND1;NBN;VEGFB;ARRB1;CD4;GPNMB;PFKFB3;ADAM17;C3;IGF1;MAVS;SLCO3A1;DVL2;MMP9;FXR2;EPHA3;LMO4;PTGES3;ENTPD5;BRAT1;FLT3;FZD7;RET;APP;FBH1;SLC4A4;DVL3;FGF2;WDFY2;HSP90AA1;LMTK2;DRD4;MET;PRKAA1;LIMCH1;AKTIP;PAK1;PGF;CD74;GAS6;VAC14;THBS1;DAXX;KIT;PECAM1;CSF1R;CD40;PIN1;ARNT;AXIN1;DAB2;PFKFB1;SIRT1;RASGRP1;ABL1;TNF;FLT1;FNIP1;PINK1;TNIK;IL1B;AXIN2;AR;KCTD20;ENG;FMR1;FAS;ROCK2;RAD50;ITGA6;PLAUR;CCN1;NRP1;ZBTB20;HIF1A;NTRK3
gsea,negative regulation of interferon-gamma production (GO:0032689),-0.3612319709806127,-1.1447513567498657,0.2458628841607565,0.3891963847974955,1.0,7/19,29.36%,HAVCR2;C1QBP;TNFSF4;PDCD1LG2;VSIR;AXL;TLR4
gsea,cytosolic transport (GO:0016482),0.2908432235136175,1.1446091111559895,0.2390057361376673,0.34735005618054193,1.0,35/53,47.63%,LAMP1;EHD3;EEA1;TBC1D10B;DENND5A;HOOK3;DCTN1;KIF16B;GBF1;TBC1D5;ANKFY1;CORO7;AP1G1;AP4M1;CCDC91;VPS13C;CLTC;BAIAP3;TMEM87A;EPS15;HOOK1;GAK;AKTIP;VPS35;LMTK2;RGP1;STX16;ERC1;HEATR5B;TBC1D23;HEATR5A;HOOK2;RBSN;KLHL20;RNF126
gsea,cellular response to decreased oxygen levels (GO:0036294),-0.29669450141628934,-1.142795094395798,0.262,0.39123113348107746,1.0,23/45,43.44%,PGK1;ADAM8;HILPDA;MT3;EPAS1;MYC;HYOU1;P4HB;EGLN1;MGARP;HMOX1;BNIP3;TIGAR;UBQLN1;HP1BP3;AK4;NDRG1;EGLN3;VEGFA;BMP7;CPEB2;PICK1;NDNF
gsea,cation transmembrane transport (GO:0098655),-0.390699318834863,-1.141457172040828,0.3,0.39236924998883843,1.0,5/15,38.19%,SFXN1;SLC25A19;SFXN2;SLC36A4;SLC7A3
gsea,blood circulation (GO:0008015),0.39036127165900847,1.1414384122735397,0.29464285714285715,0.3514406509353243,1.0,11/19,32.08%,GUCY1A1;ROCK1;STAT1;CXCL10;ROCK2;ADORA2A;ACVRL1;GUCY1B1;PLN;OLR1;HTR7
gsea,DNA-dependent DNA replication (GO:0006261),0.3233393875431999,1.1404024318058346,0.2975206611570248,0.35231441359493726,1.0,45/96,33.84%,UBB;RAD51;DBF4;CDC45;BLM;GMNN;MCM10;GINS3;POLA1;RFC4;MCM8;RFC5;POLE;PRIM2;PRIM1;CDC6;RECQL4;CDC7;ORC6;TOPBP1;CDT1;REV3L;WRN;GINS4;RFC1;RPA3;MGME1;POLA2;WDHD1;RPA2;POLD3;HELB;PRIMPOL;GINS1;ORC1;RPA1;CDK2;RECQL5;ORC5;RFC2;POLE3;ORC2;RFC3;POLD1;RPAIN
gsea,positive regulation of phagocytosis (GO:0050766),-0.3433089788591079,-1.1403013666221897,0.28287841191067,0.3932290332281894,1.0,9/27,36.15%,CALR;FCER1G;IL15RA;SLC11A1;LMAN2;RAB27A;LYAR;IFNG;C4A
gsea,cellular response to peptide hormone stimulus (GO:0071375),0.2936106814812658,1.1388704933804745,0.25,0.3539784654310114,1.0,19/49,28.30%,ZFP36L1;NR4A1;TBC1D4;NFKB1;NR4A3;PDPK1;C2CD5;IRS2;PCK2;KAT2B;FOXO1;HDAC5;HDAC9;PIK3R2;PDE3B;PIK3R1;MYO5A;TRIB3;DENND4C
gsea,negative regulation of lymphocyte proliferation (GO:0050672),-0.3484960891602801,-1.1352950973678926,0.2886178861788618,0.4000928883196354,1.0,8/23,24.15%,TNFRSF21;PDCD1LG2;LYN;GLMN;CD80;ATM;IL4I1;IL10
gsea,regulation of dendrite morphogenesis (GO:0048814),-0.3935171179290686,-1.1349156900523754,0.2946768060836502,0.39963037325723677,1.0,8/15,34.59%,RAP2A;CAPRIN1;CDKL3;NEDD4;LZTS1;SS18L2;FBXW8;KNDC1
gsea,regulation of protein modification process (GO:0031399),0.3216429074986021,1.1336471288398262,0.2657200811359026,0.360703661937633,1.0,19/31,40.08%,SOCS1;PHIP;CORO1C;STAT2;KAT2B;FNIP1;CCDC88A;PML;PIN1;ATG10;SESN2;ATG7;KDM4D;SPRED1;HPF1;PPP1R16A;ABCA2;CCAR2;FN1
gsea,chemokine-mediated signaling pathway (GO:0070098),0.3728750479853014,1.1312531986282164,0.2925531914893617,0.36358710097372526,1.0,13/26,39.80%,XCL1;WNK1;CXCL10;RBM15;SH2B3;CCL1;OXSR1;CX3CL1;PF4;CCL22;CXCL9;CXCL2;CCL17
gsea,negative regulation of neuron death (GO:1901215),-0.2981726264029586,-1.1305172522940248,0.26476578411405294,0.40564497248628206,1.0,25/43,44.81%,ADAM8;MT3;AKT1;PARK7;SET;MSH2;REST;CD200R1;F2R;EIF4G1;BHLHB9;SOD2;TGFB3;CLN3;IKBKG;CSF1;GRN;LRRK2;PRKCI;LIG4;GPNMB;FOXQ1;PTK2B;NDNF;CHGA
gsea,cellular response to oxygen-containing compound (GO:1901701),-0.2433140476250651,-1.129668236726929,0.2169811320754717,0.4060054668176891,1.0,137/137,97.47%,ACTB;HSP90B1;VIM;MT3;CCR5;AKT1;VCP;UPF1;XBP1;TNFSF4;EZR;CAPN2;SELENOS;PDCD1LG2;PDXP;LYN;TPM1;CASP1;PRDX3;CD14;WNT11;PDGFB;INSIG1;CD80;IMPACT;TESC;DAB2IP;RRAGB;ATM;IL10;SHMT1;AXL;TICAM2;CAMKK2;TLR4;CHUK;IP6K2;PLAA;NFKBIB;WNT10B;RUVBL2;TNIP2;FZD4;SH3BP4;PTK2B;ADCY6;TSHR;GFI1;CTR9;CTSG;TLR2;MEF2C;MMP9;CCL2;ADNP2;RAPGEF2;NLRP3;FES;EPHA3;NR1H3;ADAM9;CXCL13;FZD7;MAPK8;DMTN;RET;CDC73;AHR;ACOD1;GLRA1;CACTIN;NCF1;RORB;MTOR;ZFP36;TRIM41;CXCL2;ABCB4;CXCL9;DAPK1;RELA;ERCC6L2;CCDC62;PID1;PDE4B;CD180;RPTOR;PF4;P2RY6;SBNO2;WNT6;SIRPA;WNT3;MTR;CIB2;SESN2;CDK2;GUCY1B1;LPL;CD274;EGR1;CD86;CX3CR1;RAPGEF1;RAMP3;SLC38A9;PTPRK;TGM2;SSH1;FOXO1;IPO5;PDK2;IL1B;NCOA3;SETX;P2RX4;CD68;ATP2B4;RORA;HTRA2;ZC3H12A;TNIP3;ROCK2;CREB1;SERPINE1;CXCL10;JUN;NRIP1;PDCD4;NR4A3;TAF1;NFKB1;HMGB1;FOS;HMGB2;ZFP36L1;TNFAIP3
gsea,positive regulation of cell adhesion (GO:0045785),-0.3126829905180677,-1.128857321622571,0.26865671641791045,0.40631468404085797,1.0,16/35,44.09%,ADAM8;C1QBP;ADGRG1;NPNT;CITED2;P4HB;CCL5;TPM1;PDGFB;ATM;FUT7;VEGFA;FOXC2;PPM1F;NDNF;FBLN2
gsea,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.36819601048551676,-1.1270592009155265,0.2880658436213992,0.40834011910627327,1.0,17/17,93.42%,HSP90AB1;ABCE1;RNASEL;ZBP1;MAVS;TTLL12;METTL3;CACTIN;FADD;USP18;ISG15;OAS3;PTPN6;STAT2;PTPN11;SAMHD1;IFNAR2
gsea,unsaturated fatty acid metabolic process (GO:0033559),-0.3747853996518793,-1.1264241865335243,0.3013392857142857,0.4084075817590608,1.0,9/16,36.22%,GPX1;PTGR1;DECR2;PTGS1;ACOX1;ALOX5;ACSL1;ELOVL2;ABCD1
gsea,lymphocyte chemotaxis (GO:0048247),-0.36025177909238526,-1.126228345513194,0.30455635491606714,0.4077075250401175,1.0,23/23,97.67%,ADAM8;CCL4;CCL3;CCL5;CXCL16;MSMP;CCL7;CCL2;CCL25;CH25H;CXCL13;CCL8;CCL17;SLC12A2;CCL22;GAS6;PIK3CG;CX3CL1;GPR183;CCL1;PIK3CD;CXCL10;XCL1
gsea,cellular response to lipid (GO:0071396),0.27067862775169005,1.1252024018674303,0.26118067978533094,0.37192264875063163,1.0,58/100,47.47%,TNFAIP3;HMGB2;HMGB1;NFKB1;PDCD4;NRIP1;CXCL10;SERPINE1;CREB1;ROCK2;TNIP3;ZC3H12A;HTRA2;RORA;CD68;SETX;AR;NCOA3;IL1B;RAMP3;CX3CR1;CD86;CD274;LPL;MAP4K1;WNT3;SIRPA;WNT6;TFPI;SBNO2;PF4;CD180;MGST1;PDE4B;SPHK2;PID1;CCDC62;RELA;CXCL9;ABCB4;CXCL2;TRIM41;URI1;ZFP36;RORB;CACTIN;ACOD1;AHR;CDC73;RET;MAPK8;FZD7;CXCL13;ADAM9;NR1H3;EPHA3;ATP1A1;FES
gsea,negative regulation of protein catabolic process (GO:0042177),0.3683903348708042,1.124965367437495,0.29979879275653926,0.3717601042393081,1.0,9/19,29.34%,MAD2L1;MDM4;ROCK1;TIMP2;SNRNP70;PIN1;PTPN3;AZIN1;TIMP1
gsea,regulation of protein kinase B signaling (GO:0051896),-0.25771424095409057,-1.1248477990711,0.2328159645232816,0.4089222564451872,1.0,84/84,97.61%,HSP90AB1;ADAM8;C1QBP;PHB;CCL3;AREG;AKT1;PARK7;MYDGF;RACK1;OSM;PLEKHA1;PDGFB;PDGFA;MTDH;HAX1;CD80;PIK3AP1;RASD2;HPSE;AXL;TGFA;RCN3;DAG1;FAM110C;PHLPP2;BANK1;HBEGF;MC1R;PHLDA3;HYAL2;FLT3;RET;PIK3CB;GCNT2;CASS4;TSC2;PHLPP1;MAZ;FGF2;TCF7L2;HSP90AA1;MET;STRN;BTC;THEM4;GAS6;MFHAS1;THBS1;KIT;TRIB3;F3;PIK3R1;PIK3CG;RICTOR;PTPRJ;CX3CL1;PIK3R2;CD86;SIRT1;CX3CR1;ICOS;RAMP3;XDH;PIK3R5;TNF;PIK3CA;SPRY2;HIP1;PINK1;DDIT3;ENG;GATA3;TRAT1;P2RX4;CPNE1;PTPN11;IRS2;SH2B3;PIK3CD;PDPK1;NTRK3;CCR7;ITGB1
gsea,positive regulation of growth (GO:0045927),0.31665788176354814,1.1247941728486592,0.27920792079207923,0.37149982166307777,1.0,17/35,40.48%,DNPH1;HDGFL2;BCL2;RFTN1;EIF4G2;DDX3X;USP47;PRSS2;DERL2;IL2;EXOSC4;RPTOR;NCBP1;FXN;RPS6KA3;INO80;SPHK1
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.38586226585634065,1.1230302107580488,0.3091286307053942,0.37356421843811205,1.0,7/18,36.61%,LSM3;LSM2;PATL1;EXOSC4;EXOSC8;EDC4;DIS3L2
gsea,muscle contraction (GO:0006936),-0.30295652545107604,-1.1227235063897871,0.26146788990825687,0.4113763370004018,1.0,17/38,32.85%,ALDOA;VIM;TPM3;NEB;TPM1;TNNT1;CHRNE;TMOD1;ASPH;TPM4;MYL6B;CACNA1S;SORBS3;TNNI3;MYL10;CRYAB;TMOD4
gsea,regulation of sodium ion transport (GO:0002028),0.384444153438004,1.1225055472921917,0.32,0.3737901041587272,1.0,5/16,27.43%,WNK1;PER1;ATP2B4;P2RX4;NKAIN1
gsea,monocarboxylic acid transport (GO:0015718),-0.3586290238549063,-1.122463610415396,0.30151843817787416,0.4107796805687794,1.0,7/20,23.60%,SLC6A13;SLC16A11;SLCO2A1;SLC16A13;CEACAM1;SLC27A1;SLC6A12
gsea,regulation of humoral immune response (GO:0002920),-0.42036170502442055,-1.1216914934879132,0.3248081841432225,0.4110237042801641,1.0,17/17,97.55%,C1QBP;PHB2;CD55;C4A;C3;C2;C1QA;CXCL13;C3AR1;C1QB;C1QC;CFB;FCGR2B;C5AR1;CFP;CD81;CCR7
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2338520172544928,-1.121617229768955,0.17676767676767677,0.4101274689018617,1.0,162/162,99.42%,ACTB;ACTG1;NUS1;HNRNPA1;NCBP2;DDIT4;AKT1;PTBP1;NEDD9;HNRNPM;POLR2F;HNRNPF;HRAS;POLR2L;ACTR2;CASP3;MVP;RHOQ;ATP6V0A2;ITGB3;RYK;LYN;POLR2H;MAPKAPK3;CYFIP1;GALNT3;SLC39A14;PDGFB;MAPKAPK2;PSEN2;BAIAP2;GTF2F2;PDGFA;CAV2;SPRED2;NCF2;GFRA2;NCKAP1;ELMO2;CD7;AXL;VEGFA;FOXC2;NAMPT;CSF1;ATP6V0E2;POLR2C;PLAT;CLNK;EIF2AK3;GRB7;POLR2E;HAP1;VEGFB;ANKS1B;CD4;DNM1;ADRB2;EFNB2;SOCS2;PTK2B;BCAR1;STYK1;MUC20;MTSS1;KALRN;IGF1;SORBS1;COL1A1;GTF2F1;MMP9;RASA1;AP2A2;RAPGEF2;FES;EPHA3;GRIN1;BCAR3;MPZL1;FLT3;VAV3;SOS1;ITSN1;RET;NCK2;PIK3CB;ARHGEF28;NCF1;SH2B2;TNK2;CASS4;FOXO4;TSC2;FLRT3;SULF2;FGR;FGF2;EFNB3;AP2B1;PIK3C2A;VAV2;ESRP2;HSP90AA1;LMTK2;NRP2;NCBP1;CNKSR1;MET;BLNK;RBFOX2;SYK;ATP6V1G3;IDE;PAK1;PGF;GIGYF2;SPRED1;AP3S1;DOCK1;KIT;CSF1R;HCK;PIK3R1;CBL;PTPRJ;SIPA1L1;PIK3R2;CYBB;RAPGEF1;GRB10;POLR2B;STAT3;TCIRG1;FLT1;KIF16B;FOXO1;PDK2;SHOC2;PIK3CA;AHI1;SHC1;LCP2;SETX;PRKD2;PTPN11;IRS2;HNRNPH1;GSK3B;ROCK2;TIAM1;ELMO1;ROCK1;JAK2;NRP1;PHIP;POLR2A;NR4A3;NTRK3;CEP57;SLA;STMN1;SHCBP1
gsea,protein-containing complex assembly (GO:0065003),0.24726631533510465,1.1213364746485448,0.24214417744916822,0.3749557011347466,1.0,80/134,47.69%,TCF7;KNTC1;BLM;CNIH2;ZW10;MDM4;PPP6R3;CREBBP;TRAPPC9;KMT2A;TIAM1;FAS;PDZD11;FANCA;GSK3B;ZC3H12A;PPP6R1;WIPF1;KMT2D;EP300;AXIN2;TRRAP;LPXN;TLE4;FANCC;TRAF2;KIFAP3;LEF1;ANO6;TNF;PYGO2;TUBGCP4;PML;ANKRD28;TRAF1;CX3CL1;AXIN1;SMARCA4;NSF;PPIH;CUL3;AFDN;CD40;CD2AP;CTSZ;MCU;GOLGA2;MDM2;HSF1;CD74;HFE;MEFV;DNAJB12;FADD;LIN7A;ASH2L;YAP1;CDC123;SEC16A;BCL9L;TCF7L2;PDE4DIP;HGSNAT;TUBGCP2;PICALM;FN1;BOK;SLC9A1;CDC73;DMTN;MEN1;SPG7;SHANK1;REPS2;VIL1;FARP2;LEO1;LLGL1;MITF;DHX9
gsea,phosphatidylcholine biosynthetic process (GO:0006656),-0.38002504255123243,-1.1210218307003674,0.30628803245436104,0.4101003835187222,1.0,7/15,33.16%,MFSD2A;PCYT1A;SLC27A1;LPCAT1;PCTP;LPIN2;ACHE
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3945140079228796,1.1198177302821886,0.32091097308488614,0.3766306841583055,1.0,6/17,36.28%,LSM3;LSM2;PATL1;EXOSC4;EXOSC8;EDC4
gsea,regulation of interleukin-6 production (GO:0032675),0.29097140040680464,1.1196980373473098,0.2737226277372263,0.376272789268669,1.0,27/58,34.22%,TNFAIP3;HMGB1;POU2F2;MBP;ZC3H12A;PTPN11;NLRC3;IL1B;CD200;IL17RA;POU2AF1;IL16;TNF;STAT3;TLR7;RAB7B;PTPN6;CX3CL1;LPL;ARHGEF2;SIRPA;GAS6;CD74;TYROBP;SYK;SPHK2;F2RL1
gsea,sensory perception of sound (GO:0007605),0.3323636370542202,1.1190210649116876,0.28544061302681994,0.37669650686211953,1.0,11/28,39.08%,BIRC5;RIPOR2;TBL1X;CCDC50;GRAP;ATP2B2;KIT;USP53;MKKS;LHFPL4;CDC14A
gsea,regulation of T cell proliferation (GO:0042129),-0.3039297784196672,-1.1182935076155953,0.2733050847457627,0.413312100138661,1.0,17/36,40.34%,ANXA1;TNFSF4;TNFRSF21;PDCD1LG2;LGALS3;CCL5;TFRC;RIPK3;GLMN;CD80;IL4I1;IL10;IDO1;IL21;CCDC88B;GPNMB;ARG1
gsea,calcium-mediated signaling (GO:0019722),0.2970006453665479,1.116360622037002,0.2725694444444444,0.38009941052817686,1.0,29/52,40.48%,CCR7;CCR6;TNFSF11;CXCR3;NUDT4;PDPK1;PPP3CB;CXCR4;CXCR5;MCTP1;P2RX4;PLCG1;PRNP;CX3CR1;PTPRJ;ATP1B1;ADGRL1;SELP;MCU;VCAM1;KSR2;CCR8;CCR4;PRKAA1;CCR9;BTK;PPP1R9B;SLC8A1;SPHK1
gsea,regulation of innate immune response (GO:0045088),0.3029334547834729,1.1162335326274937,0.29571984435797666,0.37975437312488997,1.0,20/38,49.00%,TNFAIP3;BIRC3;IRF1;IFNAR2;AKIRIN2;SAMHD1;GBP5;PTPN11;NLRC3;TRAFD1;PLSCR1;PTPN6;USP18;FCGR2B;FGR;CACTIN;ACOD1;DHX9;APPL2;POLR3F
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3609969016635147,-1.1137251151496323,0.3235867446393762,0.4196432496456664,1.0,8/23,26.22%,HNRNPA1;SRSF6;PTBP1;HNRNPU;REST;RBM15B;CELF4;MAGOH
gsea,response to gamma radiation (GO:0010332),0.353800822690041,1.112997042348497,0.30392156862745096,0.38407449787593073,1.0,8/19,34.98%,FANCD2;ATR;WRN;MDM2;HSF1;TLK2;PRKAA1;YAP1
gsea,regulation of macroautophagy (GO:0016241),-0.29108643034310505,-1.1122702717445927,0.2868369351669941,0.42096119976770074,1.0,20/45,36.51%,GAPDH;AKT1;CASP3;SNX5;ATP6V0A2;NEDD4;USP36;ERN1;BNIP3;LARP1;RRAGB;UBQLN1;LZTS1;CLN3;GPSM1;IKBKG;ATP6V0E2;SMCR8;LRRK2;UCHL1
gsea,cellular response to ketone (GO:1901655),-0.3550100417718698,-1.1114978548991261,0.3049792531120332,0.42119524016017673,1.0,8/18,29.34%,SPP1;TNFSF4;NCOA4;LARP1;PTGER2;TRERF1;NDOR1;NR3C1
gsea,cellular response to organic cyclic compound (GO:0071407),0.27805538157602516,1.1102715004935828,0.2702702702702703,0.3877516166218123,1.0,35/63,48.73%,RAD51;BRCA1;ZFP36L1;BLM;TAF1;NR4A3;NRIP1;SPIDR;ROCK2;ZC3H12A;RORA;P2RX4;AR;NCOA3;IL1B;SSH1;TNF;TGM2;RAMP3;RAPGEF1;EGR1;CIB2;TFPI;P2RY6;DIAPH1;CCDC62;CDH1;ABCB4;URI1;AHR;DMTN;ATP1A1;FES;ATP1A3;RAPGEF2
gsea,negative regulation of interleukin-6 production (GO:0032715),0.3816043448884765,1.1087906501480644,0.30798479087452474,0.3893797908733793,1.0,9/18,28.92%,TNFAIP3;ZC3H12A;NLRC3;CD200;TNF;PTPN6;CX3CL1;SIRPA;GAS6
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),0.31355752900336115,1.1076416752506406,0.2781456953642384,0.39066387305171807,1.0,26/42,44.77%,SLA;NTRK3;JAK2;LIF;LCP2;SHC1;AHI1;FLT1;RAPGEF1;HCK;CSF1R;KIT;IL6ST;SYK;BLNK;MET;CNKSR1;LIFR;LMTK2;FGR;CASS4;TNK2;PIK3CB;RET;FLT3;MPZL1
gsea,negative regulation of viral genome replication (GO:0045071),0.3394807325775029,1.107373922712075,0.34274193548387094,0.39052522709389553,1.0,16/28,32.47%,FAM111A;IFITM1;ILF3;TASOR;PLSCR1;RESF1;TNF;TNIP1;RSAD2;OAS3;IFITM3;IFITM2;ISG15;SLPI;SRPK1;SETDB1
gsea,negative regulation of cell projection organization (GO:0031345),-0.35706742681402387,-1.1048062538085524,0.3130434782608696,0.43082149578993356,1.0,8/18,43.81%,MT3;HDAC2;CRMP1;PAQR3;EFNB2;PTPRS;ADCY6;GFI1
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3404077855398357,1.10444812105986,0.3456032719836401,0.3942839471837443,1.0,12/25,36.28%,LSM3;LSM2;CNOT1;CNOT10;PAN2;PATL1;TNKS1BP1;EXOSC4;PARN;RC3H2;EXOSC8;EDC4
gsea,positive regulation of protein polymerization (GO:0032273),0.31950865376250964,1.1016388459832678,0.31368821292775667,0.39809643933316824,1.0,17/32,42.93%,CCR7;NUMA1;CDK5RAP2;EVL;CLASP1;DCTN1;PINK1;PSRC1;HCK;ARL2;PAK1;CDC42EP3;MET;HSP90AA1;TPPP3;NCK2;CTTN
gsea,nucleocytoplasmic transport (GO:0006913),0.3365390994839691,1.1003654723917127,0.33832976445396146,0.399481538354738,1.0,16/31,35.57%,BACH2;AAAS;NXT1;RSRC1;GEMIN6;NUP205;ATXN1;DDX20;XPO1;NUP98;MALT1;ANP32A;GEMIN2;GEMIN8;SNUPN;NCBP1
gsea,positive regulation of MAPK cascade (GO:0043410),0.26242965528263706,1.1002661591758434,0.26143790849673204,0.39909499243369495,1.0,58/110,44.87%,EZH2;XCL1;CCR7;TNFSF11;HMGB1;NTRK3;PRKCA;CD44;NRP1;ROCK1;ROCK2;PTPN11;NOTCH1;CCL1;LIF;PRKD2;SHC1;TAOK2;SPRY2;MID1;TAOK1;FLT1;TNF;GPR183;PIK3R5;PIK3R6;RASGRP1;RAMP3;FBXW7;CX3CL1;PTPRJ;CD40;PIK3CG;CSF1R;KIT;PRKCZ;MFHAS1;HTR2A;KSR1;P2RY6;GAS6;CD74;NOTCH2;CCL22;APOE;F2RL1;C5AR1;ABCA7;FGF2;CCL17;GAREM1;GCNT2;CCL8;APP;RET;CD36;FLT3;TGFB2
gsea,positive regulation of mononuclear cell migration (GO:0071677),0.3469223333777043,1.0992533555162232,0.3207207207207207,0.40012056715565125,1.0,10/21,29.59%,CCR7;CCR6;HMGB1;CXCL10;SERPINE1;CCL1;ANO6;TNF;GAS6;LGMN
gsea,telomere maintenance via telomerase (GO:0007004),-0.3695324159811344,-1.0978727743386163,0.3532818532818533,0.4410338809756155,1.0,23/23,97.11%,HSP90AB1;NHP2;DKC1;GAR1;PINX1;NOP10;SHQ1;TELO2;TERF2IP;PTGES3;HSP90AA1;WRAP53;CDK2;RPA1;TNKS1BP1;ANKRD28;RFC1;TERF2;RAD50;RTEL1;PPP6R3;PIF1;TINF2
gsea,positive regulation of neuron projection development (GO:0010976),0.31949762543413096,1.0967717801652752,0.3170289855072464,0.40336064546727907,1.0,12/31,36.76%,NTRK3;TOX;PACSIN1;ITGA6;SETX;EP300;ZDHHC15;RAPGEF1;CX3CL1;CAMK1D;APOE;KIDINS220
gsea,peptidyl-tyrosine modification (GO:0018212),0.35123600672526467,1.096119910751305,0.3279279279279279,0.40376153997618713,1.0,13/23,39.06%,JAK2;DYRK1A;TPST2;FLT1;ABL1;PTPN6;HCK;CSF1R;KIT;SYK;TTL;BTK;FGR
gsea,DNA strand elongation involved in DNA replication (GO:0006271),0.44006239372371125,1.0956198606725056,0.37449392712550605,0.40399760251059763,1.0,10/17,35.15%,GINS3;POLA1;RFC4;POLE;GINS4;POLD3;GINS1;POLE3;RFC3;LIG1
gsea,regulation of glucose import (GO:0046324),-0.36849171421577015,-1.095072222417871,0.3143507972665148,0.44457524548961747,1.0,6/16,38.47%,AKT1;SELENOS;RHOQ;ENPP1;CAPN10;PRKCI
gsea,positive regulation of neurogenesis (GO:0050769),-0.3144760527533614,-1.095043084020504,0.33,0.4435989432300394,1.0,15/28,33.46%,PLXND1;ARHGDIA;CAPRIN1;CDKL3;CTNNB1;SERPINF1;BHLHB9;NAP1L1;MAP6;SS18L2;VEGFA;IFNG;FBXW8;METRN;PLXNA1
gsea,post-Golgi vesicle-mediated transport (GO:0006892),0.29658609698329613,1.094217390684518,0.3151515151515151,0.40562210600385434,1.0,20/36,43.53%,EXOC4;AP1M1;EXOC2;HGS;KIF16B;GBF1;CORO7;AP4E1;AP1G1;MYO5A;AP1B1;AP4M1;VPS13C;CLTC;SORCS1;EPS15;GOLGB1;AP4B1;APP;HSPA8
gsea,B cell differentiation (GO:0030183),0.32185008317813546,1.0935768103574532,0.30245746691871456,0.4059025557553011,1.0,15/30,35.73%,ITGB1;KLF6;IRF2BP2;TCF3;FNIP1;HDAC5;HDAC9;PTPRJ;NFAM1;CLCF1;KIT;TPD52;VCAM1;BLNK;DCAF1
gsea,positive regulation of supramolecular fiber organization (GO:1902905),-0.279907856182255,-1.0935196856834322,0.3037974683544304,0.4449513707584175,1.0,45/45,97.55%,PFN1;GPX1;COLGALT1;SNX9;PLEK;SYNPO2;PDXP;PRKCE;BAIAP2;LIMK1;CLIP1;NCKAP1;TOGARAM1;DRG1;CDC42EP1;PFN2;CDC42EP2;PTK2B;FCHSD2;BAIAP2L1;EDN1;FES;VIL1;APP;CTTN;NCK2;CFL2;MET;F2RL1;APOE;CDC42EP3;PAK1;ARL2;HCK;CX3CL1;RB1;PSRC1;KATNB1;DCTN1;CLASP1;SYNPO;EVL;CDK5RAP2;NUMA1;CCR7
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),-0.278897431965053,-1.0928064678548886,0.28738317757009346,0.4451400248973504,1.0,52/52,97.55%,CXCR6;CCR5;CCRL2;YWHAE;CD55;CCR2;SLC35G1;F2R;CCR1;CAV2;TRPC1;ITPR3;CDH23;TBXA2R;PTGER2;CALCA;CLN3;CACNA1A;ATP1A2;GPR35;CCR3;RYR1;EDN1;S1PR4;SMAD3;CXCL13;CD36;CALCB;C3AR1;SLC8A1;LPAR3;C5AR1;F2RL1;CCR9;CCR4;CCR8;PTGER4;CYSLTR1;CIB2;PLN;ATP2B2;CX3CR1;ABL1;GLP1R;CCL1;ATP2B4;CXCR5;CXCR4;HMGB1;CXCR3;CCR6;CCR7
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3615021627844253,-1.0925775300419878,0.340956340956341,0.4444489067703212,1.0,16/16,98.54%,PPIA;EZR;MYC;DUSP3;DUSP19;FKTN;MEN1;DUSP10;F2RL1;AIDA;SIRPA;FOXO1;PINK1;PER1;DUSP1;FOXM1
gsea,nuclear export (GO:0051168),0.3029678634660492,1.0879724697379847,0.35398230088495575,0.41406663345933753,1.0,32/59,36.45%,ANKLE1;CSE1L;UPF3B;ALYREF;NUP155;ATXN1;XPO1;NUP62;NXF1;THOC2;POM121;SRSF4;NUP153;SRSF3;NUP214;CASC3;CCHCR1;MALT1;RANBP3;EGR2;RNPS1;SRRM1;XPO5;U2AF1;XPO4;DDX39B;SRSF1;NUP188;EIF4A3;XPO6;NCBP1;RBM8A
gsea,insulin receptor signaling pathway (GO:0008286),0.3058745246680237,1.0869268661688902,0.31861804222648754,0.4149894241233647,1.0,18/32,40.77%,PHIP;C2CD5;GSK3B;IRS2;SHC1;PIK3CA;PDK2;FOXO1;TCIRG1;GRB10;PIK3R2;PIK3R1;AP3S1;IDE;ATP6V1G3;PIK3C2A;FOXO4;SH2B2
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.2957024087798174,1.086666724138357,0.32432432432432434,0.4147949962622681,1.0,17/38,32.44%,SPRY1;PLAUR;NUP62;ITGA1;EPS15L1;HIP1;SPRY2;HGS;CCDC88A;ERRFI1;PTPRJ;HIP1R;PTPN3;DGKD;CBL;BTC;EPS15
gsea,negative regulation of signal transduction (GO:0009968),0.2486218204244745,1.0858918682725625,0.2946127946127946,0.41535637400661807,1.0,55/108,44.09%,EZH2;TNFAIP3;SOCS1;ASXL1;SPRY1;RNF157;BCL2;NFATC1;SOCS5;CNOT1;GATA3;RGS2;IL1B;BTRC;SPRY2;HGS;PRKCB;HMGXB4;TNF;XDH;GRB10;FBXW7;RB1;CX3CR1;CX3CL1;PTPRJ;TAX1BP3;PHACTR4;PTCH1;TRIB1;KANK2;THBS1;LRP1;PRKCZ;LGMN;NLK;KCTD21;TULP3;MGRN1;PID1;CHAC1;WWOX;TSKU;CSNK2A2;SIGIRR;FGF2;MAZ;SULF2;NR4A2;TSC2;CACTIN;METTL3;PIK3CB;DKK3;TSPAN15
gsea,autophagosome organization (GO:1905037),-0.37477572125385783,-1.0843829633238935,0.33820459290187893,0.45719518211230453,1.0,7/15,37.47%,ATG9B;ATP2A2;NSFL1C;UBQLN1;ATG14;ATG2B;UBXN2B
gsea,regulation of protein phosphorylation (GO:0001932),0.24356733175016157,1.0838109507048332,0.2982142857142857,0.4180105229449971,1.0,69/126,45.52%,ECT2;SOCS1;NTRK3;PHIP;ATF3;ATF4;CORO1C;CCN1;PLAUR;PPP2R5D;ROCK2;FAS;FMR1;ZC3H12A;ENG;STAT2;AXIN2;IL1B;TNIK;PINK1;FNIP1;PRNP;PTPN13;MYADM;TNF;ABL1;XDH;RASGRP1;CCDC88A;PML;SIRT1;DAB2;AXIN1;PIN1;CD40;SESN2;CSF1R;PECAM1;DAXX;SIRPA;KDM4D;GAS6;CD74;PGF;TTN;PAK1;INSM1;WWTR1;AKTIP;LIMCH1;PID1;AKAP8;DNAJC10;HSP90AA1;WDFY2;FGF2;DVL3;SMG8;FGR;FN1;FBH1;TRAF3IP1;CACTIN;APP;MEN1;BST1;PLXNB2;BRAT1;C9ORF72
gsea,cellular response to virus (GO:0098586),-0.33822765700951163,-1.0829365263155077,0.3384615384615385,0.45859620874603574,1.0,19/19,95.03%,EIF5A;BAX;RRP1B;CCL5;CHUK;IL21;LGALS8;DDX58;IFIH1;GSDME;HSP90AA1;GBF1;POU2AF1;DDX3X;ZC3H12A;POU2F2;FMR1;CXCL10;HIF1A
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.29986894835248856,1.0826281330592271,0.33697632058287796,0.4193507374886408,1.0,24/36,44.87%,NTRK3;JAK2;PIK3CD;IRS2;PIK3CA;FLT1;TNF;PIK3R5;SIRT1;PTPN6;CBL;PIK3CG;PIK3R1;SELP;KIT;F2RL1;FGF2;MAZ;FGR;FN1;NCF1;PIK3CB;FLT3;TGFB2
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.319390204125819,1.081323451766165,0.34290843806104127,0.4209197600681725,1.0,19/30,38.19%,ZFP36L1;PIK3CD;IRS2;GATA3;PIK3CA;PIK3R5;PI4KA;PLCH1;PLCB4;PIK3R2;NF1;PIK3CG;PIK3R1;CSF1R;HTR2A;PITPNM2;PLCB2;INPP5F;PIK3C2A
gsea,fatty acid biosynthetic process (GO:0006633),-0.3239276447091293,-1.0801338608779036,0.3466666666666667,0.462175812150146,1.0,14/26,37.12%,XBP1;NDUFAB1;HACD3;DECR2;ABCD3;ACLY;ELOVL4;ALOX5;ELOVL6;OXSM;ELOVL2;CBR4;ABCD1;MCAT
gsea,lymphocyte migration (GO:0072676),0.3672021806264017,1.0793067997602854,0.3443478260869565,0.4234710167252738,1.0,12/21,43.34%,XCL1;CCR6;CRTAM;S1PR1;CCL1;GATA3;CX3CL1;TBX21;CCL22;CCL17;CCL8;RET
gsea,B cell activation (GO:0042113),-0.28496395318502843,-1.0777572741729378,0.33774834437086093,0.4651322661447491,1.0,45/45,97.61%,SLC25A5;PHB;LAT2;HSPD1;PHB2;MSH2;PLCG2;HHEX;ADGRG3;ITGA4;IL10;RABL3;BANK1;ADAM17;CD79A;MEF2C;LAX1;HDAC4;FLT3;LYL1;CD79B;BTK;DCAF1;BLNK;VCAM1;TPD52;KIT;CLCF1;CD40;CD70;NFAM1;PTPRJ;HDAC9;CD86;HDAC5;RASGRP1;GPR183;PRKCB;MALT1;CD40LG;TCF3;PIK3CD;BCL2;KLF6;ITGB1
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.2813822957091986,-1.07678653181956,0.3373493975903614,0.4657189638331885,1.0,22/46,44.39%,RGS1;ADGRG1;AKAP12;GPR65;ADGRG3;TBXA2R;PTGER2;GNAT1;ADGRL2;CALCA;RAMP2;GRK5;CALCRL;S1PR2;ADGRG5;PTH1R;ADRB2;ADCY6;TSHR;MC1R;ADM;AKAP5
gsea,response to growth factor (GO:0070848),0.352345806027627,1.0755896522873527,0.35152838427947597,0.42865757276895006,1.0,7/18,20.28%,KLF4;CPNE3;HTRA2;STAT5B;SHC1;HDAC6;ACVRL1
gsea,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.35791925994499346,-1.0730659078972389,0.340956340956341,0.4711316339360338,1.0,10/17,35.53%,ACSL5;FASN;ACSL4;PPT2;ACLY;ACSL1;HSD17B12;ELOVL6;ELOVL2;CBR4
gsea,glycerophospholipid biosynthetic process (GO:0046474),0.24699916751097944,1.0728311036410614,0.32879377431906615,0.4322927097989692,1.0,44/90,44.25%,INPP4B;CPNE3;LCLAT1;PIK3CD;DGKA;CPNE1;MTMR14;MTMR12;MTMR3;CHKA;PLSCR1;PIK3CA;SBF1;ETNK2;PTPN13;PIK3R5;PIK3R6;PI4KA;DDHD1;PIK3R2;DGKD;PIK3CG;PIK3R1;PLA2G4A;SYNJ1;VAC14;PIP5K1C;SYNJ2;TAMM41;SLC44A1;MTMR4;PITPNM2;CPNE7;GPD1;DGKH;CSNK2A2;INPP5F;PIK3C2A;FGF2;PIK3CB;PI4K2B;FIG4;CHPT1;RUFY1
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.32262344913880936,1.0727679051610082,0.33073929961089493,0.43180538625774934,1.0,16/30,39.82%,SHCBP1;CEP57;POLR2A;HNRNPH1;PTPN11;SETX;SHOC2;KIF16B;POLR2B;CBL;SPRED1;RBFOX2;NCBP1;ESRP2;FGF2;FLRT3
gsea,negative regulation of neuron apoptotic process (GO:0043524),0.2956399870157577,1.0725400509794782,0.35856573705179284,0.43156427132092573,1.0,12/32,32.36%,KIF14;HIF1A;KDM2B;BCL2;RETREG1;PINK1;NONO;CX3CR1;CX3CL1;CLCF1;LGMN;APOE
gsea,spliceosomal complex assembly (GO:0000245),-0.34087551258408305,-1.0721322200001715,0.38058252427184464,0.47169090618373916,1.0,11/29,30.64%,SRSF6;LUC7L3;PRPF19;TXNL4A;SMN1;SNRPD1;LUC7L;SNRPE;SRSF9;CELF4;GCFC2
gsea,protein transport (GO:0015031),0.23318502008613481,1.072096025929862,0.30783582089552236,0.43165717279045185,1.0,66/144,44.81%,CENPF;NDC1;ADPRH;TBC1D4;ARL5C;AP3B1;ARL4D;TXNIP;MACF1;TBC1D10B;TBCK;HERC2;ARL4C;ABCG1;SPTBN1;HDAC6;NAPB;PRKCB;DNAJC27;KIF3B;ARL5B;TCIRG1;TBC1D5;RAMP3;GGA3;RABGAP1;SNX27;NSF;GRTP1;ARHGEF2;STXBP3;RAB5B;TBC1D1;AP4M1;LRP1;CLTC;ABCA1;SNX13;CD74;TBC1D14;TBC1D9;HFE;ATP6V1G3;TBC1D25;APOE;SCG5;ARRDC3;OPTN;MIA3;TBC1D30;AP3D1;VPS35;CEP290;EVI5L;LMTK2;LMAN2L;MYH9;STX16;EIF2D;CTTN;CD36;USP6NL;SCFD2;RUFY1;RAB23;HIKESHI
gsea,response to insulin (GO:0032868),-0.2813356104870987,-1.0707834837536856,0.35700197238658776,0.47295103523050736,1.0,22/44,40.30%,PKM;AKT1;XBP1;EIF6;SLC25A33;SELENOS;RHOQ;GOT1;PARP1;ENPP1;SLC39A14;CEACAM1;SLC27A1;INSIG1;EPM2AIP1;LPIN2;OTOP1;PPARG;CAPN10;PRKCI;CPEB2;PRKDC
gsea,regulation of T cell differentiation (GO:0045580),0.32511766074336584,1.0704025994778121,0.350597609561753,0.4338111709491567,1.0,9/23,26.46%,TCF7;CRTAM;FANCA;RUNX1;GATA3;NFATC2;ABL1;IL2;TBX21
gsea,vesicle organization (GO:0016050),-0.3185099193888446,-1.0697782580228137,0.3492407809110629,0.47353700640100427,1.0,9/26,38.96%,CORO1A;SNX10;VPS33B;CAV2;LAPTM4B;PLEKHF1;ALS2;DNAJC13;DNM1
gsea,negative regulation of phosphorylation (GO:0042326),0.27715939800113915,1.0684157876729816,0.34065934065934067,0.43637891266018913,1.0,24/52,36.41%,CDKN2D;CDKN2C;NTRK3;ROCK1;CORO1C;IRS2;ZC3H12A;PRNP;PTPN13;MYADM;XDH;PRKRIP1;SIRT1;PFKFB1;CDKN1A;SIRPA;ANKLE2;INSM1;CBFA2T3;WWTR1;NUPR1;PID1;INHA;DNAJC10
gsea,negative regulation of cell-cell adhesion (GO:0022408),0.33388252232949434,1.0679536033762778,0.35258964143426297,0.43650537335357836,1.0,12/22,38.40%,RGCC;KLF4;WNK1;MBP;NOTCH1;MYADM;EPCAM;B4GALNT2;AKNA;MIA3;CDH1;IL1RN
gsea,icosanoid metabolic process (GO:0006690),-0.36201831089410186,-1.0667336468890474,0.37697516930022573,0.4776214332157909,1.0,7/16,31.21%,GPX1;PTGR1;ABCC1;MAPKAPK2;PTGS1;ALOX5;PON3
gsea,negative regulation of hydrolase activity (GO:0051346),-0.303681708470577,-1.0660225657499869,0.34917355371900827,0.4776873427774058,1.0,17/29,42.59%,TMED2;HRAS;RRP1B;CST3;EGLN1;SLC39A14;DAB2IP;GPATCH2;GNAT1;RDX;GPSM1;RASA4;LRRK2;CPEB2;SH3BP4;NEIL1;NOS1
gsea,regulation of blood vessel endothelial cell migration (GO:0043535),0.3026302740901257,1.0653337766786632,0.3428030303030303,0.44006214720551934,1.0,19/35,32.36%,HMGB1;SP1;PRKCA;HIF1A;RGCC;PDPK1;ETS1;ATP2B4;P2RX4;PRKD2;PLCG1;TNF;ACVRL1;SIRT1;NF1;CD40;THBS1;STAT5A;APOE
gsea,protein localization to cell periphery (GO:1990778),-0.2554184433550951,-1.0647271606417597,0.35152838427947597,0.4788344408772131,1.0,64/64,93.61%,S100A10;TMED2;EZR;PKP3;FLNA;BSG;FLOT1;RAP2A;LRP6;ZDHHC2;EHD4;TNFRSF1A;JUP;TESC;RDX;RAB3D;FAM126A;RAMP2;PKP2;EHD2;TSPAN5;PLEKHF1;NKD2;TSPAN33;RAB34;SLMAP;RAB13;ACTN2;PACS2;ANK1;RAMP1;PACS1;RAPGEF2;MAP7;TSPAN15;TSPAN32;FAM126B;SEC16A;CDH1;LIN7A;GAK;CACNB3;TTC7B;GAS6;DENND4C;AP4M1;MYO5A;PTCH1;ATP1B1;RAMP3;TNF;MYADM;TNIK;FLOT2;SPTBN1;CLASP2;PDZD11;ROCK2;C2CD5;CD81;PACSIN1;FGF13;ROCK1;EHD3
gsea,positive regulation of protein binding (GO:0032092),0.3048083706489992,1.0643993232015427,0.35580524344569286,0.44083950691015794,1.0,17/32,32.99%,TAF1;TIAM1;BAMBI;GSK3B;EPB41;ABL1;HIP1R;PIN1;USP33;TRIB3;LRP1;HFE;IDE;HIPK2;STK3;APOE;AKTIP
gsea,cellular response to starvation (GO:0009267),-0.252449861804294,-1.064209594257499,0.34303534303534305,0.47864776229442346,1.0,71/71,98.78%,HSPA5;EIF2S1;DAP;HNRNPA1;MYBBP1A;XBP1;MFSD2A;EIF2AK2;ASNS;RRP8;MIOS;IMPACT;PIK3R4;RRAGB;RALB;KLF10;EIF2AK4;RNF152;GAS2L1;RIPOR1;ATG14;ATP6V0E2;SREBF2;BHLHA15;EIF2AK3;WDR24;LRRK2;NUAK2;ITFG2;MLST8;TFEB;PICK1;FADS1;NPRL3;PRKAG2;TBL2;CEBPB;PMAIP1;MAPK8;HSPA8;MTOR;GCN1;PRKAA1;FOXO3;ATP6V1G3;RPTOR;SESN1;ATG7;SESN2;DEPDC5;CDKN1A;EHMT2;USP33;SIRT1;SLC38A9;TCIRG1;FOXO1;XPR1;FNIP1;SEH1L;MTMR3;CASTOR1;SIK2;WRN;ATF2;ZC3H12A;MAP3K5;FAS;ATF4;SESN3;DAPL1
gsea,regulation of protein targeting to mitochondrion (GO:1903214),0.3673965508824391,1.0641415714146276,0.3800813008130081,0.4406628287861916,1.0,10/16,37.54%,HUWE1;HTRA2;BAG4;SAE1;PINK1;FBXW7;BAP1;NPEPPS;CSNK2A2;VPS11
gsea,heterochromatin assembly (GO:0031507),0.36775044384241173,1.0633957560306038,0.38493723849372385,0.44124286922912676,1.0,8/15,45.67%,SMCHD1;SUV39H1;SIRT1;POLE3;BAHD1;ZNFX1;BAZ2A;NRDE2
gsea,cation transport (GO:0006812),0.3159613584123848,1.0623728459953408,0.37221269296740994,0.4422436987625729,1.0,19/35,39.86%,FGF13;SLC9B2;SLC7A1;KCNMB4;TRPM1;ANO6;ATP1B1;PIEZO1;ANO10;SGK1;SLC6A9;KCNC1;KCNMB1;SLC41A1;SLC7A8;SLC12A2;SLC6A6;SLC8A1;SLC4A4
gsea,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.35935355211214587,-1.0623615349275193,0.3804573804573805,0.4806628364236725,1.0,17/17,94.51%,HSP90AB1;AKT1;ASS1;TLR4;IFNG;DDAH2;EDN1;SMAD3;CD36;HSP90AA1;PTGS2;TNF;NOS1AP;IL1B;P2RX4;KLF2;KLF4
gsea,ncRNA metabolic process (GO:0034660),-0.34808371853492703,-1.0610712551121253,0.38911290322580644,0.4818157399022756,1.0,19/19,90.70%,RAN;NIFK;DTD2;PIWIL2;DTD1;DROSHA;FKBP6;DICER1;TARBP2;TENT4B;PARN;XPO5;KHSRP;TDRKH;AGO2;PRKRA;MEPCE;DGCR8;ZCCHC8
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2785941664061896,1.0607288691342447,0.34724857685009486,0.4443378591946584,1.0,31/49,45.63%,NTRK3;JAK2;PIK3CD;IRS2;NLRC3;PIK3CA;PTPN13;FLT1;TNF;PIK3R5;SIRT1;PTPN6;PIK3IP1;CBL;PIK3CG;PIK3R1;SELP;KIT;PIP5K1C;F2RL1;DIPK2A;FGF2;MAZ;FGR;FN1;TSC2;NCF1;PIK3CB;FLT3;TGFB2;ENTPD5
gsea,positive regulation of B cell proliferation (GO:0030890),-0.3368734375887858,-1.0603608539927991,0.3860369609856263,0.4819882626748325,1.0,7/20,34.73%,MIF;TNFRSF4;TNFSF13B;TFRC;CD38;CD320;IL21
gsea,regulation of chemokine production (GO:0032642),0.3469405714214161,1.059577862177894,0.38113207547169814,0.44552565969454755,1.0,11/21,37.11%,HIF1A;FOXP1;TNF;AIRE;TLR7;EGR1;LPL;CSF1R;CD74;F2RL1;SIGIRR
gsea,ceramide metabolic process (GO:0006672),0.3566811697294406,1.058061557119904,0.37209302325581395,0.44744570773818226,1.0,9/17,46.54%,ST6GALNAC3;CLN6;SGMS1;CERK;PLPP1;ABCA2;SGPL1;CERS6;SAMD8
gsea,positive regulation of TOR signaling (GO:0032008),0.3577291660453629,1.0578894336954339,0.3766990291262136,0.4471237427471913,1.0,8/16,28.92%,SEH1L;FNIP1;PIK3CA;PIH1D1;SLC38A9;RICTOR;RPTOR;GAS6
gsea,negative regulation of MAPK cascade (GO:0043409),0.2712371779930136,1.0574459581642939,0.3339805825242718,0.4472711711140019,1.0,23/46,42.33%,FOXM1;DUSP4;DUSP1;SPRY1;SH2B3;RGS2;IL1B;SPRY2;FOXO1;DUSP6;TNIP1;RPS6KA6;PIK3R2;NF1;PTPRJ;PIN1;SIRPA;SPRED1;CD300A;APOE;ABCA7;PIK3CB;DUSP10
gsea,response to interleukin-1 (GO:0070555),0.31266108572712503,1.0568386640957215,0.35071942446043164,0.44773322577982055,1.0,23/39,46.36%,XCL1;NFKB1;PRKCA;HIF1A;RBMX;TAF9;ZC3H12A;CCL1;IL1B;YTHDC2;CX3CL1;CD40;SIRPA;CCL22;RELA;CCL17;CACTIN;ACOD1;CCL8;APP;HDAC4;HYAL2;MAPK13
gsea,"mRNA splicing, via spliceosome (GO:0000398)",-0.27897544782565564,-1.056767531999866,0.37595419847328243,0.48690544640109834,1.0,171/171,96.49%,SNRPA;YBX1;HNRNPA2B1;SNRPF;PCBP1;HNRNPA1;NCBP2;SNRPD3;PNN;SRSF6;STRAP;PTBP1;LSM7;HNRNPU;HNRNPK;SNRPA1;HNRNPM;PRPF19;SYNCRIP;WDR77;POLR2F;HNRNPF;PRMT5;SRSF2;TXNL4A;POLR2L;HNRNPC;PPIE;SMN1;CLNS1A;MAGOHB;PRPF40A;SNRPD1;POLR2H;SNRPB;GEMIN5;SFPQ;RBM19;RBM14;SNU13;PRMT7;HNRNPD;RBM15B;CPSF3;DHX15;GTF2F2;BUD31;CSTF2T;SRSF7;SNRPE;CWC22;PSPC1;PABPC1;U2AF2;HNRNPA3;SRSF9;CELF4;DDX46;COIL;MAGOH;PHF5A;PPIL1;GCFC2;POLR2C;SF3B3;POLR2E;SF3B4;PLRG1;CPSF2;PRPF38A;SPEN;CSTF2;RBM4B;AQR;HNRNPA0;DDX41;GTF2F1;DHX35;SNRNP35;DHX9;DDX1;HSPA8;DHX38;RBM17;GPATCH1;METTL3;CACTIN;TFIP11;DDX23;SART1;RBM8A;NCBP1;CPSF4;PRPF6;EIF4A3;SNRNP40;SMU1;U2SURP;SNRNP25;CWC25;SRSF10;SRSF1;RBM10;CWF19L2;SF3A2;DDX39B;SNUPN;SRPK1;DHX8;PRPF3;GEMIN8;EFTUD2;U2AF1;SYMPK;CSTF3;CHERP;SF3A1;PCF11;SRRM1;PPIH;GEMIN2;RNPS1;SF3A3;HNRNPH3;CWF19L1;HNRNPR;POLR2B;NONO;PRPF8;PRPF31;DDX42;CSTF1;DBR1;USP39;SNRNP200;SNRNP70;MTREX;CWC27;CPSF1;METTL14;CASC3;DHX16;SRSF3;BUD13;HNRNPH1;RBMX;PRPF4;SRSF4;FUS;RBM6;SART3;SCAF11;ZCCHC8;RBM15;HNRNPUL1;PPWD1;DDX20;CCAR1;LSM8;GEMIN6;WBP11;RSRC1;SRRT;SRRM2;ALYREF;POLR2A;SF3B2;UPF3B;RBMX2;LSM2;LSM3
gsea,negative regulation of protein phosphorylation (GO:0001933),0.24487253087108246,1.0556788974528075,0.34674329501915707,0.4490004236875099,1.0,43/78,48.96%,CALM2;NTRK3;PMEPA1;CORO1C;PDPK1;CEP85;ZC3H12A;ENG;SPRY2;PRNP;PTPN13;TRIB2;MYADM;XDH;PRKRIP1;ERRFI1;DVL1;RB1;SMAD7;PTPN6;NF1;TRIB1;TRIB3;SIRPA;PRKCZ;SPRED1;INSM1;WWTR1;TARBP2;PID1;DNAJC10;TSC2;TRAF3IP1;CACTIN;NCK2;DMTN;MEN1;C9ORF72;SPRED3;ZBED3;FBLN1;TWIST1;PRKAG2
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.2712141127818627,-1.0549736203122129,0.3557692307692308,0.48890438208433284,1.0,53/53,97.55%,CXCR6;CCR5;CCRL2;CD55;GPR65;CCR2;F2RL3;F2R;CCR1;F2RL2;ITPR3;TBXA2R;PTGER2;CALCA;CACNA1A;GPR55;JPH4;GNA15;GPR35;CCR3;CACNA2D1;EDN1;S1PR4;GRIN1;GPR18;CXCL13;CD36;C3AR1;SLC8A1;LPAR3;JPH3;C5AR1;F2RL1;CCR9;CCR4;CCR8;PTGER4;CACNB3;CYSLTR1;CIB2;CX3CR1;ABL1;TRPM1;GPR174;GLP1R;P2RX4;CCL1;CXCR5;CXCR4;HMGB1;CXCR3;CCR6;CCR7
gsea,ion transport (GO:0006811),0.2920658045866983,1.0546550383454742,0.37522768670309653,0.4501133107688182,1.0,23/39,42.59%,SLC25A10;WNK1;SLC9A9;SLC1A2;SLC26A11;SLC15A1;SLC12A7;SLC20A1;ANO6;PIEZO1;ANO10;TRPA1;SLC12A6;PLP2;SLC24A5;SLC15A2;SLC4A2;SLC9A2;SLC12A2;SLC12A5;SLC8A1;GLRA1;SLC9A1
gsea,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3885517829585622,-1.0546337087388307,0.38144329896907214,0.48843718602162717,1.0,3/15,12.45%,HSP90AB1;ENTPD1;CASP1
gsea,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3053272261859091,-1.0545257861283575,0.3893129770992366,0.48752214273428063,1.0,19/36,35.94%,ACTB;HMGA1;MYBBP1A;POLR2F;POLR2L;DDX21;POLR1B;KAT2A;POLR2H;POLR1E;PADI2;MYO1C;POLR1A;POLR1C;TAF1A;TAF1D;ZMIZ2;POLR2E;ERCC6
gsea,positive regulation of autophagy (GO:0010508),0.275325780857174,1.0540600160301572,0.37093690248565964,0.4504555987121563,1.0,25/50,42.24%,SESN3;HMGB1;PIM2;ROCK1;GSK3B;ZC3H12A;PINK1;FOXO1;SIRT1;ATF6;PLK2;TRIM14;MAP3K7;SESN2;SESN1;MEFV;FOXO3;PRKAA1;OPTN;DAPK1;HTT;PIK3C2A;TSC2;ULK1;PIK3CB
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2719884366685735,1.0540075192827416,0.3680672268907563,0.4499359908070846,1.0,40/69,44.05%,XCL1;CCR7;TNFSF11;HMGB1;NTRK3;PRKCA;CD44;NRP1;PTPN11;NOTCH1;CCL1;PRKD2;SHC1;SPRY2;TNF;GPR183;RASGRP1;RAMP3;FBXW7;CX3CL1;CSF1R;PRKCZ;MFHAS1;HTR2A;P2RY6;GAS6;CD74;NOTCH2;CCL22;APOE;F2RL1;C5AR1;ABCA7;FGF2;CCL17;GAREM1;GCNT2;CCL8;APP;CD36
gsea,transcription by RNA polymerase III (GO:0006383),-0.34459056227909957,-1.051793065691665,0.37087378640776697,0.4910299749247982,1.0,13/19,34.83%,POLR2L;POLR3G;GTF3A;ZC3H8;POLR3H;POLR3K;SNAPC4;GTF3C4;ICE1;IVNS1ABP;ELL;GTF3C3;ICE2
gsea,modulation by host of symbiont process (GO:0051851),-0.3384106917445473,-1.0513150785189018,0.390625,0.4908004480309833,1.0,19/19,96.29%,CCL4;CCL3;HDAC1;TFAP4;REST;RRP1B;CCL5;TARDBP;SMARCB1;SMARCA4;CTDP1;CX3CR1;CHD1;LEF1;EP300;JUN;SAP30;SP1;NUCKS1
gsea,stem cell differentiation (GO:0048863),0.3423053907896023,1.0503461574762196,0.40229885057471265,0.45511178144399633,1.0,6/17,26.84%,MLLT3;JARID2;MTF2;SETD2;KIT;EPCAM
gsea,inorganic anion transmembrane transport (GO:0098661),0.33619860653951716,1.0493113030135501,0.37522768670309653,0.45618815608534263,1.0,13/22,41.66%,SLC25A10;SLC37A3;SLC12A7;XPR1;SLC20A1;ANO6;SLC12A6;SLC4A8;SLC37A1;SLC12A2;SLC12A5;GLRA1;SLC25A14
gsea,"RNA splicing, via transesterification reactions (GO:0000375)",0.3660749271354936,1.0481968802357648,0.40702479338842973,0.45741780419743816,1.0,14/18,37.60%,SCAF11;SRSF4;PRPF4;DBR1;PRPF8;SF3A3;GEMIN2;SRRM1;KHSRP;PRPF3;SRSF10;SNRNP40;PRPF6;DDX23
gsea,negative regulation of catalytic activity (GO:0043086),-0.35136417244108237,-1.0473734096445682,0.40681362725450904,0.4964397403296371,1.0,6/15,42.59%,MT3;TMBIM1;CLN3;CAND1;PARP9;NOS1
gsea,negative regulation of growth (GO:0045926),0.26415962678822413,1.0466451038866986,0.38649155722326456,0.45931313827388387,1.0,31/55,40.60%,CDKN2D;CDKN2C;BCL6;ING1;NOTCH1;DDX3X;ING5;PSRC1;RBBP7;ACVRL1;SMARCA2;HSPA1B;PML;RB1;SIRT1;JADE1;PTPRJ;SMARCA4;CDKN1A;SESN2;GNG4;OSGIN1;NOTCH2;HSPA1A;TCHP;SPHK2;DCBLD2;EI24;PPP1R9B;CCAR2;ST7L
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.356520018227501,-1.046155310597107,0.4066390041493776,0.4973868824270521,1.0,5/15,23.07%,CALR;PARK7;PRMT2;CARM1;UFL1
gsea,negative regulation of protein secretion (GO:0050709),-0.34558246062785103,-1.0452579674856581,0.3701923076923077,0.49781519362778326,1.0,5/16,33.27%,HMGCR;REST;F2R;RHBDF2;SIRT4
gsea,nucleic acid-templated transcription (GO:0097659),-0.3226463383692697,-1.0448960305102948,0.37595419847328243,0.4973678348030818,1.0,13/25,43.66%,PTMA;POLR2F;POLR2L;E2F1;POLR2H;PWP1;DRG1;PPP5C;POLR2C;POLR2E;NFKBIB;THAP1;POLR3A
gsea,negative regulation of protein metabolic process (GO:0051248),0.3303694144633045,1.042682176262069,0.42028985507246375,0.4650348028452435,1.0,9/24,32.36%,MAD2L1;NFKB1;MDM4;ROCK1;FLOT2;PRNP;PIN1;AZIN1;APOE
gsea,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.35744793563576777,1.0417820612671183,0.4084249084249084,0.4659176584066804,1.0,10/17,38.70%,KLF4;HDAC7;MAP3K3;NOTCH1;HDAC5;HDAC9;THBS1;PTGS2;PIK3C2A;FGF2
gsea,regulation of anatomical structure morphogenesis (GO:0022603),0.26062959421196824,1.0406196510462002,0.384070796460177,0.4672188026332217,1.0,27/59,44.48%,TNFAIP3;BCL6;PHIP;ARC;CLASP2;ETS1;CLASP1;GSK3B;STAT2;TNIK;ZMYM3;ZDHHC15;SIPA1L1;NF1;STRIP1;TANC2;PAK1;ZMYM4;PID1;BCL9L;SP100;FGF2;SPARC;FMNL2;VASH2;HECW1;CXCL13
gsea,positive regulation of cellular component organization (GO:0051130),-0.25266545307123,-1.0401061020556297,0.3649193548387097,0.5047874219978734,1.0,59/59,98.12%,GPX1;BAK1;VCP;PARK7;BID;LMAN1;MTLN;BAX;FLOT1;RACK1;LGALS3;SMPD1;TFRC;BNIP3;RHOC;DAB2IP;TGFB3;SLF1;CLIP3;ICE1;VEGFA;DLL1;BMP7;CDC42EP2;IFNG;CAMK1;GNL3L;PTPN23;ADD1;TGFB2;SLF2;ABCB4;PLEKHM2;BIK;CD151;ABCB7;APOE;SYK;LRP1;ADGRL1;DAB2;RB1;AJUBA;TNF;PIH1D1;FNIP1;BCL2L11;AR;DCTN1;CDT1;GSK3B;RUNX1;MPP7;ATP10A;SPIDR;PPP1R15A;FAF1;ASAP1;CDC20
gsea,long-chain fatty acid transport (GO:0015909),-0.3383069614831832,-1.0385924173839889,0.42094017094017094,0.5063954374168264,1.0,8/17,36.22%,FABP5;MFSD2A;SLC27A1;ABCD3;ACSL1;SLC27A2;PPARG;ABCD1
gsea,COPII vesicle coating (GO:0048208),-0.3186631348284887,-1.037082666722228,0.38702928870292885,0.5056792675907191,1.0,11/22,37.69%,TMED2;AREG;LMAN1;SEC24D;MCFD2;SEC31A;USO1;SEC24A;COL7A1;TGFA;SEC23A
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3186631348284887,-1.037082666722228,0.38702928870292885,0.5056792675907191,1.0,11/22,37.69%,TMED2;AREG;LMAN1;SEC24D;MCFD2;SEC31A;USO1;SEC24A;COL7A1;TGFA;SEC23A
gsea,vesicle coating (GO:0006901),-0.3186631348284887,-1.037082666722228,0.38702928870292885,0.5056792675907191,1.0,11/22,37.69%,TMED2;AREG;LMAN1;SEC24D;MCFD2;SEC31A;USO1;SEC24A;COL7A1;TGFA;SEC23A
gsea,positive regulation of interferon-gamma production (GO:0032729),0.30861712375177985,1.0369919931122307,0.38684719535783363,0.47234502584784666,1.0,15/26,36.68%,SLAMF6;IL18R1;CRTAM;ZFPM1;SCRIB;IL1B;RASGRP1;CD226;TLR7;ISG15;FADD;PDE4B;F2RL1;IL23A;EBI3
gsea,negative regulation of cytokine production (GO:0001818),0.2528068904993771,1.0360960842991747,0.4072072072072072,0.47317443578896967,1.0,47/89,42.46%,XCL1;CCR7;TNFAIP3;HMGB1;RGCC;KLF4;PDCD4;ZFPM1;CD33;HDAC7;RPS6KA5;ZC3H12A;BCL3;NLRC3;DDIT3;CD200;PRNP;TRIB2;LEF1;TNF;PTPN6;HDAC9;CD274;CX3CL1;PIN1;TBX21;THBS1;ISG15;SIRPA;OTUD7B;GAS6;TYROBP;PTGER4;MEFV;F2RL1;INHA;FCGR2B;IL23A;SIGIRR;ZFP36;FN1;TRAF3IP1;CACTIN;SYT11;ACOD1;RARA;LGALS7
gsea,negative regulation of immune response (GO:0050777),-0.26386170093412054,-1.035749157489042,0.4105793450881612,0.5069318246086209,1.0,29/58,43.54%,HAVCR2;C1QBP;ADRB1;CCR2;LGALS3;LYN;ADORA2B;PLCG2;CYSLTR2;RHBDF2;TRIM21;PRKAR2A;PTGER2;IL10;CALCA;LYAR;RAMP2;SCT;IRAK3;DHX58;CALCRL;RLN3;PTH1R;ADRB2;ADAM17;ADCY6;TSHR;MC1R;ADM
gsea,fatty acid derivative biosynthetic process (GO:1901570),-0.34753626172711394,-1.0335043453696287,0.43775933609958506,0.5096615464890386,1.0,9/16,29.08%,FASN;BDH1;AACS;PPT2;FAR1;ACLY;GGTA1;AWAT2;ALOX5
gsea,regulation of lipid storage (GO:0010883),0.37443585971006416,1.0323986896826642,0.4232142857142857,0.47859811193673435,1.0,8/15,22.87%,NFKBIA;NFKB1;ZC3H12A;FTO;TNF;FBXW7;SIRT1;LPL
gsea,defense response to symbiont (GO:0140546),-0.25979875725460067,-1.0315266559249703,0.37938144329896906,0.512002751366396,1.0,64/64,96.61%,PRF1;NDUFAF4;DDIT4;ABCE1;G3BP1;FLNA;SHFL;BST2;RNASEL;RIPK3;EIF2AK2;BNIP3;ISG20;IFI27;ZBP1;EXOSC5;IFIT2;TRIM5;IL21;MOV10;TRIM56;MLKL;TTC4;TLR2;DDX58;MAVS;IFIH1;IFIT1;PMAIP1;AGBL5;ACOD1;RELA;CGAS;F2RL1;LYST;FADD;NCBP3;RNASE6;ISG15;IFITM2;EXOSC4;ATG7;IFITM3;OAS3;RSAD2;CD40;IFIT3;TLR7;BCL2L1;RTP4;PLSCR1;IRF7;SETD2;STAT2;MAP3K14;SKP2;SAMHD1;STAT1;IFITM1;IRF2;BCL2;IFNAR2;IRF1;SERINC3
gsea,regulation of RNA splicing (GO:0043484),-0.28790276549630006,-1.0312458830182996,0.40192307692307694,0.5113570714878065,1.0,16/37,33.59%,RPS26;PTBP1;HNRNPK;HNRNPF;RRP1B;GRSF1;ZPR1;JMJD6;ERN1;METTL16;CWC22;U2AF2;LARP7;PTBP2;AHNAK;RBM38
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.32103567893034135,1.0301551730531149,0.40194174757281553,0.48172832991596976,1.0,12/22,32.44%,SPRY1;SOCS5;ITGA1;EPS15L1;SPRY2;HGS;ERRFI1;PTPRJ;PTPN3;CBL;BTC;EPS15
gsea,regulation of developmental growth (GO:0048638),0.3787295594719406,1.029717939996359,0.43042671614100186,0.48179510761501093,1.0,7/15,32.36%,SIN3A;GSK3B;STAT5B;ABL1;STAT5A;LATS2;APOE
gsea,positive regulation of fat cell differentiation (GO:0045600),-0.31318875912504335,-1.0286448503547636,0.4057971014492754,0.5148348847425754,1.0,12/23,34.38%,ID2;AKT1;HNRNPU;XBP1;FRZB;METRNL;CARM1;TMEM64;NOCT;ZBTB16;BMP7;PPARG
gsea,regulation of apoptotic signaling pathway (GO:2001233),-0.33422678115991633,-1.0282831861688422,0.40535372848948376,0.5143775132644773,1.0,18/18,92.74%,PPIA;PTPMT1;DAPK2;DAB2IP;TRIM39;NR4A2;MAZ;CSNK2A2;CX3CL1;TRAF1;CX3CR1;RB1;TNF;ING5;SGMS1;MADD;FAS;BCL2
gsea,DNA strand elongation (GO:0022616),0.4082203948899895,1.0278137730145311,0.45090180360721444,0.484313361602292,1.0,8/15,21.97%,GINS3;POLA1;RFC4;RAD50;GINS4;POLD3;DCLRE1B;GINS1
gsea,positive regulation of ossification (GO:0045778),0.36385869649650926,1.0269785132547313,0.4211409395973154,0.4850997022699931,1.0,6/16,32.14%,GPM6B;CCN1;PTPN11;ANO6;ISG15;WNT4
gsea,metal ion homeostasis (GO:0055065),-0.3561943707427633,-1.0268555778711783,0.4192825112107623,0.5158199141815774,1.0,5/16,36.06%,MT3;SELENON;SLC12A3;FAM20A;CNNM2
gsea,cellular response to interferon-gamma (GO:0071346),0.27970807400252506,1.0268055242310412,0.39015817223198596,0.4847680217015688,1.0,31/57,48.48%,XCL1;CD44;IRF1;CAMK2D;JAK2;IRF4;IRF2;STAT1;IRF9;GBP5;CCL1;IRF7;MID1;IFNGR2;PML;CX3CL1;OAS3;HCK;SIRPA;VCAM1;CCL22;DAPK1;SP100;CCL17;GBP6;ACOD1;CCL8;AIF1;TRIM8;PTAFR;CCL25
gsea,negative regulation of mRNA catabolic process (GO:1902373),-0.3464015558898669,-1.0262511876609492,0.3948412698412698,0.5157439333462237,1.0,8/17,21.47%,YBX1;HNRNPU;PKP3;E2F1;SLC11A1;PABPC1;LARP1;NOCT
gsea,innate immune response (GO:0045087),-0.24116496825202222,-1.0250624663525074,0.413953488372093,0.5167152924434613,1.0,107/107,96.97%,PGLYRP1;PPP1R14B;FCER1G;CORO1A;PHB;PHB2;PGLYRP2;SHFL;CAPZA2;BST2;SMPD1;LYN;SLC11A1;IRF5;PLCG2;ATAD3A;TKFC;AKAP1;NRROS;TRIM21;TRIM25;TRIM35;IFI27;RIPK2;CLPB;NCF2;MID2;LTF;TLR4;CHUK;CIITA;DHX58;IKBKG;TRIM5;PPARG;NUB1;CXCL16;NOS2;TRIM56;CD300LB;PTK2B;RNF39;C3;POLR3A;STYK1;CHGA;TTC4;TLR2;DDX58;MAVS;ANKRD17;IFIH1;TRIM39;IFIT1;FES;TRIM8;KYNU;CLEC4E;APP;NCF1;TNK2;FGR;PJA2;SP100;CFB;BTK;RELA;TIFA;SHMT2;MEFV;SYK;TYROBP;CD74;SRPK1;RNASE6;MFHAS1;SLPI;ISG15;IFITM2;IFITM3;CFP;HCK;PIK3CG;CD40;TRIM14;CYBB;CX3CR1;PML;ADAR;MALT1;IRF7;DDX3X;SETD2;TRIM28;KLRC2;RELB;PIK3CD;SKP2;CXCL10;ANKHD1;IFITM1;GCH1;SLA;HMGB1;REL;SERINC3;TRIM59
gsea,lymphocyte proliferation (GO:0046651),-0.34932864023173327,-1.0244698001767936,0.403960396039604,0.516713733072337,1.0,16/16,94.39%,HSPD1;HELLS;TNFRSF4;IL10;CD79A;MEF2C;FLT3;ELF4;PIK3CG;CD40;CD70;RASGRP1;CD40LG;PPP3CB;BCL2;TNFSF14
gsea,negative regulation of cell motility (GO:2000146),-0.2644515288984331,-1.0244075953286933,0.42276422764227645,0.5157419403939294,1.0,48/48,93.06%,MIF;GTPBP4;DUSP3;CITED2;RAP2A;BST2;TPM1;WNT11;DLC1;CCDC125;DAG1;FUZ;RHOB;TCAF1;SINHCAF;DUSP22;RAP2B;FBLN1;MITF;NF2;CLIC4;DUSP10;DLG5;CDH1;MIA3;LIMCH1;FOXO3;RAP2C;CD74;SCAI;AFDN;PIN1;PTPRJ;NF1;CX3CL1;SRGAP3;SMAD7;VCL;ACVRL1;PTPRK;ARID2;ZMYND8;ENG;GATA3;MCTP1;SERPINE1;IFITM1;SRGAP2
gsea,oligosaccharide metabolic process (GO:0009311),0.3221894210051234,1.0229179854694226,0.4168336673346693,0.49058079256825254,1.0,10/20,29.12%,ST6GALNAC3;ST8SIA4;ST8SIA1;ST3GAL4;NAGA;MAN1B1;GLA;MPDU1;FUT8;B4GALNT2
gsea,positive regulation of nitric oxide metabolic process (GO:1904407),-0.339167801359903,-1.021557835053838,0.40899795501022496,0.5195963343976553,1.0,7/18,34.05%,HSP90AB1;AKT1;TMEM106A;ASS1;TLR4;IFNG;DDAH2
gsea,calcium ion homeostasis (GO:0055074),-0.28150397809991745,-1.0213767771548123,0.39473684210526316,0.5187890417036097,1.0,14/38,42.42%,CALR;CCL3;CCR2;ATP2A2;CCL5;SELENON;CCR1;STOML2;RMDN3;ATP13A1;TNNI3;FAM20A;PTH1R;ATP13A3
gsea,positive regulation of viral process (GO:0048524),0.2889936829417242,1.0200902673280179,0.4352226720647773,0.4945527218863863,1.0,12/35,32.76%,KPNA2;POLR2A;NELFE;DDX3X;MDFIC;POLR2B;ADAR;CTDP1;PPIH;NELFCD;SRPK1;TARBP2
gsea,phosphatidylcholine metabolic process (GO:0046470),-0.2896760409409573,-1.019251555436283,0.4425531914893617,0.521422198869222,1.0,13/30,33.97%,DBI;MFSD2A;PCYT1A;SLC27A1;LPCAT1;PCTP;ABHD4;LPIN2;PLA2G6;MBOAT2;PLA2G12A;ACHE;ENPP2
gsea,very long-chain fatty acid metabolic process (GO:0000038),-0.33053500597628127,-1.0187824718150065,0.42437923250564336,0.5211955184779411,1.0,10/16,36.22%,PEX2;HACD3;ABCD3;ELOVL4;ACOX1;ACSL1;ELOVL6;SLC27A2;ELOVL2;ABCD1
gsea,regulation of cell morphogenesis (GO:0022604),-0.3303862373119889,-1.0166297684460717,0.41379310344827586,0.5238297781436647,1.0,19/19,95.01%,CFL1;MFSD2A;CAMSAP1;LARP4;MOV10;PDZD8;SH3D19;VIL1;FMNL2;SPARC;BCL9L;ZMYM4;STRIP1;ZMYM3;MYO9A;MACF1;ARC;PHIP;CD44
gsea,organonitrogen compound catabolic process (GO:1901565),-0.2947297859221564,-1.0164606164248042,0.4334677419354839,0.523027209442345,1.0,12/29,34.20%,ERAP1;UCHL3;GGACT;GNPDA1;TXN2;CLN5;RIDA;IL4I1;PLA2G6;NPL;ENPP2;ADO
gsea,branched-chain amino acid metabolic process (GO:0009081),-0.35319376720165413,-1.013732384203756,0.4410058027079304,0.5256318696036333,1.0,8/15,31.13%,HSD17B10;DBT;MCCC2;BCAT2;BCAT1;DLD;ACAD8;MCCC1
gsea,branched-chain amino acid catabolic process (GO:0009083),-0.35319376720165413,-1.013732384203756,0.4410058027079304,0.5256318696036333,1.0,8/15,31.13%,HSD17B10;DBT;MCCC2;BCAT2;BCAT1;DLD;ACAD8;MCCC1
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.2476313337398304,1.0097097195549005,0.4152046783625731,0.5111672167588576,1.0,35/56,49.67%,BRCA1;BCL2;PPP1R15A;ATF4;CHEK2;ATP2A3;MAP3K5;HTRA2;DDX3X;DDIT3;BCL2L11;PDK2;TRAF2;QRICH1;BCL2L1;ABL1;AIFM1;PML;JMY;CDKN1A;CUL3;TRIB3;HIPK2;CHAC1;ITPR1;DNAJC10;BOK;BBC3;PMAIP1;CASP4;CEBPB;APAF1;TNFRSF10B;CUL4A;HIC1
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.34209006469196807,1.0096487109337273,0.44074074074074077,0.5106407367728345,1.0,9/17,37.69%,NFATC1;PPP3CB;LEF1;AGO2;MAP3K7;TNRC6A;NLK;PLCB2;TCF7L2
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.28634093060524896,1.009327962941664,0.44176706827309237,0.5105514507524981,1.0,19/34,44.32%,NRP1;ROCK1;ELMO1;ROCK2;PRKD2;PIK3CA;FLT1;CYBB;PIK3R2;PIK3R1;DOCK1;PGF;NRP2;HSP90AA1;VAV2;NCF1;PIK3CB;NCK2;VAV3
gsea,gene silencing by miRNA (GO:0035195),-0.3327191008471901,-1.005726482945737,0.4405458089668616,0.5386506482085437,1.0,17/17,88.81%,RAN;EIF6;ZC3H7B;MOV10;SPOUT1;DICER1;AGO1;ZFP36;TARBP2;TNRC6A;XPO5;AGO2;ADAR;AJUBA;PRKRA;PUM2;CNOT1
gsea,COPII-coated vesicle budding (GO:0090114),-0.29755143446350074,-1.005051818047713,0.4381338742393509,0.5387052624161687,1.0,11/25,37.69%,TMED2;AREG;LMAN1;SEC24D;MCFD2;SEC31A;USO1;SEC24A;COL7A1;TGFA;SEC23A
gsea,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3280569767472501,1.0050234411974464,0.45634920634920634,0.5170674105141895,1.0,11/18,45.29%,SRRT;DGCR8;PUM2;PRKRA;ADAR;AGO2;TARBP2;SMAD1;METTL3;SMAD3;AGO1
gsea,glycosphingolipid metabolic process (GO:0006687),0.33007883114436337,1.003659634885167,0.4523364485981308,0.5187017941265859,1.0,11/17,44.15%,ST6GALNAC3;ST8SIA1;CLN6;CERK;GLA;GM2A;GBA2;ST3GAL5;ABCA2;GALC;CPTP
gsea,regulation of endothelial cell migration (GO:0010594),0.2735812908928305,1.0019846179559693,0.41681574239713776,0.520856320405974,1.0,23/43,42.24%,PRKCA;FOXP1;NRP1;ROCK2;PIK3CD;ETS1;ZC3H12A;GATA3;PRKD2;ABL1;ACVRL1;NF1;PIK3CG;GLUL;THBS1;APOE;RIN2;BCAS3;NRP2;SP100;FGF2;SPARC;PIK3CB
gsea,canonical Wnt signaling pathway (GO:0060070),0.29237815359185265,1.0019265898848664,0.4662379421221865,0.5202855080905693,1.0,17/34,39.57%,TCF7;FRAT2;GSK3B;GATA3;LEF1;DVL1;AXIN1;WNT3;WNT6;WNT10A;WNT4;SCYL2;RARG;BCL9L;TCF7L2;DVL3;NR4A2
gsea,positive regulation of interleukin-12 production (GO:0032735),0.34331649887371246,1.001909451679066,0.46215139442231074,0.5196601602296708,1.0,8/17,36.26%,CCR7;HMGB1;LTB;CD40LG;IL16;CD40;SYK;IL23A
gsea,lytic vacuole organization (GO:0080171),-0.3147680622819757,-1.0013311594913703,0.4515463917525773,0.5441093495554679,1.0,10/19,41.91%,ARSB;NAGPA;GAA;CLN5;CLN3;GRN;ACP2;LRRK2;ZKSCAN3;TFEB
gsea,clathrin-dependent endocytosis (GO:0072583),-0.3453619187293234,-1.0005681547568093,0.44798301486199577,0.5443643552596972,1.0,15/15,73.54%,CANX;DLL1;AP2A2;FCHSD2;SIGLEC1;ITSN1;PICALM;AP2B1;FNBP1L;INPP5F;GAK;CLTB;PIP5K1C;CLTC;SGIP1
gsea,regulation of smooth muscle cell proliferation (GO:0048660),0.3077368188859176,0.996664280161945,0.4558303886925795,0.5280390721650252,1.0,12/27,48.35%,TNFAIP3;NR4A3;FOXP1;STAT1;CCN4;TNF;CX3CL1;TRIB1;THBS1;TCF7L2;AIF1;EDN1
gsea,positive regulation of T cell differentiation (GO:0045582),0.32241810394153364,0.9946815456446251,0.46065259117082535,0.5306308818422188,1.0,11/18,42.33%,SOCS1;TESPA1;BCL6;GATA3;TNFSF9;LEF1;SOX4;IL23A;SART1;ZMIZ1;DUSP10
gsea,regulation of T cell receptor signaling pathway (GO:0050856),0.3180150753441817,0.9932166920205991,0.46464646464646464,0.5325161365827844,1.0,11/20,35.04%,TESPA1;CD81;SH2D1A;TRAT1;PRKD2;PRNP;CD226;PTPRJ;CARD11;CD300A;RELA
gsea,receptor metabolic process (GO:0043112),0.292534101937836,0.9929606907666034,0.46774193548387094,0.532294813662938,1.0,13/28,39.02%,ITGB1;EHD3;CD81;GRK2;KIF16B;RAMP3;LRP1;CLTC;NSG1;LGMN;SYK;LMTK2;PICALM
gsea,positive regulation of immune response (GO:0050778),-0.27270802095545266,-0.9884712850779309,0.4899193548387097,0.5645254984565334,1.0,35/35,97.55%,ADAM8;XBP1;TNFSF4;POLR3D;IL12RB1;CCL5;POLR3G;SLC15A4;ITGAM;IL10;EIF2AK4;IFNG;GRN;POLR3B;POLR3F;NLRP3;DHX9;TGFB2;IL23A;FCGR2B;F2RL1;SPHK2;FADD;CD74;IL6ST;RSAD2;IL2;SIRT1;CD226;PLSCR1;MYB;GBP5;AKIRIN2;CD81;CCR7
gsea,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3183716938878689,-0.9874580219049462,0.4725490196078431,0.5652098941217382,1.0,20/20,95.03%,HSPA5;MT3;CREB3L1;VEGFA;MUC1;MAPK7;CEBPB;MBTPS2;GCN1;CHD6;HSF1;SESN2;ATF6;NFE2L2;DDIT3;NOTCH1;ATF4;ATF3;KLF2;HIF1A
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2637169271099836,-0.9859203356323332,0.45681381957773515,0.5669122943312254,1.0,156/156,96.49%,SNRPA;YBX1;HNRNPA2B1;SNRPF;PCBP1;HNRNPA1;NCBP2;SNRPD3;PNN;SRSF6;PTBP1;LSM7;HNRNPU;HNRNPK;SNRPA1;HNRNPM;PRPF19;SYNCRIP;POLR2F;HNRNPF;SRSF2;TXNL4A;POLR2L;HNRNPC;PPIE;MAGOHB;PRPF40A;SNRPD1;POLR2H;SNRPB;GEMIN5;SFPQ;RBM19;RBM14;SNU13;HNRNPD;RBM15B;CPSF3;DHX15;GTF2F2;BUD31;CSTF2T;SRSF7;SNRPE;CWC22;PSPC1;PABPC1;U2AF2;HNRNPA3;SRSF9;DDX46;MAGOH;PHF5A;PPIL1;GCFC2;POLR2C;SF3B3;POLR2E;SF3B4;PLRG1;CPSF2;PRPF38A;SPEN;CSTF2;RBM4B;AQR;HNRNPA0;DDX41;GTF2F1;DHX35;SNRNP35;DHX9;HSPA8;DHX38;RBM17;GPATCH1;METTL3;CACTIN;TFIP11;DDX23;SART1;RBM8A;NCBP1;CPSF4;PRPF6;EIF4A3;SNRNP40;SMU1;U2SURP;SNRNP25;CWC25;SRSF10;SRSF1;RBM10;CWF19L2;SF3A2;DDX39B;DHX8;PRPF3;EFTUD2;U2AF1;SYMPK;CSTF3;CHERP;SF3A1;PCF11;SRRM1;PPIH;RNPS1;SF3A3;HNRNPH3;CWF19L1;HNRNPR;POLR2B;NONO;PRPF8;PRPF31;DDX42;CSTF1;DBR1;USP39;SNRNP200;SNRNP70;MTREX;CWC27;CPSF1;METTL14;CASC3;DHX16;SRSF3;BUD13;HNRNPH1;RBMX;PRPF4;SRSF4;FUS;RBM6;SART3;ZCCHC8;RBM15;HNRNPUL1;PPWD1;CCAR1;LSM8;GEMIN6;WBP11;RSRC1;SRRT;SRRM2;ALYREF;POLR2A;SF3B2;UPF3B;RBMX2;LSM2;LSM3
gsea,glucose homeostasis (GO:0042593),0.286951020031909,0.9849084894265611,0.4741532976827095,0.5455006932047599,1.0,15/29,37.69%,NUCKS1;HIF1A;LRRC8D;BACE2;PDK2;FOXO1;STAT3;SIRT1;PIK3R2;PIK3R1;MCU;SOX4;HECTD4;PRKAA1;TCF7L2
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),0.2864580331958425,0.9848604207327423,0.4846153846153846,0.544880580290124,1.0,17/27,46.35%,BCL2;FAS;DDIT3;BCL2L11;ING5;TRAF2;BCL2L1;TNF;PML;BCLAF1;FADD;NUPR1;WWOX;BOK;BBC3;PMAIP1;HYAL2
gsea,cell-cell junction organization (GO:0045216),-0.27439742873675077,-0.9816160257750796,0.5123595505617977,0.5735746473875353,1.0,15/30,39.06%,PKP3;MARVELD2;F2R;CTNNA1;JUP;FSCN1;CTNND2;DSP;TGFB3;PKP2;NLGN2;CDH17;CTNND1;PRKCI;TJP1
gsea,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.31871199565999025,0.9806123350979103,0.47547169811320755,0.5516696389479874,1.0,9/20,25.99%,BRCA1;FOXP1;PER1;CNOT1;ARNTL;SIRT1;DAB2;SMARCA4;KANK2
gsea,transport across blood-brain barrier (GO:0150104),-0.2615688903501929,-0.9787574357180784,0.4780701754385965,0.5777373971500119,1.0,20/42,45.43%,SLC2A3;FABP5;MFSD2A;SLC1A5;SLC2A1;SLC6A13;TFRC;ABCC1;SLC27A1;SLC19A1;SLC1A4;SLC38A1;SLC7A3;ABCC4;ATP8A1;ABCG2;SLC2A13;SLC5A3;ATP1A2;SLC7A5
gsea,positive regulation of T cell proliferation (GO:0042102),-0.288591413438106,-0.9773630802467019,0.4860813704496788,0.579140072880072,1.0,30/30,95.35%,ANXA1;TNFSF4;CCR2;PDCD1LG2;IL12RB1;CCL5;TFRC;CD80;IL21;CCDC88B;IGF1;AIF1;NCK2;EBI3;IL23A;FADD;TNFRSF13C;SYK;VCAM1;IL6ST;CD70;IL2;CD274;CD86;IGFBP2;CD40LG;TNFSF9;IL1B;SLC7A1;HMGB1
gsea,protein processing (GO:0016485),-0.2593221972592308,-0.9773382914264233,0.4750542299349241,0.5780231230352825,1.0,19/43,42.83%,SPCS3;METAP2;ATP23;AFG3L2;PCSK4;CASP1;PSEN2;CLN5;ZMPSTE24;VSIR;STOML2;CLN3;PARL;XPNPEP3;MMP14;ADAM19;ADAM17;OMA1;AEBP1
gsea,regulation of interleukin-10 production (GO:0032653),0.29498753469742056,0.9772535221043678,0.47689463955637706,0.5569089495368427,1.0,14/25,36.26%,XCL1;HMGB1;IRF4;CD40LG;TRIB2;STAT3;CD274;ISG15;PRKCZ;TYROBP;SYK;F2RL1;FCGR2B;IL23A
gsea,positive regulation of interleukin-2 production (GO:0032743),0.3162697744564788,0.9756951541279439,0.504,0.5588142187655036,1.0,11/18,33.54%,IRF4;RUNX1;PRKD2;SPTBN1;IL1B;MALT1;TRAF2;CD86;MAP3K7;CARD11;PDE4B
gsea,cellular response to lipopolysaccharide (GO:0071222),0.2541556153188099,0.9756255301915726,0.4801587301587302,0.558240225572186,1.0,33/62,45.80%,TNFAIP3;HMGB2;HMGB1;NFKB1;PDCD4;CXCL10;SERPINE1;TNIP3;ZC3H12A;CD68;IL1B;TNF;CX3CR1;CD86;CD274;HCK;SIRPA;SBNO2;PF4;CD180;PDE4B;RELA;CXCL9;CXCL2;TRIM41;ZFP36;CACTIN;ACOD1;CDC73;MAPK8;CXCL13;ADAM9;NR1H3
gsea,negative regulation of proteolysis (GO:0045861),-0.31660710292152366,-0.974085326283163,0.5195876288659794,0.5827553812526445,1.0,9/17,36.39%,SERPINE2;AKT1;CST3;TRIM21;IL10;CLN3;PLAT;LRRK2;CAMK2N1
gsea,mRNA processing (GO:0006397),-0.2526279522390098,-0.9740466541348556,0.47884615384615387,0.581655458175879,1.0,181/181,96.49%,SNRPA;YBX1;HNRNPA2B1;SNRPF;PCBP1;HNRNPA1;NCBP2;SNRPD3;PNN;SRSF6;PTBP1;LSM7;HNRNPU;HNRNPK;SNRPA1;HNRNPM;PRPF19;SYNCRIP;POLR2F;HNRNPF;SRSF2;TXNL4A;POLR2L;HNRNPC;SARNP;PPIE;CDK7;MAGOHB;RNMT;PRPF40A;SNRPD1;TBRG4;POLR2H;SNRPB;GEMIN5;SFPQ;RBM19;RBM14;SNU13;HNRNPD;RBM15B;CPSF3;GTF2H2;ERN1;DHX15;GTF2F2;BUD31;CSTF2T;SRSF7;SNRPE;CWC22;PSPC1;PABPC1;U2AF2;HNRNPA3;THOC6;GTF2H4;SRSF9;GTF2H1;DDX46;MAGOH;PHF5A;PPIL1;GCFC2;ERCC3;THOC1;RPRD1A;POLR2C;THOC5;SF3B3;POLR2E;ERCC2;GTF2H3;SF3B4;PLRG1;CPSF2;PRPF38A;SPEN;CSTF2;RBM4B;AQR;HNRNPA0;DDX41;GTF2F1;DHX35;SNRNP35;DHX9;HSPA8;THOC3;DHX38;RBM17;GPATCH1;METTL3;CACTIN;TFIP11;DDX23;SART1;RBM8A;NCBP1;CPSF4;PRPF6;EIF4A3;SNRNP40;SMU1;U2SURP;ALKBH5;SNRNP25;CWC25;SRSF10;SRSF1;CPSF6;RBM10;CWF19L2;TCERG1;SF3A2;DDX39B;DHX8;PRPF3;EFTUD2;U2AF1;SYMPK;CSTF3;CHERP;SF3A1;PCF11;SRRM1;PPIH;GEMIN2;RNPS1;SF3A3;HNRNPH3;RPRD1B;CWF19L1;HNRNPR;POLR2B;CMTR1;NONO;PRPF8;PRPF31;DDX42;CSTF1;DBR1;USP39;SNRNP200;SNRNP70;MTREX;CWC27;CPSF1;METTL14;CASC3;DHX16;SRSF3;BUD13;HNRNPH1;RBMX;PRPF4;SRSF4;FUS;RBM6;SART3;SCAF11;CELF1;THOC2;ZCCHC8;RBM15;HNRNPUL1;PPWD1;CCAR1;LSM8;GEMIN6;WBP11;RSRC1;SRRT;SRRM2;ALYREF;POLR2A;SF3B2;UPF3B;RBMX2;LSM2;LSM3
gsea,protein export from nucleus (GO:0006611),0.32936311704507837,0.9738891734072941,0.47854077253218885,0.560535731179441,1.0,11/17,34.72%,ANKLE1;CSE1L;XPO1;NUP214;CCHCR1;RANBP3;EGR2;XPO5;XPO4;DUSP16;XPO6
gsea,axonal transport (GO:0098930),0.3116608437406674,0.9709939645541565,0.49636363636363634,0.5647859721973915,1.0,10/20,35.76%,HIF1A;AP3B1;DCTN1;KIF3B;TMEM108;KIF1B;DYNC1H1;AP3S1;NEFL;AP3D1
gsea,negative regulation of cellular catabolic process (GO:0031330),0.2722935527508979,0.9703113851004224,0.49612403100775193,0.5652791807263728,1.0,20/35,45.67%,DAPL1;ROCK1;BCL2;EIF4G3;EIF4G2;TIMP2;STAT3;PTPN3;GOLGA2;TAB3;TIMP1;TBC1D14;TLK2;KDM4A;NUPR1;MET;RGP1;MTOR;CPTP;NRDE2
gsea,positive regulation of chemotaxis (GO:0050921),-0.3086312238161016,-0.9682695841753538,0.5148741418764302,0.5911630275379437,1.0,20/20,97.67%,TMSB4X;CCR2;DSCAM;PDGFB;VEGFA;PPM1F;HSPB1;ADAM17;AIF1;FGF2;MET;F2RL1;LGMN;THBS1;F3;PRKD2;P2RX4;NRP1;NTRK3;XCL1
gsea,glutamine family amino acid metabolic process (GO:0009064),-0.3208634540088482,-0.9678480557140288,0.4932562620423892,0.590824943962608,1.0,12/17,40.41%,PYCR2;GOT2;GOT1;GCLC;ALDH18A1;ALDH4A1;GLS2;SIRT4;DDAH2;NIT2;FPGS;DGLUCY
gsea,negative regulation of cell growth (GO:0030308),0.2445986500452832,0.9674971281708789,0.5,0.5696041626004913,1.0,32/58,41.10%,CDKN2D;CDKN2C;BCL6;FGF13;ING1;DDX3X;PSRC1;RBBP7;ACVRL1;SMARCA2;HSPA1B;PML;RB1;SIRT1;JADE1;PTPRJ;SMARCA4;CDKN1A;SESN2;GNG4;OSGIN1;MAP2;HSPA1A;TCHP;SPHK2;DCBLD2;EI24;PPP1R9B;ULK2;CCAR2;ST7L;ULK1
gsea,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3355357671511815,0.9668798571484467,0.5177570093457944,0.5698892155333292,1.0,10/18,27.71%,ZFP36L1;PIK3CD;GATA3;PIK3CA;PIK3R5;PIK3R2;NF1;PIK3CG;PIK3R1;HTR2A
gsea,negative regulation of catabolic process (GO:0009895),0.3120917009117703,0.9668334784140347,0.4981684981684982,0.5692581169338308,1.0,11/23,33.77%,MAD2L1;MDM4;IL1B;TNF;PFKFB1;PDE3B;PIN1;AZIN1;CBFA2T3;NUPR1;PRKAA1
gsea,cellular response to insulin stimulus (GO:0032869),0.23742903260550996,0.9667015971485479,0.5191570881226054,0.5687900993172201,1.0,29/61,43.89%,ZFP36L1;TBC1D4;PHIP;PDPK1;C2CD5;GSK3B;IRS2;PCK2;SHC1;KAT2B;PDK2;FOXO1;TCIRG1;GRB10;HDAC5;HDAC9;PIK3R2;PDE3B;PIK3R1;MYO5A;TRIB3;DENND4C;AP3S1;IDE;ATP6V1G3;PIK3C2A;FOXO4;SH2B2;SOS1
gsea,positive regulation of interleukin-6 production (GO:0032755),0.26699818873874476,0.965102142954936,0.5064935064935064,0.5707545496058585,1.0,19/41,34.22%,HMGB1;POU2F2;MBP;PTPN11;IL1B;IL17RA;POU2AF1;IL16;TNF;STAT3;TLR7;RAB7B;LPL;ARHGEF2;CD74;TYROBP;SYK;SPHK2;F2RL1
gsea,monocyte chemotaxis (GO:0002548),-0.32236153263022327,-0.9638643699831522,0.48448687350835323,0.5968652977321836,1.0,19/19,97.67%,CCL4;CCL3;ANXA1;LGALS3;CCL5;PDGFB;CALCA;MSMP;CCL7;CCL2;CCL25;CCL8;CCL17;CCL22;CX3CL1;FLT1;CCL1;TNFSF11;XCL1
gsea,cellular response to amino acid stimulus (GO:0071230),0.3288415705753046,0.9621866019018573,0.5090543259557344,0.5751410200875198,1.0,10/15,41.48%,SESN3;CASTOR1;IPO5;SLC38A9;SESN2;SESN1;RPTOR;UBR1;MTOR;GLRA1
gsea,regulation of actin filament polymerization (GO:0030833),0.27904358562921944,0.9607550781430122,0.515686274509804,0.5768700911956717,1.0,17/30,50.51%,CCR7;SSH2;EVL;PLEKHG2;SSH1;MYADM;ARFGEF1;HIP1R;HCK;CDC42EP3;GBA2;NCK2;CTTN;VIL1;BAIAP2L1;FCHSD2;RASA1
gsea,"phagocytosis, engulfment (GO:0006911)",-0.3440951193850388,-0.9586638056891776,0.49278846153846156,0.605317906250142,1.0,4/15,16.62%,SH3BP1;VAMP7;ITGAM;XKR8
gsea,skin development (GO:0043588),-0.26337610083501495,-0.9568557264589733,0.5153664302600472,0.6074750352716549,1.0,17/31,43.00%,DHCR24;ANXA1;ST14;CASP3;SFN;PDGFA;ITGA3;KDF1;DSP;DLL1;BCR;MED1;KRT10;SPRR1A;COL5A3;FA2H;EVPL
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.25159746097024355,0.9568144428758351,0.5125,0.5831539892296156,1.0,28/55,40.70%,CD44;NRP1;JAK2;CD81;CSF2;PTPN11;LIF;SOCS3;IL3;PRNP;TNF;ABL1;STAT3;PTPRJ;IL2;CD40;ARHGEF2;CLCF1;CSF1R;PECAM1;KIT;IL6ST;GAS6;CD74;PARP14;IL23A;CASS4;TNK2
gsea,negative regulation of ERBB signaling pathway (GO:1901185),0.2960154319064255,0.955850756047742,0.5352941176470588,0.5841738179550064,1.0,12/22,32.44%,SPRY1;ITGA1;EPS15L1;SPRY2;HGS;ERRFI1;PTPRJ;PTPN3;CBL;LGMN;BTC;EPS15
gsea,lipid homeostasis (GO:0055088),0.2820155024183125,0.9553882360680628,0.5127737226277372,0.5843093353034811,1.0,16/27,42.55%,ZBTB20;THADA;IRS2;ABCG1;DDX3X;FBXW7;SIRT1;ABCA1;PNPLA8;APOE;PRKAA1;POLD1;ABCB4;ABCA2;LIPG;ADCK1
gsea,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.32743872463240575,0.9521296540882508,0.5223880597014925,0.5891798396477155,1.0,7/15,31.98%,MED4;MED14;PAXIP1;MED30;MED13;MED12;MED16
gsea,regulation of androgen receptor signaling pathway (GO:0060765),-0.3257447861273762,-0.9512115015938812,0.51340206185567,0.6164127480551043,1.0,16/16,94.57%,PHB;PARK7;HDAC1;PRMT2;NCOR2;KDM5D;PIAS2;SMARCA4;DAB2;SIRT1;AR;EP300;HDAC6;NCOA2;SAFB2;FOXP1
gsea,positive regulation of monooxygenase activity (GO:0032770),0.3100861283819717,0.9492498421940249,0.5079051383399209,0.593400093117687,1.0,9/17,42.24%,HIF1A;GCH1;DHFR;TERF2;IL1B;NOS1AP;TNF;APOE;PIK3CB
gsea,circulatory system development (GO:0072359),0.24347004399484554,0.9484116130981107,0.5581395348837209,0.5941399583605227,1.0,25/52,44.87%,NTRK3;PDLIM1;ZFPM1;KDM6B;SMG9;PTPN11;NOTCH1;HEG1;KAT2B;PIK3CA;ACVRL1;FBXW7;HDAC9;NF1;CDKN1A;POPDC2;SOX4;SMYD4;MKKS;BCOR;FLRT3;FN1;TSC2;PDLIM4;TGFB2
gsea,amino acid transmembrane transport (GO:0003333),-0.31402516711929035,-0.9465053309570232,0.5242914979757085,0.6239347906642255,1.0,7/17,36.56%,SFXN1;SLC7A6;SLC6A13;SFXN2;SLC25A22;SLC36A4;SLC38A1
gsea,snRNA processing (GO:0016180),0.3255240373426856,0.946241689127457,0.5460122699386503,0.597229868556535,1.0,6/15,27.76%,INTS1;INTS6;TOE1;INTS3;INTS6L;INTS11
gsea,negative regulation of cell death (GO:0060548),-0.25474384711999776,-0.945575997733498,0.5407554671968191,0.6243934993334994,1.0,38/38,97.06%,MT3;SRSF6;AKT1;PARK7;PSMC5;CD200R1;EIF4G1;WNT11;BNIP3;IMPACT;TIGAR;BMP7;IKBKG;CSF1;LRRK2;TM7SF3;GPNMB;CHGA;ATP13A2;DUS2;ADNP2;TMEM109;FGF2;VPS35;SOX4;HSPA1A;KANK2;HSPA1B;TRAF2;CD200;PINK1;CCN4;HTRA2;GSK3B;NUP62;CCN1;SRGAP2;RAD18
gsea,regulation of interleukin-12 production (GO:0032655),0.3002571639108839,0.9449512757868738,0.5018939393939394,0.5987215837540604,1.0,12/26,36.26%,CCR7;HMGB1;FOXP1;MAST2;LTB;CD40LG;IL16;CD40;THBS1;SYK;MEFV;IL23A
gsea,extrinsic apoptotic signaling pathway (GO:0097191),-0.25773734595752057,-0.9440434891355193,0.5626326963906582,0.626012770054199,1.0,35/35,93.27%,BAK1;BID;SIVA1;BAX;CASP3;MLLT11;TNFSF12;BLOC1S2;TNFRSF1A;BAG3;IFI27;DAB2IP;RIPK1;DDX47;IFNG;INHBA;TNFRSF10B;SMAD3;TGFB2;BOK;FADD;DAXX;CASP8AP2;CD70;DELE1;TNF;BCL2L1;TRAF2;DDX3X;HIPK1;GSK3B;FAS;PDPK1;BCL2;JAK2
gsea,inorganic cation transmembrane transport (GO:0098662),-0.2296959573270262,-0.9439060085836612,0.5686746987951807,0.6250530852852662,1.0,30/71,44.66%,SLC39A6;TRPV2;SCN1B;KCNAB2;SLC39A7;ABCB8;SLC6A13;ATP2A2;KCNK7;SLC11A1;SLC39A14;HVCN1;SLC30A4;SLC39A1;TRPC1;SLC6A12;SLC39A4;KCNQ5;SLC12A3;OTOP1;CACNA1A;ATP6V0E2;KCNN4;COX15;SCN4B;SLC9A8;KCNAB1;DMAC2L;KCNG2;ATP1A2
gsea,termination of RNA polymerase II transcription (GO:0006369),-0.3159465583018087,-0.9432594565172256,0.514,0.6250289081416677,1.0,21/21,97.20%,SNRPF;NCBP2;SNRPD3;SNRPB;CPSF3;CSTF2T;SNRPE;CPSF2;CSTF2;MAZ;NCBP1;CPSF4;SYMPK;CSTF3;PCF11;LSM11;CSTF1;CPSF1;SETX;SLBP;TTF2
gsea,establishment of protein localization to membrane (GO:0090150),-0.274142893114065,-0.9427578311666222,0.5361216730038023,0.6247389103868933,1.0,14/28,45.13%,GORASP2;BID;ZDHHC24;COX18;ZDHHC2;PIKFYVE;MYO1C;ZDHHC6;ZDHHC21;RAB3GAP2;PRKCI;ICMT;ZDHHC12;VPS37C
gsea,eye development (GO:0001654),0.3189003138536899,0.9403733142932865,0.5450081833060556,0.6060230873036956,1.0,12/21,44.87%,SMG9;HIPK1;PBX2;RAB3GAP1;ATF6;SKI;HIPK2;TSKU;CEP290;SMOC1;PBX4;TGFB2
gsea,embryonic limb morphogenesis (GO:0030326),0.33013735538301836,0.9391346973310998,0.5253623188405797,0.6074621371964726,1.0,8/16,48.82%,AFF3;CREBBP;SKI;PTCH1;RARG;MAP3K20;TGFB2;TWIST1
gsea,regulation of osteoclast differentiation (GO:0045670),-0.32951497884239644,-0.9386174764921982,0.5010309278350515,0.6310318262023678,1.0,9/15,37.55%,CCL3;TCTA;GPR137B;CCR1;TLR4;PRXL2A;IFNG;CSF1;GPR55
gsea,positive regulation of protein localization to plasma membrane (GO:1903078),0.26743762472915356,0.9384192311386614,0.5392561983471075,0.6080287148586135,1.0,12/31,36.20%,ITGB1;PDPK1;ATP2B4;SPTBN1;ACSL3;TNF;RAMP3;PLS1;PIK3R1;LRP1;CNST;KIF5B
gsea,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2981147297959974,-0.9383791523393126,0.5638051044083526,0.6301870186675625,1.0,21/21,91.49%,AREG;AKT1;ARAP1;TGFA;HAP1;HBEGF;ADAM17;ADRA2A;CNOT9;MMP9;BCAR3;NCF1;BTC;CBL;DGKD;HIP1R;FBXW7;CCDC88A;HIP1;NUP62;PLAUR
gsea,regulation of cell adhesion mediated by integrin (GO:0033628),0.32369176640436187,0.9383335600247671,0.5183150183150184,0.6074470785025121,1.0,9/16,44.87%,SERPINE1;PTPN11;LIF;PDE3B;PIK3CG;SYK;RET;ADAM9;TGFB2
gsea,protein O-linked glycosylation (GO:0006493),-0.23710555329198293,-0.9360450842125045,0.5958333333333333,0.6332419806502785,1.0,24/50,39.73%,SDF2L1;SLC35C1;ST6GALNAC4;PGM3;B4GALT5;RXYLT1;GALNT3;B3GALNT2;POGLUT3;GALNT18;B3GNT3;GXYLT1;PLOD2;GALNT1;OGA;POMGNT1;ST3GAL3;B3GLCT;POGLUT2;PLOD3;GALNT6;MUC1;XXYLT1;POMK
gsea,regulation of interleukin-17 production (GO:0032660),0.3093487503949623,0.9356033208106499,0.5478615071283096,0.6113849994959769,1.0,8/18,40.48%,SLAMF6;RFTN1;CCL1;DDIT3;PRNP;IL2;IL23A;SPHK1
gsea,regulation of actin filament-based process (GO:0032970),0.2771218806193764,0.9352636782273274,0.5771230502599654,0.6112653898025262,1.0,18/36,44.55%,IQGAP3;GPM6B;IQGAP2;ROCK1;ROCK2;TAOK2;TAOK1;ABL1;CCDC88A;HIP1R;RICTOR;LRP1;PAK1;RND3;ARHGEF19;MTOR;DMTN;BST1
gsea,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.31343720893573396,-0.9337035971304365,0.5333333333333333,0.636245056359869,1.0,16/16,93.14%,ADAM8;SNX9;IL10;IFNG;PACSIN3;SH3D19;ADRA2A;FURIN;ADAM9;APOE;TIMP1;PTPN3;TNF;IL1B;TIMP2;ROCK1
gsea,positive regulation of T cell activation (GO:0050870),0.26553717806293164,0.9333366718569773,0.5651302605210421,0.6138659109619146,1.0,18/33,42.42%,CCR7;TNFSF11;CD81;SLC7A1;GATA3;FLOT2;IL1B;CD40LG;CD86;CD274;CD70;SIRPA;IL6ST;VCAM1;TNFRSF13C;IL23A;ZMIZ1;NCK2
gsea,regulation of autophagy (GO:0010506),-0.20198069497533627,-0.9318213872061312,0.625,0.6385246610021125,1.0,112/112,98.78%,GAPDH;DAP;MT3;AKT1;CASP3;VDAC1;KEAP1;SNX5;ATP6V0A2;NEDD4;EEF1A1;RAB39B;USP36;DAPK2;TRIM65;EIF4G1;GPR137B;ERN1;WDR6;TRIM21;MTDH;IL10RA;BNIP3;HAX1;KAT8;SVIP;EIF4E;RRAGB;UBQLN1;ATM;UFL1;IL10;MID2;USP10;RNF152;RASIP1;DRAM1;IFNG;ATP6V0E2;SREBF2;HSPB1;TRIM5;PLEKHF1;WDR24;SMCR8;LRRK2;UCHL1;WDR41;SH3BP4;MLST8;ZKSCAN3;TFEB;FOXK2;KLHL22;EXOC8;PIP4K2B;ATP13A2;PRKAG2;TRIM8;C9ORF72;CPTP;MAPK8;PIK3CB;BOK;ULK1;MTOR;PIK3C2A;CSNK2A2;VPS35;DAPK1;ITPR1;MET;OPTN;PRKAA1;NUPR1;FOXO3;MEFV;KDM4A;MTMR4;TLK2;TBC1D14;RPTOR;TAB3;GOLGA2;TRIB3;DEPDC5;TRIM14;PLK2;USP33;PIK3R2;ATF6;FBXW7;SLC38A9;STAT3;ABL1;FOXO1;PINK1;DDIT3;EP300;MTMR3;HDAC6;EIF4G2;HTRA2;ZC3H12A;GSK3B;EIF4G3;BCL2;EXOC4;ROCK1;PIM2;HMGB1;DAPL1
gsea,regulation of calcium ion transport (GO:0051924),-0.29101285580468744,-0.9307385809144739,0.5629453681710214,0.6391595725801277,1.0,23/23,92.74%,CCL4;CCL3;CCL5;F2R;CTNNB1;CCR1;CAMK2G;PACSIN3;CD4;NOS1;EFHB;ADRA2A;CACNA2D1;HOMER1;CRACR2A;PLN;IL16;P2RX4;EPB41;STIM2;CD33;ORAI1;BCL2
gsea,import into cell (GO:0098657),0.30473240902412707,0.9278289525542083,0.5576923076923077,0.622951407116996,1.0,8/18,39.12%,SLC29A1;LRRC8D;SLC7A1;SLC12A7;GLUL;SLC12A6;SLC7A8;SLC6A6
gsea,positive regulation of mitochondrion organization (GO:0010822),-0.2597251317123671,-0.9269875956707557,0.5711462450592886,0.64493803375951,1.0,32/32,98.72%,BAK1;CHCHD10;PARK7;BID;BAX;MLLT11;MGARP;SPIRE1;BNIP3;RALA;ZDHHC6;CAMKK2;PPIF;TNFSF10;MMP9;PMAIP1;BBC3;ADCK1;BOK;VPS35;HTT;BIK;MCU;HIP1R;DDHD1;FAM162A;PINK1;BCL2L11;HTRA2;GSK3B;PLAUR;AURKA
gsea,positive regulation of cell junction assembly (GO:1901890),0.32054358471971056,0.9257746878201623,0.582089552238806,0.6258833579106654,1.0,7/15,37.96%,MAP4K4;NRP1;ROCK1;ABL1;TSC1;PTPRJ;DLG5
gsea,endoplasmic reticulum organization (GO:0007029),0.25925637056452805,0.9245390857061804,0.5675675675675675,0.6272339621767946,1.0,16/33,47.36%,REEP4;ATL2;RTN3;LNPK;ATL3;PRNP;REEP1;GAK;MIA3;GET4;LMAN1L;SEC16A;LMAN2L;APP;REEP2;ZBED3
gsea,cell-substrate junction assembly (GO:0007044),0.3045453346543385,0.9233805258509296,0.571969696969697,0.6285335791213581,1.0,10/19,45.85%,ITGA6;PLEC;TAOK2;PTPRK;PEAK1;ACTN1;CD151;FN1;CTTN;ITGB4
gsea,non-motile cilium assembly (GO:1905515),0.29636762519417315,0.9209134758942183,0.5557768924302788,0.6321044658804393,1.0,9/19,36.05%,CEP89;ARL13B;C2CD3;DCTN1;PCM1;TMEM107;IFT88;BBS4;CEP290
gsea,negative regulation of protein modification process (GO:0031400),0.24056297677348265,0.9206500837116965,0.5895953757225434,0.6318040996539301,1.0,27/46,48.61%,TINF2;NTRK3;XRCC1;PPP1R15A;CORO1C;GSK3B;ZC3H12A;ATP2B4;PRNP;PTPN13;MYADM;XDH;SIRT1;SIRPA;MFHAS1;FXYD1;INSM1;WWTR1;PRKAA1;PID1;DNAJC10;TRAF3IP1;CACTIN;MEN1;C9ORF72;ZBED3;FBLN1
gsea,lysosome localization (GO:0032418),0.30366301311920646,0.9185199905284931,0.5645472061657033,0.6348547036146561,1.0,10/20,42.81%,NR4A3;PIK3CD;HDAC6;MILR1;PIK3CG;KIT;KIF5B;PLEKHM2;MYH9;PLEKHM1
gsea,positive regulation of cell projection organization (GO:0031346),0.24599139151480187,0.9169131972311264,0.6305609284332688,0.6369646796892688,1.0,22/44,48.73%,NTRK3;TOX;ITGA6;TIAM1;PLXNC1;CUX1;SETX;EP300;RAPGEF1;DVL1;CX3CL1;CAMK1D;APOE;KIDINS220;DVL3;MAP3K13;RET;PLXNB2;EPHA3;CUL7;FES;RAPGEF2
gsea,regulation of neurotransmitter receptor activity (GO:0099601),0.33408290788571304,0.9162748936065448,0.5746753246753247,0.6372945248820158,1.0,10/16,49.68%,CNIH2;NETO1;NEFL;DAPK1;APP;DLG2;SHANK1;GRIN1;MINK1;NPTX1
gsea,integrin-mediated signaling pathway (GO:0007229),-0.24907678168097486,-0.9146301228733769,0.583732057416268,0.6669321412220605,1.0,36/36,97.61%,NME2;TXK;NEDD9;PLEK;ITGB3;CEACAM1;COL16A1;DST;CDH17;PTK2B;BCAR1;SEMA7A;TEC;RCC2;FBLN1;ITGB4;ITGA5;ADAM9;FN1;FGR;MYH9;MADCAM1;SYK;ITGA10;DOCK1;ISG15;HCK;ITGB8;CUL3;DAB2;ABL1;CD40LG;ERBIN;ITGB7;NRP1;ITGB1
gsea,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3128195303562436,0.9139147491772626,0.5823045267489712,0.6407847909579504,1.0,9/15,35.98%,HIF1A;ATF4;NOTCH1;EP300;NFE2L2;SESN2;CHD6;RELA;SMAD1
gsea,phospholipid metabolic process (GO:0006644),-0.266153610897659,-0.9130589102461436,0.5611814345991561,0.6685663856986782,1.0,13/29,36.54%,GDE1;AGPAT2;PDXP;SMPD1;PLPP2;LPCAT1;AGPAT5;AGPAT4;PCYT2;ENPP2;PLAA;GNPAT;FDFT1
gsea,mRNA polyadenylation (GO:0006378),-0.3211720020210811,-0.9120506191810296,0.5723014256619144,0.6678580252943441,1.0,5/15,20.55%,GRSF1;PNPT1;CPSF3;TUT1;PABPC1
gsea,RNA polyadenylation (GO:0043631),-0.3211720020210811,-0.9120506191810296,0.5723014256619144,0.6678580252943441,1.0,5/15,20.55%,GRSF1;PNPT1;CPSF3;TUT1;PABPC1
gsea,protein tetramerization (GO:0051262),-0.259051293748053,-0.911538778248543,0.611764705882353,0.6675113952330354,1.0,30/30,97.58%,ALDOA;ALDH9A1;HSD17B10;FARSA;FARSB;SOD2;ALDH1A3;SHMT1;THG1L;OSBPL2;KRT10;CBR4;CRYZ;RYR1;APPL2;CBY1;GRIN1;ACACA;HOMER1;SHMT2;CPSF6;KCNC1;GOLGA2;TRPA1;APIP;CTH;GLS;GBP5;SAMHD1;TK1
gsea,protein deacetylation (GO:0006476),-0.26580273806858845,-0.9096304654591271,0.5654885654885655,0.6698737427533191,1.0,29/29,91.78%,PHB;FLNA;HDAC1;HDAC2;RBM14;MTA2;TRERF1;PRDM5;MIER2;MORF4L2;SIRT4;BRMS1L;RCOR3;SIRT3;HDAC4;HDAC10;BAZ2A;TBL1XR1;SIRT5;MIER3;HDAC9;SIRT1;HDAC5;MTA1;HDAC6;SIRT6;TBL1X;HDAC7;SIN3A
gsea,histone deacetylation (GO:0016575),-0.26709540150427735,-0.9092632676347872,0.58125,0.6693159776958291,1.0,28/28,91.78%,PHB;HDAC1;HDAC2;REST;SFPQ;RBM14;MTA2;TRERF1;PRDM5;MIER2;MORF4L2;BRMS1L;RCOR3;HDAC4;HDAC10;BAZ2A;TBL1XR1;MIER3;HDAC9;SIRT1;HDAC5;MTA1;HDAC6;SIRT6;TBL1X;ELK4;PER1;SIN3A
gsea,regulation of endocytosis (GO:0030100),0.26511862661599483,0.9087291458853408,0.6066790352504638,0.6492659862493425,1.0,18/30,41.53%,ROCK1;PACSIN1;MCTP1;HIP1;ABL1;HIP1R;DAB2;STON1;RAB5B;LRP1;ZFYVE16;APOE;CD151;ABCA7;PICALM;TSC2;SPHK1;SYT11
gsea,regulation of hydrolase activity (GO:0051336),0.2699851851232106,0.9082345150981241,0.6124314442413162,0.6493992055990305,1.0,13/27,46.96%,TBC1D10B;TDG;PLXNC1;WRN;RAB3GAP1;RABGAP1;SIPA1L1;NF1;VAV2;VAV3;PLXNB2;CHN2;EPHA3
gsea,negative regulation of viral process (GO:0048525),-0.24794731458808156,-0.9048225851986897,0.5956607495069034,0.6762307924556162,1.0,38/38,92.83%,PPIA;SHFL;BST2;CCL5;RNASEL;EIF2AK2;TRIM21;BANF1;TRIM35;ISG20;LARP7;MID2;LTF;PARP10;TRIM5;MAVS;IFIH1;IFIT1;TRIM8;ZFP36;SRPK1;SLPI;ISG15;IFITM2;IFITM3;OAS3;RSAD2;TRIM14;PML;TNIP1;TNF;HEXIM1;PLSCR1;TRIM28;ILF3;STAT1;IFITM1;FAM111A
gsea,positive regulation of axonogenesis (GO:0050772),-0.2961823386863308,-0.9038809161620394,0.5867237687366167,0.6766989770933897,1.0,10/16,44.84%,PLXND1;ARHGDIA;LIMK1;MAP6;GOLGA4;METRN;PLXNA1;L1CAM;SEMA7A;SHTN1
gsea,positive regulation of smooth muscle cell proliferation (GO:0048661),0.28182097817390983,0.9036136358418417,0.6023294509151415,0.6568471680102873,1.0,14/26,48.35%,NR4A3;FOXP1;JUN;STAT1;DNMT1;CCN4;TNF;FOXJ2;CX3CL1;THBS1;P2RY6;FGF2;AIF1;EDN1
gsea,spermatid development (GO:0007286),0.31525474753343397,0.9023486298611337,0.6,0.658291653900239,1.0,8/15,43.38%,CEP57;YTHDC2;PRM2;RNF8;BBS4;MKKS;CCDC63;NECTIN2
gsea,positive regulation of RNA metabolic process (GO:0051254),-0.264600700115891,-0.9021660239059297,0.5826771653543307,0.6785455598672041,1.0,16/28,44.55%,WDR75;WDR43;HRAS;GRSF1;RIOK2;ZPR1;HEATR1;PNPT1;ERN1;DIMT1;U2AF2;BUD23;RIPK1;UTP15;HNRNPLL;HABP4
gsea,regulation of cytoskeleton organization (GO:0051493),0.24419995188502003,0.9013308542454747,0.6332179930795848,0.659276860384255,1.0,26/52,46.96%,IQGAP3;GPM6B;IQGAP2;ROCK1;ROCK2;CLASP1;GSK3B;TAOK2;BICD2;TAOK1;ABL1;CCDC88A;HIP1R;RICTOR;LRP1;PAK1;DIAPH1;RND3;PRKAA1;ARHGEF19;TRAF3IP1;MTOR;DMTN;BST1;CLIC4;EPHA3
gsea,RNA phosphodiester bond hydrolysis (GO:0090501),-0.28609082027065685,-0.8990270981152201,0.591182364729459,0.6830095020819716,1.0,19/19,93.18%,NHP2;POP1;NUDT16;CPSF3;ERN1;ZC3H12C;LACTB2;RNASEH1;DICER1;KHNYN;RNASE6;PARN;CSTF3;PCF11;TOE1;ZC3H12D;ZC3H12A;XRN1;RPP30
gsea,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.30244855278698407,0.8960580022258124,0.5985130111524164,0.6677355505792794,1.0,8/19,41.59%,TNFAIP3;RAB7B;MFHAS1;CD300A;F2RL1;CD300LF;CACTIN;ACOD1
gsea,organic acid transport (GO:0015849),0.24380554836052498,0.892241249399086,0.6289752650176679,0.6736294363992674,1.0,18/38,50.92%,SLC25A10;SLC38A2;LRRC8D;SLC7A1;NCOA1;NCOA2;RXRA;SLC3A1;SLC23A2;SLC7A8;SLC6A6;SLC25A14;SLC13A3;SLC43A2;SLC16A1;STARD5;SLC25A17;SLC3A2
gsea,regulation of cardiac conduction (GO:1903779),0.2808117845138204,0.8895290249348249,0.6146953405017921,0.6777352591063608,1.0,14/23,48.63%,ATP2A3;ITPR2;ATP2B4;TMEM65;ATP1B1;ATP2B2;FXYD1;FXYD3;ITPR1;SLC8A1;AHCYL1;ATP1A1;FXYD7;ATP1A3
gsea,regulation of actin cytoskeleton organization (GO:0032956),-0.23030542696398276,-0.8885930175526656,0.66270783847981,0.7006016822902296,1.0,45/45,97.35%,CORO1A;SH3BP1;ARHGDIA;EZR;NEB;BST2;RHOQ;BAIAP2;PDGFA;DLC1;RHOC;FSCN1;ARHGEF5;SMIM22;RHOB;RHOBTB3;MLST8;PTK2B;ABI3;ARHGAP35;RHOF;EPHA3;C9ORF72;BST1;DMTN;MTOR;ARHGEF19;RND3;EPS8;NOTCH2;PAK1;LRP1;CSF1R;RICTOR;HIP1R;CCDC88A;ABL1;TAOK1;PIK3CA;TAOK2;ROCK2;ROCK1;IQGAP2;GPM6B;IQGAP3
gsea,negative regulation of autophagy (GO:0010507),0.2510533961400429,0.8874574646186166,0.626204238921002,0.6806826685348615,1.0,17/35,34.69%,DAPL1;BCL2;EIF4G3;EIF4G2;PINK1;SNRNP70;PIK3CA;STAT3;TSC1;ATG7;GOLGA2;TAB3;TBC1D14;TLK2;KDM4A;NUPR1;MET
gsea,regulation of viral transcription (GO:0046782),0.2718894860392842,0.8867213625585174,0.6231578947368421,0.6812857369377646,1.0,11/22,40.01%,POLR2A;NELFE;HEXIM1;MDFIC;POLR2B;CTDP1;TRIM14;NELFCD;IFITM3;TARBP2;ZFP36
gsea,natural killer cell activation (GO:0030101),0.30069017648755136,0.8858665021500921,0.6183953033268101,0.6820249543157814,1.0,10/15,44.37%,TOX;PIK3CD;ULBP1;RASGRP1;KAT7;SNX27;IL2;IL21R;SLAMF7;ELF4
gsea,synapse assembly (GO:0007416),-0.3110925456199677,-0.8849935499335685,0.6030701754385965,0.7060956304936901,1.0,7/15,33.16%,PLXND1;RYK;DSCAM;DNM3;LGI2;NLGN2;ACHE
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.24639362213781996,0.8811691800150384,0.6401446654611211,0.6894515837231358,1.0,23/41,45.66%,CD44;NRP1;JAK2;CD81;PTPN11;LIF;IL3;PRNP;ABL1;PTPN6;PTPRJ;ARHGEF2;PECAM1;PRKCZ;CD74;RAP2C;IL23A;TNK2;APP;DMTN;BST1;IL22RA2;ITGA5
gsea,collagen fibril organization (GO:0030199),-0.24889101549107295,-0.8807672713120392,0.6658031088082902,0.7124201112534627,1.0,13/32,31.79%,COLGALT1;ADAMTS14;P4HB;CRTAP;COL16A1;LAMC2;PLOD2;P3H1;P4HA1;COL7A1;COL17A1;DST;PLOD3
gsea,regulation of insulin secretion (GO:0050796),0.25038582891155553,0.8803546220456417,0.6660869565217391,0.6900586624886422,1.0,15/38,37.69%,PRKCA;PPP3CB;ITPR2;IRS2;IL1B;GLP1R;ARNTL;TNF;MCU;RAPGEF4;SOX4;ITPR1;MIDN;CACNA2D2;TCF7L2
gsea,positive regulation of response to biotic stimulus (GO:0002833),-0.2782090982643002,-0.8782690084993386,0.6371490280777538,0.715890626439087,1.0,22/22,95.08%,ADAM8;POLR3D;CCL5;POLR3G;SLC15A4;SCIMP;DHX58;GRN;LY86;POLR3B;ANKRD17;POLR3F;DHX9;ACOD1;DDX60;CD180;USP15;PLSCR1;PUM2;GBP5;AKIRIN2;PRKCA
gsea,carboxylic acid transmembrane transport (GO:1905039),0.2890158299324964,0.8764686464972555,0.6451612903225806,0.6959983848825486,1.0,9/18,43.21%,SLC25A10;SLC38A2;SLC38A9;ABCC5;SLC23A2;SLC38A6;SLC7A8;SLC25A14;SLC13A3
gsea,protein homotetramerization (GO:0051289),-0.2657955683253206,-0.8759121062991974,0.6457142857142857,0.7187714109231647,1.0,23/23,97.58%,ALDOA;ALDH9A1;HSD17B10;SOD2;ALDH1A3;SHMT1;THG1L;OSBPL2;CBR4;CRYZ;RYR1;APPL2;CBY1;ACACA;SHMT2;GOLGA2;TRPA1;APIP;CTH;GLS;GBP5;SAMHD1;TK1
gsea,positive regulation of stress fiber assembly (GO:0051496),0.27216683697885274,0.8750715735076443,0.6432748538011696,0.697664369320653,1.0,22/22,99.57%,RGCC;EVL;NRP1;ROCK2;ABL1;CCDC88A;PAK1;LIMCH1;FHOD1;NF2;ARHGEF10L;PPM1F;PFN2;TGFB3;SORBS3;ARHGEF5;RHOC;LIMK1;WNT11;TPM1;GPR65;S100A10
gsea,regulation of receptor-mediated endocytosis (GO:0048259),-0.29590372236947565,-0.8747589102983467,0.6535087719298246,0.719480570794277,1.0,15/15,91.13%,HNRNPK;FLOT1;BICD1;BMP2K;C3;PIK3CB;TNK2;PICALM;HFE;SGIP1;CBL;HIP1R;HIP1;AAK1;SERPINE1
gsea,negative regulation of B cell activation (GO:0050869),-0.30337581133739505,-0.8722513880183254,0.6090909090909091,0.7226817982505974,1.0,15/15,97.47%,ID2;TNFRSF21;LYN;ATM;IL10;BANK1;INHBA;CTLA4;FCGR2B;INHA;TYROBP;CD300A;TNFRSF13B;PARP3;TNFAIP3
gsea,regulation of translational initiation (GO:0006446),0.24402031591927786,0.8718330972932374,0.6565656565656566,0.7024816261345292,1.0,16/34,46.86%,GLE1;ATF3;ATF4;EIF4G3;FMR1;EIF4G2;DDX3X;EIF5;AGO2;PAIP2B;NCBP1;KLHL25;CDC123;NCK2;DDX1;CEBPB
gsea,carboxylic acid transport (GO:0046942),-0.25670835462112074,-0.8711499384466633,0.6484210526315789,0.7233411324196847,1.0,13/26,46.46%,SLC7A6;SLC1A5;SLC6A13;SLC16A11;SLC16A13;SLC15A4;SLC6A12;CLN3;SLC1A4;SLC36A4;SLC38A1;SLC7A5;SLC6A11
gsea,endomembrane system organization (GO:0010256),-0.19473326616742298,-0.8700530768951699,0.7082494969818913,0.7239689282561405,1.0,97/97,98.20%,TMED2;GORASP2;SYNGR2;FAM174B;SERP1;SNX10;LMAN1;ARL1;TLCD2;SYNGR1;VPS33B;NSFL1C;ATP8B4;SEC61A1;LMAN2;CAV2;TLCD1;STX17;SEC31A;SMPD4;REEP6;BNIP1;TICAM2;LAPTM4B;ATP8B2;FBXW8;EIF2AK3;OSBPL2;PLEKHF1;DOP1B;LRRK2;ALS2;LYSMD3;ARHGAP21;DNAJC13;UBXN2B;DNM1;MYO18A;ALS2CL;COG7;EXOC8;TMED1;DNAJC28;SEC23IP;WASHC5;ARFGEF2;TRAPPC12;VPS18;NPLOC4;RAB30;CTDNEP1;CUL7;HOOK2;WASHC4;SYP;USP6NL;TRAPPC11;PI4K2B;BAG5;LEMD3;LMAN2L;VPS11;SEC16A;COG3;GOLGB1;SPAG4;PLEKHM2;AP3D1;BCAS3;HTT;LMAN1L;MIA3;OPTN;AKTIP;GAK;HOOK1;SYNE1;HACE1;GOLGA2;DYM;DYNC2H1;ARFGEF1;GBF1;USP8;ATL3;HOOK3;SPTBN1;LNPK;NUP93;HUWE1;ATL2;CLASP1;CLASP2;NUP155;SUN2;ZW10;REEP4
gsea,inflammatory response (GO:0006954),-0.22166341458885463,-0.8698878853109228,0.6721698113207547,0.7228789158810627,1.0,95/95,97.67%,ADAM8;CCR5;CCL4;CCRL2;CCL3;ANXA1;TNFRSF4;TNFSF4;CCR2;KLRG1;CCL5;F2R;TPST1;SLC11A1;CD14;IL2RA;CCR1;MAPKAPK2;TNFRSF1A;NRROS;ABCF1;RIPK2;TBXA2R;PTGER2;LTB4R2;FUT7;TLR4;CHUK;CIITA;IKBKG;IFNG;GPR68;NOS2;ADM;HNRNPA0;TLR2;CCR3;CCL7;CCL2;CCL25;NLRP3;SIGLEC1;PLA2G4B;CEBPB;AIF1;HDAC4;LY75;CXCL13;CCL8;C3AR1;CCL17;PJA2;IL1RN;CXCL2;LIAS;CXCL9;FCGR2B;C5AR1;RELA;BLNK;NFX1;CCL22;MEFV;PTGER4;OLR1;PF4;MFHAS1;THBS1;KIT;CSF1R;PIK3CG;CD40;NFAM1;ADGRE5;CX3CL1;HDAC9;CYBB;HDAC5;STAT3;TNF;CD40LG;IL1B;ADORA2A;CCL1;RELB;PIK3CD;CXCR4;CXCL10;CD44;NFKB1;HMGB1;FOS;REL;CCR7;XCL1
gsea,positive regulation of endocytosis (GO:0045807),-0.2614116928096591,-0.8687358056028035,0.6559633027522935,0.7236089192672357,1.0,22/22,91.13%,HNRNPK;FLOT1;BICD1;SMPD1;CLN3;CLIP3;AXL;DLL1;C3;APPL2;CD151;F2RL1;APOE;HFE;LRP1;SGIP1;CBL;DAB2;ANKFY1;ANO6;HIP1;SERPINE1
gsea,regulation of epithelial cell migration (GO:0010632),0.26673530060098954,0.8670042541783658,0.6344463971880492,0.71009619300632,1.0,28/28,99.94%,HIF1A;EVL;CORO1C;MACF1;CLASP2;CLASP1;HDAC6;PLCG1;CTSH;GLUL;DOCK1;DUSP10;TGFB2;VIL1;PTPN23;RAB25;ENPP2;IFNG;PPM1F;PFN2;DOCK5;DAB2IP;CEACAM1;PRKCE;PLCG2;GLIPR2;ARSB;PFN1
gsea,glycolipid biosynthetic process (GO:0009247),0.2787182227235932,0.8649677237782134,0.6686507936507936,0.7127686149172161,1.0,10/18,37.15%,ST8SIA1;ST3GAL4;PIGA;PIGF;PIGN;PIGV;PGAP3;B3GNT5;ST3GAL5;PGAP2
gsea,"DNA-templated transcription, elongation (GO:0006354)",-0.23857491015335386,-0.8635301266934586,0.6819047619047619,0.7315211499441402,1.0,22/41,45.12%,NCBP2;ELOC;POLR2F;POLR2L;CDK7;ADRM1;POLR2H;POLR1E;GTF2H2;EAF1;GTF2F2;ELP2;GTF2H4;GTF2H1;ELL;ERCC3;POLR2C;POLR2E;ERCC2;GTF2H3;CTR9;PCID2
gsea,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.29819698806802597,-0.8625555612476594,0.6417910447761194,0.7319650853872832,1.0,15/15,91.46%,HNRNPU;WDR43;EAF1;LARP7;ELL;LEO1;CDC73;CDK12;TCERG1;RNF8;RECQL5;NELFCD;HEXIM1;RNF168;NELFE
gsea,response to reactive oxygen species (GO:0000302),-0.2608710792005689,-0.8602437787328957,0.6613226452905812,0.7347000002950744,1.0,10/24,40.09%,GPX1;AKT1;TPM1;PRDX3;PLK3;HMOX1;SOD2;CAMKK2;CHUK;TXNRD2
gsea,regulation of Notch signaling pathway (GO:0008593),0.23758976649981067,0.8596543396735918,0.6576576576576577,0.7211206271596586,1.0,19/38,46.71%,CREBBP;MAML2;NOTCH1;EP300;AAK1;KAT2B;STAT3;FBXW7;POFUT1;IL6ST;DTX1;CHAC1;YAP1;ZMIZ1;METTL3;MAML3;TSPAN15;TGFB2;LLGL1
gsea,negative regulation of T cell proliferation (GO:0042130),0.28386558221185826,0.859528359647944,0.6698473282442748,0.7205096116394208,1.0,10/18,47.19%,CRTAM;SCRIB;PRNP;SPN;CD86;CD274;DLG5;SDC4;CEBPB;FOXP3
gsea,receptor internalization (GO:0031623),-0.25963616734261524,-0.8563121554854489,0.6651982378854625,0.7403397971381671,1.0,24/24,97.61%,FCER1G;NEDD4;TFRC;CD9;GTF2H2;DNM3;CEACAM1;RAMP2;CALCRL;ARRB1;DNM1;ADM;RAMP1;CD36;SAG;PICALM;SCYL2;SYK;CLTC;LRP1;RAMP3;GRK2;CD81;ITGB1
gsea,central nervous system development (GO:0007417),0.20294956005611706,0.8536440937919113,0.7591973244147158,0.7298909286408944,1.0,48/93,45.15%,CDK5RAP2;MARCKSL1;ATXN1;BPTF;CIC;CXCR4;JARID2;MBP;SMG9;DCLK1;PTPN11;PBX2;ADORA2A;AHI1;RAB3GAP1;EGR2;PHF8;STAT3;CX3CR1;RPS6KA6;NF1;PTCH1;ROGDI;SOX8;SYNJ1;MARCKS;ANKLE2;SETD1A;SYNJ2;SOX4;ATN1;GBA2;SCYL2;B3GNT5;LSR;WWP1;SOX10;RPS6KA3;BTD;TUBGCP2;CHD8;NR4A2;CDK5RAP1;PBX4;TBC1D23;PLXNB2;EML1;SCIN
gsea,regulation of axonogenesis (GO:0050770),-0.2930096792587925,-0.8535777278672525,0.6561844863731656,0.7437622654145487,1.0,15/15,90.57%,PLXND1;ARHGDIA;KIF13B;MAP6;METRN;PLXNA1;ARHGAP35;RUFY3;PLXNB2;EFNB3;PAK1;SIPA1L1;PLXNC1;GSK3B;TIAM1
gsea,mRNA splice site selection (GO:0006376),-0.28997714412382236,-0.8469153865381174,0.6489151873767258,0.7542005737974912,1.0,17/17,90.01%,SRSF6;LUC7L3;LUC7L;SRSF9;CELF4;PRPF39;CELF5;SRSF10;SRSF1;SF3A2;CELF2;SFSWAP;SF3A1;SF3A3;PSIP1;SETX;CELF1
gsea,regulation of tumor necrosis factor production (GO:0032680),0.21368979286218526,0.8460704564544932,0.7160068846815835,0.7419122386645686,1.0,33/65,43.17%,TNFAIP3;HMGB1;FOXP1;JAK2;CD33;FRMD8;ZC3H12A;PTPN11;NLRC3;SPN;STAT3;RASGRP1;CX3CR1;PTPN6;CX3CL1;PTPRJ;LPL;ARHGEF2;OAS3;THBS1;SIRPA;PF4;GAS6;TYROBP;SYK;FADD;SPHK2;IL23A;ZFP36;CACTIN;SYT11;RARA;APP
gsea,negative regulation of tumor necrosis factor production (GO:0032720),0.27780463872024974,0.845903013584773,0.696078431372549,0.7413239175101465,1.0,11/23,41.82%,TNFAIP3;CD33;ZC3H12A;NLRC3;PTPN6;CX3CL1;SIRPA;GAS6;CACTIN;SYT11;RARA
gsea,positive regulation of interleukin-1 beta production (GO:0032731),0.27958753200551767,0.8450688066115732,0.6627218934911243,0.7419184669389907,1.0,11/19,44.05%,JAK2;GBP5;MALT1;TNF;STAT3;EGR1;LPL;TYROBP;F2RL1;APP;CD36
gsea,regulation of secretion by cell (GO:1903530),-0.2637162621563114,-0.8428177006992477,0.7017937219730942,0.7599330914272906,1.0,8/20,35.71%,ANXA1;VAMP8;RHBDF2;DISP1;RALA;RAB3D;P3H1;HAP1
gsea,myeloid cell differentiation (GO:0030099),-0.24482183749620717,-0.8419657594647396,0.7037815126050421,0.7600436706845911,1.0,26/26,93.27%,SLC25A5;HSPA9;CASP3;LYN;PRDX3;KAT8;UFL1;ZBTB16;CDKN2B;DYRK3;INHBA;NCOA6;FLVCR1;INHA;HIPK2;MFHAS1;KIT;IKZF1;SPI1;SNRK;TET2;KAT6A;CSF2;RUNX1;ZFPM1;JAK2
gsea,cellular protein localization (GO:0034613),0.182590036084445,0.8370580734938692,0.7960644007155635,0.7544577463506249,1.0,63/131,47.74%,ADPRH;TBC1D4;ARL5C;PACSIN1;AP3B1;ARL4D;TBC1D10B;TBCK;CNTLN;HERC2;ARL4C;HDAC6;AXIN2;NAPB;AHI1;HGS;BICD2;ZDHHC15;DNAJC27;RTP4;ARL5B;REEP1;TBC1D5;PTPRK;VCL;GGA3;RABGAP1;SNX27;NSF;GRTP1;ARHGEF2;STXBP3;RAB5B;TBC1D1;AP4M1;CLTC;SNX13;CD74;ARMCX3;TBC1D14;TBC1D9;BBS4;TBC1D25;SCG5;FBLN5;TBC1D30;AP3D1;VPS35;EVI5L;COG3;STX16;EIF2D;CPE;CTTN;ITSN1;PIGU;USP6NL;SCFD2;RAB23;STX19;ID1;RPGR;TBC1D13
gsea,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2762057750151556,0.8362099960757188,0.702,0.7549113151519434,1.0,7/18,32.24%,RGCC;MTBP;CDC6;DDX3X;LSM11;RPTOR;UBE2E2
gsea,regulation of axon extension (GO:0030516),-0.2602592757233134,-0.8341820489004426,0.6978723404255319,0.7719890952019888,1.0,11/20,45.54%,MT3;CDKL3;TRIM46;LIMK1;GOLGA4;OLFM1;L1CAM;PTPRS;SEMA7A;SHTN1;NRCAM
gsea,cellular response to nutrient levels (GO:0031669),0.2312041579304218,0.8336523703920995,0.7076612903225806,0.7584045369313981,1.0,16/30,43.53%,CD68;WRN;FNIP1;PDK2;FOXO1;TSC1;SIRT1;LPL;USP33;EHMT2;ATG7;RPTOR;PRKAA1;MTOR;ULK1;HSPA8
gsea,positive regulation of cytokine production involved in immune response (GO:0002720),0.28995103365205593,0.833595490367543,0.7080745341614907,0.7576130682127106,1.0,8/15,34.22%,XCL1;MALT1;TRAF2;CD226;MAP3K7;KIT;SPHK2;F2RL1
gsea,positive regulation of interferon-beta production (GO:0032728),0.25217685016451313,0.8334970194069644,0.6878727634194831,0.7569217679218937,1.0,8/24,36.71%,IRF1;PTPN11;DDX3X;IRF7;TLR7;OAS3;ISG15;HSP90AA1
gsea,B cell receptor signaling pathway (GO:0050853),-0.26427937667646495,-0.833022350382581,0.7183406113537117,0.7726116694982339,1.0,22/22,92.74%,LAT2;BAX;PLCG2;PLEKHA1;CD38;BCAR1;CD79A;TEC;CTLA4;MEF2C;VAV3;CD79B;SH2B2;BTK;BLNK;SYK;NFAM1;PRKCB;NFATC2;RFTN1;PIK3CD;BCL2
gsea,acylglycerol metabolic process (GO:0006639),0.29374490199132186,0.8322556192308457,0.6992337164750958,0.7580714261040339,1.0,9/15,37.41%,DGKA;DGAT1;LPL;DGKD;DGKI;ABHD6;APOE;DGKH;GK
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.2506405346551308,-0.8317790008477207,0.6937901498929336,0.7732289873876953,1.0,21/21,96.36%,PHB;EZR;DUSP3;LYN;DAB2IP;SPRED2;TLR4;CAMK2N1;CNKSR3;FBLN1;SPRED3;DUSP10;SPRED1;SIRPA;PIN1;RPS6KA6;TNIP1;DUSP6;SPRY2;SPRY1;DUSP4
gsea,cellular macromolecule catabolic process (GO:0044265),0.2502246220813187,0.8315102798663344,0.6895833333333333,0.7584563873962701,1.0,12/26,47.67%,RNF5;CHEK2;HTRA2;MTREX;RNASEH2A;DNASE1L3;RNASE6;SND1;IDE;NCBP1;SUPV3L1;STT3B
gsea,endosome organization (GO:0007032),0.25541106925501866,0.8300499903937006,0.7115749525616698,0.7601157854457906,1.0,10/24,45.34%,CORO1C;EEA1;HOOK3;USP8;HOOK1;AKTIP;VPS11;PI4K2B;WASHC4;HOOK2
gsea,regulation of mitochondrion organization (GO:0010821),0.2531437110754793,0.8295247106278623,0.7,0.7600697607096428,1.0,11/24,36.02%,GSK3B;HTRA2;HDAC6;STAT2;EP300;PINK1;FBXW7;RHOT2;PID1;VPS35;CSNK2A2
gsea,glycosaminoglycan metabolic process (GO:0030203),-0.26390648506791076,-0.8255626416702906,0.7309236947791165,0.782333516686247,1.0,7/19,37.01%,GUSB;GNS;HS6ST1;SLC35D2;HPSE;SDC1;B3GALT6
gsea,cartilage development (GO:0051216),0.28094052339412684,0.8230336871187769,0.7100371747211895,0.7698949248696543,1.0,7/16,46.35%,CD44;RUNX1;ITGB8;FGF2;CREB3L2;SULF2;HYAL2
gsea,mRNA 3'-end processing (GO:0031124),0.2278820858909849,0.8213126364393958,0.6795698924731183,0.7719207675877308,1.0,30/51,43.66%,UPF3B;ALYREF;SLBP;THOC2;SRSF4;SRSF3;CASC3;CPSF1;CSTF1;LSM11;RPRD1B;RNPS1;SRRM1;PCF11;CSTF3;SYMPK;U2AF1;DDX39B;CPSF6;SRSF1;TENT4B;EIF4A3;CPSF4;NCBP1;RBM8A;DHX38;THOC3;CDC73;APP;AHCYL1
gsea,positive regulation of lipid biosynthetic process (GO:0046889),-0.2819373495624804,-0.8202588804599911,0.6962809917355371,0.7897226945472684,1.0,7/15,33.27%,AKT1;MFSD2A;LPGAT1;SLC27A1;LDLR;SCARB1;SIRT4
gsea,heart development (GO:0007507),0.21311275785404094,0.8198180903638878,0.8086206896551724,0.7735263782912687,1.0,25/57,47.30%,NTRK3;PDLIM1;ZFPM1;KDM6B;SMG9;PTPN11;NOTCH1;HEG1;KAT2B;TGFBR3;ACVRL1;HDAC9;NF1;CDKN1A;POPDC2;SOX4;SMYD4;MKKS;BCOR;FLRT3;FN1;TSC2;PDLIM4;TGFB2;NCOA6
gsea,cellular response to peptide (GO:1901653),-0.24900064761113827,-0.8167314045970284,0.7274826789838337,0.794178351619434,1.0,28/28,97.42%,VIM;XBP1;ABCC1;ITGA4;TIMELESS;ICAM1;RIPK2;TLR4;CACNA1A;ADRB2;IGF1;ATP1A3;CACNA2D1;GRIN1;CASP4;CD36;APP;TRIM41;FCGR2B;VCAM1;LGMN;MDM2;LRP1;ARHGEF2;PRNP;DDX11;GSK3B;ZFP36L1
gsea,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.274202304494137,-0.8164847146675944,0.6929133858267716,0.7931338368291657,1.0,7/16,29.06%,BID;BAX;BLOC1S2;TNFRSF1A;BAG3;DAB2IP;DDX47
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),0.2658343587491153,0.8158682144596915,0.7279279279279279,0.7790458235116829,1.0,14/23,47.47%,JAK2;DYRK1A;FLT1;ABL1;PTPN6;HCK;CSF1R;KIT;SYK;BTK;FGR;FLT3;EPHA3;FES
gsea,cellular response to retinoic acid (GO:0071300),0.28638368155630733,0.8153747160944435,0.7159468438538206,0.7789570713094236,1.0,9/17,46.96%,CREB1;HTRA2;SETX;WNT3;WNT6;RORB;RET;FZD7;EPHA3
gsea,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.26634312322369047,-0.8140959053205756,0.7061503416856492,0.795655663851114,1.0,17/17,87.59%,BID;PPP2R1B;TNFSF12;RIPK1;TNFSF10;LTBR;INHBA;HYAL2;PMAIP1;RET;WWOX;FADD;THBS1;PML;TNF;TRAF2;HTRA2
gsea,sodium ion transport (GO:0006814),0.2817616971651307,0.813162245968768,0.7658802177858439,0.781634476369297,1.0,11/18,39.86%,FGF13;SLC9B2;ANO6;ATP1B1;SGK1;SLC6A9;SLC4A8;SLC12A2;SLC6A6;SLC8A1;SLC4A4
gsea,secondary alcohol metabolic process (GO:1902652),-0.2677769078981198,-0.8119247128791712,0.7319819819819819,0.7978151528685629,1.0,18/18,86.26%,FDX1;SQLE;IDH3A;IDH1;NSDHL;OSBPL5;SCAP;CH25H;TSKU;APOE;GBA2;SOAT1;ABCA1;IDH2;RXRA;SULT2B1;CLN6;ABCG1
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2197333948613571,-0.8057973598744249,0.794392523364486,0.8061221449373704,1.0,18/37,43.54%,ADGRG1;ADRB1;GPR65;ADGRG3;TBXA2R;PTGER2;ADGRL2;CALCA;RAMP2;CALCRL;S1PR2;ADGRG5;PTH1R;ADRB2;ADCY6;TSHR;MC1R;ADM
gsea,vascular transport (GO:0010232),0.2233907937470047,0.8050214202894144,0.7937384898710865,0.7935638651886288,1.0,20/40,47.89%,SLC29A1;SLC38A2;SLC1A2;ATP2A3;SLC7A1;ATP2B4;ABCC5;SLC6A9;LRP1;SLC15A2;SLC44A1;SLC4A8;SLC7A8;ABCA2;SLC12A2;SLC6A6;SLC4A4;SLC13A3;SLC16A1;KCNJ8
gsea,positive regulation of neuron apoptotic process (GO:0043525),-0.2799259074539199,-0.8035081560095461,0.7221095334685599,0.8085349074205328,1.0,15/15,91.88%,CCL3;BAX;CTNNB1;ITGAM;GRN;TGFB2;NUPR1;FOXO3;TYROBP;NF1;FBXW7;TNF;PRNP;DDIT3;ATF4
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.22199217122221618,-0.8013998555050401,0.7715930902111324,0.8104583030800034,1.0,40/40,94.88%,NCBP2;ELOC;POLR2F;POLR2L;CDK7;ADRM1;POLR2H;GTF2H2;EAF1;GTF2F2;ELP2;GTF2H4;GTF2H1;ELL;ERCC3;POLR2C;POLR2E;ERCC2;GTF2H3;CTR9;PCID2;GTF2F1;LEO1;CDC73;ELOA;CDK12;NCBP1;MLLT1;CCNK;NELFCD;CTDP1;POLR2B;ELP4;SETD2;SSRP1;ELOF1;NELFE;MLLT3;IWS1;POLR2A
gsea,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.257341439294285,0.8009315095766851,0.7524916943521595,0.7991296239763374,1.0,12/25,41.82%,TNFAIP3;CD33;ZC3H12A;NLRC3;PTPN6;CD274;CX3CL1;SIRPA;GAS6;CACTIN;SYT11;RARA
gsea,RNA 3'-end processing (GO:0031123),0.22867144128142766,0.800191321447896,0.7213822894168467,0.7994271657490483,1.0,25/45,42.22%,UPF3B;ALYREF;THOC2;SRSF4;SRSF3;CASC3;CPSF1;TENT4A;CSTF1;RPRD1B;RNPS1;SRRM1;PCF11;CSTF3;SYMPK;U2AF1;DDX39B;SRSF1;TENT4B;EIF4A3;CPSF4;NCBP1;RBM8A;DHX38;THOC3
gsea,mRNA metabolic process (GO:0016071),-0.2271985196413609,-0.7960194753487724,0.7221135029354208,0.8175226620029892,1.0,59/59,96.49%,HNRNPA2B1;SNRPF;NCBP2;SNRPD3;PTBP1;SSB;SRSF2;NUDT16;TBRG4;SNRPB;SFPQ;PNPT1;CPSF3;ERN1;DHX15;SRSF7;SNRPE;METTL16;U2AF2;RIDA;SRSF9;HIPK3;SF3B4;HNRNPA0;METTL3;ZFP36;DIS3L2;NCBP1;ALKBH5;SRSF1;CPSF6;HSPA1A;TCERG1;SF3A2;HSF1;PRPF3;U2AF1;CSTF3;SF3A1;PCF11;GEMIN2;SF3A3;HNRNPR;HSPA1B;LSM11;NONO;PRPF8;USP39;ZC3H12D;CNOT10;SRSF4;SCAF11;CELF1;DXO;SLBP;SF3B2;ZFP36L2;LSM2;LSM3
gsea,chloride transport (GO:0006821),0.2635476913637236,0.7952307904533431,0.7589743589743589,0.8061216000567122,1.0,13/22,41.48%,SLC12A7;TTYH3;ANO6;ANO10;SLC12A6;FXYD1;SLC4A8;TTYH1;FXYD3;SLC12A2;ANO8;SLC12A5;GLRA1
gsea,endocytic recycling (GO:0032456),0.2655406735461276,0.7928709864676052,0.748046875,0.8088257515043733,1.0,8/17,36.52%,EHD3;ARL4C;RAB11FIP4;SNX27;ANKRD50;EPS15;VPS35;LMTK2
gsea,negative regulation of macroautophagy (GO:0016242),-0.2763075889512391,-0.792272795720418,0.7708333333333334,0.8218533053270112,1.0,8/15,42.58%,AKT1;USP36;UBQLN4;LZTS1;SMCR8;LRRK2;FEZ1;TMEM39A
gsea,macrophage activation (GO:0042116),0.2799866848855755,0.7918482196435813,0.7289377289377289,0.8095226143649333,1.0,11/18,48.54%,FOXP1;JAK2;TNF;CX3CL1;SBNO2;SYK;C5AR1;IL13;APP;AIF1;C1QA
gsea,glycosaminoglycan biosynthetic process (GO:0006024),-0.21869164850877107,-0.7894430104085975,0.8033826638477801,0.8246609535656417,1.0,17/34,39.23%,CHPF;CHSY1;DSEL;B4GALT5;ST3GAL6;B4GALT4;B3GNT3;HS6ST1;SLC35D2;VCAN;CHPF2;SDC1;ST3GAL3;CHSY3;CHST2;B3GALT6;CHST11
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24892412957900178,-0.7878532601459335,0.7433264887063655,0.8256063457867965,1.0,19/19,95.30%,RPL5;RAD23B;GLMN;UBQLN4;UFL1;DESI1;NUB1;LATS1;PTK2B;RAD23A;TRIM39;CSNK2A2;HIPK2;HFE;AXIN1;PML;FBXW7;XPO1;TAF1
gsea,negative regulation of protein kinase B signaling (GO:0051898),-0.25434640985921214,-0.7856688278339967,0.7620967741935484,0.8274939937700037,1.0,18/18,89.59%,AKT1;RACK1;PLEKHA1;DAG1;PHLPP2;BANK1;PHLDA3;HYAL2;PIK3CB;TSC2;PHLPP1;THEM4;TRIB3;PTPRJ;SIRT1;XDH;DDIT3;SH2B3
gsea,negative regulation of defense response (GO:0031348),0.22223557521084425,0.7816806329702382,0.8104026845637584,0.8238824211713226,1.0,22/38,50.40%,TNFAIP3;KLF4;RORA;NLRC3;GATA3;TRAFD1;RB1;SIRPA;MFHAS1;TNFAIP8L2;PTGER4;MEFV;APOE;VPS35;IL13;TRAF3IP1;CACTIN;ACOD1;NR1H3;NLRP3;MAPK7;FFAR4
gsea,potassium ion transport (GO:0006813),-0.24006025854020013,-0.7813629192030165,0.8076923076923077,0.8325703729250994,1.0,23/23,90.74%,KCNAB2;ABCB8;KCNK7;KCNQ5;KCNN4;SLC9A8;KCNAB1;KCNG2;ATP1A2;KCNJ10;KCNJ8;KCNK5;SLC9A1;KCNQ3;SLC9A2;KCNK13;KCNJ14;KCNK10;KCNMB1;KCNC1;CCDC51;KCNMB4;SLC9A9
gsea,regulation of cellular catabolic process (GO:0031329),0.21596740520355295,0.7756901292174433,0.8125,0.831777771682841,1.0,15/34,35.21%,ROCK1;HDAC6;MTMR3;EP300;DDIT3;ABL1;PIK3R2;USP33;DEPDC5;TRIB3;RPTOR;MTMR4;NUPR1;ITPR1;DAPK1
gsea,glycolipid metabolic process (GO:0006664),-0.2385948972196657,-0.7751557306576119,0.7854251012145749,0.8403684706911122,1.0,22/22,91.15%,ST6GALNAC4;SMPD1;SCCPDH;NEU1;ST6GALNAC6;ST3GAL6;PGAP1;SUMF2;SMPD4;HEXA;CPTP;GALC;ABCA2;B3GNT5;PGAP3;GBA2;GM2A;GLA;CERK;NAGA;ST3GAL4;ST6GALNAC3
gsea,negative regulation of response to external stimulus (GO:0032102),0.2079124270745437,0.772791274495695,0.8258620689655173,0.8350931477914549,1.0,27/47,49.01%,TNFAIP3;KLF4;SERPINE1;RORA;NLRC3;GATA3;TRAFD1;RB1;KLK8;TRIB1;SIRPA;MFHAS1;TNFAIP8L2;PTGER4;MEFV;APOE;VPS35;SIGIRR;INPP5F;FGF2;IL13;TRAF3IP1;CACTIN;ACOD1;NR1H3;NLRP3;MAPK7
gsea,diterpenoid metabolic process (GO:0016101),0.2595572079995042,0.7658153705320887,0.7728119180633147,0.8439191492623683,1.0,8/17,32.36%,ADH4;RDH12;DHRS3;LPL;RDH11;LRP1;SDC3;APOE
gsea,amide biosynthetic process (GO:0043604),-0.2550099023414369,-0.7626505602695363,0.8306264501160093,0.8566160265590598,1.0,9/15,42.92%,SMPD1;NANP;ASS1;SMPD4;AGK;ARG1;FA2H;SLC25A15;SLC25A2
gsea,regulation of protein tyrosine kinase activity (GO:0061097),-0.26262506544254005,-0.7574663096325637,0.7809110629067245,0.8622203747689409,1.0,15/15,92.41%,NEDD9;MVP;PDGFB;LRP8;RAP2B;HYAL2;APP;NCK2;CASS4;RAP2C;GAS6;CSF1R;PRNP;SHC1;SH3BP5
gsea,response to organonitrogen compound (GO:0010243),-0.2510638559564695,-0.7563107760559787,0.8433476394849786,0.8623848818754903,1.0,7/17,36.10%,VCP;SYVN1;IRF5;CCDC47;HLCS;IRAK3;RCN3
gsea,myelination (GO:0042552),-0.24865873008552405,-0.7556910969404463,0.7726269315673289,0.8617429180685798,1.0,11/18,37.46%,TNFRSF21;EIF2B5;B4GALT5;MARVELD1;MALL;FAM126A;PMP22;EIF2B4;ACER3;ABCD1;CMTM8
gsea,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2353895121513203,-0.7530819413764623,0.8465909090909091,0.8637656143573773,1.0,24/24,83.57%,GPR65;F2RL3;F2R;F2RL2;CALCA;GPR55;TRHR;PTH1R;ACTN2;GNA15;ADRA2A;GPR35;GNA14;GPR18;C3AR1;HOMER1;C5AR1;F2RL1;P2RY6;HTR2A;CX3CR1;GNA11;TGM2;GPR174
gsea,extracellular structure organization (GO:0043062),0.2023190789741224,0.7526998564516073,0.8947368421052632,0.8608214318370037,1.0,36/69,45.88%,ITGB1;CD44;ITGAX;ITGB7;SERPINE1;ITGA6;ITGA1;COLQ;ADAMTS6;TGFBI;ADAMTS20;NF1;ITGB8;COL27A1;PECAM1;THBS1;ITGA7;ITGA10;VCAM1;SPOCK2;NID1;FBLN5;CDH1;MMP24;MADCAM1;COL4A4;FGF2;ICAM2;SPARC;FN1;COL6A3;SMOC1;APP;ITGA5;ITGB4;FURIN
gsea,external encapsulating structure organization (GO:0045229),0.20258144851223026,0.7509696078644654,0.9006211180124224,0.8621393937314669,1.0,36/68,45.88%,ITGB1;CD44;ITGAX;ITGB7;SERPINE1;ITGA6;ITGA1;COLQ;ADAMTS6;TGFBI;ADAMTS20;NF1;ITGB8;COL27A1;PECAM1;THBS1;ITGA7;ITGA10;VCAM1;SPOCK2;NID1;FBLN5;CDH1;MMP24;MADCAM1;COL4A4;FGF2;ICAM2;SPARC;FN1;COL6A3;SMOC1;APP;ITGA5;ITGB4;FURIN
gsea,inorganic cation import across plasma membrane (GO:0098659),-0.2283004177456858,-0.7451140478957179,0.8687089715536105,0.8726281513560962,1.0,25/25,90.74%,SLC39A6;TRPV2;SLC39A14;SLC39A10;SLC39A4;SLC12A3;FXYD2;ATP1A2;KCNJ10;SLC12A4;ATP1A3;CACNA2D1;KCNJ8;ATP1A1;SLC9A1;SLC8A1;SLC12A5;SLC12A2;SLC9A2;KCNJ14;SLC12A6;ATP1B1;SLC12A7;ATP2B4;SLC9A9
gsea,skeletal system development (GO:0001501),-0.19396349626310133,-0.7441415663599126,0.8970976253298153,0.8723430804647657,1.0,19/40,42.02%,PRDX1;FRZB;TRPS1;WNT11;ETS2;ZBTB16;P3H1;PLS3;VCAN;BMP7;HAPLN4;GDF11;RPL13;EIF2AK3;CHD7;WNT1;MMP14;PTH1R;SH3PXD2B
gsea,regulation of chemotaxis (GO:0050920),0.26923576505605196,0.743518821069848,0.8232235701906413,0.8708591927678,1.0,9/15,38.58%,CXCR4;P2RX4;GPR183;ZSWIM8;THBS1;F2RL1;USP14;ZSWIM4;ZSWIM6
gsea,regulation of ossification (GO:0030278),0.25722592002542927,0.7363229551467497,0.8161764705882353,0.878744097697772,1.0,15/15,90.26%,S1PR1;PTPN11;NOTCH1;ECM1;TGFB2;TWIST1;MEF2C;ACVR1;TXLNG;KREMEN2;ZBTB16;BMP2K;ENPP1;LRP6;CHSY1
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.19945475743210006,-0.7363043416432226,0.8944723618090452,0.8805885040653969,1.0,22/42,43.54%,ADRB1;SELENOS;LYN;ADORA2B;PLCG2;CYSLTR2;RHBDF2;PRKAR2A;PTGER2;IL10;CALCA;RAMP2;SCT;CALCRL;RLN3;PTH1R;ADRB2;ADAM17;ADCY6;TSHR;MC1R;ADM
gsea,plasma membrane organization (GO:0007009),-0.21166366226523134,-0.7360684101517365,0.873015873015873,0.8793216213952931,1.0,13/28,40.88%,SERP1;SNX9;TLCD2;SMPD1;TLCD1;PACSIN2;PLSCR3;CLN3;EHD2;PACSIN3;OSBPL2;ABCD1;FA2H
gsea,calcium ion transport (GO:0006816),0.20819635320514468,0.730249722426349,0.8937282229965157,0.8850715916186535,1.0,25/41,50.92%,TPT1;ORAI1;STIM2;ATP2A3;ATP2B4;P2RX4;TRPM1;MCOLN2;ANO6;RAMP3;ATP2B2;TRPA1;SLC24A5;GAS6;CACNB3;GRIN3A;CRACR2A;ITPR1;SLC8A1;CCL8;CACNA2D4;CACNA2D1;RAMP1;RYR1;SLC3A2
gsea,visual system development (GO:0150063),0.2584498109413628,0.7293354797803631,0.835236541598695,0.8851467118121235,1.0,10/19,50.60%,SMG9;HIPK1;PBX2;ATF6;HIPK2;SMOC1;PBX4;TGFB2;C1QA;ZDHHC16
gsea,cellular amide metabolic process (GO:0043603),0.19237664900639515,0.7204366582763423,0.9020979020979021,0.8945971684570013,1.0,25/51,40.69%,MTHFD2;ATF4;PDZD11;DHFR;ACSL6;ST3GAL1;CERK;PLPP1;CPM;CPD;PCCA;ST6GAL1;MTHFR;CPXM1;THEM4;ACSF2;SHMT2;ACOT1;THOP1;MIPEP;MLYCD;BTD;ABCA2;SGPL1;CPE
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.20715832630187572,0.7158703605818209,0.8878676470588235,0.8988722482788001,1.0,19/33,48.98%,ROCK1;RNF157;RGS16;ROCK2;RGS2;RAMP3;USP33;GNG4;RIC8B;RGS12;TULP3;MGRN1;USP20;PPP1R9B;SAG;SYP;RPGRIP1L;EDN1;FNTB
gsea,regulation of dendrite development (GO:0050773),0.24052509693090515,0.7142690348223526,0.8517110266159695,0.8996120563095349,1.0,9/18,45.40%,PACSIN1;GSK3B;TNIK;ZDHHC15;CAMSAP2;CAMK1D;BCL11A;HECW1;RTN4IP1
gsea,regulation of bone mineralization (GO:0030500),-0.21880153369728494,-0.7116931146855592,0.9159090909090909,0.906350545335219,1.0,12/23,42.10%,CCL3;OSR2;ENPP1;CCR1;BMP2K;TGFB3;TMEM119;ALOX5;BMP7;TXLNG;ACVR1;PTK2B
gsea,O-glycan processing (GO:0016266),0.21399233856027552,0.7093650600887795,0.8615702479338843,0.9040321192202033,1.0,9/22,43.84%,GALNT14;ST3GAL1;ST3GAL4;ST6GAL1;POFUT1;B3GNT5;GALNT7;GALNT10;GCNT1
gsea,organonitrogen compound biosynthetic process (GO:1901566),-0.16744692131628658,-0.7052456024881331,0.9591280653950953,0.9116656249490862,1.0,70/70,94.02%,GSTO1;MFSD2A;HACD3;B4GALT5;GSTM5;PCYT1A;PLPP2;TYW5;NANP;ASS1;SLC27A1;LPCAT1;ALDH3A2;ALAS1;PCTP;ELOVL4;MGST3;LPIN2;LCMT2;ELOVL6;ACHE;ELOVL2;ACER3;STARD10;ARG1;FA2H;SLC25A15;SLC25A2;LPCAT2;INHBA;NMRAL1;LPIN1;STARD7;GSTK1;GSTM1;GPAT4;HACD4;SAMD8;FURIN;GCNT1;CHPT1;HACD2;CERS6;PPM1L;SPHK1;SGPL1;GSTT1;TYW1;CSNK2A2;INHA;SPHK2;APOE;MGST1;SLC44A1;ALDH3B1;GSTZ1;HACD1;PLA2G4A;GSTA4;PRKD3;TNIP1;PLPP1;CHKA;SGMS1;ST3GAL4;GPHN;PRKD2;PCSK1;MGST2;GCH1
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",0.19684544508970933,0.698784917430117,0.904397705544933,0.9141553888226792,1.0,21/35,47.63%,EHD3;TBC1D10B;DENND5A;DCTN1;GBF1;TBC1D5;ANKFY1;RAB7B;CLTC;BAIAP3;TBC1D14;TMEM87A;VPS35;RGP1;STX16;ERC1;HEATR5B;TBC1D23;HEATR5A;RBSN;RNF126
gsea,sterol homeostasis (GO:0055092),-0.21486280081583287,-0.6970074765304526,0.8932038834951457,0.9186441288621694,1.0,23/23,93.33%,CNBP;XBP1;INSIG1;MALL;LDLR;SCARB1;ABCD1;LIMA1;NR1H3;LIPG;NPC1;ABCA2;TSKU;APOE;TMEM97;SOAT1;ABCA1;LPL;HDAC9;SIRT1;ABCG1;RORA;GRAMD1B
gsea,cholesterol homeostasis (GO:0042632),-0.2182727500903046,-0.6956237495434207,0.8968058968058968,0.9183959423949132,1.0,22/22,93.33%,CNBP;XBP1;INSIG1;MALL;LDLR;SCARB1;LIMA1;NR1H3;LIPG;NPC1;ABCA2;TSKU;APOE;TMEM97;SOAT1;ABCA1;LPL;HDAC9;SIRT1;ABCG1;RORA;GRAMD1B
gsea,positive regulation of macroautophagy (GO:0016239),0.20539072716393486,0.6952643876865199,0.8879837067209776,0.9166345911799787,1.0,14/26,45.52%,SESN3;PINK1;RAB3GAP1;VPS13D;SIRT1;MAP3K7;SESN2;SESN1;FYCO1;OPTN;HTT;TSC2;SCOC;C9ORF72
gsea,negative regulation of inflammatory response (GO:0050728),0.18473256577066718,0.6920612152372437,0.9580745341614907,0.9187397540385038,1.0,38/73,50.40%,TNFAIP3;KLF4;CREB1;RORA;NLRC3;GATA3;ADORA2A;PLCG1;GLP1R;CD200;RAMP3;RB1;PLK2;HCK;SIRPA;MFHAS1;CYSLTR1;TNFAIP8L2;PTGER4;SYK;HTR7;MEFV;APOE;VPS35;PRKAR2B;SLAMF8;MYH9;FGR;IL13;ACOD1;CALCB;VIPR2;NR1H3;FURIN;NLRP3;MAPK7;RAMP1;FFAR4
gsea,wound healing (GO:0042060),-0.1944746874611917,-0.6914765180158046,0.9561643835616438,0.9208872280817932,1.0,15/30,46.74%,ITGB3;SMPD1;TPM1;SLC11A1;PDGFA;HMOX1;DSP;SCARB1;HPSE;PRCP;SRF;DST;EVPL;IGF1;SYT7
gsea,bone development (GO:0060348),-0.22638832931955688,-0.6911156652066575,0.8795180722891566,0.9196785309817639,1.0,9/16,42.02%,OSR2;LRP6;LTF;P3H1;PLS3;RPL13;SFRP4;WNT1;SH3PXD2B
gsea,positive regulation of synaptic transmission (GO:0050806),-0.21599302111362972,-0.6905732853848771,0.8790496760259179,0.9186067124954969,1.0,20/20,92.11%,CCR2;FLOT1;ZDHHC2;EIF2AK4;NLGN2;HAP1;PTK2B;ZDHHC12;AKAP5;CLSTN1;CCL2;APP;KCTD13;LGMN;BAIAP3;PRKCZ;PLK2;TNF;FMR1;ARC
gsea,gonad development (GO:0008406),-0.2342811528855241,-0.6879132150650292,0.923943661971831,0.9195639802562916,1.0,16/16,95.68%,BASP1;MSH2;UTF1;NCOA4;WNT2B;INHBA;TGFB2;MKKS;BIK;WNT4;SOX15;KIT;SOX8;AR;GATA3;NUP107
gsea,snRNA 3'-end processing (GO:0034472),0.2275159804535601,0.6859533773980957,0.8707753479125249,0.9235673433044825,1.0,6/17,34.61%,INTS1;INTS6;TOE1;INTS6L;EXOSC4;EXOSC8
gsea,glycerophospholipid metabolic process (GO:0006650),0.18673145065596722,0.6822835298904656,0.937381404174573,0.9259863930578418,1.0,19/36,47.02%,CPNE3;CPNE1;PGP;PLCG1;PLA2G4F;PIGA;PIGF;PLA2G4A;CSF1R;SYNJ1;PIGN;CPNE7;PIGV;ABHD6;DGKH;PLCB2;PLA2G7;PLA1A;PLA2G4B
gsea,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.24251291815751844,0.6780459034223081,0.8973451327433628,0.9286794210897179,1.0,9/15,43.17%,SOCS5;SHC1;FBXW7;ERRFI1;CBL;BTC;NCF1;NCK2;APP
gsea,retinoid metabolic process (GO:0001523),0.21785988007089047,0.6714542403269468,0.8989547038327527,0.9334450547005908,1.0,11/23,44.27%,ADH4;RDH12;DHRS3;LPL;RDH11;LRP1;DHRS9;SDC3;APOE;SCPEP1;SDC4
gsea,protein lipidation (GO:0006497),0.19233709170694369,0.6675960501488273,0.9259259259259259,0.9356580190466296,1.0,13/27,44.01%,ZDHHC15;PIGA;PIGF;ATG10;GLUL;ATG7;PIGN;PIGV;PGAP3;ZDHHC14;PGAP2;ZDHHC13;PIGU
gsea,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2021007194647773,0.6675291520688725,0.9014869888475836,0.9346990492778269,1.0,13/27,50.85%,HIF1A;CXCR4;CPNE1;HSPA1B;GAS6;CD74;HSPA1A;FADD;PARP14;CD300LF;CASP4;EDN1;C1QTNF4
gsea,potassium ion transmembrane transport (GO:0071805),-0.18057870777481927,-0.6349608582855257,0.9720930232558139,0.960547091268109,1.0,31/31,90.74%,KCNAB2;ABCB8;KCNK7;KCNQ5;SLC12A3;FXYD2;KCNN4;SLC9A8;KCNAB1;KCNG2;ATP1A2;KCNJ10;SLC12A4;ATP1A3;KCNJ8;ATP1A1;KCNK5;SLC9A1;KCNQ3;SLC12A5;SLC12A2;SLC9A2;KCNK13;KCNJ14;KCNK10;KCNC1;SLC12A6;ATP1B1;CCDC51;SLC12A7;SLC9A9
gsea,mononuclear cell differentiation (GO:1903131),-0.22136225763557774,-0.6317644643509817,0.9164785553047404,0.9610289427898977,1.0,15/15,88.55%,IRF8;LYN;AXL;VEGFA;PPARG;THOC5;FLT3;MYH9;GAS6;LY6D;BATF3;CSF1R;IKZF1;RELB;CSF2
gsea,chemical synaptic transmission (GO:0007268),0.16124546616040697,0.6278299125801378,0.9872813990461049,0.962105891787397,1.0,41/68,49.68%,EXOC4;PDZD11;SLC1A2;MBP;NAPB;SLC12A7;KCNMB4;DVL1;KIF1B;STXBP3;SLC12A6;HTR2A;NSG1;CACNB3;APBA3;KCNMB1;HTR7;APOE;LIN7A;DRD4;ATXN3;HOMER1;PRKAR2B;RPS6KA3;SPG11;SYN1;LPAR3;SLC12A5;MYCBPAP;ERC1;KCNQ3;GLRA1;PDLIM4;DLG2;HSPA8;GRIN1;UNC13A;MINK1;PDE7B;FCHSD2;NPTX1
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2038231093701885,-0.6236222893737369,0.9406593406593406,0.9644412270998594,1.0,10/21,44.40%,PLCG2;PDGFB;ITGAM;DCXR;RAB27A;GADD45A;CBR1;RIPK1;TLR4;SLC5A3
gsea,amino acid transport (GO:0006865),-0.19825444565373002,-0.6214284267096163,0.9474885844748858,0.9640524840682729,1.0,11/20,45.43%,SLC7A6;SLC1A5;SLC6A12;SLC16A10;SLC1A4;SLC36A4;SLC38A1;SLC7A3;SH3BP4;SLC25A45;SLC7A5
gsea,sodium ion transmembrane transport (GO:0035725),-0.19562585449161907,-0.6125779913745648,0.9678800856531049,0.9672160129018464,1.0,21/21,90.74%,SCN1B;SLC6A13;SLC6A12;SLC12A3;FXYD2;SCN4B;ATP1A2;SLC6A11;ATP1A3;ATP1A1;SLC9A1;SLC4A4;SLC8A1;SLC6A6;SLC12A2;SLC9A2;SLC4A8;SLC6A9;ATP1B1;ANO6;SLC9A9
gsea,phospholipid translocation (GO:0045332),0.20914837699133157,0.6053678053684853,0.9544592030360531,0.9734320689264759,1.0,8/15,36.99%,ATP10A;PLSCR1;ANO6;ATP11C;ABCA1;ATP11A;ABCA7;ABCB4
gsea,aminoglycan biosynthetic process (GO:0006023),-0.20419635080831694,-0.6001674893241546,0.934560327198364,0.9719047688684187,1.0,6/15,37.01%,B3GALT5;B3GNT3;HS6ST1;SLC35D2;SDC1;B3GALT6
gsea,phosphatidic acid metabolic process (GO:0046473),-0.16952815213627132,-0.5760217020901734,0.9859154929577465,0.9806192638298082,1.0,14/24,43.79%,AGPAT2;DGKE;SLC27A1;LPCAT1;AGPAT5;ABHD4;PLA2G6;AGPAT4;PLA2G12A;GPD1L;PLD2;GNPAT;AGPAT1;DGKG
gsea,ncRNA catabolic process (GO:0034661),-0.19302829368310714,-0.5729847128614298,0.9415204678362573,0.9800833847155033,1.0,19/19,90.70%,POP1;NUDT16;EXOSC2;DIS3;EXOSC5;EXOSC7;EXOSC10;EXOSC9;EXOSC3;DIS3L;DIS3L2;EXOSC8;TENT4B;SND1;PARN;EXOSC4;MTREX;XRN1;ZCCHC8
gsea,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.18831948302221535,-0.5476970641797808,0.9649122807017544,0.9846178861688312,1.0,9/17,45.62%,PARP1;DDB1;GTF2H2;GTF2H4;GTF2H1;ERCC3;ERCC2;GTF2H3;ERCC4
gsea,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.18831948302221535,-0.5476970641797808,0.9649122807017544,0.9846178861688312,1.0,9/17,45.62%,PARP1;DDB1;GTF2H2;GTF2H4;GTF2H1;ERCC3;ERCC2;GTF2H3;ERCC4
gsea,phosphatidic acid biosynthetic process (GO:0006654),0.16426991582652767,0.5339396877712607,0.982791586998088,0.9970807377067701,1.0,23/23,92.41%,LCLAT1;DGKA;DDHD1;DGKD;PLA2G4A;GPD1;DGKH;PLA2G4B;GPAT4;ACP6;DGKG;AGPAT1;GNPAT;PLD2;GPD1L;PLA2G12A;AGPAT4;ABHD4;AGPAT5;LPCAT1;SLC27A1;DGKE;AGPAT2
gsea,response to amyloid-beta (GO:1904645),0.1840720979127374,0.5335501779520156,0.9812925170068028,0.9960673294607932,1.0,13/22,48.63%,GSK3B;PRNP;RAMP3;LRP1;LGMN;VCAM1;FCGR2B;APP;CD36;CASP4;GRIN1;CACNA2D1;ATP1A3
gsea,membrane lipid biosynthetic process (GO:0046467),0.16435824600137763,0.5322015712910193,0.9758364312267658,0.9952625361429163,1.0,15/25,46.54%,PRKD2;ST3GAL4;SGMS1;PLPP1;PRKD3;HACD1;ALDH3B1;SPHK2;B3GNT5;SGPL1;SPHK1;PPM1L;CERS6;HACD2;SAMD8
gsea,sphingolipid metabolic process (GO:0006665),0.14070952094429207,0.5234713558827477,0.9944029850746269,0.9959423155695395,1.0,24/42,50.07%,ST6GALNAC3;PRKD2;SGMS1;CERK;PLPP1;GLA;PRKD3;CERKL;HACD1;ALDH3B1;GM2A;GBA2;SPHK2;ABCA2;SGPL1;SPHK1;PPM1L;GALC;CERS6;HACD2;CPTP;SAMD8;PDXDC1;HACD4
gsea,cholesterol transport (GO:0030301),0.1840282304093058,0.5124207539855302,0.9914675767918089,0.9968316510521962,1.0,13/18,47.64%,ABCG1;OSBP;ABCA1;SOAT1;APOE;TSKU;ABCA7;NPC1;LIPG;CD36;MSR1;LIMA1;STARD5
gsea,sphingolipid biosynthetic process (GO:0030148),0.15365696067611484,0.5092221330997888,0.9963636363636363,0.9962522608221861,1.0,15/27,46.54%,ST8SIA1;PRKD2;SGMS1;PLPP1;PRKD3;HACD1;ALDH3B1;SPHK2;ST3GAL5;SGPL1;SPHK1;PPM1L;CERS6;HACD2;SAMD8
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.13878464859568518,0.48312866422562545,0.9983633387888707,0.9985368347208818,1.0,19/41,49.64%,CD81;CREB1;ADORA2A;PLCG1;GLP1R;RAMP3;PLK2;HCK;CYSLTR1;PTGER4;SYK;HTR7;PRKAR2B;MYH9;FGR;CALCB;VIPR2;FURIN;RAMP1
gsea,response to steroid hormone (GO:0048545),0.16329021235050045,0.4773364259680191,0.9982993197278912,0.9980231405986718,1.0,11/17,48.63%,AR;THBS1;TFPI;YAP1;ABCA2;URI1;TGFB2;NR1H3;ATP1A1;SOX30;ATP1A3
gsea,anterograde trans-synaptic signaling (GO:0098916),-0.1161059957869014,-0.4482897657624471,1.0,0.9977714698339185,1.0,49/49,93.13%,NRGN;LRP6;CHRNE;GABRR1;UNC13B;RAPSN;PRKAR2A;GABRB1;NPY;CAMKK2;PMP22;PENK;CACNA1A;GIPC1;PNOC;NLGN2;CAMK1;CACNA1B;HAP1;AKAP5;SLC12A4;NPTX1;PDE7B;MINK1;GRIN1;DLG2;GLRA1;KCNQ3;MYCBPAP;SLC12A5;LPAR3;SYN1;SPG11;RPS6KA3;PRKAR2B;HOMER1;ATXN3;DRD4;HTR7;KCNMB1;APBA3;CACNB3;HTR2A;SLC12A6;KCNMB4;SLC12A7;MBP;SLC1A2;EXOC4
gsea,anterograde axonal transport (GO:0008089),0.14087042471526426,0.44795227748389904,0.9980582524271845,0.9990604064187056,1.0,11/21,43.43%,AP3B1;TRAK1;KIF3B;KIF1B;AP3S1;NEFL;AP3D1;KIF5B;MAP1A;KIF1C;DLG2
gsea,cellular response to amyloid-beta (GO:1904646),0.1552669267613015,0.43831963522619083,0.9948364888123924,0.9984251407578152,1.0,12/19,48.63%,GSK3B;PRNP;LRP1;LGMN;VCAM1;FCGR2B;APP;CD36;CASP4;GRIN1;CACNA2D1;ATP1A3
